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Nonhuman primate experimentation provokes passionate and opposing exchanges, 
particularly in the UK. This disagreement contributes to an impasse which in turn has 
prevented the exploration of the important question, if and how primate research could 
be ended This project aims to support the examination of this question of impasse 
presenting data on how it might be overcome by providing a novel and challenging 
perspective using a multimethod approach, and insights from science and technology 
studies, to better understand the animal research controversy. 
 
The project primarily draws on data from facetoface semistructured interviews with 
primate users and with scientists who do not use primates across two areas of 
research, namely schistosomiasis and Parkinson’s disease. This multiplecase study 
method was combined with a documentary analysis of primate reports produced by 
key stakeholders. The dataset was then analysed using a semiinductive, thematic 
approach to identify how aspects of the social dynamics of science can help to explain 
the different viewpoints provided by participants. The analysis showed that issues of 
(i) competition and reputation, (ii) expectations, core sets and publications, (iii) 
entrenchment and policy, and (iv) ethics and speciesism are centrally relevant to a 
better understanding of the apparent stalemate in replacing primate experiments. 
 
The key finding is therefore that the social dynamics of science play a critical role in 
explaining why the primate impasse persists, and can also help to understand how to 
overcome it. Constructive recommendations to achieve progress are made, focussing 
on improved collaboration and communication, increasing flexibility and explicit 
 
 
examination of the ethical considerations. The thesis also draws conclusions on how 
best to ensure the necessary involvement of key stakeholders. Recommendations from 
this project also have wider implications for scientific practice particularly for those 
involved in alternatives to animal research, and for the field of science 
communication.
 
 
	
	
 
I would like to thank my supervisors past and present: Professor Robert Dingwall, 
Professor Michael Balls, Professor David Kendall and Dr Pru HobsonWest for 
guiding me through the long but interesting process. In particular, thank you to Dave 
and Pru for their many helpful comments on drafts of this thesis, and for their 
understanding when things were tough. 
 
I extend my thanks to the FRAME trustees and staff for giving me the opportunity, 
and support to conduct this research. 
 
I am extremely grateful to those who gave up their precious time to be interviewed, 
and without whom I would not have gained the insight to make my recommendations. 
 
Finally, I will be eternally grateful to my family and friends for their continuing 
patience, encouragement, and keeping me sane until I reached the finish line. I could 
not have done it without you. 
 

		
 

)*!%-#!%"!#        -
1.1 Rationale for Research          8 
1.2 Research Questions, Design and Process        16 
1.3 Structure of Thesis            19 
 
)*!%+!"(&        +/
2.1 Introduction           24 
2.2 Research Techniques and Qualitative Methods       25 
2.2.1 Primate Report Documentary Analysis       25 
 2.2.2 Case Study Selection         33 
 2.2.3 PeerReviewed Literature Review       36 
 2.2.4 Interviewing Relevant Experts        44 
2.3 Theoretical Rationale          64 
2.3.1 Referencing as Persuasion and Assessing Documentary Sources   67 
 2.3.2 Theory of Expectations         68 
 2.3.3 Core Sets          70 
 2.3.4 Social Appraisal of Technology       71 
2.4 Conclusion           72 
 
)*!%0 #!)%&#)&'% )!*%!    1.
3.1 Introduction           75 
 3.2 Persuasive Referencing          80 
3.3 Expectations           95 
3.4 Core Sets          107 
3.5 Conclusion         110 
 
)*!%/)!"&-2! )3)#)%   --0
4.1 Introduction         113 
4.2 The Scientific Institution        115 
4.3 Practical Science         132 
4.4 Animals and Ethics        145 
4.5 Health and Ethics         157 
4.6 Conclusion         164 

)*!%.)!"&+2)%4##5))%   -1,
5.1 Introduction         170 
5.2 The Scientific Institution        171 
5.3 Practical Science         188 
5.4 Animals and Ethics        203 
5.5 Health and Ethics         214 
5.6 Conclusion         222 
 
)*!%6#2#"%!)#"#(! *)    ++1
6.1 Introduction and Background       227 
6.2 Social Dynamics Involved in the Impasse     229 
 6.2.1 Competition and Reputation      231 
  6.2.2 Expectations, Core Sets and Publication    239 
 6.2.3 Entrenchment and Policy      250 
 6.2.4 Ethics, Speciesism and ‘Others’     259 
6.3 Conclusion         269 
 
)*!%1##2$% #(! *)&)#"   +1+
%)! *)!#
7.1 Introduction         272 
7.2 Recommendations for Overcoming the Impasse     273 
7.3 Policy and Practice Implications       296 
7.4 Reflections on the Methodology       309 
7.5 Future Research         311 
7.6 Conclusion         317 
 
(%)*&         0-7
 
**#"          0/0 
Appendix 1: Primate Reports Analysed in the Review    343 
Appendix 2: Schistosomiasis Interview Schedule     347 
Appendix 3: Parkinson’s Disease Interview Schedule    351 
Appendix 4: Summary of the recommendations for overcoming the   355 
current impasse about replacing primates in biomedical research for  
the two case studies explored in this project, schistosomiasis and  
Parkinson’s disease. 
Appendix 5: Presentations and Posters Related to the PhD    358 
  
Page | 1  
 
	

	
 
Animal experiments can be traced back to the time of the ancient Greeks, when 
anatomical studies of dissected animals were done to overcome the taboos associated 
with vivisection and dissection of humans (see Franco 2013 for more detail). In more 
recent times, animal experiments have played a substantive role in important medical 
discoveries such as immunisation against diphtheria and tissue engineered organ 
transplantation (see AnimalResearch.Info 2014 for more examples). The seventeenth 
century saw the first real questioning of the scientific and moral reasoning behind 
animal use (Franco 2013). The modern animal research debate has its roots in the UK, 
which was the first country in the world to have specific legislation to control animal 
experiments (	
 		 ) and where the first antivivisection 
organisation was founded in 1875. This organisation was called The Victoria Street 
Society for the Protection of Animals Liable to Vivisection and is now known as The 
National AntiVivisection Society (NAVS). The UK debate about whether or not 
animal experiments should be conducted is well known for its intense, emotive, and 
controversial nature (Matfield 2002); it receives significant media coverage (see for 
example Thew 2014 and Fox 2014), divides public opinion (Ipsos MORI 2014) and is 
increasingly political (Editorial; 	, 2013).  
 
This tension has resulted in vociferous arguments from organisations based on both 
sides of the debate, such as NAVS and the British Union for the Abolition of 
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Vivisection (BUAV)1 campaigning against animal experiments, and Understanding 
Animal Research (UAR) and ProTest speaking in favour. The impact of the debate 
can clearly be seen when considering animal rights extremism, where individual 
activists and some organisations such as the Animal Rights Militia have gone beyond 
peaceful and legal protest, attacking researchers, biomedical facilities, companies and 
staff with any links to animal work. One high profile example was the Darley Oaks 
Farm guinea pig breeding business which was subjected to a campaign of intimidation 
and vandalism that culminated in the desecration of a management relative’s grave 
and theft of her body (UAR 2014). Events such as this have resulted in the UK 
Government introducing legislation to tackle these extreme tactics, which has led to 
many of the most notorious activists being jailed (Matfield 2002; AREInformation 
2013). These kinds of attack have declined in the UK in recent years, but they have 
been replicated in other countries in Europe and the USA (Paterlini 2013; Matfield 
2002).  
 
Within the general debate there is one particular area which provokes especially 
passionate and polarised arguments; that is the use of nonhuman primates (referred to 
as primates henceforth) in biomedical research and testing (Nuffield Council on 
Bioethics 2005). The evolutionary closeness and physical resemblance of the other 
primates to humans creates a psychological affinity that causes strong emotional and 
ethical reactions against using them in biomedical research, yet it is the similarities 
between us and them which form the scientific rationale for using them as 
experimental models. As will be discussed in subsequent chapters, primate users say 
that they only use primates when they absolutely have to, and opponents say that 
                                                 
1 As of 1 June 2015 the BUAV became Cruelty Free International. Throughout this thesis it is referred 
to as the BUAV. 
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primate use must be stopped immediately. These opposing views seem irreconcilable, 
yet it could be said that, essentially, the two sides aspire to achieve the same aim of 
finding effective therapies and cures for disease without using primates. This is the 
primate use impasse; in which neither side seems able to move beyond the arguments 
to work towards this common goal. The controversial and emotive nature of the 
debate and impasse are outlined further below. 
 
The existing examinations of the animal experimentation debate are largely framed in 
the context of discussing the morality of animal research or investigating a scientific 
controversy. The moral philosophy literature which considers animal experimentation 
is the more extensive of the two. While it is beyond the scope of this thesis to 
thoroughly review this body of knowledge, it is important to note that there has been 
specific moral discussion of primate experimentation. For example, Quigley (2007) 
argues that the main justifications for the use of primates in biomedical research, the 
‘least harm/greatest good’ and the ‘capacity’ arguments are equally applicable to 
considering whether humans are appropriate subjects of biomedical research. She 
makes the case that the benchmark for deciding that primate experiments are morally 
justifiable seems to be whether we would carry out certain types of research on 
humans of a similar capacity. Therefore, if we decide that it is right to do such studies 
on humans then primate experiments are not necessary as the scientific evidence 
indicates human data is better. Conversely, if we decide it is not right to do the 
experiments on these humans then there is no good reason to do it in primates either 
(Quigley 2007). Moore (2008) also questions some of the ethical interpretations used 
for justifying primate research such as the teaching hospital fire thought experiment, 
where people would expect patients to be rescued before the laboratory animals, thus 
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humans think it is morally required to sacrifice animals to save human lives, so this 
can then be applied to medical research. But Moore (2008) argues that the two 
situations are not comparable because in the hospital scenario after the people had 
been rescued attempts would be made to save the animals, whereas in medical 
research the intention is that animals will be sacrificed.  
 
It is clear that there is significant academic interest in the ethical analysis of primate 
research and there are examples of the scientific community discussing the topic. For 
example, Sughrue 	. (2009) aimed to provide a balanced examination of the ethics 
of primate stroke research using examples from the experimental studies they had 
undertaken. However, Rossi (2009) argued that Sughrue 	 (2009) did not advance 
or defend any explicit ethical argument for the use of primates, but instead ‘
							
			
 	’ (Rossi 2009, 
p.21). To some extent this example of a separation in the moral and scientific 
arguments illustrates why for the purpose of the current project a philosophical 
approach is not suitable, as the intention is to focus on the scientific viewpoints of 
those engaged in the research. Although, as discussed in later chapters, the findings of 
the present research indicate that ethics are an important dynamic in the primate 
debate the overall framing of the thesis is not in that context.  
 
However, there are some key aspects of the philosophical literature that place this 
current piece of research into context. The 1970s saw the first rapid expansion of 
literature which academically addressed the ethical issues associated with animal 
experiments (Rollin 2007; Nuffield Council on Bioethics 2005), with authors such as 
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Ryder (1975), Singer (1975), Rollin (1981) and Regan (1983) arguing for higher 
moral status for animals. These publications are viewed by many opponents of 
vivisection as the cornerstone of their arguments and campaigns (Nuffield Council on 
Bioethics 2005). The moral status and capacities of animals are still the focus of 
theoretical discussions about the justification for and against animal use, as 
exemplified by the extensive coverage of the topic in the Nuffield Council on 
Bioethics (2005) report !	"#$$. There continues to 
be deliberation about how to assign moral status and what the consequences of 
reaching a conclusion might be. For example, Walker (2006) argues that the 
capacitiesbased view of moral status (i.e. when ‘capacities’ such as cognitive, social 
and emotional abilities are used to assign moral status, with beings with more 
complex capacities having higher moral status) is not sufficient to justify the contrast 
in the greater protection afforded to humans in regulations controlling research on 
humans versus that afforded to nonhuman animals in the regulations controlling 
animal experiments. There is also a broad literature discussing which normative 
theoretical framework should be applied to animal experimentation, with the key 
paradigms considered being consequentialism, deontology and virtue ethics2 (See 
Nuffield Council on Bioethics 2005 and Dolan 1999 for further details). 
                                                 
2 The Nuffield Council on Bioethics (2005) provides a nice summary of these three paradigms (p.49) 
describing them as follows. %	 – according to this approach the moral value of 
individual human actions, or rules for such actions, is determined primarily by their outcome. Such 
approaches do not usually put strong emphasis on the inviolable rights of moral agents or subjects. 
Utilitarianism is an important type of consequentialism. &	
 – the name of this theory is derived 
from the Greek , which means duty or obligation. In this theory certain actions are right or wrong 
independent of their outcome. Instead, their rightness or wrongness is defined by a formal system, 
which defines certain actions as intrinsically right or wrong. Rights of moral agents or subjects can be 
violated if they are not treated according to the principles derived from the system. The concept of 
animal rights is a form of deontology. '	!	 – according to this approach moral value depends 
less on duty to follow rules given by formal systems, or on duty to maximise beneficial consequences, 
than on the character of the moral agent. A virtuous moral agent is someone who deliberates and acts in 
a way which displays virtues such as justice, truthfulness and courage. 
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In contrast to the moral philosophy literature there has been relatively little scholarly 
empirical investigation of the animal experimentation debate and, as noted above, it is 
usually framed in the context of examining a scientific controversy. Nelkin (1995) 
uses animal research as an example of ‘	$
(’ (p. 451) in 
her analysis of the dynamics of science controversies as expressions of political 
tensions and moral reservations about the value of certain scientific practices. Michael 
and Birke (1994a) also note the moral character of the animal experimentation 
controversy when they illustrate, using Collins’ (1988) concept of the ‘core set’, that 
scientists attempt to dictate the terms of the debate by trying to control who has a 
legitimate voice. The concept of the core set is discussed in much more detail in 
Chapters 36. 
 
Much of the existing literature focuses on two main approaches. First, research looks 
at public attitudes toward animal experimentation and the experimenters (Lund 	) 
2012), and the roles they play in shaping policy (Schuppli and Weary 2010; Von 
Roten 2009) and legitimising the practice (HobsonWest 2012). Second, authors aim 
to understand the debate over the use of animals, often by investigating how people on 
either side of the debate view themselves; the issues involved in animal 
experimentation; and those that oppose their stance. Paul (1995) did this through the 
use of questionnaires, while others have used ethnography (Holmberg and Ideland 
2010) or interviews (HobsonWest 2012; Michael and Birke 1994a). Although this 
literature questions how animal research is justified and examines the persistence of 
the status quo, there is very little, if any, exploration of how to resolve the debate or 
move away from biomedicine’s reliance on animal models. 
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Work investigating other areas of contentious science indicates that a productive way 
to gain a more comprehensive understanding of the animal experimentation debate 
and to explore possible resolutions could be to adopt science and technology 
approaches such as the ‘theory of expectations’ (Brown and Michael 2003) and ‘core 
sets’ (Collins 1988); see Chapter 2 for further explanation of these concepts. 
Wainwright 	)(2006) examined the highly contentious area of embryonic stem cell 
research using the analytical motif of expectations to offer insight into why difficulties 
exist in getting potential therapies to move from the laboratory bench to treating 
patients in the clinic. Mulkay (1999) used the rhetorics of hope and fear to explain 
differences in the arguments presented in the debate about the rights and wrongs of 
human embryo research and assisted reproduction. As noted above, Michael and Birke 
(1994a) had already used the core set concept in the context of animal research, and 
Hedgecoe (2006) combines core sets and expectations to understand the disagreement 
over the continued citation of a controversial scientific result in the field of 
Alzheimer’s disease research. 
 
Within the general topic of animal experimentation there are studies that focus on 
specific types of animal use, such as genetically modified animals (Schuppli and 
Weary 2010) and xenotransplantation (Brown and Michael 2001). However, it 
appears that none of the current literature is specifically aimed at understanding the 
controversy surrounding primate experiments, despite this being a dominant feature in 
many of the discussions about animal experimentation. 

Therefore, to expand current knowledge in this area of scientific controversy and 
introduce a novel standpoint from which to explore it, this thesis specifically examines 
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the primate experimentation debate, and unusually investigates the impasse that exists 
and how it might be overcome using a multimethod approach. 
 
This introductory chapter will explain the rationale for conducting this research, give 
an overview of the aim, research questions, design and process and, finally, outline the 
structure of the thesis as a whole. 
 
 
	
 
 
The decision to undertake this research project was borne out of personal experience 
with the polarised nature of the primate experimentation debate and frustration at how 
to move constructively beyond it. As yet, it appears no one has actively investigated 
whether replacing primate use is feasible and, if it is, how to practically achieve it. A 
new approach is needed if the debate, and indeed the science, is ever to move forward. 
In order to do this it was decided that it was important to talk to the scientists in fields 
of research where primates are used, to get to the perspectives that cannot be reached 
simply from reading the literature. The multimethod approach used to do this is 
briefly outlined below and is described in detail in Chapter 2. It involved using 
qualitative methods and integrating science and technology studies with more 
traditional scientific enquiry. This is, as far as I am aware, a unique way of studying 
primate use. The remainder of this section provides the background to the polarisation 
of the primate debate and explains why it was important to undertake this study. 
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Over the past decade, there has been a downward trend in primate experiments in the 
EU. In 2011 (latest available statistics), 6095 primates were used for experimental 
purposes in the EU (European Commission 2013a), with UK research accounting for 
the use of 1459 of these animals. The majority (3435) of the animals in the EU 
statistics were used in toxicological and other safety evaluations, followed by 
research, development and quality control of products and devices for human 
medicine and dentistry and for veterinary medicine (1375), and fundamental 
biological studies (631). The remainder were involved in education and training3, and 
other types of experiments. 
 
When considering the UK alone the picture is slightly different and, over the past two 
decades, the number of primates used has fluctuated around 3000. In 2011, there was 
a significant fall in the number of primates involved in experimentation with the 
fewest ever (1459) recorded. However, in 2013 for the second year in succession the 
number of primate experiments increased to 2202 (Home Office 2014a). In addition, 
there has been concern raised that the development of genetic techniques (making 
genetic alterations of primates more practical) could lead to a substantial rise in the 
number of primates used (Combes and Balls 2014). At present, the primates used in 
the UK include the Cynomolgus macaque ((), the Rhesus macaque 
((		) and marmosets and tamarins, with the first of these making up the 
majority. In line with the EU, the majority (78%) are involved in safety (toxicity) 
testing, particularly in relation to pharmaceutical safety and efficacy evaluation. 
 
                                                 
3 As of January 1 2013 this use is no longer permitted under Directive 2010/63/EU 
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Despite relatively low levels of usage in Europe, laboratory primates have received 
increasing regulatory protection in recent years. The European legislation which 
controls animal experimentation, &	$*++,-,!., does so through a system of 
authorisations. The breeders, suppliers and users of experimental animals have to be 
authorised and registered, as do their establishments. Before any animal 
experimentation can go ahead the researcher must apply for authorisation to conduct 
their proposed project. To be authorised the project must meet the following criteria; 
be justified from a scientific or educational point of view or required by law; the 
purposes of the project justify the use of animals and; the project is designed so as to 
enable procedures to be carried out in the most humane and environmentally sensitive 
manner possible. The procedures can only be carried out for certain purposes, such as 
translational or applied research for the assessment, detection, regulation or 
modification of physiological conditions in human beings, animals or plants. When 
the original European legislation controlling animal experimentation,  
&	$ ,+/,!!0 was revised in 2010 and the new &	$ *++,-,!. 
adopted, there were a significant number of changes that focused on primate use. In 
the original Directive, only one Article (Article 18) specifically mentioned primates, 
requiring them to have individual identification marks and for that identity and their 
origin to be recorded. In the new Directive, there are more than ten Articles which 
specify conditions regarding the use of primates, including two that are dedicated to 
primates: 	  1 	 and 	 * 2 		
  1
	.  
 
As well as being more specific in regard to primates, the new rules also distinguish 
primates from other species, with unique conditions applied to them. For example, 
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primates can only be used for four out of nine permissible purposes for which animal 
experiments are allowed to be conducted, and there has to be scientific justification 
that the purpose of the procedure cannot be achieved using any other species. There is 
further restriction on the translational or applied aspects of primate experiments, in 
that they can only be undertaken with ‘$		$0$	0
			3				
1			
3’ (Article 8, p.40). In addition, all facilities where primates are used must be 
inspected at least once a year (Article 34); researchers cannot simplify the 
administrative process when primates are involved (Article 42); and the origin and 
species of primate must be reported in the annual statistics (Article 54). The Directive 
also places special emphasis on reviewing if and how primate use can be reduced or 
replaced, as illustrated by all projects involving primates having to undergo 
retrospective review to evaluate whether the objectives of the project were achieved 
and what harms were inflicted on the animals (Article 39), and in the setting apart of 
primates in Article 58, which deals with reviewing the Directive:  
 
$	&	$3
+$3*+0		
	$		$			$			
	   0  	  1 	0   
	0	)

  4 	  		 $  	
	0 	  	  	     0

				1	0	$	0
	1)(p.51, author’s emphasis) 
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The reasoning behind this increased protection for primates is succinctly described in 
the preamble of the Directive: 
 
5$  	 	 	 		  	 0 	   1
 	  	   	 
  3
)&				
	3		

$0	1		
  	  	 3  	  	 	
3$0 $	      3	
 $	)
6	0	1						
3)	1	3		

	3		3	30
			$		
	$3) (Preamble 17, p.34
35) 
 
This extract nicely illustrates why primate use stands out from the general animal 
experimentation debate. The following section describes in more detail the basis of the 
primate debate and its controversial and emotive nature. 
 
% )!)!
In the context of overall animal experimentation, the use of primates appears minimal, 
accounting for less than 0.1% of all the animals used in the UK and throughout 
European research and testing facilities (Home Office 2014a, European Commission 
2013a), yet there is a highly visible and polarised debate about primate 
experimentation. Provocative and often distressing images of primates in cages and 
undergoing experiments dominate many antivivisection campaigns (Kugler 2014). 
There have been several high profile campaigns and exposés aimed at stopping their 
use, improving welfare and preventing their transportation, with a recent example 
being the BUAV’s  7$ 	 campaign (BUAV 2014) detailing an 
undercover investigation into primate use in a German research facility. There have 
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also been several reports published by the scientific community specifically to address 
primate use; for example, the Weatherall Report (Weatherall 2006) and the Bateson 
Review (Bateson 2011). By contrast, such explicit discourse is not evident for the 
most commonly used experimental animals, rodents and fish. 
 
The two opposing viewpoints on primate experimentation can be characterised as 
follows: that their use is scientifically necessary and that their genetic similarity to 
humans makes them essential models for understanding and developing treatments for 
human diseases (Bailey 2014). In contrast, opponents focus heavily on ethical and 
welfarerelated issues, highlighting the significant physical and psychological costs to 
these animals when used experimentally. Discussions revolve around the evidence 
that primates are highly social animals that have complex behavioural and 
environmental needs with the ability to understand some of what has been, and will 
be, done to them; and to empathise with their cagemates. This is said to be 
compounded by the nature of the procedures to which these animals are often 
subjected (Bailey 2014; HudsonShore 2013), which is highlighted in the Animals in 
Science Regulation Unit Annual Report 2012 (Home Office 2013). The report notes 
that in 2012, seven project licence applications involving primates in procedures of 
potentially substantial severity were referred to the Animal Procedures Committee, 
which under UK law provides independent advice to the Home Secretary about issues 
related to the regulation of animal experimentation. Substantially severe procedures 
were defined, at the time, as those ‘		
 	  8 	  	
9			13):			

 	 3	
  	   	0  
 		  	1
3	$08
0 
Page | 14  
 

3
’ (Anonymous [2000], section 5.42). It should 
be noted that a section of the opposition to primate use community does question the 
scientific validity of primate research in addition to making the ethical and welfare 
arguments (e.g. Bailey 2010; Bhogal 	 ) 2005), but there are very few detailed 
evidencebased examinations of the scientific value of primate experiments (Conlee 
and Rowan 2012). 
 
There seems to be no obvious way to resolve the gap between these two positions, and 
there has been very little dialogue about how to do so. As noted above, there is a body 
of texts dedicated to discussing the ethics of animal research which span the period 
from the 1970s (such as Singer 1975) to the present day (such as Rollin 2007). These 
usually call for a greater moral status for animals including ‘animal rights’ (Regan 
1987) or are written from the perspective of the ethics involved in legislative control 
of animal experiments (i.e. utilitarianism and the cost/benefit decision; Hudson and 
Balls 2012). However, there is very little, if any, academic appraisal or discussion 
specifically focused on why the primate aspect of the debate persists and how, or if, it 
can be resolved. 
 
One exception to this is the proposal to move toward the ‘zero option’; that is, to 
progressively eliminate the need for any experiments on primates, which was first put 
forward in 1995 (Balls 1995). It was principally proposed at this time to counter 
pressure in Europe to fund expensive primate breeding programmes whose purpose 
was to provide sufficient animals for experimentation. Balls’ (1995) point was that the 
level of demand was unknown, as was the proportion of such demand that was truly 
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scientifically justified, and that, if the Three Rs principles4 were rigorously applied by 
the time the additional primates were available, they would not be needed. The 
proposal received a mixed reaction and, in 2000, Balls reiterated the importance of the 
Zero Option, giving seven main reasons to adopt it; moral, behavioural, scientific, 
logistical, safety, economic and the Three Rs. He proposed eight ways to achieve it, 
including a decision to end the use of primates by a certain date; support for the 
development of alternatives to procedures currently deemed as an essential use of 
primates; active discouragement of the use of more than mild procedures; and active 
discouragement of the use of invasive surgical techniques (Balls 2000). The proposal 
did not include an immediate ban on primate use but, instead, emphasised the need to 
make the necessary efforts to replace primate experiments. However, there have been 
no further attempts to develop a full strategy incorporating practical actions, evidence, 
research and/or input from stakeholders and, as such, the Zero Option has not, so far, 
been adopted or widely discussed. 
 
This brief overview of the primate debate illustrates its emotive and controversial 
nature but shows how important it is in the context of animal experimentation from a 
scientific, ethical and legislative point of view. It underpins why a new perspective is 
                                                 
4 In 1954 UFAW commissioned Dr William Russell and Mr Rex Burch to conduct a systematic study 
of the ethical aspects of laboratory techniques. This resulted in the publication of their book 
;5!	%(Russell and Burch 1959) in which they described the 
Three Rs concept of "	0"	"	 as a way in which the inhumanity directly 
or indirectly involved in performing potentially painful experiments on animals can be diminished or 
eliminated altogether (Russell and Birch 1959). That is, "	of experiments and studies on 
animals with other methods; "	of the number of animals used in each experiment or for a 
specific purpose; and "	 of experiments on animals towards more humane practices. At the 
time their findings went largely unnoticed but as the antivivisection movement progressed in the 1970s 
and 80s the book became important and now their concept forms the core of the new European 
legislation. The Three Rs underpin the regulations and are explicitly cited as requirements meaning that 
scientists wishing to conduct animal experiments must ensure that where possible a nonanimal 
procedure is used, that the number of animals is reduced to a minimum, and that procedures, breeding, 
accommodation and care are refined to minimise any possible pain distress or lasting harm to the 
animals. 
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needed. The following section outlines the approach taken in conducting the present 
research project. 
 
! "
	#$		

 
This section outlines the overall aim of the project, the research questions examined in 
order to fulfil the aim and the methodological approach taken in order to address the 
polarisation of the primate experimentation debate. 
 
 
To understand the impasse in the animal research debate about whether primates 
should or should not be used, by examining how biomedical research scientists view 
the opportunities and challenges of primate use, to determine if and how the impasse 
can be overcome. 
 
)%9!#
1. What arguments/justifications are given for and against using primates in 
biomedical science? 
2. Are there differences in the justifications/arguments between: 
a. Different fields of research? 
b. Different specialist users? 
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3. To what extent do the social dynamics of science help to explain the continued 
impasse in the debate? 
4. What are the policy implications for primate use and scientific practice? 
 
!"(&
As noted above, an unusual multimethod approach was used involving a mixture of 
qualitative methods. The main stages of research are summarised here, with further 
details and reasoning described in Chapter 2. 
 
This thesis does not contain a traditional literature review; instead a documentary 
analysis of primate reports published since 1986 (see Chapter 3) was conducted. The 
aim of this was to identify how the opposing sides of the debate present the scientific 
arguments for and against primate use, and to provide answers to the first research 
question. The documentary analysis also enabled the identification of important areas 
of primate research from which to choose the case studies that followed (see below), 
and provided the first indications that the social dynamics of science do indeed have a 
role to play in explaining the primate experimentation impasse. 
 
Given the limitations of a PhD study and the complexity of the subject matter, this 
project focuses on two case studies. The two contrasting cases, research into 
Parkinson’s disease and schistosomiasis, are used collectively in an effort to broaden 
the applicability of the findings. The choice of cases is explained and justified in 
Chapter 2. Before conducting interviews, it was necessary to undertake a review of 
peerreviewed publications for each case study. This was done for the purpose of 
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aiding general understanding of the scientific aspects of each research area, initially 
identifying prospective interviewees, and developing the interview schedule. 
 
In order to determine how research scientists view the opportunities and challenges of 
primate experiments, to answer research question 1 in more detail, and to provide 
answers for question 2, semistructured interviews were conducted. A schedule (see 
Appendices 2 and 3) was used for the interviews to provide structure, but with the 
flexibility to enable changes to be made and for participants to have some freedom in 
their answers. For each case study, ten interviews were conducted with experts who 
either used or had never used primates. All the interviews were recorded and fully 
transcribed and the transcripts analysed. 
 
The transcript analysis revealed key themes related to the social dynamics of science, 
which provided answers towards research questions 3 and 4: namely, competition and 
reputation; expectations, core sets and publications; entrenchment and policy; and 
ethics, speciesism and ‘others’. In interpreting the data an objectivist approach was 
adopted, viewing the participants’ responses as direct access to their experiences and 
views, rather than using a constructivist approach which would see them as narrative 
accounts. It is acknowledged that the objectivist approach is taken less often than the 
latter, but the decision was taken after deliberating about the various assumptions 
attached to these different interpretative frameworks and, as outlined in Chapter 2, the 
benefits and limitations of the chosen approach were carefully considered.  
 
The methodological approach was initially underpinned and guided by several 
theoretical Science and Technology Studies (STS) concepts, which are briefly 
Page | 19  
 
outlined here but are described in more detail in Chapter 2. Elements of the ‘Strong 
Programme’ (Bloor 1991) are used to sustain the neutrality of the thesis, in terms of 
explaining both sides of the debate and adopting a symmetrical style of explanation. 
The work of Gilbert (1976; 1977), Thorpe (1973) and Scott (1990) on referencing as 
persuasion and assessing documentary sources was taken into account when 
conducting the documentary analysis. The ‘Theory of Expectations’ (see for example 
Brown 2003; Hedgecoe 2006) provided some of the impetus for analysing the primate 
reports as a medium for translating and stabilising information and shaping people’s 
ideas and expectations about the primate debate. As noted earlier the concept of ‘core 
sets’ as defined by Collins (1988) has previously been used in examining animal 
experimentation, and this partly influenced the decision to conduct interviews in order 
to access the views of the key scientists in each field. The social appraisal of 
technology literature (see for example Stirling 2008) also contributed to the decision 
to conduct the documentary analysis. This is because the primate reports can be seen 
as a means of engaging the public in the primate experimentation debate and thereby 
involving them in the decisionmaking surrounding it. The final section of this chapter 
explains the structure of the thesis and introduces the key findings. 
 
%&
'
 
Having introduced the basis of the study and outlined the aim of the project and the 
research questions addressing that aim, the structure of the remaining thesis chapters 
will now be explained and the contribution of each chapter towards supporting the aim 
of the thesis described. 
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Chapter 2 gives a detailed account of the multimethod approach taken to conduct this 
research. It outlines the key methodological decisions made throughout the course of 
the project and explains why the study design is the most appropriate way to answer 
the research questions and to address the aim of the thesis. The chapter describes the 
practical methods undertaken for each phase, such as the documentary analysis, case 
study choice and interview technique. In addition, Chapter 2 explains the theoretical 
approaches that influenced the practical decisions and those that were adopted in 
analysing the findings, in particular the objectivist view of interview data. 
 
Chapter 3 reports the documentary analysis of primate reports and represents the first 
phase of the research project. This chapter is not a traditional literature review as the 
aim was to conduct a more indepth analysis to identify how the opposing sides of the 
debate present the scientific arguments for and against primate use, and so to provide 
answers to the first research question. The chapter also describes the first indications 
that the social dynamics of science do indeed have a role to play in explaining the 
primate experimentation impasse. Therefore, in conjunction with Chapters 4 and 5, 
Chapter 3 informed the answer to the third question regarding the extent to which the 
social dynamics of science help to explain the continued impasse in the debate. The 
findings presented in this chapter guided the choice of case studies for the second 
phase of the project. Therefore, Chapter 3 is a combination of background information 
and data. 
 
Chapter 4 covers the case study on schistosomiasis vaccine research. It reports the 
results of the empirical work undertaken on this case. It contributes to the thesis by 
providing evidence that supports the conclusion that the social dynamics of science 
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are essential for explaining the continued impasse in the primate debate and, in 
conjunction with Chapter 5, indicates that there are important differences in the 
justifications given for and against primate use between different fields of research 
and different specialists − but that there also many similarities. Together with 
Chapters 3 and 5, Chapter 4 supports the recommendations made in the final chapters 
of the thesis in relation to overcoming the impasse and the implications for primate 
use policy and scientific practice. 
 
Chapter 5 examines the second case study, on Parkinson’s disease research. As in the 
previous chapter, it reports an analytical summary of the data collected during the 
interviews. In addition to the contributions noted above, this chapter provides more 
detail on the comparisons between the two cases to avoid repetition. This chapter and 
Chapter 4 outline the key social dynamics which emerged from the data. Considering 
how these dynamics interacted and impacted on the primate debate was essential for 
understanding the impasse and making recommendations to overcome it. 
 
Chapter 6 draws together the findings from Chapters 3, 4 and 5 and directly addresses 
the research questions posed. It illustrates that the social dynamics of science do help 
to explain the continued impasse in the primate debate and that they could account for 
some of the observed differences between the two case studies and the views of the 
specialists involved in them. It explores the intricate relationships between the various 
dynamics such as competition and reputation, the impact they have on the impasse 
and the consequences that the findings have for existing social thinking, including 
where they support or contradict it. 
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Chapter 7 discusses how the aim of the thesis has been achieved by describing the 
implications for policy and practice. Recommendations for overcoming the impasse, 
founded on the evidence and discussion detailed in the previous chapters, are 
presented. Central to the recommendations are: improving collaboration and 
communication; increasing flexibility in scientific practices; and addressing ethical 
considerations surrounding experimental models. Chapter 7 also acknowledges that 
the recommendations cannot be implemented in isolation, and the consequences for 
current policy and practice and the key stakeholders that will need to be involved are 
discussed. As with any research project, there are limitations and avenues for future 
research, and these are also described and reflected upon here, in particular how to 
widen the applicability of the findings and areas that could add value to existing STS 
literature. 
 
Overall, this thesis shows that, despite the persistence of the animal experimentation 
debate and, in particular, the polarisation surrounding the use of primates, by using an 
unusual multimethod approach it is possible to gain a deeper understanding of the 
debate and to make recommendations for ways to overcome the impasse. This project 
has identified the arguments involved, the differences in the justifications given 
between different fields of research and different specialists within those fields and, 
importantly, that the social dynamics of science are essential to explaining the 
continued impasse in the primate debate and how to overcome it. In addition, it has 
shone a light on the complexity and multifaceted nature of the problem, showing that 
there are not only the two established positions of for and against, but tensions within 
and between scientists engaged in animal experimentation. The findings mean that it 
can be concluded that in Parkinson’s disease and schistosomiasis research the impasse 
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preventing a move towards replacing primates can be overcome. The insight gained 
from the study has enabled the making of specific, constructive recommendations for 
how to begin to achieve this. 
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Following the description of the study rationale in Chapter 1, this chapter will outline 
the key methodological decisions made throughout the course of the project in more 
detail and explain why the chosen research design is the most appropriate way of 
addressing the aim and objectives of the thesis. The chapter is chronological and 
describes the practical and theoretical approaches taken for each phase of the research, 
namely; documentary analysis, multiplecase study choice, peerreviewed literature 
review and interviews, including aspects such as interview strategy and analysis. The 
theoretical approaches that influenced the practical decisions and those that were 
adopted in the analysis are summarised at the end. The rationale for including this 
theoretical literature here is the semiinductive approach taken in designing the study. 
That is, the intention was not to test a hypothesis about the topic based on existing 
practical and theoretical knowledge as one would if following a deductive approach 
(Hammond and Wellington 2013). Instead, the aim was to see what emerged from the 
data in terms of the social dynamics of science and the associated theoretical 
frameworks. However, the indication that such dynamics could be important for 
interpreting the primate research impasse and the decisions about empirical 
approaches taken (documentary analysis and interviews) were informed by the 
existing literature. Hence, the process was not wholly inductive. 
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In place of a traditional literature review a documentary analysis of primate reports 
was conducted to gain greater insight into the debate and to identify how the opposing 
sides present the scientific arguments. This also influenced the case study choice 
detailed below and provided the first indications that the social dynamics of science 
have a role to play in explaining the primate experimentation impasse. 
 
The advantages of analysing textual data are summarised well by Silverman (2006). 
Texts provide rich (revealing presentational subtleties and skills), naturally occurring 
(documenting what participants are actually doing in the world, without being 
dependent on being asked by researchers), accessible (usually readily available) data 
which have real effects in the world (influencing how we see the world and the people 
in it and how we act). 
 
This documentary analysis is the first of multiple methods employed in this study and 
represents the first phase of the research. The second phase, (described later in section 
2.2.2) was a multiplecase study comparing two cases, Parkinson’s disease and 
schistosomiasis. This second phase involved a review of the scientific peerreviewed 
literature associated with, and qualitative semistructured interviews with scientists 
involved in, the two fields of research. 
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Using multiple methods in this way gives richer understanding than looking at the 
science or social aspects separately could, with the focus being on enriching and 
completing knowledge. The documentary analysis provides information on the 
arguments that characterise the primate debate, which are presented by opponents and 
proponents of primate experimentation but not scientific users of primates or 
alternative models. It informs and complements the semistructured interviews. The 
interviews provide an opportunity to further examine why these arguments persist and 
gather detailed information on the views of those directly involved in the research, 
regarding the opportunities and challenges of primate research, which are not readily 
accessible via other sources. As such this approach was not designed as a strict 
attempt at triangulation as defined by Flick (2014) as ‘	 3	  	
	0 	
 0   	 		  	 		
	$ 	’ (p.183). However, undertaking multiple 
methods was done in the spirit of Denzin and Lincoln’s (2000) understanding of 
triangulation as a strategy to add rigor, breadth, complexity, richness and depth to the 
findings. 
 
"	
Primate reports rather than traditional scientific peerreviewed papers were analysed 
because they represent the special focus that is placed on primates within the general 
animal experimentation debate. In particular they illustrate the polarised nature of the 
issue and are unusual in containing scientific citations but not being peerreviewed, so 
are somewhat less restricted than scientific papers in their content and structure. 
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As noted above the reports are not peer reviewed and have not been critically assessed 
collectively. It was important to analyse these reports because, as Brown (2003) 
argues about press releases, they translate and stabilise information that might 
otherwise go unnoticed in the wider world and they are characterised by language and 
discourse that would never appear in traditional peerreviewed texts. They also serve 
as a space to construct expectations about biomedical research and carry them to a 
wider audience, so are useful for shaping peoples’ expectations about the field in 
much the same way as review papers (Hedgecoe 2006). The reports can be seen as 
impacting on society’s views of primate research and in some cases have been aimed 
at influencing policy and regulatory decisions. Since, in processes of social appraisal, 
substantive perspectives call for participation in decision making, including the 
involvement of lay people (Stirling 2008), then, an additional function of these reports 
could be to engage the public in the primate experimentation debate. This makes them 
an important tool in altering the course of such experiments and thus worthy of 
analytical investigation. 
 
The majority of reports identified using the strategy outlined in the next section were 
analysed with the criteria for inclusion being as follows. The documentary analysis 
was conducted on reports which have a scientific focus, in that they contain 
information on the experimental use of primates in research and testing; as such any 
report that is purely welfare, transport, housing and husbandry or ethics based was 
excluded from the analysis. Of the 18 reports analysed (Appendix 1), ten specifically 
discuss the ethical aspects of primate research and testing, illustrating that it is an 
important factor in the debate. However, although it can be difficult to dissociate the 
ethical argument from the scientific one, as one is often used to support the other, 
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evaluating the ethical discourse is beyond the scope of this analysis, which aimed to 
identify how the opposing sides of the debate present the scientific arguments for and 
against primate use and what those arguments are. 
 
In addition the reports had to be accessible to anyone when circulated and be 
published in Europe between 1986 and July 2007. The implementation of the 
<	 ;  	 / (ASPA), represents a major milestone in the 
protection of laboratory animals and in the regulation of animal experimentation in 
Great Britain, so presented a logical starting point. The decision to focus on Europe 
was partly due to the time restrictions associated with a PhD study, accessibility to 
reports including language considerations, and the European origins of the animal 
experimentation debate. There were no exclusions based on author, publishing 
organisation or on the length of the reports. Therefore, reports were from 
organisations both for and against the use of primates in biomedical research. 
 
"	#		
Due to the nature of these publications (i.e. not in peerreviewed journals) it was not 
possible to use traditional citation databases to identify possible reports for inclusion 
in the analysis. Instead, the following strategy was employed in an effort to minimise 
the chance of omitting any relevant reports. The majority of the reports were 
identified through personal association with FRAME (Fund for the Replacement of 
Animals in Medical Experiments), where I am currently the Scientific Programme 
Manager. As a recognised stakeholder in this area of research, FRAME often receives 
reports of this nature from the authors. Each of the reports held by FRAME was 
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checked for further citations. An internet search was then conducted with the = 
online search engine using various search terms (table 1). For each set of search terms 
the first 100 results were checked for relevance (conducted October 2007). In order to 
check for other literature that might relate to relevant reports an #<#>3< 
search between 1986 and 2007 was conducted using the search terms detailed in table 
1. The publications/available resources pages of stakeholders’ websites were also 
checked for relevant links or references (table 2). 

)- Search terms used in Google online search engine (www.google.co.uk) and 
ISI Web of Science (WOS) to identify primatebased scientific reports (conducted 
October 2007) 
( ;
Animal experiments 
Animal report 
Ban OR stop primate use 
Essential primate 
Medical primate 
Monkey report  
Primate biomedical 
Primate experiments 
Primate report 
Primate research 
Primate use 
Primates report 
Primate AND Report AND Review 
Medical AND Primate AND Review 
Primate AND Biomedical AND Review 
Primate AND Research AND Review 
Primate AND use AND Report 







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) + Stakeholder websites checked for primate based publications (conducted 
October 2007) 
	)   *)(
Altweb http://altweb.jhsph.edu/ 
Animal Aid http://www.animalaid.org.uk/h/n/AA/HOME/ 
Biosciences Federation http://www.bsf.ac.uk/default.htm (no longer 
available)5 
Biotechnology and Biological   
Sciences Research Council  
http://www.bbsrc.ac.uk/ 
British Union for the Abolition of 
Vivisection  
http://www.buav.org/index.php6  
EU Primate Network  http://www.euprimnet.eu/ 
Fund for the Replacement of 
Animals in Medical Experiments 
www.frame.org.uk 
Medical Research Council  http://www.mrc.ac.uk/index.htm 
National Antivivisection Society  http://www.navs.org/home 
National Centre for the 
Replacement, Refinement and 
Reduction of Animals in 
Research  
http://www.nc3rs.org.uk/ 
Primate Info Net  http://pin.primate.wisc.edu/ 
The Royal Society http://royalsociety.org/ 
Wellcome Library http://library.wellcome.ac.uk/ 
Wellcome Trust  http://www.wellcome.ac.uk/ 
 


The content of each report was analysed taking into account: i) the areas of research 
covered, ii) the main arguments/conclusions about those areas, iii) whether these were 
referenced and iv) if any references were repeated in different reports. The findings 
are discussed chronologically to aid in the assessment of whether the arguments 
presented have changed over time and, if so, how. In analysing the reports their 
persuasive nature had to be taken into account because, as Scott (1990) noted in his 
discussion of sincerity in scientific discourse, authors may try to ‘			
                                                 
5 In 2009 the Biosciences Federation merged with the Institute of Biology to become Society of 
Biology (https://societyofbiology.org/). 
6 As of 1 June 2015 became https://www.crueltyfreeinternational.org/. 
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$3  $3 	   	  	 	   	
3    	     3   		’ (p.23). This is a 
strategy, which given the emotive and controversial nature of this debate, is highly 
likely to be a characteristic of these public reports. It was also important to consider 
who the intended audience for each report was, as this can affect the intended meaning 
of the text and can alter the possible interpretations of it (Scott 1990). 
 
When reading the reports, I attempted to avoid impressing my own perspective, that of 
a scientist and interested stakeholder, onto the analysis. However, as a member of the 
intended audience of these reports, how I interpret them is of general interest and may 
indicate how others might receive them. In order to induce as much neutrality as 
possible in the analysis, making judgements about the validity of the justifications 
given for the arguments presented was avoided. Instead, the focus was on what 
arguments and justifications are given and how and why they are given in the manner 
that they are. 
 
The reports (Appendix 1) are cited by a number in square parentheses. The fields of 
biomedical research to which they refer have been categorized (see table 3) to allow 
for a more coherent analysis. The assigned categories are mainly based on those 
presented in the Royal Society for the Prevention of Cruelty to Animals 
(RSPCA)/FRAME report [2], with additional categories added when necessary. The 
fields of research initially covered by the documentary analysis are highlighted in bold 
in table 3. These are the fields that are covered in ten or more of the reports (i.e. over 
half), as it is reasonable to assume that these represent the most important fields in 
terms of scientific and lay opinion. Fields one to five were excluded from the analysis 
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as they are very general and, as such, too wide ranging to be adequately evaluated 
here; they would require a dedicated review of their contents. The emphasis of this 
analysis is biomedical research, so the field of toxicology (number 17, table 3) has 
been excluded, as this is based on satisfying safety regulations and not on the pursuit 
of advancing biomedical science. As the analysis progressed it became clear that the 
resulting report was too extensive for the current study. Therefore, the documentary 
analysis presented in this thesis (Chapter 3) largely focusses on the fields of 
Parkinson’s disease (PD) and schistosomiasis research which were subsequently 
chosen as the case studies (see below), so is consistent with the presentation of the 
interview data later in the thesis (Chapters 4 and 5). However, when data related to 
Alzheimer’s disease and other infectious disease including HIV/AIDS provides 
important contrast and support to the findings from PD and schistosomiasis they are 
included. 
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)0 Categories of research reviewed in primate reports including the number of 
reports containing information on that particular category. 
 #!'" 	:'*%!
1 General Model 13 
2 General Physiology 8 
3 Neuroanatomy 11 
4 Neurophysiology 15 
5 Neuropathology 10 
6 )%4##5) 11 
1 < %5) 11 
8 Behaviour 6 
9 Drug R&D 9 
10 Dentistry 5 
11 Reproduction 6 
-+ #'!)#"#(! )=3> 10 
13 Immunology 3 
14 Vaccine Testing 7 
15 Transplantation 4 
16 Toxicology 12 
17 Biotechnology 5 
18 Experimental Husbandry & Behaviour 2 
19 Experimental Surgery 1 
 
+:+:+)!"&!#
According to Ragin (1992), ‘casing’ or deliberately making something into a case is 
‘					
			
      $ 	 		 	’ (p.225). In 
attempting to academically appraise the primate debate and impasse, conducting case 
studies, therefore, was an appropriate choice, particularly as ‘  $ 	
	$3’ (Ragin 1992, p.225). In addition, as 
the specific area of investigation was views on primate experiments which occur in 
different fields of research within science it seemed logical to adopt a cases study 
approach because as Bryman (2008) explains ‘4	38				
	0		$1			(p.54). The 
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semiinductive approach taken in this project is also compatible with a case study 
design, which when the research strategy is qualitative tends to take an inductive 
approach to the relationship between theory and research (Bryman 2008). 
 
A multiplecase study was undertaken using a comparative framework that is two 
contrasting cases were studied using the same methods, because social phenomena 
can be better understood when ‘	
    	 	 	  

 		   		’ (Bryman 2008, p.58). The decision to 
conduct two rather than several case studies was due to the resource and time 
limitations associated with a PhD study, which limited the ability to adequately 
address the complex and extensive nature of each individual area of scientific research 
identified in the documentary analysis. However, the selection of two cases strikes a 
balance between the recent arguments for a greater use of case study research that 
involves more than one case and the criticism that a multiplecase study approach can 
lead to researchers paying less attention to the specific context and more to the ways 
in which cases can be compared (Bryman (2008). 
 
This research focuses on two case studies; schistosomiasis, a parasitic disease, and 
Parkinson’s disease, a neurodegenerative disorder. These two cases contrast in various 
ways as outlined below. As Flick (2014) recommends, this choice has been 
accomplished by purposive sampling, with the cases being selected to represent 
different aspects of the primate research controversy. In terms of choosing the cases a 
maximal variation approach to sampling has been taken, whereby the cases are as 
different as possible to disclose the range of variation and differentiation in the field 
(Flick (2014). These are instrumental case studies (Silverman 2005), but they are used 
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collectively to achieve the overall aim. That is, they are examined individually to 
provide insight into the primate impasse in their respective fields, but the findings 
from both are used to examine how that impasse might be overcome. By choosing 
contrasting examples, it may be possible to make recommendations for primate 
research more widely, because, as Silverman (2006) notes, ‘?3	

%		$33
$3
	
		sampling’ (p.311). The documentary analysis described 
above was used to identify these two cases and the rationale for selection is described 
below. 
 
<	
@<	$: This is a field where the number of 
primates used in the search for a vaccine is relatively low, involving relatively mild 
procedures conducted during the end stages of the research process. It is also an 
example of the study of a parasitic disease that, despite affecting over 200 million 
people, is a relatively low profile Developing world disease when compared to the 
second case study, which often receives media attention and large amounts of funding.  
 
<	
*@;9 			: In contrast to Case Study 1, this is a 
field of research where much of the research is fundamental in nature. Parkinson’s 
disease is a neurological disease primarily of the Western world, in which primates 
are used to facilitate the search for effective therapies or a cure. It involves more 
primate use than schistosomiasis and the procedures are relatively more severe. The 
polarisation in this case seems very strong and much more contentious both ethically 
and scientifically. 
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%
$?"!%)!%$?
After selecting the case studies, peerreviewed literature for each one was examined. 
In his guide to writing a dissertation literature review Randolph (2009) identifies the 
purpose of a literature review as being threefold; i) demonstrating knowledge, ii) 
producing a publishable document and iii) identifying the influential researchers and 
groups in a field. In this sense the case study literature reviews were not traditional. 
Although they were used to identify relevant experts for interview, the aim was not to 
demonstrate knowledge in a publication/report, but to gain insight into the two fields 
of research, to aid with general understanding of the scientific aspects of each case.  
 
The rationale for conducting these reviews conforms to a selection of Hart’s (1998) 
reasons for reviewing literature, namely: discovering important variables relevant to 
the topic; synthesizing and gaining new perspective; establishing the context of the 
topic; enhancing and acquiring the subject vocabulary; and identifying the main 
methodologies and research techniques that have been used. This helped a great deal 
with preparing for the interviews, establishing pertinent areas for further investigation 
in the interview stage and designing the interview schedules (Appendices 2 and 3). As 
such these aspects are detailed in this chapter but the review as a whole is not 
reported. 
 
The reviews were narrative in nature in that they were done to describe and discuss 
the state of the science of the two specific cases from a contextual point of view 
(Rother 2007). However, as detailed below in order to improve transparency and be as 
inclusive as possible a more systematic approach to sourcing and selecting the 
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literature was adopted; with an explicit search strategy devised and criterionbased 
selection being uniformly applied (Rother 2007). 
 
<	
The peerreviewed literature was identified via electronic searches of the WOS and 
PubMed databases. The primary search terms were “Schisto* OR Bilharzia” in the 
title or key words, limited to the years 1986 – 28 August 2008 (when the search was 
conducted). As with the primate report analysis the implementation of ASPA in 1986 
represented a logical starting point. The results were imported into Endnote. This first 
search returned over 13,000 papers, therefore a strategy to find the most relevant 
papers was undertaken. Endnote was searched and duplicate entries removed and then 
certain papers excluded; see table 4 for the exclusion criteria, rationale and search 
terms used. The abstracts of the remaining papers were checked to ensure any 
remaining extraneous papers were removed; the criteria for these exclusions are given 
in table 5. 
 
The identified papers that were available via the University of Nottingham’s 
electronic journal subscription portal were then read in more detail. The main 
conclusions from each were categorised based on the type of model used, for example, 
two of the categories were primate models and rodent models, which were then 
subcategorised into species (baboon/macaque/chimpanzee for the former and 
mouse/rat for the latter), and the main research aim such as, attenuated vaccine or self
cure. Findings from these were summarised and listed with the reference. This 
continued until no new information was extracted. Although effort was made to 
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ensure as many papers and as much information as possible was included in the 
review complete saturation was not as important as it is in traditional narrative or 
systematic reviews as the main aim was to develop a personal knowledge base to 
inform the next stage of the project rather than answer a specific research question. In 
addition, the intention was to explore and, in some cases, check the findings from the 
review with the interview participants. 
 
This collated information was used to identify the scientific rationale for using 
primate or other animal/nonanimal models for schistosomiasis vaccine research. In 
addition, the review informed the interview schedule as it revealed controversies, 
knowledge gaps, influential outcomes and important discoveries. As explained below 
(section 2.1.4), the literature was also used to identify experts for interview and 
improve the rapport and flexibility in the semistructured interviews. 
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) / Strategy used to identify relevant peerreviewed articles about 
schistosomiasis vaccine research: Exclusion via bibliography search.
@#%!%# )# )%!% AB"#
#"#!
Review Not reporting new findings “Review” in Title OR Notes 
OR Reference type 
Proceedings Usually reports work that is in 
progress, has previously been 
published or is about to be 
published 
“Proceedings” in Title OR 
Notes OR Reference type 
Workshop or 
Meeting 
Usually a report of the 
conclusions and/or 
recommendations of the 
workshop/meeting not 
original research 
“Workshop OR Meeting” in 
Title OR Notes 
Snails Removing papers solely 
focused on the host of the 
parasite and not on vaccine 
research 
“snail*” in Title OR 
Keywords 
None of the authors 
based in Europe  
Time constraints The following terms were all 
used in Author Address 
sequentially, results were 
checked and any without 
collaborators in Europe were 
excluded 
“US OR USA OR United 
States of America” 
“Japan OR China” 
“Australia OR New Zealand” 
“Egypt OR Brazil OR Brasil” 
“Kenya OR Ghana OR 
Nigeria” 
“Canada OR Mexico” 
“India OR Saudi Arabia” 
Papers with no address or 
where it was missed by the 
terms above were excluded 
NonEnglish abstract Do not have the resources to 
translate papers 
“English Abstract” in Notes 
(match words) 
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) . Strategy used to identify relevant peerreviewed articles about 
schistosomiasis vaccine research: Exclusion via abstract content. 
@#%!%#
No abstract available 
Infection risk/rate/transmission  
Schistosomiasis associated with other diseases  
Diagnosis and methods of diagnosis 
Treatment not vaccination 
Not main focus/cursory mention 
Snail ecology/infection/control (missed in previous search) 
Meeting report/review (missed in previous search) 
Parasite biology not related to vaccine development 
Schistosomiasis aetiology/progression/clinical condition 
Schistosomiasis species that do not infect humans 
Economic evaluations 
Behavioural studies 
Study methods 
Not English (missed in previous search) 
Duplicates (missed in previous searches) 
 
;9&
The strategy used to identify the Parkinson’s peerreviewed literature differed slightly 
from that for schistosomiasis. An electronic search was conducted in the >A< and 
;3(databases. From an initial examination, and based on the experience from the 
previous search, it appeared that the majority of the ;3(results were duplicates. 
Therefore, it was felt that it was sufficient to use only the >A< results. 
 
The primary search term used was “Parkinson*” in the title OR topic, limited to the 
years 1986 – 22 February 2010 (when the search was conducted). This returned over 
60,000 papers, so the results were refined within >A<, imported into !	 and 
further distilled using the criteria in table 6. As with the previous case study, the 
abstracts of the remaining papers were checked to ensure any remaining extraneous 
papers were removed; the criteria for these exclusions are given in table 7. 
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)6Strategy used to identify relevant peerreviewed articles about Parkinson’s 
disease research: exclusion via bibliography search and refinement terms. 
@#
%!%#
)# '# #!!% AB
"#;
)%!% AB
"#
#"#!
Review/Proceeding
s/Workshop or 
Meeting 
Not reporting new 
findings/reporting 
work that is in 
progress or 
previously 
published/reportin
g of the outcome 
of 
workshop/meeting 
not original 
research 
Document 
Type=(ARTICLE) 
 
NonEnglish 
abstract 
Lack of resources 
to translate papers 
AND 
Language=(ENGLISH) 
 
None of authors 
based in Europe  
Time constraints AND 
Countries/Territories= 
(HUNGARY OR 
ENGLAND OR 
WALES OR 
GERMANY OR 
IRELAND OR 
LITHUANIA OR 
CZECH REPUBLIC 
OR ITALY OR 
SERBIA MONTENEG 
OR FRANCE OR 
SPAIN OR NORTH 
IRELAND OR 
ARMENIA OR 
NETHERLANDS OR 
CROATIA OR MALTA 
OR SWEDEN OR 
SLOVENIA OR 
ESTONIA OR BOSNIA 
& HERCEG OR 
SWITZERLAND OR 
BULGARIA OR 
AUSTRIA OR 
SLOVAKIA OR 
FINLAND OR 
UKRAINE OR 
BELGIUM OR 
YUGOSLAVIA OR 
DENMARK OR 
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@#
%!%#
)# '# #!!% AB
"#;
)%!% AB
"#
#"#!
SERBIA OR POLAND 
OR SCOTLAND OR 
CYPRUS OR TURKEY 
OR NORWAY OR 
LATVIA OR GREECE 
OR REP OF GOERGIA 
OR PORTUGAL OR 
RUSSIA OR 
LUXEMBOURG OR 
ALBANIA OR 
BYELARUS OR USSR 
OR 
CZECHOOLOVVAKI
A OR FED REP GER) 
No Abstract  Time constraint 
for identifying 
relevant papers 
 “a” in Abstract 
Papers on methods 
of diagnosis 
Removing papers 
not solely focused 
on treatment 
research 
 “Diagnosis” in 
All Fields 
Papers not 
primarily focused 
on Parkinson’s 
disease  
Removing papers 
where Parkinson’s 
is only given a 
cursory mention 
 “Parkinson” in 
Abstract 
(checked and 
removed 
remainder) 
Then searched 
sequentially for 
the following in 
All Fields and 
removed after 
checking 
abstract 
“White AND 
Syndrome” 
“Schizophrenia
” 
“Alzheimer’s 
OR AD” 
“Huntington’s” 
 
The identified papers that were available via the University of Nottingham’s 
electronic journal subscription portal were then read in more detail. The main 
conclusions from each were again categorised based on the type of model used and 
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the main research aim such as, surgical or pharmacological therapy. Findings from 
these were summarised and listed with the reference. As with the first case study, this 
continued until nothing new was being identified, and the collated information was 
analysed and utilised in the same way. For example, it was used to identify the 
scientific rationale for using primate or other animal/nonanimal models and to inform 
the interview schedule. 
 
)1 Strategy used to identify relevant peerreviewed articles about Parkinson’s 
disease research: Exclusion via abstract content. 
@#%!%#
Diagnosis and methods of diagnosis (missed in previous searches) 
Describing symptoms or clinical signs 
No direct reference to PD (missed in previous searches) 
Side effects of known treatments 
Not main focus/cursory mention (missed in previous searches) 
Causative agents/ susceptibility 
Meeting report/review (missed in previous search) 
Sociological studies of PD management 
Compound structure 
Mechanism of action of treatments/MPTP 
Drug interactions 
Brain anatomy/morphology/physiology (not directly related to PD) 
Aging studies 
Vision research 
Pathogenesis 
Case studies 
Tissue storage 
Drug sensitisation/ Drug delivery 
Toxicity 
Genetic screening 
Movement studies (of patients) 
Imaging substances 
Economics of treatment 
 
Page | 44  
 
+:+:/#!%$?#($)#!@*%!
Interviews were the most suitable method of data collection for this project because as 
Liamputtong and Ezzy (2006) highlight: 
a. they provide a way of discovering the subjective meanings and interpretations 
that participants give to their experiences 
b. they allow aspects of social life such as social processes to be studied, which 
could not be achieved any other way 
c. participants’ responses are less influenced by direct pressure from peers, so 
they may be more prepared to discuss sensitive matters 
d. participants can find the experience rewarding  
 
Points a and c were particularly important given that scientists’ views on a 
controversial topic were being sought. Point d was also found to be true with several 
participants expressing thanks for making them think about the topic again and/or 
giving them the opportunity to revisit or talk about their work. Other methods such as 
focus groups or ethnography were unsuitable; in the former case because the aim was 
to generate indepth information about the views of individuals and in the latter, 
because of time constraints and wanting to seek the scientists’ views rather than an 
understanding of the environment in which they worked. 
 
These interviews allowed exploration of the scientific issues/questions that arose from 
the literature review and a more indepth look at the social dynamics apparent in the 
prior documentary analysis. They have allowed detailed access to expert perspectives 
and exploration of some of the nuances of the debate. As part of the case studies, the 
intention was to investigate: (a) whether there are differences between the work of the 
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specialists within in each field (i.e. the core set, see 2.2.3 for more detail), (b) how that 
work is represented and (c) what impact this has on the perception of primate 
experiments. Another purpose was to reveal if the status quo (continuing primate use) 
is due to the actions of key scientists; again to determine this it has been essential to 
speak to those scientists. The interviews are important, therefore, for constructing 
answers to each of the research questions; in particular whether there are differences 
in the justifications/arguments between the fields of research and the different 
specialists and to what extent the social dynamics of science help to explain the 
continued impasse in the debate. 
 
#	$<		

For each case study, ten interviews were conducted with experts involved in each of 
the two fields − see below for details on how these were identified and accessed. 
Table 8 provides an overview of the participants for each case. Interviews lasted 
between an hour and two hours with one exception of just over 40 minutes. They were 
all conducted in the participants’ offices within their academic institution, with one 
exception which was conducted in a café over lunch. 
 





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)COverview of the academic position, background and range of participants for 
the two case studies 
! )3)#)% )%4##5)%)! #!)%
Academic Position Academic Position 
5 Professors 3 Professors 
3 Senior researchers/lecturers 7 Senior researchers/lecturers 
2 Postgraduate researchers (figures include 2 clinicians) 
  
Models Used Models Used 
5 Have worked with primates 4 Have worked with primates 
5 Have not worked primates 6 Have not worked primates 
  
Location Location 
6 Different academic institutions in the 
UK and France 
7 Different academic institutions in the UK 
and Ireland 
 
The interviews were semistructured to give the flexibility to make changes during the 
interviews, while still providing enough structure to ensure that the information most 
relevant to meeting the aim of the study was collected. This involved using an 
interview schedule (Appendices 2 and 3) consisting of several themes, each having 
several prompt questions depending on the response of the participant (see below for 
more details). Thus, as the interviewer I shaped the discussion, as the questions were 
influenced by the research aims. However, by using this semistructured approach 
rather than an openended one, the aim was to allow participants to use their own 
ways of defining their environment, work and viewpoints, and to raise important 
issues not contained in the schedule, whilst, at the same time, avoiding creating an 
interpretive problem for the participants in worrying about what is relevant (Silverman 
2006). Each interview was recorded and was stored in accordance with the University 
of Nottingham research guidelines. As Liamputtong and Ezzy (2006) note, recordings 
provide a level of detail and accuracy that are not obtainable from memory or by 
taking notes. Indeed, a further advantage of recording is that as the interviewer I was 
able to concentrate on maintaining flexibility in the interview such as, following up 
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interesting points, probing when necessary and highlighting inconsistencies in 
responses rather than making extensive notes on what was said (Bryman 2008). 
 
The interview recordings were fully transcribed in an ongoing manner in order to 
make the process more manageable. While the majority of the analysis of the resulting 
transcripts was done when all the interviews in each case were complete it is 
important to note that the production and use of transcripts are essentially ‘research 
activities’ (Atkinson and Heritage cited in Silverman 2006), involving close, repeated 
listening to recordings that can often reveal previously unnoted recurring features of 
the organisation of talk. Therefore, taking this consecutive approach to transcription 
allowed for some initial analysis in terms of raising awareness of emerging themes 
(Bryman 2008) and identifying areas in the interview schedule that needed to be 
developed or changed as the interviews continued. The transcription process and 
analytical approach taken are described in more detail in the Transcription and 
Analysis section (p.53) 
 
The schedule design was the same for both cases with examples specific to each field 
of research being substituted as necessary. The schedules (Appendices 2 and 3) were 
designed to cover certain themes that had arisen from the documentary analysis and 
literature review with the aim of gathering data relevant to the research aim and 
questions, in particular questions 2 to 4. They are divided into background, and five 
themes; 
1. Expectations and justifications used in biomedical research 
2. Scientific controversies and misunderstandings 
3. Perceptions of biomedical research  
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4. Shaping biomedical research, barriers and facilitators 
5. Views on implications for primate use policy and regulation 
The background section included questions about factual aspects of the participants’ 
career and research to enable a rapport to be developed before tackling the more in
depth or difficult questions. Each theme represented an aspect that was considered to 
be important for understanding the primate debate impasse. Within each theme there 
was a maximum of six questions. The initial question was a general introductory 
question to begin and guide the conversation, with the remaining questions acting as 
probes to clarify answers if necessary or as follow up questions to pursue the 
implications of a given answer. As far as possible the questions were designed to be 
impartial and encourage detailed responses rather than oneword answers. The 
schistosomiasis schedule was adapted when it became clear, after the first couple of 
interviews, that a question in theme 4 regarding a change of emphasis in their work 
(see Appendix 2) was causing confusion. Experience gained during the interviews, 
also informed some slight changes of emphasis in some of the questions in the 
schedule in some instances. For example, specifically asking some Parkinson’s 
disease participants about the problem of research moving abroad, when they did not 
spontaneously mention it. 
 
All interviews were facetoface, with the exception of one of the Parkinson’s disease 
interviews, which, due to time constraints for the participant (I14NP), was conducted 
over the telephone. Facetoface interviews are preferable for this kind of study as 
they have been reported to: result in a better response to sensitive items; decrease the 
social distance between the interviewer and respondent; and allow participants to self
generate what is on their minds (Shuy 2002). Therefore, in undertaking the telephone 
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interview, it was important to be aware that the participant might be more likely to 
avoid the more sensitive/controversial aspects of my schedule. Aquilino (1994) 
describes how this is often due to problems with the participant being less persuaded 
by the confidentiality claims made by the interviewer. Therefore, to try and avoid 
these problems the anonymity of the data was emphasised and in general it was felt 
that a good rapport was established. In addition, the participant (I14NP) gave 
extensive answers that did not differ significantly in terms of detail from the other 
interviews. 
 
During one of the schistosomiasis interviews, the recorder malfunctioned and 
approximately half of the conversation was not recorded. However, the participant 
(I8P) later agreed to go over some of the main points again so that they would be 
recorded. A transcript for the missing parts was written using the notes taken during 
the interview and a copy of this was sent to the participant to ensure they were happy 
that the conversation had not been misrepresented. 
 
!	#		
When deciding who to interview a purposive sampling approach was taken in order to 
ensure that those that were interviewed were the most relevant to the research 
questions being asked (Bryman 2008). Indeed Bryman (2008) notes that ‘

	    %		$  3  	$  		
$   	’ (p.458). In contrast probability sampling was not 
appropriate for this study as the research questions were aimed at a particular category 
of people (biomedical scientists) within specific fields of research (PD and 
Page | 50  
 
schistosomiasis) rather than a wider population and although some generalisation 
might be possible the intention to conduct case studies means that the focus is on 
those specific occurrences rather than broader applicability (Bryman 2008). 
 
Identification of experts to be interviewed was done via a variety of means. The 
papers collected for the literature review were used as the basis for the purposive 
sample, as it was assumed that those who were the most prolific publishers were likely 
to be very active within their fields so be more likely to give a rounded and current 
overview of the research. The papers were organised by first author using the 
bibliography software Endnote. Authors who had published four or more papers were 
highlighted and their current research status investigated, initially using the addresses 
given in the papers and then, if necessary, using the internet search engine =. 
Having identified those that were still active with available email addresses, the most 
senior researchers in each associated group were targeted for initial communication, 
as it was thought that these would have the greatest amount of experience and could 
give an overview of the group’s work in the field. In addition, certain experts were 
identified from presentations/posters at conferences and via previous association with 
FRAME and other Three Rs organisations.  
 
Additionally, a snowballing approach was adopted where participants were asked if 
they could recommend anyone to approach and, on one occasion, this led to an extra 
unsolicited interview with another member of the research team on the same day. 
Snowballing was appropriate in these circumstances as the sampling frame (i.e. the 
list of all the units within a population from which a sample is selected; Bryman 2008) 
was limited by identifying researchers via the literature as this was dependent on them 
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having published research so it was not possible to have a complete list of all 
researchers in each scientific field from which to draw a sample. It must be noted that 
seniority was not a definitive criterion; hence the interviews with two post graduate 
researchers, who were conducting extremely relevant research and who, it was 
thought, might have a different outlook on the field. The recommendations of other 
relevant researchers by participants also provided reassurance that a good breadth of 
respondents was being targeted, as many of those identified by participants were 
among those approached. There was also reasonable coverage in terms of the fields of 
research, with representatives from most of the main research aims identified by 
participants and the peerreviewed literature review being involved. 
 
7	
The interviews were conducted in academic institutions, with the exception of the one 
conducted in a nearby café (in the telephone interview, the participant called from 
their academic institute). Location was not used as a criterion for deciding which 
interviews to conduct as this was decided purely by where the research is carried out.  
 
The controversial nature of animal experiments, particularly primate use, and the 
sometimes violent response by animal rights extremists towards researchers involved 
in it (see Chapter 1) meant that access to the identified experts required a particularly 
sensitive approach. It was extremely ethically important to give consideration to the 
scientists’ safety and to attempt to mitigate any negative consequences that might 
arise from participating (Bryman 2008). To this purpose all responses were treated as 
confidential and transcripts coded and anonymised. Information regarding 
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participants’ names and contact details were stored securely and separately from the 
interview recordings and transcripts. The project received ethical approval from the 
University of Nottingham and adhered to its research code of practice. The process for 
gaining access is detailed below. 
 
In order to gain access to the identified experts, an initial approach letter on 
Universityheaded paper was sent via email requesting assistance with the PhD 
project. It outlined the sponsor, the research aims, the intention to conduct interviews 
and the themes that would be explored in them. The letter also detailed the steps to be 
taken regarding confidentiality and anonymity, and the ethical approval. Agreement to 
be interviewed was taken as consent to participate, but in addition at the beginning of 
each interview participants were asked to confirm their willingness to proceed and be 
recorded. The anonymity aspect was also reiterated at the beginning of each interview, 
and on concluding the interview all participants were given my contact details should 
they have any concerns or queries at a later stage. 
 
For schistosomiasis the approach letter led to immediate acceptance by some 
participants. Having conducted the first round of interviews the snowballing approach 
also aided with access as well as identification of potential participants, in that some 
of those interviewed offered to act as a referee/gatekeeper. Those who had not 
responded were contacted again and it was emphasised that other participants had 
recommended that they be spoken to. This was very successful, there were no refusals 
and only one expert did not reply, with another not being able to fix a suitable date for 
interview. Indeed, as detailed above, this strategy led to an extra unsolicited interview 
at one institution. In the case of Parkinson’s disease it was envisaged that the snowball 
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approach might need to be utilised more extensively as the primate models used in 
this field are more contentious and so the researchers might be more reticent to 
participate. However, it was pleasantly surprising that the majority of the targeted 
experts were willing to participate. Of those contacted, three did not reply, one 
accepted but was unable to arrange a suitable date for the interview and three declined 
due to other commitments or because they were no longer working in the field. 
 
	

Each interview was transcribed verbatim by me and given a code number to ensure 
anonymity. Flick (2014) notes that as yet no standard has been established in terms of 
how exact or comprehensive a transcription has to be, arguing that: 
 
Where linguistic and conversation analytical studies focus on the organization 
of language, this kind of exactness [formulaic rules for transcription] may be 
justified. For more psychological or sociological research questions, however, 
where linguistic exchange is a medium for studying certain contents, 
exaggerated standards for exactness in transcriptions are justified only in 
exceptional cases… (Flick 2008, p.389). 
 
Given that the intention was to conduct a thematic analysis of the transcripts it was 
important to transcribe the interviews in full to ensure that nothing important was 
missed and to facilitate comparison within and between the cases. This included 
making note of pauses, stresses and emphasis but not the fine grained details required 
for conversation or discourse analysis such as, prolongation of sounds, turn taking, in 
takes of breath and measuring periods of silence to the tenth of a second (Bryman 
2008). Neither conversation analysis or discourse analysis were suitable for the 
purposes of this project, the former because it focusses on how the patterns in 
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naturally occurring talk elucidate hidden aspects of interaction (Scott and Marshall 
2005) and the latter as it is constructionist approach concerned with the strategies 
people employ in trying to create different effects (Bryman 2008). 
 
It can be argued that thematic analysis is one of the most common approaches applied 
to qualitative data (Bryman 2008). Yet, as Bryman (2008) discusses, unlike other 
strategies such as grounded theory, it does not have an identifiable heritage or defined 
set of criteria or techniques. However, this method offers practical means to pin down 
activities in qualitative data analysis, particularly when the research aims beyond 
developing a theory from the material (Flick 2014). Indeed, Braun and Clarke (2006) 
argue that thematic analysis ‘3		
3
	 
 %		$ 	’ (p.77). In their paper on using thematic analysis in 
psychology Braun and Clarke (2006) provide a useful outline of what thematic 
analysis is and give guidelines on how to conduct it in a more deliberate and rigorous 
way. 
 
Given the semiinductive approach taken in designing the present study, thematic 
analysis as defined by Braun and Clarke (2006) as ‘ 	  	
0

  	 		 	 	 	 	’ (p.79), is an appropriate 
methodological framework to adopt. Therefore, in the process of transcribing and 
analysing the interview data (described below) Braun and Clarke’s (2006) six steps 
for searching across a data set to find repeated patterns of meaning were considered. 
These are: 
1. Familiarising yourself with your data 
2. Generating initial codes 
3. Searching for themes 
4. Reviewing themes 
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5. Defining and naming themes  
6. Producing the report (Braun and Clarke 2006, p.87) 
 
The following describes the stepwise process of transcription and analysis of the 
interview data. As noted above transcription (or familiarisation with the data) was 
completed in an ongoing manner but the analysis in terms of coding and identifying 
themes was conducted once all of the interviews in both cases had been completed 
and transcribed. This allowed comparison across all participants’ response within and 
between the cases. 
 
Each interview was transcribed verbatim into an electronic Word document. Any 
names of places or people were omitted to reduce the chances of participants being 
identified. Participants were given a code number and each transcript file was given 
an anonymous code name. 
 
Each transcript was then manually analysed, using insight from Science and 
Technology Studies (STS; see Section 2.2), to highlight information that is relevant to 
understanding which experimental models and techniques are used to investigate 
schistosomiasis vaccines and treatments for Parkinson’s disease from a scientific 
perspective, and what the benefits and problems are with each of them. In addition, 
responses that had social science consequences were identified, such as utterances 
related to conflict in a field or building expectations.  
 
These sections of the transcripts were then grouped (or coded) and examined to 
decipher what the main emerging themes were. The categories/codes used were; 
expectations, drivers, barriers, justification, knowledge creation and model choice. 
Page | 56  
 
The extracts were not limited to one category if it was felt that they were illustrative 
of more than one. This continued until all extracts had been assigned to a category. 
The categories were collated and the relevant extracts gathered together to identify the 
key themes described in Chapters 4 and 5. It was important to consider if there were 
any contradictory data and what impact they might have on the findings, and to be 
aware of any omissions in the data, as what the participants have not said may have 
consequences for how the debate on primate use is framed.  
 
Once the themes were identified they were examined to see how they linked together 
and how responses within them differed or concurred between different types of 
participant and between the two cases. In much the same way as Bryman (2008) 
describes, the comparison allowed the distinguishing characteristics of the two cases 
to act as springboard for the theoretical reflections about the contrasting findings. 
When reporting the findings of the analysis, quotations that were illustrative of the 
majority of the responses or that represented a significant contradictory or unique 
viewpoint were chosen. Thick description was adopted, that is quotations were more 
than a sentence or a few words, in order to provide context, validity and richness to 
the analysis. 
 
In terms of interpretation of the data, an objectivist approach was adopted, in that the 
participants’ responses were taken as giving direct access to their experiences and 
views rather than seeing them as narrative accounts, that is, from a constructionist 
viewpoint. This decision was taken after deliberating about the various assumptions 
attached to these different interpretative frameworks and, as outlined below, carefully 
considering the benefits and limitations of the chosen approach. 
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There is a great deal of literature which discusses the use of interviews as elicitation of 
accounts. This stance is foundered in constructionism, that is, interviewer and 
interviewees are actively engaged in constructing meaning. This means that interview 
responses are not taken as simply true or false, but are displays of perspectives or 
moral forms which draw upon available cultural resources (Silverman 2006). A useful 
discussion of the basis for treating interviews in this way is given by Dingwall (1997). 
In summary, he proposes that when interpreting interview data the analyst must 
consider that the interview situation is never an occasion where the respondent can tell 
whatever story they like. There is always a deliberate topic that the interviewer is 
interested in. Therefore, the interview is a joint accomplishment involving interaction 
which should be analysed in terms of impression management. That is, the respondent 
will be concerned about demonstrating competence as a member of the community 
under study and will do so in response to intentional or unintentional cues given by 
the interviewer about what is or is not acceptable about their answers. For the 
constructionist this places emphasis on the interaction or how the respondents create 
meaning as a topic in its own right, so ‘accounts’ are not representations of the world 
but are part of the world they are describing. 
 
Critics of constructionism argue that it suffers from narrowness by focussing on the 
properties of social interaction and seemingly denying the value of treating interview 
data as saying anything about any other reality than the interview itself. That is, it 
focusses on the ‘how’ questions rather than the ‘what’ questions. Silverman (2006) 
notes that this means that many interview researchers complain that following a 
constructionist position results in a ‘…  	 $	   	
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									

				
			$’ (p.131). 
 
In contrast to the constructionist approach, in viewing data as real, in and of 
themselves, objectivists assume; that research participants can and will relate the 
significant facts about their situation; that the researcher remains separate and distant 
from research participants and their realities; that the researcher represents the 
participants and their realities as an external authority and; that the research report 
offers participants a useful analysis of their situations (Charmaz 2002). Abraham 
(2002) proposes that objectivist realism provides a theoretical framework for 
producing knowledge and for gaining knowledge of the historical, economical, 
psychological, political and sociological explanations and implications of 
technological risk and benefit. He argues that this does not imply that knowledge is 
never socially constructed but rather that it is not wholly constructed, for example; 
 
In the case of scientific research involving the natural world this is because of 
objective natural mechanisms which exist and have properties independently 
of scientists (e.g. cell proliferation), even though the social activity and 
organisation of science is needed to produce knowledge about them. (Abraham 
2002, p.307) 
 
He goes on to say that realists can be sceptical about scientific knowledge claims and 
that in fact they tend to challenge such claims much more deeply and 
comprehensively than relativists/constructionists because they can include a degree of 
examination of the validity of the claims. van Zwanenberg and Millstone (2000) also 
feel that realism can acknowledge that social factors affect scientific activity but that it 
does not feel the need to explain scientific developments purely in terms of those 
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factors. They also argue that realists have more appreciation than scientistic and 
relativist analysts do of the reliability and robustness of certain parts of science. 
 
Having chosen the objectivist approach it is acknowledged that there is a literature 
surrounding what some argue are ‘problems’ which can distort participants’ 
responses. Denzin (1970) provides a useful list of these, which are now used to 
describe how it is believed that many of the issues about interpreting the data as actual 
experiences were either overcome or, at least, taken in to consideration in the present 
study. 
 
"	  	 		   	 	$ – This 
relates to respondents possibly assigning a different role to the interviewer, so the 
situation is not respondent/interviewer, but instead it might be teacher/pupil, 
male/female etc. In essence this may not be as problematic as it seems if the 
interviewer adopts the role indicated by the respondent; in actuality it might improve 
the relationship and make talking easier for the interviewee. In this study this was not 
particularly a problem, with the exception that sometimes it was felt that a small 
selection of the participants took on a teaching role in some instances. This was dealt 
with by accepting the ‘lesson’ passively and then moving on to the next question. This 
aspect of Denzin’s discussion of problems that might distort participants’ responses 
may also not be as relevant today, because as a society we are much more aware of 
the interview and are exposed to them daily in the media (e.g. newspapers, magazines 
internet blogs and television). Scientists are also increasingly expected to engage with 
the public by grantgiving bodies and their institutions, so are much more familiar 
with the role of interviews and how they are conducted. 
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;3  B1		9  	 	$  
  	 
 	 
	$ – To address this, an attempt was made to remain neutral and approachable 
and to build a rapport with the participants. Fontana and Prokos (2007) explain that to 
establish a rapport ‘		33					
 	 		  	 $	 	 	     1
	  	’ (p.116). Therefore, having a scientific background and 
reviewing the peer reviewed literature was advantageous in developing and 
maintaining the rapport as it enabled an understanding of the vocabulary and culture 
of the participants (Fontana and Frey 2000). Denzin (1970) argues that rapport varies 
by dimensions such as class, perceived social status and consensual meaning 
conveyed by the interview, and that the closer the fit is in these dimensions between 
the interviewer and the interviewee the greater the rapport will be. Despite the benefits 
of rapport the interviewer must avoid ‘going native’ and becoming a member of the 
study group so foregoing their academic role (Fontana and Frey 2000). Taking these 
various recommendations into consideration an attempt to establish a rapport with 
each participant was made in the following way. The interviews began with questions 
asking for factual information such as academic position and time spent working in 
the area to ease the participant in to the interview. They were asked about their work 
prior to the more controversial questions so that they could discuss something familiar 
and agreeable to them before tackling the more difficult questions. A passive voice 
was used when asking questions, that is, aggressive questioning was not used – the 
questions were not phrased to indicate a right or wrong stance. Finally, general terms 
were deferred to such as ‘others have said’ or ‘the literature indicates’ rather using ‘I’ 
or indicating that they were personal thoughts. 
 
Page | 61  
 
;3  B$	90 B	9 	 	  	 $ 		
		3				3			 – This relies 
on participants feeling that the interviewer will not have objective evidence to counter 
fabricated ‘tales’ and the risk of it is thought to be amplified if the probability of 
future encounters is low. Given that the interviews were conducted as part of a PhD 
project and all of the participants are familiar with the process and methods that 
accompany such a project they would have been aware that background research on 
their field will have been conducted, and that their peers/associates would be spoken 
to as well. In addition, because of the association with FRAME it is reasonable to 
think that many, if not all, of the participants would perceive that I had some 
knowledge of the situation under investigation. Therefore, taking these factors into 
account, they would be less inclined to give false responses that I might be able to 
question the authenticity of. In terms of a volatile/fleeting relationship there was no 
experience of any of the indications that this was the case such as the participants 
breaking off or refusing to answer questions. Neither was there experience of any 
‘flooding out’ or apparent embarrassment that meant that the participant could not 
carry on, or that it was necessary to intervene to change the topic or move the 
interview on. 
 
&	
		$	– There were several instances 
that indicate that this was not an issue in these interviews. Where participants were 
particularly aware of my background and association with FRAME there was no 
hesitation to talk about the negative aspects of their work, which might have been 
expected if they were telling me what they thought I would want to hear rather than 
their experiences. Some of the participants that did not use primates still said they 
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would be needed to some extent. So they were not ‘preaching’ alternatives or reluctant 
to say primates might be needed, as you might expect them to be if they were 
uncomfortable with the situation or giving an account based on what they thought 
might be deemed acceptable. Many also wished me luck with the project and were 
interested in the findings of the thesis and any publications that arise from it. Denzin 
(1970) also proposes that the interview should be viewed as a special relationship 
which has often been freely entered into, and one in which information is exchanged. 
As such any information which is given freely may be assumed to be more valid. In 
the interviews none of the participants were coerced in any way to take part, and to 
strengthen the freegiving of information all were assured of the anonymity of the data 
so that they had fewer worries of negative consequences from their responses.  
 
In addition, Holstein and Gubrium (1995) cite telltale phrases such as ‘if I were in his 
shoes’ or ‘wearing my professional hat’, which participants use to signal shifts in 
roles, indicating that they are active narrators weaving skilful, appropriately located, 
stories (accounts). There is a very low incidence of this kind of phrase within the 
interview transcripts.  
 
	$			$	$ – This can cause problems if there 
is inequality between the two. For example, if the interviewee is superior to the 
interviewer they may talk past them, perhaps in a lecturing or dismissive tone. 
Equally, if the interviewer perceives the interviewee to be of lower status they may 
force their morality on to them or talk down to them, all of which may influence the 
participant’s response. The interview can be seen as a transaction or understanding 
wherein the interviewer gets access to and can direct the participants’ communications 
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and in return the participant is assured there will be no reprisal. So, in order to 
maximise selfexpression of the participant and create a free atmosphere, a degree of 
equality in the interview is desirable. This might be a fit in backgrounds or status for 
example. 
 
In my experience the inequality of all of the participants being of higher status in an 
academic context (i.e. postdoctoral or above) than me was balanced by the respect that 
is given to the PhD process and outcomes. I never felt that I was being talked down to, 
and all the participants engaged with me an open manner.  
 
 B		9 	 	$ ))00 	 – Denzin (1970) contends 
that few studies succeed in locating interviews within the same situational class (e.g. 
homes, offices or laboratories), which may lead to betweenclass variance making it 
difficult to justify comparability across interviews. The fact that all of the interviews 
were conducted in the participants’ offices within their academic institutions helps to 
mitigate this problem. Even with the exceptional interview that was conducted in a 
café, the participant had chosen that location and it was still within the academic 
sphere as it was frequented by the University staff and students. Thus participants 
were comfortable and secure, and were able to discuss research within a research 
setting in each interview. 
 
It is acknowledged that this objectivist approach to the analysis of the interview data 
could be seen by some as contradictory to the stance taken in the documentary 
analysis. Taking into consideration the persuasive nature of the primate reports could 
be seen as quite a constructionist reading of them, with the concern perhaps being 
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about how the reports are assembled and evaluated rather than their content  . 
Silverman (2006) notes that from a constructionist position researchers are interested 
in texts as ‘topics’ but not as ‘resources’. However, in the documentary analysis in 
this study the reports were treated more as a resource to establish which fields of 
scientific research were seen as important in the context of concerns about primate 
experiments and to identify what the main arguments in the primate debate were. 
Although the analysis involved interpreting why those arguments might have been 
presented as they were, this was not just about how they were presented, but rather 
what theoretical paradigms might underpin them. Therefore, it was once again used as 
a resource to inform the next stage of the project both in terms of highlighting that the 
social dynamics of science could, as hinted in the existing literature, play an important 
role in understanding the primate impasse, and in choosing the case studies and 
developing the interview strategy. 
 
!%'
 
	
 
Elements of the ‘Strong Programme’ of science and technology studies (STS) (Bloor 
1991) are used to sustain the neutrality of the thesis. The Strong Programme is defined 
by four tenets in which Bloor (1991) says of a proper sociology of knowledge that; 
1. It would be causal, i.e. concerned with the conditions that bring about belief or 
states of knowledge. Naturally there will be other types of causes apart from 
social ones which will cooperate in bringing about belief. 
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2. It would be impartial with respect to truth and falsity, rationality or 
irrationality, success or failure. Both sides of these dichotomies will require 
explanation. 
3. It would be symmetrical in its style of explanation. The same types of causes 
would explain, say, true and false beliefs. 
4. It would be reflexive. In principle its patterns of explanation would be 
applicable to sociology itself. Like the requirement of symmetry, this is a 
response to the need for general explanations. It is an obvious requirement of 
principle, otherwise sociology would be a standing refutation of its own 
theories. 
 
The second and third of these are mostly utilised within this thesis, in that both sides 
of the primate use debate will be described without making an distinction as 
to which is right or wrong. The principle of symmetry will be adopted with the same 
resources used to explain each side’s beliefs. The Strong Programme may at first seem 
incompatible with the adopted objectivist/realist approach, as it is frequently classed 
under the label of ‘social constructivism’ (Bloor 1999) and allied with a more 
relativist reading (Kochan 2009). However, Lewens (2005) argues that the Strong 
Programme is compatible with realist thinking and provides an accordant 
interpretation of each of the four tenets. For example, Lewens feels that the reading of 
the symmetry principle given in the following quotation from Barnes and Bloor 
(1982) gives nothing for the realist to disagree with: 
 
Our equivalence postulate [an alternative name for the symmetry principle] is 
that all beliefs are on a par with one another with respect to the causes of their 
credibility. It is not that all beliefs are equally true or equally false, but that 
regardless of truth and falsity the fact of their credibility is to be seen as 
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equally problematic. The position we shall defend is that the incidence of all 
beliefs without exception calls for empirical investigation and must be 
accounted for by finding the specific, local causes of credibility.  [Sociologists 
of knowledge] simply investigate the contingent determinants of belief and 
reasoning without regard to whether the beliefs are true or the inferences 
rational. They exhibit the same degree of curiosity in both cases (Barnes and 
Bloor 1982 in Lewens 2005). 
 
He feels that this is a problem: 
 
…of explaining why certain beliefs, or practices of inference, are found 
credible by those who hold them. Even realists agree that true beliefs can be 
explained causally, and beliefs about what reasons are good reasons need 
causal explanation too (Lewens 2005). 
 
This indicates that this approach is appropriate for this thesis, as it is the views of 
scientists that are being sought and, so long as an awareness of possible reasons for 
those views is maintained, then the Strong programme is applicable in helping to 
preserve an element of neutrality in the analysis and presentation of results. 
 
In addition, when looking at scientific controversies, such as cold fusion or in this 
case whether primates are the best model for a disease, it is important to take a 
symmetrical approach to avoid seeing losing participants as being unreasonable 
(Sismondo 2003). Given that participants in disputes or debates always have, what at 
least seem, to them, good reasons for taking the positions that they do, then there 
should be an attempt to decipher the forces behind those reasons for both protagonist 
and antagonist viewpoints on primate experimentation. 
 
The following summarises the key theories that initially influenced this study. It is 
included in this chapter because of the way in which these approaches have influenced 
the methodological design. It is acknowledged that this summary of theoretical 
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frameworks is not an extensive review but instead provides an overview of the point 
from which the research began. The intention from the outset was to see what 
emerged from the data in terms of social dynamics of science and the associated 
theoretical frameworks. The findings from the documentary analysis (Chapter 3) and 
case studies (Chapters 4 and 5) revealed the key social dynamics at play in 
interpreting and understanding the primate debate impasse, which formed the structure 
of the discussion in Chapter 6 (i.e. competition and reputation, expectations, core sets 
and publications, entrenchment and policy, and ethics, speciesism and ‘others’). 
Therefore, throughout the thesis as each dynamic is presented the associated literature 
is described and critiqued. In Chapter 6 the direct consequences for existing social 
scientific thinking are specifically detailed. Indeed, Jensen and Holliman (2009) note 
that this type of inductive approach, which does not necessarily fulfil all aspects of 
Glaser and Strauss ‘Grounded Theory’ has been adopted by many qualitative 
researchers. In their research of certain forms of science communication Jensen and 
Holliman adopt this inductive orientation, while acknowledging that it is not possible 
to start completely from scratch their approach ‘33
		
	$  	  		  $  	 3 $’ 
(Jensen and Holliman 2009 p.57). In a similar vein the following theoretical 
frameworks are those which initially informed and guided my methodological 
approach. 
 
+:0:-'%##()%)#)#"#( #!)%&%
Gilbert (1976) examined the creation of scientific knowledge through the writing of 
research papers. He noted that citations within research papers are used to establish 
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the authority of the author’s argument, but that the reader of the paper may come to a 
different conclusion than that of the author. He also suggested that, given the way that 
knowledge claims are constructed, it is extremely difficult for a scientist to achieve 
recognition when proposing an alternative to an established model. In a later paper, 
Gilbert (1977) described the use of references as persuasive tools, with the most 
effective way to justify an argument being to cite papers that the intended audience 
believe present wellfounded, valid results. However, not all relevant articles are 
equally valuable for achieving this, leading to selective citation. Prior to Gilbert’s 
discussion, Thorpe (1973) made the interesting observation that there are ‘takenfor
granted references’ within scientific discourses that become acknowledged as valid 
evidence in support of arguments or new/counter hypotheses, without ever being 
critically reevaluated. These concepts are extremely relevant to understanding how 
the various parties construct the primate debate and for examining why certain 
arguments are used to establish authority. In analysing relevant reports and scientific 
papers, their persuasive nature has to be taken into account because, as noted earlier 
due to the controversial nature of the debate could mean that authors present matters 
in a favourable or unfavourable light to improve the standing or beliefs of the group 
they belong to Scott (1990).  
 
+:0:+%&'@*!)!#
The theoretical framework, the ‘Theory of Expectations’, provided some of the 
original impetus for analysing the primate reports, because, as Brown (2003) argues 
about press releases, they translate and stabilise information that might otherwise go 
unnoticed in the wider world, and they are characterised by language and discourse 
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that would never appear in traditional peerreviewed texts. They also serve as a space 
in which to construct expectations about biomedical research and carry them to a 
wider audience, and are useful for shaping peoples’ expectations about the field in 
much the same way as review papers (Hedgecoe 2006). This choice was shown to be 
appropriate as the documentary analysis indicated that, in several ways, this 
framework can be applied to the primate experimentation controversy and possibly to 
biomedical science more generally. This includes the use of sickness narratives to 
create space for and justify morally challenging research (Brown 2003 and Mulkay 
1993) and using examples of established techniques to serve as a basis for visions of 
future benefits in an attempt to shift the emphasis of the research (Brown 2003 and 
Hedgecoe 2006). Hypothetical future benefits are also offered by the scientists to 
legitimise the costs to the primates retrospectively being seen to be morally 
unjustifiable (Brown 2003). There is an apparent hype/disappointment cycle (Brown 
2003 and Konrad 2006), where expectations have been raised but beneficial outcomes 
remain elusive, resulting in a rapid downturn in expectations and a shift in the type of 
research conducted. When discussing the use of expectations or ‘visions’ in emerging 
biotechnologies, Hedgecoe and Martin (2003) argue that: 
 
…the creation of a bioethical discourse around a controversial technology is 
important as it provides a negotiation space to explore the socially acceptable 
limits of the technology and acts as a means of enrolling support from key 
actors (p.329). 
 
The theory of expectations has previously been used to consider why hype and overly 
optimistic forecasts of the benefits of scientific research might have been made, and 
how that might affect the reputations of the scientists and their organisations (Pollock 
and Williams 2010). Pollock and Williams (2010) argue that expectations can be 
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performative or ‘selffulfilling prophecies’, in that because people are convinced by 
the claims, they continue to fund and conduct research into them. This may well be 
the case for primatebased research or indeed may be a way forward to increase 
investment in alternative techniques, and so is considered in the analysis in Chapters 3 
to 5. 
 
It has also been established that expectations are the outcome of competition, with the 
most vociferous actor/group being the most likely to have their expectations 
disseminated widely enough for them to be seen as a normative anticipation of the 
future (Brown 2003). How this relates to the use of primates and the consequences for 
explaining the path of biomedical science is explored later in Chapters 3 to 5.  
 
+:0:0%!
The ‘core set’, defined by Collins (1988) as ‘	   	
 
	  		  	 	  	 	$
 	 	
	 		$	
’ (p. 728), has previously been examined in the context of 
the animal experimentation controversy. Michael and Birke (1994a) investigated how 
scientists involved in animal experimentation restricted access to their core set and 
placed criteria on whom they regarded as having legitimate membership and thus a 
voice in the debate. The decision to conduct interviews was partially guided by this 
theoretical framework as, in order to interpret how primate experimentation is viewed 
and justified, the core set of primate researchers and alternatives users had to be 
accessed. In addition, as Collins (1999) discusses, relying entirely on published 
literature may give a false sense of what are the salient and important aspects of 
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research within a field, because as an ‘outsider’ I might interpret published papers as 
being significant to the field, whilst those within the field may actually see them as 
marginal or may even ignore them altogether. In order to better understand the 
predominant interpretation of the published literature it was necessary to have access 
to members of the core set and even perhaps the ‘core group’ (the members of the 
core set who hold the dominant viewpoint). Exploring this relationship between what 
is published and how that is controlled and interpreted by the different layers of the 
community helped in the interpretation of what is driving certain areas of research and 
why there may be barriers to others. This literature contributed to understanding the 
observed interactions and helped in explaining why certain actors have more or less 
influence on biomedical science and its perceived value. 
 
More recently, Hedgecoe (2006) combined the ideas of the ‘core set’ and the theory of 
expectations to explain why a disputed link between carrying a certain gene and 
reduced response to the Alzheimer’s disease (AD) drug Tacrine continues to be cited. 
Whether a combination of the concepts of the core set and the theory of expectations 
can explain the continuation of the primate experimentation controversy is explored in 
Chapter 6. 
 
+:0:/)**%))'#(&
This literature provided further reasons to analyse the primate reports. Since, in 
processes of social appraisal, substantive perspectives call for participation in decision 
making, including the involvement of lay people (Stirling 2008), the reports could be 
seen as engaging the public in the primate experimentation debate. Indeed, in some 
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cases the reports have been aimed at influencing policy and regulatory decisions. As 
many of the reports have a specified outcome, to end or promote primate research, one 
would expect ‘	 8		’ for that outcome. It is argued that deliberate 
conditioning of the framing of the appraisal of technology, or in this case the 
failures/successes of primate experiments, will provide a promising means to secure 
the desired outcomes (Stirling 2008). In Chapters 4 and 5 this framework helped in 
explaining how and why scientists provide different levels of justification for their 
work and whether some of the findings are examples of ‘sound science’ being used to 
legitimise certain decisions within biomedical science policy/practice, even when the 
evidence is equivocal (Millstone and van Zwanenberg 2002). 
 
!,
	
	
 
The primary focus of this research is to examine and understand the controversial 
primate experimentation debate in an effort to determine if the stalemate which exists 
in moving towards replacing such studies can be overcome, and if so how. This 
chapter explains how the different phases of the project were designed to effectively 
and rigorously conduct the research, including the methodological decisions and the 
analytical approaches that were taken in the process. 
 
The description of the multimethod design adopted in this project highlights how 
combining different approaches has enabled a new perspective on this complex, 
polarised topic and provides a powerful means to qualitatively investigate scientific 
controversy and practice. This chapter sought to show that although strategies such as 
documentary analysis, and thematic analysis of semistructured interviews are not 
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well defined in current methodological literature they can be effectively implemented 
in conjunction with a multiplecase study to elucidate the nuanced complexities of 
how and why an area of scientific debate exist and persists. Comparing contrasting 
cases enables important identification of the dimensions and interactions within the 
social dynamics of science that are different or similar between cases, which in turn 
allows possible solutions to overcome the identified impasse to be distinguished. 
 
On reflection the decision to adopt a semiinductive approach to the design and 
analysis of this project resulted in a sound basis from which to build the research in a 
coherent way. The methodological decisions to conduct a documentary analysis and 
interviews were guided by the existing theoretical literature, but by not restricting the 
analysis to those theories, important details about the influence of other social 
dynamics such as entrenchment and competition could be identified. The nature of the 
interviews as oneonone, facetoface allowed access to viewpoints that are often 
regarded as difficult to reach. Providing assurance of anonymity, and my own 
scientific background were also important for building the trust and rapport that 
helped the participants to feel comfortable and confident in providing those views. 
 
Combining methods in the way that is described in this chapter enabled appropriate 
cases to be identified and provided a rich data set from which to make the 
comparisons to answer the research questions and make recommendations to meet the 
overall aim. 
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The next chapter presents the documentary analysis which represents the first phase of 
the methodological approach described here. The second phase of the study, the case 
study interviews are detailed in Chapters 4 and 5. 
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In terms of the broader thesis, this chapter represents the first phase of the project to 
identify what arguments are given and to compare and contrast how they are presented 
by the opposing sides in the debate. It describes the indepth documentary analysis of 
reports describing primate experimentation, so combines background information and 
data. The rationale and methods are detailed in Chapter 2 (2.2.1). In summary, 18 
reports published 19862007 were analysed and classified as antiprimate use or pro
primate use. This classification was based on whether the organisations or individuals 
responsible for the reports were known to support or oppose primate use. When the 
stance was unclear then the decision was based on the amount of proprimate versus 
antiprimate use content the report contained. If the reports are discussed they are 
referred to as antireport or proreport, and cited by an allocated number in square 
parenthesis (Appendix 1). 
 
The reports range in length from six to 147 pages and many are professionally 
produced including photographs. Table 9 describes the appearance and overall style of 
the reports. The content of each report was analysed with the aim of establishing how 
the authors of each one attempt to make their claims. The findings incorporate 
descriptions of the scientific claims made and are divided by the theoretical themes; 
persuasive referencing, expectations, and cores sets, which enable understanding and 
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explanation of why those claims are made and how they impact on the primate debate. 
As described in Chapter 2 the final report which resulted from this analysis was too 
extensive for the current study. Therefore, to provide consistency with the case studies 
presented later the primary focus in this chapter is the findings resulting from the 
reporting of research into; Parkinson’s disease (PD) − a chronic neurodegenerative 
disorder leading to severe motor impairments and cognitive dysfunction; and 
schistosomiasis – a macroparasitic infection, which can lead to a variety of chronic 
symptoms, such as abdominal pain and seizures. However, where data from the other 
diseases analysed is particularly important to provide contrast and/or additional 
support relevant in the overall context of the thesis these are reported. 
 
)7A summary description of the appearance and style of the primate reports 
analysed in the documentary analysis. Appendix 1 contains further bibliographical 
detail. 
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Anti
primate 
use. 
A4 booklet style with a blue front 
cover, including a large black and 
white photograph of a primate and 
smaller bluetoned photographs of 
people using alternative techniques, 
such as microscopy. It includes the 
logos of the organisations. Further 
bluetoned photographs of people 
involved in alternative methods are 
found on the back cover. Black text 
only including tables. Contains 100 
references. 19 pages. 
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As noted in Chapter 2 (2.3.1), Gilbert (1976) examined the creation of scientific 
knowledge through writing of research papers and explored ‘ 
’ (Gilbert 1977 p.115), including selective citation. Scott (1990) also 
commented on authors of scientific discourse presenting matters in an unfavourable or 
favourable light to support their stance. This section describes how the reports provide 
clear examples of persuasive referencing but that the form it takes and the successful 
application of it varies depending on the overall stance of the authors. It also describes 
interesting findings which indicate that ‘balanced referencing’ could be being adopted 
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in two of the reports as a means to improve the credibility of the authors overall 
stance. The findings are presented under the subheadings Parkinson’s disease and 
Schistosomiasis, but where examples from other fields of research are pertinent they 
are also included within these subdivisions. 
 
;9&
The authors of reports dealing with PD appear to use persuasive referencing with 
varying degrees of success and in both obvious and less explicit ways. Several anti
reports ([3, 4, 10, 15 and 18]) appear to use persuasive referencing when refuting 
scientific justifications for using 1methyl4phenyl1,2,3,6tetrahydropyridine 
(MPTP) primates − the controversial MPTP primate model of PD was developed after 
the discovery in 1982 that MPTP induced Parkinsonism in young adults (Langston 	
) 1983). For example, the British Union for the Abolition of Vivisection (BUAV) 
discusses scientific drawbacks of the model, including differences in aetiology of the 
two syndromes leading to a host of variations between human PD and MPTP 
primates, such as an absence of Lewy bodies (intraneuronal inclusions). Central to 
the argument is this quote, ‘[with human PD] 			
			(;;
	9 (Rose 	)1989, p.308), 
which in isolation is apparently convincing as it is from a group well known for its 
primate research in this field. However, while Rose 	 ) (1989) identified several 
limitations of the marmoset (	 8) MPTP model, they still conclude it 
will be useful in studying early stage disease. Their report [3] comes to a different 
conclusion than that of the original research, a fact which is concealed by selective 
quotation. This may not be deliberate as Gilbert (1976) observed; ‘4		
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	’ (p. 295), depending on the scientific perspective with which the reader 
approaches the work. Here, Crawford’s [3] perspective is one against using primates 
so he has taken the above as a conclusion in support of his ideas rather than those of 
the authors of the paper. It could be, as Gilbert (1976) proposed, that Crawford is 
ignoring claims within Rose 	 ) (1989) which do not seem consistent with his 
perspective, so is perhaps inadvertently using persuasive referencing to reinforce what 
he sees as failure of the MPTP model. 
 
There is some evidence that antiauthors are sporadic or inefficient in their use of 
persuasive referencing, particularly when discussing alternatives. For example, 
Crawford [3] fails to use citations when asserting that alternatives to MPTP primates 
are already in use and will be much more likely to produce useful and relevant results. 
Because these claims are not substantiated by references, it is difficult to establish, 
from this report [3] how realistic these ideas were considered at the time. This 
illustrates the importance of ‘’ (Gilbert 1977, p.115) to verify 
a new knowledge claim. In constructing knowledge claims, scientists are required to 
demonstrate that the procedures/models used are standardised and widely recognised 
already (Gilbert 1976). Here, the established model is primate experiments and 
Crawford [3] is proposing new alternative models, which is recognised as being 
extremely difficult to achieve recognition for (Gilbert 1976). Therefore, to persuade 
the scientific community and other interested parties of the veracity of these new 
alternative models, the author needed to provide persuasive references. The reader is 
likely to be less convinced as to whether the proposed alternative techniques can 
replace established primate experiments because Crawford [3] fails to relate 
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alternative models to current knowledge, how they then advance that knowledge and 
illustrate the new models incorporate appropriate techniques and theories. 
 
Another BUAV report [13], which presents arguments against primate use in acquired 
immunodeficiency syndrome (AIDS)/human immunodeficiency virus (HIV) research, 
is of particular interest here. As in other reports, the key differences between simian 
immunodeficiency virus (SIV; the primate equivalent to HIV) and HIV are given, but 
the author’s [13] choice of supporting citations is surprising in some instances and in 
others is superficial, when more detail would have strengthened the presented 
argument. For example, she notes SIV is not as virulent as HIV and does not produce 
severe illness, but fails to describe the genetic reason for this as provided by the cited 
reference (Hardman 2006), which gives the scientific context for the difference. In the 
same way as Crawford [3], Taylor [13] uses citations to draw conclusions that the 
authors probably did not intend. For example, Gardner and Luciw (1989) are cited as 
evidence for differences in presentation of symptoms between macaques and humans. 
They discuss advantages and limitations of various models, but overall they advocate 
using macaque models. This approach is somewhat unusual given that this report [13] 
has a specified outcome – to end primate AIDS research – and as such one would 
expect ‘strong justification’ for that outcome. It is argued that deliberate conditioning 
or framing of the appraisal of technology, or in this case failures of primate 
experiments, will provide a promising means to secure the desired outcomes (Stirling 
2008). Therefore, it seems unusual that this author has not given stronger justification, 
which may explain why primate experiments continue to dominate AIDS/HIV 
research as well as indicating that antiauthors may be unaware of the impact 
persuasive referencing can have, so are using it sporadically. 
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It is apparent that some antiauthors are developing their persuasive technique. For 
example, the European Coalition to End Animal Experiments (ECEAE) [4] refutes 
what they identify as claims made that major findings concerning PD originate from 
primate experiments by presenting a literature search that shows approximately 90% 
of publications on PD from 19841996 were based on human studies. They argue this 
indicates that scientists consider patient studies to be more relevant than primate ones. 
This is a compelling argument for opponents of primate research. However, the report 
fails to give a full account of how the search was conducted; doing so would have 
strengthened the claims made by giving the reader reassurance they had sought to 
omit their biases as antiprimate advocates. Unlike the Crawford report [3], this one 
provides references in relation to alternatives to primate models, which illustrate how 
methods such as Positron Emission Tomography (PET) and $	 cell systems can 
be used to study PD. But it does not indicate how or when these techniques could 
replace the primate model or why they have not already. Ruhdel and Sauer [4] appear 
to be developing a more ‘scientific’ approach to presenting their claims. By this I 
mean they are using references to demonstrate the veracity of their proposed 
alternative approaches in an attempt to show they have ‘ 	 	
$			9(Gilbert 1976, p. 285). 
 
When reporting on a second neurological disorder, Alzheimer’s disease, Ruhdel and 
Sauer [4] use ‘scientific’ citation again but provide an interesting example of a 
different kind of reference. They justify the inappropriateness of using elderly 
primates in AD research by quoting primate users Podlisny 	)(1991) and Bons 	
) (1992) expressing doubt over the contribution of primate models to AD 
knowledge. However, it is unclear if they read these papers independently or have 
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simply taken the citation from Crawford [3] or another source. The misspelling of 
Podlisny (Podlinsky in [4]) and a slight error in the Bons 	)quotation indicate the 
latter is most likely true. If so, this may be an example of ‘takenforgranted 
references’ which Thorpe (1973) defines as: 
 
…an original empirical study. The findings of which become accepted and 
thereafter acknowledged as valid evidence in support of argument or for the 
generation of new hypotheses or counter hypotheses without presentation of 
critical reevaluation. (Thorpe 1973, p.361) 
 
Ruhdel and Sauer could have accepted these quotations without consulting or 
assessing the original papers, particularly if this is a case of the original study fading 
away from consciousness and only the quoted findings becoming relevantinuse 
(Thorpe 1973). 
 
The proprimate reports contain very little discourse regarding the MPTP model. The 
Boyd Group, a forum for dialogue on contentious issues in laboratory animal use, 
merely include a case study advocating the suitability of MPTP marmosets for 
studying acute pharmacological interventions, but not for surgical treatments for PD, 
in order to ‘4				3				
3	’ ([7], p.16). 
 
The pro>	 "	 [17], includes the MPTP model, but requires 
contextualisation. It was commissioned by organisations with a long history of 
funding primate research (The Academy of Medical Sciences, Medical Research 
Council [MRC], The Royal Society and the Wellcome Trust) although it is 
emphasised they played no part in determining the contents of the report, which were 
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written by members of a working party. For reasons that become clear throughout this 
chapter, this report is deemed proprimate use. 
 
The report [17] gives an unreferenced list of deficiencies of primate models that were 
submitted to the authors by various stakeholders. From personal experience, I am 
aware that many of those stakeholders provided references to support information they 
submitted to the report. During the consultation period for the report [17] I co
authored the FRAME submission to the Weatherall group which contained many 
references. Following the publication of the report [17] FRAME solicited views about 
its contents and recommendations from the organisations that had contributed to it. As 
part of this FRAME asked the responding organisations to provide a copy of their 
original submission to the Weatherall group (if it had not already been published). 
From these submissions it was clear that scientific literature had been cited to support 
claims that were being made by many of the stakeholder groups. This appears to be a 
clear case of selective citation by the report’s [17] authors, as they seem to have 
ignored all references that could validate a claim which opposes their stance that 
primate use is necessary. It is impossible to say if this was a deliberate attempt to cast 
doubt on opposing assertions, but given that the sponsors state it is an ‘	
	 	 	 	 3  	 	0 	  	   1
	’ (sponsors’ statement), it seems unusual that the report provides 
some references for pro aspects of the discussion but none for the counterpoints. It 
could be that the authors did not accept the validity of claims made in the submitted 
citations so did not want to imply any acceptance by including them (Gilbert 1976), 
but for a balanced evaluation of the arguments, submitted evidence should be 
presented to the reader and reasons for not accepting the counter arguments explained. 
Page | 87  
 
Further evidence of this selective citation by omission can be seen in the pro
>	"	 report’s [17] treatment of AIDS/HIV research. It claims primates 
are vital for investigating pathogenesis of HIV and for developing treatments. The 
authors note limitations of primate models that have been extensively discussed in 
previous reports. However, they provide no references for these limitations, yet when 
a counterargument is made, citations are given. Similar to some antireports not 
providing any proprimate evidence, the proreports give very little if any 
consideration to alternatives to primates in the case of AIDS/HIV. This in itself is 
selective citation. For example, the >	 	 [17] does not discuss any 
alternative methods of researching AIDS besides an explanation of a transgenic mouse 
model that might be useful in investigating ‘primeboost’ vaccines. Instead it directs 
the reader to two reviews on different approaches to developing HIV vaccines. Given 
the stated aim of this report, this seems very superficial compared to the coverage that 
primate models receive, and given that even a cursory search of the literature reveals a 
great deal of AIDS/HIV research is conducted without using primates. 
 
<	
One anti [2] and one proreport [17] cover schistosomiasis studies. Both use 
persuasive referencing, although the antireport does this in an unusual way. 
 
The antireport [2] presents an unexpectedly positive account of the schistosomiasis 
research. Hampson 	) [2] describes five studies spanning 19841988 by the same 
lead author (Sturrock), which used olive baboons (; 3) to investigate 
induction of resistance to reinfection and curative drug therapy for schistosomiasis. 
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These studies conclude that this primate model produced different results to earlier 
findings in mice, and that consequently, rodent results should be extrapolated to 
humans with caution. They found a positive therapeutic action from a test compound 
and chemotherapy that could be the basis of evaluating the effects of treatments for 
human infection. While the report[2] is mostly descriptive the tone is relatively pro
primate use in this case, detailing the positive conclusions of the citations that support 
using baboons in this field and providing a proprimate quotation from one of the 
papers: 
 
…Primates, in many ways better than rodents, though too expensive for 
general use, remain invaluable for testing the relevance of rodent findings to 
man (Sturrock 1986 in [2], p.46) 
 
There is no criticism of the work or counterpoints made, which given the antiprimate 
use stance of the RSPCA and FRAME, tends to lead the reader to believe this work 
was justified and provided some benefit toward treatments for the disease. However, 
at least one of the citations provides some cause for questioning the asserted 
usefulness of the baboon model when it concludes: 
 
So far, though, the weight of our evidence and that from previous studies 
indicates that baboons develop neither hepatic fibrosis nor collateral 
circulation comparable to that seen in man or mice. If this is so, it limits the 
usefulness of baboons for investigating schistosomal liver fibrosis. (Sturrock 	
) 1988, p.46) 
 
Unusually, the report [2] did not describe this finding even though it is obviously 
more in keeping with their viewpoint. This appears to be a case of persuasive 
referencing through selective citation but in the opposite direction than would be 
expected. It is difficult to know why the authors omitted this, but it may be they think 
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that the evidence is strong and do not feel a counter argument would be credible so 
have not made one. Alternatively, perhaps they are purposefully not trying to persuade 
the reader as would be expected, given that the majority of the other reports do. 
 
One explanation for purposively not being persuasive, and in some instances actually 
being more persuasive in the opposite prodirection, may be that the FRAME/RSPCA 
report [2] was trying to remain neutral and present both sides of the debate in the hope 
of adding credibility to their overall stance of being against primate use. This analysis 
suggests that this could be because they wanted to avoid accusations of bias so were 
overly ‘neutral’. This is strengthened when the general discussion is taken into 
account. This section clearly lays out the concerns the authors have about primate 
work and justification for it, which was not present in the individual disease sections, 
for example: 
 
The most striking impression gained from our survey…was the uneven quality 
of the research itself and of the way it was recorded in the published literature 
([2], p.61] 
 
Most of the papers contained no justification of choice of species, and in many 
cases the impression is given that animals were used merely because they 
happened to be around…([2], p.63) 
 
Therefore, it may be that, as I term it, the ‘balanced referencing’ used earlier in the 
report was done to give a more impartial impression, so when the authors make their 
final summaries about the survey, the reader would be more convinced that they had 
made a reasoned decision about their claims, so giving them more credibility.  
 
This application of ‘balanced referencing’ to persuade the reader of an overall anti
stance and give greater strength to the suggested alternatives was also evident in 
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Bottrill’s antireport [5], especially in her discussion about AIDS/HIV research. This 
particular example also illustrates a unique example within all these reports of an 
explicit conflict among primate users as to whether a primate (chimpanzee) model 
should be used. The AIDS/HIV section of Bottrill’s report [5] exhibits a lack of 
selective citation when it provides a referenced account of the different models 
available for studying AIDS/HIV, such as the severe combined immunodeficiency 
(SCID) mouse and the feline immunodeficiency virus (FIV) cat, including the benefits 
and limitations. The author [5] presents justifications for using chimpanzees, and the 
refutations of the claims associated with them, more or less equally. Noting for 
example, the Biomedical Research Centre (BPRC)’s opinion that chimpanzees are 
useful in vaccination studies to investigate protection against HIV infection, as they 
do not develop AIDS, so they may have something in common with longterm HIV 
survivors; as well as the Paul EhrlichInstitute (PEI) opposition that this may result 
from evolutionary adaptation to the virus in chimpanzees, but not humans, so can be 
studied in other species of primate. This could simply be reflective of the conflict 
within the field at the time as Bottrill notes, ‘[chimpanzee research]
 	 	
  	 3     	 	 	
	
’ ([5], p.74). However, to be associated as a member of that community she 
has possibly reported it in this way in order to give credibility to other aspects of the 
report that would be seen as more anti, such as suggestions for reducing primate use, 
or using alternatives, so improving the likelihood of them being accepted. Therefore, 
this may be a means of becoming accepted into the ‘core set’, that is, the experts in the 
field who participate in resolving this particular scientific controversy (Collins 1988), 
which is discussed in more detail in section 3.3. 
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The AIDS/HIV discourse also included only the second example of explicit conflict 
within all of these reports, this time regarding which overall research aim was most 
appropriate. Two antireports [4 and 5] questioned if trying to develop a vaccine was 
the right approach to take. This was the only disease in these publications where the 
foundation upon which expectations about primate models − and to some extent 
alternatives − were being constructed, was questioned. This contention about which 
overall aim a field of research as a whole should work toward was more evident in the 
interview stage of this project (Chapters 4 and 5), so why there were not more 
examples in the primate reports is perplexing. The nature of these reports may provide 
some explanation. They are publicly available and generally aimed at influencing 
policy and/or garnering support for the stance they advocate. Therefore, authors may 
want to present a ‘united front’ so as not to detract from the overall message they are 
trying to impart on the reader, by avoiding indicating that there may be disagreement 
about it. 
 
The proreport [17] provides evidence of more traditional persuasive referencing. The 
discussion about primate use in schistosomiasis studies is based on a single 
submission from one research group and hence the entire primate related citations, 
except for one, have members of the group as authors. The report uncritically 
summarises the findings of the group’s four cited papers as: 
 
Research over the last ten years has shown that nonhuman primates are the 
only animals for which it is possible to produce infections that closely mimic 
those in humans in every aspect of the complex life cycles of the parasites. 
([17], p.54, my emphasis) 
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The citations provide evidence for a physiological argument for using rhesus 
macaques (( 		) and olive baboons as infection models for 
schistosomiasis, based on features of these species that facilitate a study of 
concomitant immunity allowing a more realistic schistosome worm burden to be 
achieved, which is not easily replicated in rodent models (Wilson and Coulson 1998; 
Wilson and Coulson 1999). Primate models also permit the direct measurement of 
worm burden to more accurately evaluate the efficacy of a candidate vaccine, rather 
than requiring indirect measurements, used in human trials, which overestimate 
protection from infection (Kariuki 	 ) 2004). However, the report [17] does not 
describe any of the beneficial research conducted in other species that is evident in 
some of the same citations. For example, much of the discovery and development of 
potential therapeutic candidates has been a result of studies in mice (Wilson and 
Coulson 1998; Wilson and Coulson 1999), humans, and by using $	 techniques 
(Capron 	)2005; Wilson and Coulson 1998). This appears to be a clear example of 
selective citation to persuade the reader of the report’s stance that the primate should 
be used in this area. This is strengthened further when examining the report’s [17] 
assertion: 
 
…it seems inevitable that nonhuman primates will be required for their 
[potential vaccines] evaluation. ([17], p.54, my emphasis) 
 
Supporting this is an example of a current vaccine trial that ‘…%1
		$	’ ([17] p.54). The citation (Capron 	)2005) given for 
this features work in primates, but this is talked about in conjunction with parallel 
studies on cattle and humans, which appear to have given the same results as the 
primates, begging the question: is it inevitable to use primates or could cattle studies 
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perhaps be used instead? Additionally, the majority of the discussion in Capron 	)
(2005) revolves around studies on rats, mice and humans, none of which is described 
by the report [17]. 
 
This report [17] has made bold statements about the need for primates based on one 
group’s submitted information, with no indication of any checking of the assertions 
made by that group or any description of alternative models that have and could be 
used. Therefore, as well as being a case of selective citation, this could be related to 
the reputations of the submitting group. The authors of the report [17] may have 
viewed this research group as being the ‘core set’, which is discussed in more detail in 
section 3.4. 
 
  )%&
This analysis shows that the primate report authors use persuasive referencing in 
describing Parkinson’s disease and schistosomiasis research, and indeed for other 
scientific fields, such as Alzheimer’s disease and AIDS/HIV. What is more interesting 
in the context of this thesis is the different ways that anti and proreports do this. 
Opponents and proponents attempt to create scientific knowledge for and against 
using primate models by using references as persuasive tools (Gilbert 1977). 
Importantly, they do it slightly differently. Proauthors selectively cite by omission 
that is, they do not include any (or very few) references for alternatives or for papers 
questioning the necessity of primate models. Whereas, antiauthors show some 
omission regarding limitations of proposed alternatives, but in general tend to 
selectively cite by selective quotation from papers advocating primate use that is, 
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quoting out of context. These approaches might be expected as Gilbert (1976) noted 
‘4			8	
						?		
	3		’ (p.287), so proauthors may not want to be seen 
as endorsing alternatives or antiarguments, thus do not provide references. The anti
reports appear to conform to Gilbert’s (1976) finding that a published article may 
contain a number of possible knowledge claims, from which the reader will select 
those most relevant to their interpretative stance whilst ignoring others, and which 
might be completely different to the author’s own conclusion. Additionally, anti
authors may feel criticisms which apparently come from the primate user community 
will be more credible and be less likely to be dismissed by that community. There is 
also evidence that antiauthors are perhaps not as adept at utilising selective citations 
as proauthors but that this might be improving in some instance. 
 
In addition, this analysis has revealed an interesting departure from the existing 
literature regarding referencing as persuasion. Antireports [2] and [5] show a distinct 
lack of traditional persuasive referencing. Instead, Bottrill [5] in particular presents 
citations and discussion for both aspects of the debate, including expectations and 
supportive quotations for primate and alternative models alike. This opposes what 
would be expected by Gilbert (1976 and 1977) and others. It may illustrate that 
Bottrill felt that presenting as balanced a discussion of the situation as possible would 
give credibility to her overall stance by avoiding accusations of bias. So I have termed 
it ‘balanced referencing as persuasion’. It could be a further illustration of an attempt 
to be more ‘scientific’ or ‘rational’ so as to be accepted by scientists conducting the 
work (i.e. the core set) as a valid voice in the debate. 
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Persuasive referencing was not used in isolation, as the next section illustrates it was 
often combined with another strategy for gaining support for the claims made, that of 
building expectations. 
 
%%-
	
 
#!%"!#
As noted in Chapter 2 (2.3.2), expectations are used to understand mobilisation of 
resources for, and acceptance of, emerging technologies via construction and 
dissemination of expectations about benefits that might accrue from those 
technologies. This analysis shows that this theoretical framework is applicable to 
scientific techniques and models as well as to emerging technologies. There are 
interesting contrasts between how proauthors and antiauthors appear to utilise 
expectations, including the use of sickness narratives. Again the focus is on PD and 
schistosomiasis research, but examples from other fields of research are included. 
 
;9&
Some authors appear to present information to support their assertions about which 
experimental models will be most beneficial for understanding PD and other diseases 
that can be understood by considering the theory of expectations, including utilising 
‘sickness narratives’ to convince readers of the importance of said benefits. However, 
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the emphasis on expectations is slightly different dependent on the stance of the 
report. 
 
As described in the previous section antireports focused on the MPTP primate model 
in their discussions. They did not consider primate experiments conducted for the 
purpose of investigating Deep Brain Stimulation (DBS) – a surgical intervention that 
involves implanting electrodes into patients’ brains to control the symptoms of PD. In 
contrast the proreports seem to use DBS as their flagship for showing the necessity 
and success of primate studies. In particular the >	"	[17] focuses on the 
‘		’ (p.74) role of MPTP primates in developing ‘	
 	$
			 [DBS]  	 		’ (p.74). It gives an historical overview of how 
DBS was developed from primate work in the early nineties. This account is based on 
information submitted to the authors by researchers in the field and does not include 
supporting citations. It could be that expectations developed about the role of primates 
in DBS have become ‘	$		’ (Konrad 2006, p.431; i.e. have become 
unattributable to specific groups or individuals), with scientists taking them into 
account and assuming others will too. Collective expectations can take on the status of 
‘	11	 1$	 	 		   $ 	 3 8	’ 
(Konrad 2006, p.433), so the authors may have felt it unnecessary to validate the 
assertion that primates were essential in this particular area. 
 
The report [17] argues primates could be needed in future research on stem cell 
therapies, citing studies with early results in this area. Similarly to the antireport [12] 
below, the authors have put their expectations into current context in an attempt to 
show that their visions of future primate use are realistic and achievable (Brown 
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2003). They included a section emphasising the debilitating nature and financial 
implications of PD, so are utilising ‘sickness narratives’ to put greater importance on 
the expectations they are building, as Brown (2003) argues; ‘4		
	$						
 0 			$ $		  8	
 
  ’ 
(p.8). This is discussed in more detail in the schistosomiasis section below. 
 
As the previous section illustrates, antiprimate reports use persuasive referencing to 
discredit proprimate evidence but not to bolster their own claims about alternatives. 
Instead, they appear to construct expectations about alternatives. The antiprimate 
BUAV/ECEAE report [12] provides the most comprehensive discussion of possible 
alternatives to MPTP primates. However, unlike in previous reports this includes fully 
referenced examples of what has already been discovered via the alternative methods 
involved. This account provides optimism that at least some aspects of primate PD 
research can and will be replaced. Importantly, this might be an example of Brown’s 
(2003) using precedence to build expectations about alternatives in order to gain 
acceptance for them. By illustrating how technologies/techniques have already been 
implemented and have led to recognised and accepted findings, the authors are 
providing validation for the expectation that these methods can replace primate studies 
in this field, in order to convince readers their vision of the future is achievable. This 
is also evident in the BUAV report on AIDS research [13], where there is a referenced 
section on ‘6	 B		$9		 		5#'’ (p.11), 
which describes various nonanimal methods and how they ‘$
		’ (p.11). 
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This building of expectations by antiprimate report authors has not always been as 
evident, as illustrated by the lack of examples in the schistosomiasis section below. 
Instead, it appears to have developed over time with the examples above being some 
of the most recent. In the interim between the report featuring schistosomiasis [2] 
published in 1990 and the later reports above [12; 13] both published in 2006, other 
reports illustrate a gradual shift towards presenting information that can be understood 
as expectation building. For example, in Crawford’s 1994 report [3] there is no 
evidence of expectation building, other than the important exception that it features a 
sickness narrative, beginning ‘#&<	
0		

		’ (p.120). As noted above and described 
later, sickness narratives are something which this analysis has found to usually be 
associated with proreports. Given the relatively low number of scientific citations in 
his report Crawford may be using this to add justification to his antistance. By 
highlighting disease severity to illustrate damage that is being done by what he claims 
is a delay in development of a vaccine due to wrongful reliance on primate models. 
 
A few years later (1997c.), Ruhdel and Sauer’s report [4] again contains very little 
evidence of expectation building, with the exception of another unusual use of a 
sickness narrative. They document a primate study conducted to understand the cause, 
origin and progression of Bovine Spongiform Encephalopathy (BSE) with the aim of 
finding a treatment. BSE is one of a group of diseases of the brain known as 
transmittable spongiform encephalopathies (TSEs), which affect humans and animals. 
The documented study revealed similar histological results in the primate brain as 
those in a human variant CreutzfeldtJakob disease (vCJD) brain, suggesting BSE was 
a causative agent of vCJD (Lasmézas 	 )1996). Ruhdel and Sauer [4] deny this 
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work could make any contribution to combating the BSE crisis. They defend this by 
detailing the severity of procedures involved and describing how the animals will 
suffer, for example: 
 
This means that the animals will suffer all the terrible stages of the 
disease…The destruction of the brain is manifested in behavioural changes, 
motor disturbances and violent convulsions, to name but a few. ([4], p.14) 
 
This appears to be a sickness narrative, which parallels those given by proprimate 
reports, but instead of focusing on the suffering of the human patients; these authors 
are using it to highlight the suffering of the animals involved. In doing so they are 
perhaps attempting to garner sympathy for the animals in order to gain support and 
acceptance for their view that the cost to primates in terms of suffering is not 
outweighed by the proposed benefits of the work, in much the same way primate users 
might use sickness narratives to add importance to the benefits they are proposing.  
 
<	
As noted previously, one anti [2] and one proreport [17] cover schistosomiasis 
studies. There is a distinct difference between the two in regards to expectations. In 
this field of research the reports present limited data relating to expectations so this 
section contains several examples from other fields covered by additional reports to 
compare and contrast in more detail how the two sides of the debate differ. 
 
In the antireport’s [2] discussion of schistosomiasis there are no examples of 
descriptions of the present or future benefits of alternatives that could be understood 
as expectations building, or any comments on failures of promises made about primate 
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experiments, which are evident in other antireports (see below). It is difficult to 
explain why this might be the case from this limited information, However, there is a 
lack expectation building throughout the report [2] not just in the case of 
schistosomiasis research. Therefore, it could be indicative that the authors were 
unaware that highlighting the usefulness and future beneficial consequences of the 
alternatives research could act to increase acceptance and resources for it. This is 
supported by the fact this report was published earlier (1990) than all of the others 
(with the exception of [1]) and as noted in the previous section it appears that the anti
authors have only recently begun to exhibit these techniques. 
 
Fifteen years later the proreport [17] presents the stance that primates have and 
should still be justifiably used in evaluating schistosomiasis vaccines. In doing this the 
authors provide references to previous successes with primate models and then justify 
their assertion that ‘4	 $	3 		1	3%’ 
([17], p.54) for evaluating the new approaches to schistosomiasis vaccine 
development, by giving an example of preliminary work that shows positive results to 
this effect. Therefore, they are showing precedence for the promised benefits while at 
the same time placing them in current context to illustrate that they are realistic and 
achievable expectations. 
 
In addition, the report [17] begins with a sickness narrative describing how and why it 
is important to develop an effective schistosomiasis vaccine, thus building up the 
importance of the expected benefits they then describe. This particular report [17] uses 
sickness narratives extensively for the majority of diseases it discusses. For example, 
the report describes how AD affects patients including its ‘ 	’ ([17], 
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p.78) and how the cost implications related to the care of those patients is set to rise as 
incidence increases. This strong emphasis on the debilitating effects of AD is not seen 
in any of the other reports, but it does add credence to the observations of Crawford 
[3] and others over ten years earlier, that scientists engaged in primate research were 
using the severity of the illness to justify their research rather than whether it will ever 
provide any actual benefits for AD sufferers. 
 
Crawford [3] argues that proponents of primate AD models make unsupported claims 
about their usefulness. He feels the seriousness of the condition is used to justify 
primate experimentation or to imply such research is the only hope for sufferers, when 
in fact it has diverted resources away from nonanimal alternative methods that have 
so far led to the most progress. This observation is credible as it is established that 
telling sickness narratives in this way is a powerful means of creating research space 
for and justifying morally challenging research (Brown 2003 and Mulkay 1993). 
Ruhdel and Sauer [4] and Langley [6] also express concern that fear of the disease is 
being exploited by primate researchers to justify invasive and unrelated studies in AD. 
Therefore, it may be that the context into which Shakespeare (2006) put this is most 
appropriate. He talks about a ‘cure rhetoric’, where the scientific and medical 
community and sometimes people with a disease and their families, represent patients 
as being desperate for a cure in order to draw public attention and garner charitable or 
government funding. The controversial nature of primate procedures involved in AD 
research, and the often fundamental nature of the work, could be the reason why this 
proreport [17] and other primate proponents indicated by the antireports have used 
sickness narratives and cure rhetoric in an attempt to add further justification to their 
claims and to make the expected benefits appear more important. 
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An interesting contrast in relation to expectations is that antiauthors focus on failed 
expectations whereas proauthors do not. For example, the AIDS/HIV discourse 
illustrates the role which expectations can have in developing a scientific field. Anti
authors such as, [4], [6] and [13] argue that promises about AIDS/HIV primate models 
remain unfulfilled, with no human vaccine being available despite decades of primate 
research. They contend that these failed expectations make primate research 
unjustified. As future benefits are used to legitimise costs in the present (Brown 2003) 
this viewpoint does not seem unreasonable. However, the proreport [17] defends the 
expectations, arguing that it is unrealistic to expect rapid answers and that the 
longevity of the work merely reflects the complexity of the problem. This may also be 
a valid comment, as Konrad (2006) notes crucial expectations are typically the last to 
be ascertained, and there is often uncertainty as to what constitutes success or failure.  
 
Antireports [4, 6 and 13] also argue that there has been a clear shift away from using 
chimpanzee HIV models. Again this seems to be framed as a consequence of failed 
expectations resulting from physiological and genetic differences as well as logistical 
and financial restrictions. This is best illustrated by the BUAV [13] introducing 
chimpanzee research with ‘	
3:	 
’ ([13], p.5). Brown (2003) and Borup 	) (2006) suggest that exaggerated 
promises (hype) about technologies are necessary to attract sufficient interest and 
funding but this leads to inevitable disappointment as unforeseen problems arise and 
organisational and cultural factors come into play, which can ‘4	   
	’ with past disappointments tending ‘4	3	?		
	
 	   		 	  $ 		’ (Borup 	 ) 2006, 
p.290). The primate reports indicate that this cyclic operation of expectations is 
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applicable to scientific models as well as technologies. Historically HIVchimpanzee 
research appears to have undergone a hype/disappointment cycle (Brown 2003 and 
Konrad 2006), as expectations were raised in the early 1980s that chimpanzees would 
provide a vaccine for HIV, attracting increased funding and leading to a boom in 
studies. However, failure to produce any beneficial outcomes meant this rhetoric of 
hype could not be maintained, and by the late 1990s there was a rapid downturn in 
expectations and scientists (and funding) shifted from chimpanzees to other primates. 
As illustrated by a citation from Ruhdel and Sauer [4], which details the US National 
Institute of Health (NIH) redirecting money for chimpanzee research to other primate 
models as it sees chimpanzees as an ‘…    #&<
	4’(Cohen 1996, p.590). The proreport [17] confirms that this shift has 
occurred by concluding that the chimpanzee has now been replaced. 
 
Proreports [16 and 17] provide very little discussion of alternatives, so do not 
construct expectations about them, which is not unusual given that they want to create 
acceptance for primate models, not alternatives. However, they do not take the 
opportunity to question promises made about alternative models in the same way anti
authors do about primate ones. This seems unusual at first, but it may be they are 
concerned about being construed as unethical, given the value now being placed on 
the Three Rs in legislation and by funding bodies and publishers (Chapter 1). 
 
Interestingly, none of the reports discuss the ethical implications of implementing 
alternative techniques and technologies, despite recognition that they can be ethically 
problematic (Smith and Boyd 1991). This implies that alternatives are seen as morally 
acceptable when compared with the strong ethical objections to animal use or perhaps 
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ethical considerations have not been taken into account; commenting on this is 
difficult and would require further investigation beyond the scope of this thesis. 
However, as Hedgecoe and Martin (2003) observed for pharmacogenetics, alternative 
advocates have possibly attempted to construct expectations that distance the 
alternative methods from the seemingly more serious ethical problems surrounding 
animal experiments, in an effort to shape alternatives as more ethically sound. 
 
  )%&
This analysis shows that expectations were a feature when the reports covered PD, but 
not so much when they discussed schistosomiasis, particularly the antireport [2]. 
However, this could be related more to the age and format of the report [2] than to the 
field of research , as the later interviews indicate that expectations are important 
for understanding some of the schistosomiasis researchers responses (Chapters 4 and 
6). 
 
These findings indicate that different aspects of the theory of expectations concept 
help to explain the opposing sides of the debate. Proauthors construct expectations by 
making promissory statements about benefits that will accrue from primate studies 
and extensively use sickness narratives to strengthen those promises. There is also 
evidence of collective expectations indicating that justifications for primate work may 
be takenforgranted. Proreports do not attempt to question or discredit expectations 
related to alternative methods. In contrast, antireports repeatedly use ‘failed’ 
expectations in primate research to argue it is unjustified. The descriptions of failed 
expectations also provide evidence that the concept of hype/disappointment cycles 
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(Brown 2003; Borup 	 ) 2006) could be applicable to scientific techniques and 
models as well as to emerging technologies. 
 
Whereas proauthors appear to use persuasive referencing and create expectations to 
support their claims about primates, antiauthors almost exclusively rely on the latter 
to justify their assertions about alternatives, particularly in later reports. The reason 
for this may be twofold. Firstly, because alternatives are novel and challenge the 
established primate models, it is more difficult to gain acceptance, associated funding 
and expert interest for them (Gilbert 1976). Therefore, emphasising benefits that will 
accrue from alternative studies may be the most effective way of mobilising the 
necessary resources to cause a shift in research emphasis towards replacing primates 
with these methods. Indeed, the reports themselves provide a platform for building 
expectations and disseminating them to a wider audience than is possible with peer 
reviewed literature. Due to the controversial nature of this debate this may be the most 
efficient route for establishing visions of the future of biomedical science as 
mainstream viewpoints. Secondly, it can be seen that expectations are the outcome of 
competition (Brown 2003), so it may be that antiauthors have noted how proauthors 
have used expectations to so far win this ‘competition’ and are now adopting the same 
approach in attempting to overcome them. The use of a sickness narrative focussing 
on animals [4] may illustrate this. 
 
PD and AD are both neurological disorders generally associated with aging, which 
have limited symptomatic treatments available, yet the reports present the associated 
primate work differently. While authors build expectations about methods they are 
advocating in both areas, there was a greater use of sickness narrative or cure rhetoric 
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in AD. In particular, antiauthors showed awareness of researchers using the 
seriousness of the condition to justify primate models and were concerned that fear of 
the disorder was being exploited to justify invasive and unrelated studies. Sickness 
narratives are used to create space for and justify morally challenging research 
(Brown 2003 and Mulkay 1993), indicating that in AD scientific justification for using 
primates may not be as strong as in other fields. It could also explain why this was not 
evident in PD, where primate studies are more directly applicable to the human 
disorder, and in some cases have been translated into treatments. It could also indicate 
an underlying pressure on scientists to provide an applied justification for their 
research in order to secure funding for it, which is not explicit in these reports but 
which became apparent when speaking to scientists during the case studies (Chapters 
4 and 5). 
 
The final section of this chapter describes how the reports indicate that ‘core sets’ 
could be important in explaining some aspects of the primate debate and indeed why 
certain authors have presented their arguments in the manner that they have, as 
detailed in this section on expectations and the previous one on persuasive 
referencing. 
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As noted in Chapter 2 (2.3.3), the concept of the ‘core set’ was conceived and defined 
by Collins (1988) as ‘		
			
	 	  	 	$
 	 	 	 	 	$	
’ (p. 
728). In 2006, Hedgecoe described it as providing an explanation for ‘	
			0	$
	’ (p.723). The 
findings from this analysis support this description. Interestingly, the importance of 
the concept of a core set is only suggested in the discussions relating to infectious 
diseases such as, schistosomiasis and BSE, but not in the coverage of neurological 
diseases, PD and AD. 
 
;9&
There is nothing in the reports that is indicative that core sets might be applicable to 
understanding the arguments which are presented regarding primate experiments in 
PD or in the other main neurological disease discussed, AD. As noted below this 
might be related to the nature of the field and number of specialists working in it. It is 
also consistent with the findings from the Case Study 2 interviews, which indicated 
that core sets were less influential in PD research than in schistosomiasis (Chapter 5). 
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In contrast to PD there is some evidence that the core set concept could be important 
in explaining the framing of some of the justifications given in schistosomiasis and 
other infectious disease including the balanced referencing described earlier. 
 
As described earlier (section 3.1), proreport [17] made statements about the need for 
primates in schistosomiasis research based on the submissions of one research group. 
This appears to be a case of selective citation as there is no indication of any checking 
of the assertions made by that group or any description of alternative models that have 
and could be used. This uncritical acceptance of the submitted information could also 
be related to the reputations of the submitting group. The authors of the report [17] 
may have viewed this research group as being the core set that is, the experts in the 
field who participate in resolving this particular scientific controversy, and as 
outsiders they did not question the assertions they made or look for counter evidence. 
Hedgecoe (2006) describes this effect as ‘		’ (p.742) with the outsiders 
being further from the scientific fact so seeing it as more certain and straightforward. 
 
In their earlier report, Ruhdel and Sauer [4] make an interesting observation about the 
value which scientists attribute to science itself and as a consequence to animal 
experiments. They note that despite a great deal of epidemiological evidence 
suggesting a causative link between BSE and vCJD, scientists still feel obliged to 
distrust their personal conviction until they have experimental evidence to support it. 
Thus, the primate experiments merely confirm what they already know. This also 
appears to be ‘enchantment9 as the scientists are members of the core set (i.e. actively 
engaged in the experimentation at the heart of the primate controversy) and as such 
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always show an element of doubt about their findings, whereas those outside the core 
set and further from the actual science are more certain about that science (Hedgecoe 
2006). Hence, the scientists feel the need to provide evidence to justify their opinions, 
even when it most likely would not be required by those said to consume their 
findings in a wider context. Why the core set appears influential in these infectious 
disease examples, but not in the neurological examples, may be related to the small 
and specialised nature of the fields. That is, the influence of those in the core set is 
more pronounced and any competition or controversy between them has a magnified 
impact on the direction of the field and techniques and models adopted. 
 
As noted previously (section 3.1), two antireports [2 and 5] appear to be attempting 
‘balanced referencing’ when discussing work being conducted in several areas of 
research including schistosomiasis [2]. As Michael and Birke (1994a) noted, scientists 
in the animal experimentation controversy place criteria on who can be a member of 
the core set. Therefore, attempting to present a more balanced account could be a 
means to be accepted into the core set and be seen by scientists as a credible voice in 
the debate. This could have the consequence of being able to then influence those 
scientists and the direction of research away from primate use, with a greater chance 
of novel ideas (i.e. alternatives) being seen as valid and realistic. 
 
  )%&
This analysis has revealed an interesting difference between the fields of research: a 
possible influence of a core set of scientists in the reporting of primate infection 
models. In the proreport [17] it seemed that the authors may have seen the group who 
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submitted evidence as the specialists that are solving the controversy about the 
validity of the schistosomiasis primate models (i.e. the core set), so did not question 
their evidence. An antireport [4] observed the relationship core set scientists had with 
their own findings, noting that BSE scientists were distrusting their personal 
conviction and epidemiological evidence until they had experimental primate data to 
support it. Both of these examples could be seen as enchantment (Hedgecoe 2006). It 
is unclear from this analysis why core sets may be influential in the field of infectious 
disease but not of neurological disorders, but the case study findings later in the thesis 
(Chapters 4 and 5) indicate it may be related to the size and specialisation of these 
often relatively small fields of research, with disagreements about appropriate 
research strategies being more pronounced among fewer lead scientists. 
 
%.
	
	
 
The central aim of this analysis was to distinguish what kinds of scientific arguments 
are given in support of and against the use of primates in various areas of research, 
and to decipher how they are presented and framed by the two sides of the debate, that 
is, proprimate use and antiprimate use. This analysis has shown that the debate about 
using primates in biomedical science is still controversial, not just between proponents 
and opponents but also within scientific disciplines. It has revealed that authors utilise 
persuasive referencing and expectations to convince the reader of their particular 
stance, and core sets may be influencing some areas of research. There are differences 
in disease framing and in how these theoretical themes explain the two sides of the 
debate. The antiprimate reports use persuasive referencing to discredit proprimate 
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evidence but not to bolster their own claims about alternatives. Instead, they appear to 
construct expectations about alternatives, while extensively highlighting failed 
expectations of primate studies to argue that they are unjustified. In contrast, pro
authors apparently use persuasive referencing and expectations, especially sickness 
narratives, to show the reader their primate research is justified and beneficial, but do 
not attempt to discredit alternative models. Perhaps most interesting was evidence of 
balanced referencing as persuasion, which was not predicted by existing literature. 
 
There was also the intriguing observation that the antiauthors appear to alter the 
emphasis of their argument presentation over time. Together, a slight improvement in 
persuasive referencing, extensive use of expectations and possible balanced 
referencing indicate that antiauthors may be shifting to a more ‘scientific’ way of 
presenting their arguments. This could be due to antiauthors having to address the 
scientific grounding for alternatives, due to more pressure being placed on research 
scientists to do so, as awareness of alternatives increases, which was more apparent in 
the interviews (Chapters 4 and 5). In addition, antiauthors may be attempting to 
engage with scientists at the same level. The modern antimovement has an ethical 
foundation of questioning the morality of experimenting on animals rather than the 
scientific justifications as such (see Franco 2013 for an overview of this). This means 
that many antiauthors may have had less experience in a more scientific arena so are 
only just developing similar approaches to proauthors who mostly argue the scientific 
aspects in reports like these. In addition to simply attempting to discredit primate 
studies, antiauthors now appear to be drawing on scientific work in the expanding 
alternatives field and presenting it as the scientifically justified means of investigating 
diseases. In utilising references and expectations, they show that they follow the 
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correct scientific procedures; that is, presenting experimental work on alternatives, 
which has been done using the same scientific practices as the primate work. 
Theoretically, this makes it more difficult for primate scientists to dismiss claims as 
unscientific or misinterpreted without appearing to have double standards; whether 
this occurs in practice still remains to be seen. Significantly, research scientists seem 
unaware of this shift in approach, as during interviews (Chapters 4 and 5) neither 
primate nor alternative users made any specific comments about it. Therefore, it may 
be a phenomenon associated with this kind of publication or more likely may only be 
in its infancy, but it presents an interesting area for future research. 
 
In the context of the overall thesis these findings provide the basis from which to enter 
the second phase of the project, looking at two of the featured cases, PD and 
schistosomiasis research in more depth. The contrasts between the reporting of the 
primate experimentation in PD and schistosomiasis research, such as differences in 
the use of sickness narratives and the potential influence of the core set, informed my 
purposive choice of these two fields as my case studies, Chapter 2 details the full 
rationale for this choice. This analysis suggests that these two cases provide an 
interesting comparison from which to investigate the primate debate. Given that the 
theoretical themes are applicable across both fields it provides further impetus to 
examine in more depth, through interviews with the scientists conducting the research, 
how important the social dynamics of science are in understanding the impasse in the 
debate. The results of this second stage are reported in Chapters 4 and 5. The 
consequences of the findings from this documentary analysis and the two case studies 
for understanding and overcoming the primate debate impasse are described in 
Chapters 6 and 7. 
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The next two chapters present an analytical summary of the themes that emerged from 
the case study interviews. The interview process is described in detail in Chapter 2, 
along with the rationale for choosing schistosomiasis as a case study. The analysis 
builds upon information gleaned from the documentary analysis (Chapter 3). The 
findings indicate that scientists identify several challenges to and/or opportunities for 
replacing primates in this particular field, and that the social dynamics of science have 
an important role to play in explaining the participants’ responses. These were 
important for understanding the primate impasse (Chapter 6) and developing the 
recommendations for overcoming it (Chapter 7). 
 
Schistosomiasis is a macroparasitic disease caused by trematode worms affecting 
approximately 200 million people at any one time, with the majority of sufferers 
living in Africa (WHO 2010). Its complex lifecycle involves eight morphological 
stages and two hosts (mollusc and mammal). Five species of Schistosoma can infect 
humans causing chronic disease: <	 0 <) 80 <)
	30<)		and <). The first two of these result in an acute 
schistosomiasis state and are the focus of most vaccine research. The disease is 
predominantly treated with oral doses of the drug Praziquantel (or Oxamniquine 
outside the US) but effectiveness varies, with rapid reinfection following treatment 
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making this an expensive option requiring substantial infrastructure (Butterworth 	) 
1987). Additionally, evidence of  resistance is emerging (Capron 1998, Butterworth 	
. 1987); thus there is strong impetus to develop a preventative vaccine. 
 
Early efforts were focused on a vaccine that would protect humans against natural 
infection. Although attenuated larvae induce a good level of immunity in various 
experimental models, consensus was that a nonliving, defined vaccine would be 
easier to produce on a large scale, via recombinant DNA technology (Boulanger 	. 
1991). So far, vaccineinduced immunity has been incomplete, with only partial 
protection being achieved (Capron 1998). For further historical insight on 
schistosomiasis vaccine research see Wilson and Coulson (2006). 
 
In this and the subsequent chapter, participants are identified by a number and ‘P’ for 
primate user or ‘NP’ for not a primate user. I am identified as MH. For one 
participant, some identifiers include [NR] (not recorded). This refers to quotes taken 
in note form rather than transcribed, due to recorder malfunction (see Chapter 2 for 
details). Genderspecific pronouns are not used to avoid compromising anonymity. 
 
Throughout the respondents’ answers they justified science, being a professional 
scientist, conducting certain types of research and studying certain fields of research. 
This was done both explicitly and implicitly. Data fell broadly into four themes that I 
have described as: the Scientific Institution; Practical Science; Animals and Ethics; 
and Health and Ethics. Each theme is broken done into subthemes to illustrate its 
nuances. Comparisons between primate and nonprimate users are given where 
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applicable. This case study was compared to the second PD case study and any 
important observations are presented in the next chapter. 
 
,!'&		
	
 
Participants identified underlying factors that influence how science is done as a way 
of justifying their position and research. Using the language of Merton (1957) I 
categorised these factors as the ‘scientific institution’; that is, processes ingrained in 
the fabric of science illustrating why scientists conduct science as they do. Data are 
presented under the following subthemes: competition, reputation, knowledge 
acceptance and publication.
 
 *!!#
Participants identified the competitive nature of science as a whole as key to 
facilitating or restricting their work. This was sometimes explicitly stated, but also 
subtly inferred, for example I8P considers that they might eventually have been beaten 
to their discovery by another scientist working in the same area: 
 
…if I didn’t discover it somebody over the pond would’ve discovered at the 
same sort of time… (I8P) 
 
Some participants viewed competition as negatively influencing dissemination of 
research findings, by limiting information sharing and collaboration. Fear of having 
their ideas stolen or being ‘		’ (Hagstrom 1974, p.2) was crucial to 
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participants feeling that they or others in the field would not openly discuss their 
work. For example: 
 
Yes I think a meeting would be good bringing together the good and the 
wise….There might also be problems with getting people to reveal their new 
ideas. ([NR]I8P) 
 
A relatively low level of collaboration could account for the apparent strength of the 
negative impact that competition seems to have in this field. While a small number of 
participants reported collaborating with others when choosing models, the majority of 
responses about collaboration called for more, in order to move the field forward. This 
included primate and nonprimate users with the following statement summing up 
responses: 
 
…I think that’s one thing that actually needs to be dealt with on a more serious 
level, larger groupings of collaborations across the field. (I7NP) 
 
This indicates that collaboration might overcome some of the perceived competitive 
challenges to moving the schistosomiasis field forward. 
 
Mixed opinions were expressed in reference to competition, in the context of which 
vaccine strategy or experimental model is likely to contribute most to the field. Some 
regarded competition as positively driving research effort to improve the chance of 
finding solutions − for example, I10P smiled when they spoke of their competition 
with another researcher and how it pushed them to pursue their chosen model and 
strive to make a contribution: 
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…was a good friend of mine…we were extremely competitive together…and 
we had the entirely opposite view…But sometimes it happens that the relations 
are a little bit you know disturbed by {laughs} some conflicting results or 
findings but that’s life and that’s science. (I10P) 
 
Meanwhile, others expressed concern that competition can lead to unnecessary and, in 
this case, morally unacceptable repetition of effort and/or experiments: 
 
…the one side of things that I find morally unacceptable should I say is 
when…the competitive nature of science means that sometimes there can be 
people reinventing the wheel on both sides of the Atlantic for example. 
Because you don’t know what your competitors are doing. And that has 
happened on occasions. (I5P) 
 
While this dual impact of competition has been documented (Hagstrom 1974), it is 
unclear how the scientist’s role in the competition might affect their view of it or 
whether they use it as justification for how science is done. For example, it is 
reasonable that those who see themselves as ‘winners’ see competition more 
positively as opposed to those who class themselves as ‘losers’ who might be more 
negative about it. I6P did this by describing their research group as 	
	 	 $ and, despite using terms such as  and 3		 when 
discussing competing to get their strategy accepted, seemed to relish how it had 
pushed them to continue and develop new ideas: 
 
…when I first stood at Cambridge and said sorry folks it’s all a result of the 
vascular changes…I was not popular…so then ensued a battle…That’s when 
we came to work with people in the States who were likeminded and we kind 
of sorted that out to our satisfaction and eventually I think other people have 
accepted it…it’s not an argument anymore. (I6P) 
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I3NP had recently won an award for their research and, while initially being negative 
about competition, went on to express that it could be useful for driving knowledge 
claims about alternatives: 
 
…I think also the fact that research labs tend to be competitive is not 
particularly helpful. Although it is helpful in some ways I think if you can 
prove from a scientific point of view that animal usage is not desirable then I 
think that can almost force people you know because it makes the data not 
publishable. (I3NP) 
 
In contrast INP described several instances where they had been ‘beaten’ in the 
competition, and their negativity about this extends to withholding information so 
others cannot do the research. In essence the competitive environment may in this 
case slow down research, and INP seems well aware of this: 
 
What I tend to be more reluctant to do is to discuss ideas that I think will rock 
the boat…But you know if it’s an idea that I want to work on and think I can 
work on I‘m not going to go to a discussion group and let someone else 
because they have the resources to do it to you know give them the knowledge 
so that they can do it first…I’m gonna be doginthemangerish and say sod it. 
(INP) 
 
Another participant (I2NP) describes  	 in publication, and expresses 
frustration that competition is delaying dissemination of their work and that this 
particular area of research is not seen as highly ranking in competition terms; it is not 

. 
 
Positive impressions of competition all came from primate users (except I3NP above). 
Therefore, the influence of competition on expectation building and how that might 
have influenced participants’ responses needs consideration. Brown (2003) 
acknowledges that in a competitive environment the most vociferous voices are most 
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likely to have their expectations disseminated widely enough to become more 
generally accepted as ‘what will happen’, and will consequently attract more 
resources for their research. From this data it seems that primate users are currently 
winning this ‘competition’, but indications are that nonprimate users are now more 
aware of this and are using it as a means to attract resources and acceptance for their 
work. For example, this participant recognises they have to ‘sell’ their research to get 
acknowledgment: 
 
…And it’s something which I don’t like but I think it’s necessary in order to 
be able to sell your work you have to have something that makes it a saleable 
thing. (I7NP) 
 
Additionally, participants identified, as Merton (1968) did, that scientists deemed to 
have a strong reputation in the field are at an advantage in the competition. In some 
cases this is disproportionate and possibly damaging for vaccine development. I5P’s 
response to the question of whether those with big reputations influence the field 
summarises this: 
 
Yes. Too much sometimes…like in in other walks of life you get personalities 
who are able to sort of corner the market, they get the funding because of who 
they are not necessarily because of what they’ve produced…so it goes on it’s 
selfperpetuating and not necessarily always for the benefit of everyone else. 
(I5P) 
 
The full significance of scientific reputation is detailed in the next section. 
 
#   )%&, the concept of competition in science was first indicated by Merton 
(1957) who discusses how emphasis on the value of originality in science leads to 
pressures to make contributions to knowledge and to be first to do so. While scientific 
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competition was addressed more extensively in the late 1960s and 70s (see Merton 
1968; Hagstrom 1974; Barber 	 al. 1979), and despite its apparent role in the 
mechanism of the ‘Scientific Institution’, Bonitz and Scharnhorst (2001) noted it has 
fallen out of favour more recently: 
 
Less widely addressed in this literature is one aspect of science that is actually 
one of the necessary conditions for the functioning of science, namely 
“competition in science”. Competition is one of the key mechanisms of the 
science system. Scientists compete for being first and for scientific reward 
institutions compete for the allocation of resources… (Bonitz and Scharnhorst 
2001, p.37) 
 
These findings indicate it is still an important influencing factor on how scientists 
conduct their research. It seems to impact on the direction and progression of the field; 
as such it deserves renewed attention. Particularly interesting is how perceived size 
and importance of the field may affect incidence of competition. Hagstrom (1974) 
posits: 
 
Competition and concern about it will be greatest in specialties perceived to be 
most important for further developments in science because the number of 
competent researchers relative to the number of known research problems will 
be greatest there. (Hagstrom 1974 p.12) 
 
This does not appear to be applicable in this case as concern is high but 
schistosomiasis researchers perceive the work is deemed unimportant by those outside 
the field. Instead, it may be that because there are few aspects within the field to focus 
research on, then competition for resources and acceptance within the small 
community is more acute. This data indicates that, according to researchers, 
competition is influencing this field of research, but that its impact differs with the 
reputation and success of the scientist involved. This is intertwined with needing to 
Page | 121  
 
‘sell’ the research to gain resources and acceptance for it by being the most vociferous 
in building expectations about it. 
 
*!)!#
The influence of a person’s reputation was a key factor in explanations of why certain 
areas of research within the field dominated, or were more readily accepted by the 
schistosomiasis community and funding agencies. There were positive examples of 
how those with a reputation have their ideas accepted, leading to trends in funding and 
further research. But many participants were quick to point out that while reputation 
can be positive for individuals or groups, it is not necessarily best for the field as a 
whole from a scientific perspective: 
 
I think after a while if you get to be a very wellknown person that you end up 
having a sufficient weight or clout which allows you to continue peddling your 
point of view…there are certain of my colleagues in my field who I feel have 
continued to do it well past the sell by date of their particular point of view. 
(I7NP) 
 
Another negative aspect was the influence certain people can have on the peer review 
process. Some participants felt there are individuals who, when acting as referees, 
blocked their research or at least slowed publication: 
 
…because of course all the work is peerreviewed. And unfortunately it isn’t 
always rejected on the grounds of whether or not it has merit it’s rejected on 
personalities…I don’t know how you get round that problem but it’s there... 
(I5P) 
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This concern is found in other fields of science, for example stem cell experts recently 
published an open letter expressing concern that ‘4    		 
	$
$	%	
3	8’ (Ghosh 2011). 
 
Many participants commented on their perception of their own and close colleagues’ 
reputations and the consequences of that for the field. Primate users tended to be more 
positive about their reputations and felt they had a greater impact on improving 
knowledge in the field, for example: 
 
…they were pioneers in the use of primates for understanding the evolution of 
schistosomiasis, and you can also usefully rely on their publications because 
they have been very seminal observations…and can be used forever. (I10P) 
 
Conversely, nonprimate users tended to see themselves as less influential, for 
example: 
 
…for me I’m not, if you are a very famous person you say something all 
people believe you, but if you are just very junior and young may be the more 
you say it the more people do believe {laughs}. (I4NP) 
 
One primate user appeared to be an exception; when asked early in the interview what 
they felt was their most important work they identified some results that altered 
thinking at the time. But later in the discussion they indicated that as a researcher they 
were not important enough to contribute to moving the field forward: 
 
I’m not really important enough to attend things like that. There are others 
who would be able to contribute before me. ([NR]I8P) 
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Therefore, even those who do not expressly recognise themselves as having a 
particularly strong reputation, still indicate that they place importance on reputation as 
a means of influencing the field. I5P felt that association with a scientist with a good 
reputation was sufficient to increase the chance of justification and acceptance for 
research. 
 
#  )%&, it seems that reputation may have a significant effect on how scientists 
perceive their ability to justify their research and knowledge claims to others and, as 
previously indicated, it has an influence on the impact of competition. This could be 
an example of Merton’s (		 !	 (1968) where eminent scientists gain 
disproportionately greater credit for their contributions to science, compared to 
relatively unknown scientists who get less credit for similar contributions. 
 
8#?"(*!)#
Participants placed emphasis on how knowledge claims are accepted, related to who 
needs to or should accept them and whether the claims are novel or established. 
Several participants view the field as belonging to a select few, identifying different 
groups of people they feel are knowledgeable about their work and/or could or should 
have an influence on the field, and the acceptability of that work. Some participants 
indicated that it was more important for their knowledge claims to be accepted by 
those within the group, and that views of those outside the group were less or not 
important. I5P thinks the public perception of schistosomiasis is low because of the 
nature of the disease, which may account for the participants not being particularly 
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interested in gaining acceptance from the public. But they still emphasise needing to 
influence those inside their group (i.e. other scientists): 
 
…So I don’t think I’m influencing the general public in any way. I think it’s 
more the scientific community that I would be looking to influence. (I5P) 

This apparent lack of consideration for the views/acceptance of those outside the 
participants’ main group(s) might be a result of how the outsiders are perceived or 
characterised by the insiders. For example, when discussing participating in 
workshops I6P was quite forceful in characterising those outside the specialist groups 
as being irrational and inaccurate, in comparison to their rational willingness to debate 
and provide justification for their 	 research: 
 
…only insane individuals would suggest that [testing on prisoners], would not 
see the contradiction in what they’re saying. You know for animal welfare but 
not people welfare…I’m always happy to debate. And to justify use of animal 
experimentation where it’s essential, where there is no other way. (I6P) 
 
Some participants expressed a less extreme view of those outside as having no or little 
understanding of the research/disease. In contrast to this were comments related to 
insiders possessing specialist knowledge which only they can understand or pass 
judgement on, indicating that specialist knowledge of the field could be a criterion for 
membership of the group. For example, I3NP argues that those outside do not present 
the correct information and indicates it is more difficult to explain knowledge claims 
to those who are not members of the specialist group: 
 
…they’re [scientists] an important people to be involved in the debate cos 
some of the factual information involved in debates is sometimes not accurate 
I find. But…sometimes it’s quite a difficult thing to convey nonspecialists 
kind of thing but I think it should be done. (I3NP) 
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Participants indicated that only the specialist group could move the field forward, and 
that for those outside − whether they are other scientists or members of the public − to 
have any influence, would need to meet certain criteria or their input would not be 
valid. As noted in Chapter 2 these specialist groupings have been identified by Collins 
(1981; 1988) as the ‘core set’. This may be another example of Michael and Birke’s 
(1994a) observations that scientists involved in animal experimentation place criteria 
on whom they regard as having a legitimate membership in the core set and 
consequently a voice in the debate. Further support of this argument is found in 
responses indicating that within the core set there have been conflicts resulting in a 
‘core group’ being created which holds the dominant view (Collins 1999). For 
example, I6P talks about how the work they were doing conflicted with the 
established model so they constructed a separate group within the area, which 
eventually became the dominant view: 
 
…it turned out to be the lungs, not the skin as all the previous workers had 
said…That’s when we came to work with people in the States who were like
minded. And we kind of sorted that out to our satisfaction and eventually I 
think other people have accepted it…it’s not an argument anymore. (I6P) 
 
Another aspect of acceptability is the intrinsic nature of the knowledge. That is, 
participants often distinguished between what they saw as novel knowledge and what 
was seen as established knowledge. Gilbert (1976) noted that getting novel scientific 
ideas accepted is difficult, and this was illustrated by a couple of participants. For 
example, I3NP indicates that novelty is important for acceptance but qualifies this by 
adding that it should be put into the context of established knowledge: 
 
…we’re slightly driven by publication as well so it has to be novel and it has 
to be referenced to what people have done before so you have to be aware…I 
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very much felt with the paper…like I had to directly compare it to what had 
been done before to be taken seriously. (I3NP) 
 
Discussion about novel knowledge was limited to publication, which is discussed in 
the next section. Here, emphasis appears to be on the impact of established 
knowledge. Some participants explicitly stated the importance of building on current 
knowledge, or described that this was what they were doing. 
 
Some indicated that established knowledge was a factor in driving the direction of 
research. For example, I7NP suggests that as knowledge becomes established, it 
perpetuates more research in that area: 
 
…But yes I think we’re all the time reading other peoples research ideas and 
there are things that often when two or three people are beginning to nudge 
towards something you then start looking at that area in more detail and it can 
then chime with something that you’ve always believed which is very nice. Or 
it challenges something that you think that is really difficult to accept but 
given the fact it’s turned up two or three times it’s worth more than just 
thinking this is an aberrant result… (I7NP) 
 
Therefore, it appears that most participants place importance on the historical or 
established nature of knowledge when deciding whether to accept it or not.  
 
Except for I7NP, all responses related to the impact of established knowledge were 
given by primate users. This may indicate that they place more emphasis on the 
established nature of their work. This may function as a means of showing that their 
research has a history, so can be more strongly justified. 
 
#   )%&, this data indicate that Collins’ (1988; 1999) ‘core set’ concept is 
important in understanding why certain viewpoints dominate in the primate impasse 
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and why it can be difficult for alternative models to be accepted or even 
acknowledged by sectors of researchers within a field. Certain schistosomiasis 
researchers appear to be placing restrictions on who can make knowledge claims, 
which is a factor in the slow progress of the field and in the difficulties of getting non
primate findings accepted. The reluctance to communicate with those ‘outside’ the 
specialist group could be accentuating the lack of cooperation related to competition 
identified above. 
 
)!#
Participants see publication as an enormously important means of substantiating their 
knowledge claims, in many cases using it as a measure of their success. Although they 
do not always apply this in a selfreflexive context, they do see publication as a means 
by which others judge them. Only two participants did not mention publication. 
 
Publication’s importance was emphasised by apparent distrust directed toward 
research where findings were not published: 
 
…I mean the other disgraceful thing is that the results of that trial have never 
been published the actual results …I think it’s questionable why these results 
were not published. (INP) 
 
There is indication that where research is published is important for judging the 
validity of knowledge claims. When asked about difficulties with acceptance or 
dissemination of work, INP replied 3#3  8. This was 
said during a conversation where the participant was quite negative about the impact 
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of their work, and it was obvious they were disappointed not to be publishing in 
‘better’ journals. 
 
Not unexpectedly, here a participant emphasises that they must consider where they 
publish, aiming for higherranking journals to ensure their work has maximum 
impact: 
 
…we’re in a very competitive field and we always try to publish in highest
ranking journals. Yes we’re not all publishing in the top ranking journal all the 
time. So I think in that sense we are always trying to do better and we’ll try 
and publish in the journal which is going to have the highest impact… (I7NP) 
 
However, for some participants a journal’s ranking did not guarantee the quality or 
importance of the work, especially according to I6P during an exchange about 
publication quality versus where it is published (the journal name has been removed 
as I6P requested not to be quoted): 
 
…Getting a paper that really changes the way people think that’s hard. There’s 
a journal called {name} which is one of the top journals…You could also 
describe it as the {derogatory name for journal omitted}, because to get in 
there you have to have something that’s so you know kind of way out off the 
wall, trendy. There’s fifty per cent chance it’s rubbish. (I6P) 
 
The following participant’s response to what makes a piece of work seminal illustrates 
that even publication in one of the highest ranking scientific journals, Nature, does not 
ensure long term impact: 
 
…I mean you know very well that you can have beautiful papers in Nature and 
which are destroyed six months later and they’re therefore at long term have 
no impact. (I10P) 
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Despite the theoretical difficulties of getting new knowledge accepted, illustrated by 
the emphasis on established knowledge in the previous section, novelty was cited by 
some participants as being an important factor in initially getting a publication noticed 
and possibly accepted. For example: 
 
…I mean we’re slightly driven by publication as well so it has to be novel and 
it has to be referenced to what people have done before so you have to be 
aware. (I3NP) 
 
Thus, there seems to be a dichotomy where novelty is both an opportunity and a 
challenge to gaining acceptance for knowledge claims. Myers (1985) argues that this 
is a result of a negotiation between the writer and the potential audience, because: 
 
…the researcher tries to show that he or she deserves credit for something 
new, while…the editors and reviewers try to relate the claim to the body of 
knowledge produced by the community. (Myers 1985 p.595) 
 
I5P made an important point about the nature of publication, which was noted by 
others. They expressed regret that a great deal of data is never published as it is seen 
as negative findings. It seems this is ‘lost’ knowledge rather than useless knowledge 
because it still provides valuable indications of where research should go and what has 
already been explored. Indeed, I5P felt quite strongly that this information should be 
made available; to help speed up progression in the field by preventing repetition of 
‘unsuccessful’ studies, but also to prevent unnecessary animal use:
 
Plus the fact there are no journals of negative results…But nobody wants to 
hear negative data like that, so it never gets published. There is no repository 
for that kind of stuff and so I think there’s a lot that’s lost to the scientific 
community. Not just about animals but in general. But what can you do about 
it? But in the case of animals it does mean that sometimes things are wasted 
because somebody else tries out the same procedure. (I5P) 
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As well as scientific publication, respondents talked about publication in the context 
of media coverage. The majority of responses were negative about the hype the media 
such as, newspaper journalists, radio programmes and television reporters, puts on 
scientific findings. Participants expressed concern that hype can be wrong or 
unscientific and that it might be damaging to the reputation of the field, by causing 
disappointment when promises are perceived as not being achieved: 
 
…everybody just wants you know the cure for AIDS and this that and the 
other straight away…I guess they don’t see the final consequences and might 
just think you know nobody’s actually achieving anything… (I2NP) 
 
I10P was particularly vocal about the media aspect, feeling there had been a shift 
toward greater use of media hype by the newer generation of scientists and this was all 
about selfpromotion rather than science for which it is detrimental: 
 
I’ve been privileged to make the main part of my research activities at a period 
where science was still a very noble activity…people have changed and I say 
that science is a little bit polluted…there’s a striking difference between the 
behaviour of an old man and an old generation, which are generally discreet at 
work and are not going to the TV or out to general newspapers every day and 
the rest younger people who are building up their reputation it’s very striking. 
(I10P) 
 
This observation was supported by responses from other participants, indicating it was 
necessary to ‘sex up’ your research in order for it to be noticed: 
 
…therefore you have to make your science sexy…And it’s something which I 
don’t like but I think it’s necessary in order to be able to sell your work you 
have to have something that makes it a saleable thing. (I7NP) 
 
Although there is negativity toward media hype there is also acknowledgement that it 
can generate interest and support for the research, for example: 
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…it’s again a balance attitude I would say between the necessity to provide 
proper information to the public who needs it. And if we need its support we 
need also to give them the proper information but on the other hand we have 
absolutely to resist to the temptation of delivery immature results or at an 
inappropriate time that’s my point of view. (I10P) 
 
#   )%&, the data indicate that participants identify scientific publication as an 
important means of gaining acceptance and justification for research. As noted in the 
previous section this can be influenced by the core set of scientists through the peer 
review process. The findings regarding uncertainty about hype illustrate the tension in 
the management of expectations identified by Brown (2003), where: 
 
…hype and the noisy clamour of future projection are indispensably central to 
the shaping of technology. And yet…we want to avoid the costly price of 
disillusionment, overshoot, hype and overselling. (Brown 2003 p.5) 
 
Understanding how the schistosomiasis participants view hype, and how they do or do 
not create expectations through publications, has important consequences for 
overcoming the impasse. These are discussed in Chapter 7. 
 
#!'#!!!###
These data indicate that the responses which can be analysed as being associated with 
the ‘scientific institution’ are an important means by which participants justify their 
research. Competition appears to be a particularly strong factor in this field, with 
reputation and the Matthew Effect seemingly affecting the influence it has and how it 
is viewed by the various participants. Participants placed greater emphasis on gaining 
acceptance from their peers, with publication being presented as an important way to 
achieve this. They see schistosomiasis as being an unknown disease to the public, and 
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view the public as well as some scientists as being outside the specialist group. The 
data suggest that the ‘core set’ concept is applicable here. As indicated in the 
documentary analysis (Chapter 3), it may be particularly influential in this field 
because of the relatively small pool of researchers and the limited availability of 
funding due to the low profile of the disease, making any competition or conflict 
much more pronounced. There was evidence of negativity toward expectation
building in the form of media hype that could be further restricting communication in 
this field. The chapter now turns to the second theme, scientists’ views of the 
practicalities of conducting scientific research. 
 
,%&	
 
I have termed the second theme that emerged from responses, ‘practical science’ that 
is, the doing of science and the everyday encounters related to it. Participants used a 
variety of factors related to the practicalities of engaging in scientific experimentation 
to justify the research and/or models they use/used, including physiological reasons 
for model choice, research question and overall aims, policy and logistics, and 
alternatives.  

&())#'%"
All participants described scientific reasons for their choice of whether to use a 
particular model or not. Typically these included descriptions related to physiology, 
parasitology, immunology and experimental methods and tools. A summary of 
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responses is given in table 10. In the documentary analysis (Chapter 3) the limitations 
of models were usually given by opponents of primate use; for example antireports 
presented extensive problems with primate models. Here, participants were willing to 
talk about the scientific limitations of their own and other models and, while this was 
not always spontaneous, it was freely discussed when prompted. Some participants 
gave information more readily about their own work: for example, I9P gave the 
limitations of each of the models they had used. Others gave problems with models 
they didn’t use more easily than those they did: for example, I6P only gave cost and 
ethics as limitations of the baboon model they had used, whereas when discussing 
other models they gave several scientific problems. Additionally, some participants 
emphasised that due to the limitations of each individual model it was important to 
utilise more than one, in order to get a fuller picture of what was happening: 
 
…I’m not choosing between them [animal models] as you see I’m saying that 
each one has its own validity and I would say as each is inadequate to totally 
represent the picture you’ve got to actually probably do comparative things. 
(I9P) 
 
) -,A summary of the ‘scientific’ reasons participants gave for and against 
using different experimental models for schistosomiasis vaccine research.
" )#'% % 
Mouse  Permissive to <)
 Maintains parasite’s whole 
lifecycle 
 Identifying diagnostic antigens 
 GM strains used to identify 
immune response class 
 Observing parasite migration  
 Many immune reagents 
available 
 Heavy infection with few worms 
 Difficult to model chronic 
infection 
 No concomitant immunity 
 Subtle differences in immune 
response compared with humans 
 Too small for infection intensity 
studies 
 Circa 30% worm maturation 
Hamster  6070% worm maturation 
 Modelling skin penetration 
 Takes more parasites than mice
  Only permissive to <) 
and <)	3  
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Rat  Possibly selfcures – rejects 
worms as they mature  
 Non or semipermissive to  <)
  
 IgE (allergic) response to worms 
Rhesus 
Macaque 
 Permissive to <) and <)
	3
 Realistic worm burden 
 Studying infection intensity 
 Possibly selfcures – eliminates 
adult worms  
 Long lasting immunity 
 Studying chronic infection 
 8090% worm maturation  
 Needs multiple vaccinations/ 
infections for a relevant antigenic 
load 
 Sacrificed to get worm burden 
Baboon  Large size – realistic worm 
burden 
 Large worm burden without 
suffering adverse effects 
 Permissive to <) and <)
	3
 Studying infection intensity 
 Optimising vaccination 
 Studying chronic infection 
 8090% worm maturation 
 Needs multiple vaccinations/ 
infections for a relevant antigenic 
load 
 Sacrificed to get worm burden 
 Lack of immune reagents 
 Pathology less intense than 
humans 
 Induced immunity decreases with 
time 
Sheep  Natural model of 
Schistosomiasis 
 Host to <)		and <)
3which are related 
to <. 	3  
 Permissive to <	) 
which do not infect humans 
 Species specific animal vaccine 
Cattle  Natural model of 
Schistosomiasis 
 Studying natural infection 
effects on protection 
 Permissive to <)3$which is 
related to <. 	3 
 Permissive to <)8 
 Noninvasive sample collection 
 Not chronic infection 
 Cannot do long term safety studies 
 Species specific animal vaccine 
Pigs  Natural model of 
Schistosomiasis 
 Permissive to <)8 
 Vaccine would treat humans 
and animals 
 High levels of protection with 
irradiated  <)8vaccine 
 Immunologically similar to 
humans 
 Similar mass to humans 
 Not chronic infection 
 Selfcures over time so not 
directly analogous to human 
 Logistical problems of housing in 
laboratory 
Human  Studying agerelated resistance 
 Uses fresh parasite isolates 
 Immune response does not kill 
worms 
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
reflecting true variability 
 Evaluating blood/sera based 
diagnostic tests  
 Studying pathology and clinical 
outcomes 
 Investigating acquired 
immunity 
 Studying chronic infection 
 Cannot measure true worm burden 
 Sample sizes too small 
 Difficulty translating genome 
information into an intervention 
 No evidence of complete 
immunity 
 Complex factors surrounding age
related resistance 
# '	/ 
Omics 
 Identifying candidate molecules 
and site of expression 
 Studying parasite gene 
expression 
 Studying parasite strain 
variance 
 No selective pressure on 
parasites, as not passaged in 
animals 
 Developing diagnostic tools 
 Maintaining parasite lifecycle 
$	 
 Available information needs fully 
cataloguing and annotating 
 Do not get full range of immune 
responses/interactions $	
 Cannot grow adult worms$	
 Does not provide information on 
how to present candidate 
molecules to stimulate the wanted 
immune responses 
 
#  )%&, these responses indicate that, according to participants, there are many 
scientific reasons for and against using the various models available for 
schistosomiasis vaccine research, which are not immediately apparent from the 
literature. It is possible that this leads to the described need to use several models 
during investigations. Importantly, participants were willing in interviews to discuss 
the limitations of their models, which rarely occurs in publications like those analysed 
in Chapter 3 or in peerreview literature, where authors are ultimately focussing on the 
benefits of their claims to improve their acceptability. 
 
)%9!#)#"$%) 
The type of research question being asked was highlighted as a reason for model 
choice, with half of the participants mentioning it in this context. Raising the influence 
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the scientific question has on model choice may indicate a tendency to want to 
conform to the scientific ‘norm’, that is, to show they are conducting science in an 
appropriately logical way. Interestingly, several primate users emphasised that the 
question must be particularly important and vital to progressing the field when it came 
to decisions to use primates, for example: 
 
…the same is true of primate experiments again we move up several orders of 
magnitude in terms of expense, difficulty and ethical considerations we would 
only even envisage using a primate when there was completely vital question 
which is crucial or blocks our further studies on humans... (I9P) 
 
A couple of participants also commented that the complexity of the disease means 
that, in order to answer all relevant questions several models need to be used. 
 
It seems that there is interplay between the research question and the physiological 
reasons, that provides the scientists with a means by which to make the decision about 
the appropriate model(s) to use. It appears that some participants use this interplay to 
morally justify their choice when they note that only important questions should be 
answered using primates. This ethical aspect is explored further in the next section. 
 
Another factor determining which questions are asked is the overall research aim the 
participant is following. From the peerreviewed literature (see Chapter 2) three main 
areas of research for investigating schistosomiasis vaccines were identified: attenuated 
vaccines, selfcure and naturally occurring infection. These aims were checked with 
participants and they detailed two further examples; IgE (allergic) response and 
engineered/recombinant vaccines. Participants were relatively balanced in their 
descriptions of the pros and cons of the various aims they were most familiar with, but 
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there was obvious contention about which one should be pursued to reach a beneficial 
outcome. 
 
In the documentary analysis (Chapter 3), overt reporting of conflicts within fields was 
rare. In contrast, in these interviews, participants were explicit about the 
disagreements surrounding which research aim should be used, including suggesting 
that more effort should be put into certain ones. Perhaps the most controversial aim 
and most illustrative example is that of selfcure. One participant in particular 
advocated this as a way forward: 
 
…now of course we can be inspired by spontaneous or selfcure mechanisms 
that are used by the rat for instance and this has been one of the reasons of the 
choice of this model for us particularly…(I10P) 
 
Yet several other participants expressed that selfcure could never be beneficial and in 
some of their opinions should not be pursued further for example: 
 
I would not go down that route [selfcure]…The intrinsic mechanism is not 
likely to lead to a vaccine candidate. The irradiated vaccine is the best model 
and effort should be concentrated using the best models to find the antigens 
that can mimic that effect.A[NR]I8P) 
 
Despite this conflict each of the given aims persists, so maybe this is a form of 
Hedgecoe’s (2006) enchantment; with scientists in the coreset (these participants) 
being afraid to dismiss a model, just in case it does provide an answer. There may also 
be an influence of publication bias, as scientists have to focus on publishing the 
positive aspects of their research in order to keep interest and funding high, rather than 
expressing the negatives of other aims. 

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#   )%&, it seems the schistosomiasis participants tend to use the research 
questions as a means to justify their choice of model, especially when using primates. 
There was a great deal more discussion about the conflicts that are apparent in the 
field than there is in the primate reports and peerreviewed literature, but seemingly 
counterintuitively, despite there being explicit views that some overall aims are better 
than others, they all continue to be explored. This may be inadvertently slowing 
progress in this field and was taken in to consideration when making the 
recommendations in Chapter 7. 
 
&)#"(!
Participants identified policy and logistical issues that were affecting their choice of 
model and/or research aim, including comments on economic factors, availability of 
appropriate facilities and lobbyists’ influence on policy. 
 
National policy and political influence were viewed as having positive and negative 
effects on the schistosomiasis field. For example, the quote below illustrates that if 
there is a political need to follow a certain research aim, in this case vaccination, then 
it might outweigh the evidence of whether it is scientifically plausible or not. So even 
if results are negative, research might continue because policy dictates it should be 
done that way: 
 
I think if we hadn’t demonstrated immunity in humans but we’d demonstrated 
such high levels of immunity in primates there would still be a push to develop 
a vaccine for schistosomiasis if the political will was there. (I8P) 
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Significantly, when asked how they might move the schistosomiasis field forward 
I3NP indicated it could be outside public health policies that are influencing the 
direction of the field, rather than a scientific agenda dictated by the schistosomiasis 
community: 
 
…there has been…an open research group to determine the score for 
determining the sort of research priorities from the public health agenda rather 
than from any other sort of agenda…So I think that’s sort of that agenda has 
been pushed by the success of the control programmes, …it actually sort of 
came from not quite the research community sort of it came from the public 
health community. (I3NP) 
 
I10P went as far as to say that scientists needed to engage with policy makers to help 
move the field forwards: 
 
…I think absolutely we need regular joint meetings not only between scientists 
but between science and policy makers and eventually industry people this is 
absolutely essential… (I10P)
 
 
As well as health policy influencing the scientific agenda, a couple of other 
participants indicated that the public and lobbyists may be directing research policy, 
for example: 
 
…the European Union you might say they’re a stakeholder that they’ve 
already taken their point of view because they’re being pressurised by the 
general public the voting public not to support working on primates…I think 
that they’re taking more of just a reaction rather than to actually thinking it 
through…And I think as soon as you get into the stakeholders there’s 
obviously the politics therefore lots of lobbyists who suggest you know saying 
this should be the case or that should be a case and…the stakeholders aren’t 
completely independent in that sense because they’ve got people they’re 
having to listen to. (I7NP) 
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Participants talked about economic limitations that specifically affected their ability to 
choose or use certain models. In particular, primates are perceived as expensive, and 
this can outweigh their scientific utility: 
 
… But working with baboons is much harder. They’re more expensive, it’s 
harder to get the funding. And so whilst I consider the baboon a much better 
model it’s harder to get the data. (I6P) 
 
This view was also expressed to a lesser extent regarding animal models in general. 
But expense is not just limited to animals; the vaccine strategy that can be pursued is 
constrained by financial costs associated with it: 
 
…But you still have the problem of keeping the damn things alive for long 
enough you know to distribute them to 200 miles from… It’s gonna be 
expensive, that route. (INP) 
 
There is some suggestion that whether a scientist uses a particular model or not may 
be decided by what facilities or animals are available to them. This may be especially 
true of primates as this participant recounts: 
 
…I think whether people use primates or not depends on availability the 
colleagues of mine who I know have worked on primates it’s because those 
primates are actually available… And those people who haven’t worked on 
primates it’s largely because they’re working in environments where they 
couldn’t get access to primates… (I7NP) 
 
I2NP further illustrates that logistical constraints might overcome the scientific utility 
of a model, in this case whether there are have adequate facilities for larger animals: 
 
…because it works absolutely fantastically in a pig and you know if you got 
the facilities to give a pig a nice house…that might be fine but you know if 
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you’re in a hospital you’re not gonna have a herd of 40 pigs downstairs but 
you may be allowed 40 mice. (I2NP) 
 
#  )%&, these responses indicate some perceived influence of policy, which can 
be positive for moving the field forward. However, others viewed policy more 
negatively because it can mean that an avenue of research persists even if it is not 
scientifically plausible. One respondent felt the public/lobbyists may be having too 
much influence by making kneejerk political decisions rather than decisions based on 
facts. The data suggest that logistics and economic factors may be having more impact 
on the research agenda for these participants, as these factors were mentioned more 
than the political effects.

!%#)!$
When making recommendations for overcoming the primate impasse it is crucial to 
establish whether there are alternatives to primate models currently available, or 
whether they could be developed. Therefore, participants were specifically asked 
about their thoughts on this. 
 
The majority of participants (7/10), including both types of user, did not feel it was 
possible to replace primates completely in schistosomiasis research. However, many 
commented that their use could be confined to the later stages of testing prior to 
clinical trials, and alternatives could be used during the developmental phases. For 
example: 
 
…it’s possible I think to a good extent…I don’t think they would be necessary 
to use during the early developmental stages…I think there are a series of 
models…rats and mouse, in vitro or whatever and screening past human 
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populations if you need that sort of information…Before you got to primates.  
I personally don’t think that you could go in to humans before you went, 
without primates. (I9P) 
 
Some participants were particularly adamant that it was impossible to replace primates 
but this was not confined to primate users as might be expected. In particular, INP, 
I7NP, I6P and I10P were unable to envisage not being able to use primates even when 
they were asked to theorise a situation where no primates were available, for example: 
 
There is no…I can’t conceive of that situation arising ever, because I can’t 
conceive of any new drug being used without having gone through the 
fullest… (INP) 
 
Two of the three participants who did not give an outright ‘no’ were nonprimate 
users (I2NP and I3NP), and they were uncertain as to whether it could be achieved or 
not. For example, I3NP gave several examples where they felt primates could be 
replaced or alternatives used, but towards the end of the interview seemed less certain, 
giving the following response when asked if a ban on primate use would impact on the 
field: 
 
I don’t think so…although I guess I would hold the proviso that it would be if 
at some point in the future if somebody did come up with a really good 
vaccine that for scientific reasons which I don’t quite know what they are 
would require primate use it would be a shame not to be able to do it I 
suppose. (I3NP) 
 
The final participant (I8P) had used primates in the past but seemed sure progress 
could be made without them. I8P made several references to using pigs as alternatives 
to primates for example: 
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…So that is one of the species which one could argue from the point of view 
of vaccine development, drug development might be the best way of avoiding 
using primates…that you could test those things in pigs. (I8P) 
 
However, I8P was also conscious of their limitations, such as the possibility they may 
selfcure or that ethically it may not be any better to use the pig than the primate. I8P 
was not alone in considering the pig as possible alternative in at least some 
circumstances, as I4NP and I10P also mentioned it. 
 
Additionally, I8P posed the potential for precedence in similar fields for taking 
vaccines straight into human trials and bypassing preclinical primate studies, for 
example: 
 
…in elephantiasis there is no relevant primate model so they have to test in 
cattle or straight in humans. You should check current practice in other areas 
with regard to what is done when there isn’t a suitable animal model or 
intermediate animal model. (I8P) 
 
Hookworm was given as another illustration of this, although I8P did note some 
problems with the models used, and I9P mentioned there were problems with the 
resultant clinical trials. Despite the described problems this does illustrate that the 
perception held by the majority of participants in this study, of primates $ to be 
used preclinically, may be misplaced. 
 
#   )%&, the majority of participants argued that it would not be possible to 
completely replace primates in schistosomiasis research. They placed particular 
emphasis on necessity at the end stages of the vaccine process prior to entering into 
clinical trials. This challenge may be due to safety fears and/or perceptions about 
regulation which are discussed in section 4.4. However, the inability by some even to 
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imagine not being able to use primates may indicate that their use is entrenched in this 
community, making it difficult to change to a different model. Collingridge (1980) 
discussed ‘entrenchment’ as the process by which a technology becomes firmly 
embedded in its use context, particularly through the establishment of supporting 
institutions or infrastructure, systemic interdependence, economic advantage, shared 
evaluations, and their mutual reinforcement. In doing so he highlights and accounts 
for the difficulty of removing, changing or controlling the technology. The lessons 
learnt from Collingridge’s case study of entrenchment of technologies, namely that 
change is expensive, change is hotly debated and that in debate the status quo has an 
unfair advantage, may be able to explain why primate experiments have become the 
status quo and remain so. 
 
It could also be that the alternatives have not been, or cannot be, developed for this 
final stage of the process. However, the responses of the two uncertain participants 
and of I8P above indicate that this is less likely to be the case. 
 
%)!)###
These findings indicate that, for schistosomiasis, the practicalities of doing scientific 
studies can impact on how that research is conducted and what decisions scientists 
make about which models to use. Participants openly discussed the scientific reasons 
why they do or do not use the various models available for developing a 
schistosomiasis vaccine. While it is not surprising that they would want to be seen to 
be conforming to the scientific norm or institution, what is most useful, is that not all 
the reasons given in the interviews are apparent from the peerreview literature, 
Page | 145  
 
indicating that scientists are more aware of the limitations of the science than they 
portray in publications. 
 
Participants used the research question as a way to justify their model choice. There 
was explicit conflict about which overall research aim to follow but each one appears 
to persist. While there was evidence of a direct influence of policy, participants 
seemed to be more concerned about the impact that financial and logistical factors 
might be having on the direction of the field and which research was being facilitated. 
However, consideration must also be given to the subtle interplay between policy, 
economics and logistics, which was not explicit in these responses. In terms of 
alternatives to primate testing most participants felt that progress could be made 
without using primates during the developmental stages of vaccine research but that 
they would still be necessary during the end preclinical stage. However, there was 
some indication of precedence in other similar fields where primates had not been 
used in this manner, so the reluctance to accept that replacement might be possible 
could be related more to entrenchment and perceived need than an actual deficiency in 
alternatives. 
 
,,		
 
The third theme identified is animals and ethics. This involves talk about implications 
related to personal choices about animal use, the choice of species and the choices 
made by other parties. As the title suggests, ethical considerations are brought into 
play in each of these factors. 
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When participants talked about model choice or dealing with the moral challenges of 
biomedical research there were several instances where they explicitly mentioned 
justifying the research to themselves, for example: 
 
…I think any scientist and any person obviously weighs up the costs and 
benefits in an ethical sense. And have to justify it to themselves…animals and 
humans for me have to weigh up personally against my personal morals and 
ethics… (I9P) 
 
Participants indicated how they achieved personal justification. One particularly 
interesting and different response was given by I6P who seemed to be using humour 
about the nature of the animals to justify using them: 
 
…inevitably if you think about it the more distance the model is from us the 
less you’re going to have qualms about it, it won’t look like us, it will bite you. 
It’ll smell horrible you know it won’t be attractive. But it is you know a cute 
little baboon, Toto, then you know you clearly you must have feelings or 
qualms about what you’re doing. And that doesn’t hold for adult male baboons 
{laughs}, which are probably one of the most unpleasant creatures you would 
ever want to meet {laughs}. (I6P) 
 
Some emphasised that the model they had adopted was ethically acceptable: 
 
Again it absolutely depends on what you’re doing. I mean I would say what 
we’re doing is not morally challenging but it’s morally the opposite of 
challenging… (I2NP) 
 
Others emphasised an awareness of, and action to meet, the health and welfare needs 
of their experimental animals: 
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…at the moment policy is changing for animals we treat animals very 
carefully…Yeah as well as possible because at the moment very aware of the 
health of the animals particularly of cattle. (I4NP) 
 
I7NP went further than their own treatment of animals feeling it was necessary for 
them to teach students to be more aware about the effort needed to look after 
laboratory animals: 
 
And it’s something that I’m very keen on when we’re dealing with students 
who do research projects in our laboratory that we insist that they go on the 
animal training course. Largely so that they get a much better realisation of 
what they’re doing…they can actually realise that this [mouse] is not just 
something you can pick off the shelf and actually use. It is something that you 
have to put effort and energy in to looking after and it’s a precious resource. 
(I7NP) 
 
Another aspect is where participants place personal boundaries on what they are and 
are not willing to do. For example, the following participant’s squeamishness means 
they would alter their work so they didn’t have to use certain species. Intriguingly 
they see this as irrational, perhaps because it does not have a ‘scientific’ basis: 
 
I have pet cats and would feel uncomfortable using cats in research but I 
suppose that is irrational or hypocritical to just pick cats and dogs. I would 
choose not to go into that field of research and I would choose not to go for 
grants involving primates…I would be happier working with cattle and 
sheep…but it is not really rational.A[NR]I8P) 
 
Importantly, there are some examples in which perceived ethical concern appears to 
have overcome the scientific utility of some animal models. I8P describes the 
abandonment of the cat as model for a different disease but it illustrates that this type 
of reaction can occur within this realm of research: 
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We did have a group here working on cats when I first came here working on 
elephantiasis…the animals were recovered they sometimes of course they had 
to be dissected and worms taken out…Because of that people are reluctant 
generally to work on cats. That model is not since that time has not been 
worked on by anybody even though it’s a very good model. (I8P) 
 
MH: Do you think that is because of the pet aspect of it? 
 
I’m sure it is, yeah. And I think that has delayed advances in that field. (I8P) 
 
Secondly, I5P and I6P gave an example from schistosomiasis where ethical concerns 
related to experimental use of chimpanzees have, led them to the decision that, despite 
having used them in the past, they now feel they cannot. They make this choice even 
though, as the quote illustrates, they class chimpanzees as the best model for the job: 
 
Well I think the great apes…and I can say that having used them, great apes so 
yes it’s something that it goes round in your head as to just how intelligent 
they are. How alike we are they are the best model without a doubt you know 
their physiology, the reagents work…So I wouldn’t want now to go beyond 
that. (I6P) 
 
#   )%&, these responses indicate it is important to participants to justify their 
work to themselves. They provided some examples of how they do this and suggest 
that they have personal limits as to which models and what type of research they will 
do. In some cases these limits appear to outweigh the scientific utility of a model. 
Birke 	 . (2007) also found that research scientists and other lab workers often 
made reference to drawing a species or scientific technique line somewhere. They 
argue that, in order to cope with the moral dilemmas associated with animal 
experimentation, scientists have to learn to distance themselves from the animals they 
use by objectifying them as tools or data. However their findings, and those presented 
here, indicate that this does not always work and scientists are increasingly 
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acknowledging a relationship between the experimental animals and humans. Birke 	
. (2007) summarise this ambivalence well: 
 
…however well they learn the psychological mechanism of distancing and 
treating the lab animal as just another tool of the trade, there is for many lab 
workers a naturalistic animal – a furry friend – there too. (Birke 	) 2007, 
p.107) 
 
'*
Beyond the personal limitations on species choice noted above, throughout the study 
there are examples of participants differentiating the ease with which they can decide 
to use one species or another, or whether to use a species at all, with primates 
generally being given much greater consideration in one form or another. 
 
When asked about knowledge gained from animal models I8P expresses more 
consideration toward whether or not to use primates − describing this as a dilemma 
rather than a simpler decision, as it seems to be with mice: 
 
…I mean there are people who will be testing things identified from that 
model natural immunity in humans, from that circumstance in mice… And I 
guess had that worked in mice really well then they would’ve then been faced 
with the dilemma of where do we go to next with this. (I8P) 
 
As well as talking theoretically about species difference, it can also be seen in 
participants’ descriptions of their actions. For example, here there is a difference in 
ethical consideration even between primate species, as chimpanzees were not 
sacrificed at the end of the study as a baboon or other animal would be: 
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That wasn’t possible in the chimpanzees for ethical reasons. So what happened 
at the end of the experiment is that the chimpanzees were treated in the same 
way that people would be treated that had schistosomiasis and then they were 
returned to the colony. (I5P) 
 
In addition to putting species choice into an ethical context several participants 
specifically indicated that they were more comfortable working with rodents or 
livestock, for example: 
 
…I think you can actually more legitimately use those sorts of large 
experimental animals to be able to do your tests and in fact in the literature you 
do see a number of experimental vaccines being performed in cattle and pigs 
on those sorts of things. But I don’t think it’s as easy probably for ethical 
reasons to say let’s just do all of these experiments in primates. (I7NP) 
 
I2NP clarified why they were more comfortable with certain species by highlighting 
that it was easier to meet the needs of some species over others: 
 
I mean I’m not specious [sic] I think yes primates you know it’s long lived and 
stuff like that but you know when the regulations are like against dogs and cats 
and horses because they’re peoples pets I think you know a rat is somebody’s 
pet and they’re just as important…the advantages may be you can have the 
facilities to give them a good size house and accommodation…one has to be 
careful not to be specious thinking you know primates then you know dogs, 
cats are not necessarily higher than each it’s what facility they can do and what 
benefits they would give. (I2NP) 
 
Further indication that primates perhaps receive greater consideration was that the 
emphasis on the degree of necessity and scientific justification required to decide to 
use primates was higher than for any other species. For example, INP would need 
extensive evidence from other species before using primates: 
 
…what we would do is check it against mouse infections…then our route 
would be to do larger animal work…so in sheep or cattle…and then having 
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done those one…could use those as justification for doing some primate 
experiments… (I1NP) 
 
One participant even felt that special collaborative programmes should be in place 
before using primates: 
 
…So I think that you would be at an agreed end stage and I think you know to 
use primates in this context it would have to be one very very strong 
candidate…you’d wanna do it with some large scale collaborative 
programme… (I9P) 
 
#   )%&, it appears that for various reasons many participants gave more 
consideration to the decision to use primate models over other models, whether they 
personally use them or not. They seem to be more comfortable working with other 
species such as rodents and livestock, as they do not flag up as many − if any − 
concerns about the ethical dilemmas or strong scientific justification that they indicate 
considering when thinking about primates. As I2NP hints at above, this may be a form 
of speciesism in action. Singer (1995) proposes, ‘	  	 		 
		$				3	’ (p.9))
Here participants identify that they appear to exhibit speciesism towards animals such 
as rodents and cattle by giving them less consideration than primates. Although the 
participants have described it as such, this is not strictly speciesism as Singer (1995) 
defined it because if it were the participants would not give consideration to any of the 
animals. Instead, this more closely illustrates a sliding scale model (DeGrazia 2002) 
where animals are given consideration proportionate to their cognitive, emotional and 
social complexity, and perhaps in this case their relationship to society. This may 
make it easier to propose alternatives to primate models, including using other 
species. 
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Participants talk about the influence of other parties such as other scientists or 
regulators on the decisions regarding which experimental model to use. They do not 
see themselves as working in a vacuum, and comment on the ethical decisions about 
research made by other parties to justify their choices. 
 
For example, I5P felt that a colleague found it much easier to suggest primate studies 
because they were detached from the actual work: 
 
…I think the primate work particularly got to me in a way that it didn’t 
necessarily get to {name omitted} because of the fact that he wasn’t the person 
at the coal face. (I5P) 
 
When asked about the moral aspect of biomedical research, I7NP indicated they 
would be happy for other people to conduct the primate work but they would not want 
to do it themselves: 
 
I would feel uncomfortable dealing with primates for example. I feel less of a 
problem dealing with small rodents because I think they’re telling me 
something which will feed on in to greater studies that other people will be 
more equipped to deal with rather than me. (I7NP) 
 
As well as other scientists doing the work that might be ethically troublesome, 
participants also used the acceptance of peers and/or communities as a means of 
making the ethical decision for them or validating their choice. For example, I7NP 
and I9P both indicated that there should be scientific community agreement to use 
primates, so again displacing the ethical choice to one they are not personally 
responsible for: 
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…I wouldn’t want to just raise the money and go off and start sticking things 
in to monkeys myself I’d want it to be part of what the community considered 
to be a good thing and to be a worthwhile investment both financially and 
ethically. (I9P) 
 
Participants did not explicitly state that it was society’s place to decide whether 
animal experiments were morally right, but there was indirect suggestion that some 
participants were displacing the ethical choice to society. For example, by giving 
public acceptance as validation for the work they do: 
 
…it’s very easy to justify to myself in terms of whether it’s a worthwhile 
activity but it’s also I think relatively easy to justify to in a more general sense 
to the public…and people are always interested…yeah people like what we do 
and I liked that fact…(I9P)   
 
There was a suggestion that the choices of the communities affected by the disease 
should be taken in to account, so the moral decision is theirs: 
 
DThe views of those suffering from the disease should also be taken into 
account. When their children are ill they would be happy for a treatment to be 
tested on a few mice.([NR] I8P) 
 
Another common strategy was to defer the decisions to regulators by using rules 
controlling animal experimentation as means to justify the research, with the 
indication being they are very tight; so if the work was deemed to meet the 
requirements demanded, then it must be justified. For example, when asked about 
emphasising reasons for model choice INP explained it has to be justified for 
regulatory acceptance, and when pressed further, the arguments presented have to be 
very good to meet the requirements: 
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Unfortunately for that, perhaps rightly for the Home Office one has to produce 
strong arguments. (INP) 
 
A second participant also highlights the complexity involved with regulatory 
acceptance by referring to the cost/benefit process that has to be performed; thus 
attempting to strengthen the validity this brings to the animal experiment: 
 
… I think any animal model where you can’t see clearly the benefits that are 
likely to ensue would be unacceptable, but I mean given that [the] majority of 
the work that is done in the UK is done through the Home Office and you have 
to go through the cost benefit analysis I don’t think there’s anything that I 
could say shouldn’t be done… (I5P) 
 
I10P went as far as to say that the regulations mean the experimental animals may be 
treated better than some patients, so inferring the restraints imposed by the regulations 
tip the ethical balance in favour of the experiments. 
 
I2NP expressed the view that, regulation might in fact be a means to encourage or 
even force scientists into greater ethical consideration particularly regarding primate 
use: 
 
…I imagine they’re gonna have to use primates. But I think making it very 
difficult and regulating…I think these rules are very good and it will make 
people think twice about you know are there alternatives… (I2NP) 
 
Some participants explicitly indicated getting funding validated their research choice: 
 
Our funding came from the European Commission and you know obviously at 
that time they thought it was appropriate for this work to be carried out it was 
all peer reviewed. (I5P) 
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As well as deferring the ethical choice to funding agencies indirectly, two primate 
researchers and a nonprimate user indicated that funders have directly influenced an 
apparent shift away from experiments on primates. They noted that primate studies 
used to attract funding, but now funding agencies do not want them to be included in 
grant applications: 
 
…To encourage the field and you know get funding in and provide proof of 
principle, I think indeed those studies in primates did serve to bolster the field 
and encourage investment at the time. (I8P) 
 
…in the European Union there is such an antagonism to doing experiments 
with primates that I’m actually being steered away from that by people in the 
European Union say don’t put this in to your grant application because we in 
the European Union don’t like it. So in a sense the feeling is sufficiently strong 
to therefore them to tell me that in advance of submitting a grant. So I have 
taken it out of the grant and I’m not doing it as a result. (I7NP) 
 
#   )%&, it appears that in order to justify their research choices, participants 
adopt a strategy of deferring the ethical decisions regarding experiments on to other 
parties such as other scientists, regulators, funders and to some extent society. Michael 
and Birke (1994b) identified that: 
 
…scientists distinguish themselves from a multiplicity of “others” and use the 
contrast to present their own practices of animal experimentation in a positive 
moral light (p.191). 
 
They found that scientists were critical of these ‘others’, such as foreigners, the 
cosmetics industry, abattoirs,  and clinicians, and portrayed them as negative in order 
to highlight that they are more humane, caring and morally superior. As the extracts 
presented above show, these negative ‘others’ were not apparent in the scientists’ 
responses in this study. Instead they focused on the role these ‘others’ played in 
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determining the justification for and direction of scientific decisions. This indicates it 
is important to address the influence that ‘others’ as well as the scientists engaged in 
the experimentation might have when considering impacts on decisions about research 
direction, policy or recommendations. 
 
# ))#"!##
This analysis indicates that participants attempt to ethically justify their research 
choices to themselves, and have personal boundaries that they do not necessarily class 
as rational. In some case these limits have outweighed the scientific utility of a model 
and they have ceased to use or avoided using it. This is indicative of the ambivalence 
that Birke 	(2007) noted when scientists attempt to objectify the animals they use 
to make it easier to justify their work. Participants expressed inconsistencies in how 
much consideration they gave to different species, with the decision to use primates 
seemingly needing greater justification and more thought than for other species. This 
‘speciesism’ needs to be considered when proposing nonprimate alternatives and in 
understanding why primates are seen as the very last resort in testing. There was 
evidence of participants distinguishing ‘others’ as being responsible for the 
justification for making certain decisions about experimentation, but this was not 
indicative of the critique of disreputable ‘others’ observed by Michael and Birke 
(1994b). Ethics, speciesism and ‘others’ are all important for understanding the 
impasse (Chapter 6) and in making and implementing the recommendations for 
overcoming it (Chapter 7). The ethical discussions were not restricted to animals; 
participants also talked about ethics in the context of patient health, as outlined in the 
next section. 
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The final theme of this analysis is Health and Ethics. Participants tended to talk about 
factors related to the impact of the disease, and the controls surrounding treatments for 
disease in the context of validating their research and justifying some of their choices. 
As in the previous theme these factors were discussed in practical and moral terms, 
this time under the subheadings, disease severity, safety and regulation. 
 
)$%!&
Descriptions of the problems associated with schistosomiasis were used extensively 
by participants as a justification for their research. Seven participants discussed this, 
especially primate users, with five of the seven instances being from them. The 
following is a typical response: 

There are 200 million people infected with schistosomes you know this is the 
starting point of an argument why I should be doing this work. There are 200 
million people infected there are 600 million people at risk the estimates of the 
number of people dying ranges from you know the thousands to the tens of 
thousands to the hundreds of thousands of people dying... (INP) 
 
These responses exemplify the use of ‘Sickness Narratives’ in biomedical research. 
The term ‘sickness narratives’ was used by Brown (2003) to describe the telling of 
stories about the precarious futures of individuals who are desperate for treatment as a 
means of promoting technological advances, gaining research space and resources, 
and justifying morally challenging research. In venting irritation that certain ‘Western’ 
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diseases get the lion’s share of funding, INP is illustrating how sickness narratives are 
utilised in an attempt to acquire resources for research: 
 
As we are doing about cancer research and heart disease and Alzheimer’s and 
arthritis and multiple sclerosis and so on, other very debilitating diseases, 
there’s plenty of money being spent on them there’s plenty of animal research 
being done on them just because these people are poor…should not the same 
attention be paid to the disease that they are suffering from… (INP) 
 
I9P emphasises the importance, to them, of ensuring a ‘happy’ outcome to the 
sickness narrative they use. They are keen to emphasise that those indicated as 
suffering in the narrative need to be engaged with the research, in order for it to be 
successful and accepted: 

…I mean if you’re working in a village you have to make sure all the people in 
the village benefit from it you know…I mean you have to come away from a 
place saying not only have you found out things which were important to do 
and justified your time and money and everybody else but you’ve also actually 
they end up coming out the people are healthier and the people happier. (I9P) 
 
Brown (2003) notes that combining expectations with the pathology of disease as 
sickness narratives ‘					0$0
		’ (p.8). Therefore, I9P’s emphasis might be a means of 
protecting those who stand to suffer the highest costs if hype and expectations 
surrounding the narrative fail to be realised. 
 
Interestingly, one of the participants who did not use sickness narratives in their 
account expressed concern over their use: 
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…yeah definitely that’s although I think you can overstate that [impact of 
research]. Because I mean you can say that for any work on schisto whether or 
not it’s likely to actually do anything useful… (I3NP) 
 
#  )%&, this extensive use of sickness narratives may be related to the size of the 
field and the low awareness of the disease outside the schistosomiasis community, 
which as outlined in previous sections seems to result in limits on available funding, 
high competition for resources and difficulty getting acknowledgement for the 
benefits of the research. So participants may be attempting to improve awareness of 
the extent and severity of the disease in order to generate interest in their field, to 
garner resources and better understanding (Brown 2003). In the documentary analysis 
(Chapter 3) there were indications that some antiprimate authors, particularly in 
schistosomiasis, were not as effective as proauthors at building expectations and 
winning the ‘competition’ for acceptance of their claims. In a similar vein, perhaps 
I3NP’s response to sickness narratives and the limited use of them by nonprimate 
users indicate that alternatives scientists have not yet perfected the approach of 
primate users to acquire resources. 

)'!&
When questioned about the possibility of completely replacing primates in 
schistosomiasis many participants (both types of user) expressed concern that this 
would lead to safety issues when giving candidate vaccines to volunteers and 
eventually patients. There were issues raised about the safety of certain therapeutic 
strategies, the impact of public perception of risk, and differences in international 
views on science, all of which could influence how they and others justified their 
research. 
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Several participants were concerned about the increased risk of adverse effects in 
human volunteers in clinical trials, and in the target patient population. This fear was 
expressed by nonprimate users who in general did not think the primate was of great 
necessity for the majority of research in this field. For example, I7NP did not feel 
methods could be developed or improved to facilitate replacing primates, and one 
reason for this was safety: 
 
 …we would have to therefore be very much more take leaps in the dark with 
respect to if we’re going to progress through having an intervention strategy in 
humans. So therefore it would put the human guinea pigs or volunteers usually 
in those sort of phase 2 phase 3 trials very much more at risk (I7NP) 
 
 
However, one exception was I6P. When asked specifically about finding another way 
to test the safety of vaccines they changed the focus of the discussion to the scientific 
aspects of why the primate was needed, indicating that, for them, safety was not an 
important reason for using primates. 
 
Another related aspect expressed by several participants was concern that the type of 
therapeutic strategy might cause harm to patients and volunteers, for example: 
 
So if you immunise with this are you going to produce immune responses that 
would be deleterious?...For the human GST?...And in particular for instance a 
possible cross reaction with one class or such class of GST in humans that are 
essential for reproduction? So we have to be extremely careful about that and 
to perform a number of studies… (I10P) 
 
Despite the concerns over this riskier strategy it was still being actively researched 
and at the time of the interview had moved into Phase III clinical trials. 
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I7NP made an interesting point that perhaps changes in public perception of risk have 
altered the level of testing and justification required before therapies can go into 
humans: 
 
…their understanding of risk and I think it’s something that general public 
have a very very poor understanding of…one of the things is say if you took a 
vaccine and one in a hundred people will die as a result of the vaccine is that 
too big a risk? And most people will say it’s too big a risk but on the other 
hand then you think if we went back 200 years to Edward Jenner they weren’t 
really aware of one in a hundred they would think if 99 people were protected 
against smallpox that was a very good risk…But in today’s society we think of 
that as being a very bad risk… I think that also goes through to using animals 
in scientific research understanding what the risk is or the benefits are… 
(I7NP) 
 
#   )%&, these data indicate that participants may be reluctant to say that 
primates could eventually be replaced due to perceived safety risks. Despite these 
safety issues there is precedence for other antiparasite vaccines going into human 
trials without primate preclinical data (section 4.2). This, in conjunction with 
examples wherein the risk issues raised about certain therapies  	 lead to the 
research in those therapies being abandoned, suggests that safety might not be as big 
an issue as first indicated. This riskier approach could be related to the relatively high 
level of competition in this field (see 4.1) and the perception of losing out to other 
fields in terms of funding (see pervious section), because Barber 	. (1979) found in 
the case of research on human subjects that ‘4		
	  	 1					   
 	
		3$$		$313		38	’ 
(preface). 
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While safety and risk underpin many regulations participants did not discuss 
legislation in this context. Instead participants focused on the role of regulation as a 
justification for primate research being conducted and for why it could not be 
replaced. These discussions centred on regulatory requirements to use primates, the 
level of regulatory control and a concern over research moving to countries with less 
stringent rules. 
 
Some participants argued that primate models would eventually have to be used at the 
end of preclinical testing in order to satisfy regulatory requirements for conducting 
clinical trials, for example: 
 
…but I just don’t see the regulatory authorities allowing any drug to go 
anywhere near a human if it hasn’t gone through the fullest and to me that 
includes primates. (INP) 
 
Some participants commented on the strictness of the regulatory controls regarding 
primate experiments, suggesting that they saw this as a way to validate the primate 
work was necessary: 
 
…When you start doing human experiments…you need to have a big file 
where you have to show that this vaccine has shown such and such properties 
in such and such animal species…in fact it’s very difficult nowadays to get the 
permission of moving to humans because you have to go through an ethical 
committee you have to go to an executive committee and so on to get the 
permission of doing that without a number of arguments. (I10P) 
 
In relation to this I2NP and I7NP expressed concern that researchers will move to 
conducting their experiments in other countries with less stringent controls: 
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…it’s such a shame because the regulations on animal use in Britain is so 
tight…it’s great that people are aware and you know absolutely great that there 
are limits on what can be done but if it gets pushed too much the last thing 
you’d want is to push the science to other countries where you don’t have 
these regulations… (I2NP, participant’s emphasis) 
 
I7NP thought that primate research could be stopped in Europe but cautioned that this 
would lead to it being conducted in other countries or by collaborations with 
researchers in those countries: 
 
I think you could remove primates from schistosomiasis research 
now…because it would be done in other continents…The Americans would 
continue to do it or Chinese or other nations…you would stop the use of 
primates in the European Union but you see the people who have an 
interest…seeing their work continued would just develop collaborations with 
other nations…Which maybe is a good thing. The downside is that with a lot 
of these other places for doing primate research don’t have very strong control 
mechanisms…you are then leading into a weakening of the control of the 
experimental system on those animals… (I7NP) 

#  )%&, these responses indicate that regulations are not seen as a challenge to 
conducting primate research, instead they are used as validation that the work must be 
necessary. There was concern over research being moved abroad where standards are 
lower and rules are less stringent, and this was used as a reason why primate 
experiments should not be completely banned. Similar responses were found by Birke 
	. (2007) when they found that scientists were often explicit about being the ‘good 
guys’ by highlighting poor practices and less restrictive regimes in other countries. 
This is interesting from an ethical and scientific point of view because if primate 
studies are deemed as not being necessary/justified in Europe or if the standards 
abroad are unsatisfactory, would the scientific community be willing to accept the 
findings from such studies? This will be explored further in the second case study 
(Chapter 5). 
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These findings indicate that factors relating to health, safety and regulations are used 
by primate and alternative users to justify their research, but there were some 
differences in how the various participants viewed these. Both types of user provided 
statements that can be classified as sickness narratives (Brown 2003), but primate 
users did this extensively, possibly because of the impact of competition and limited 
funding in this field. Safety initially appeared to be a significant challenge to replacing 
primates for both types of user. However, participants’ examples of other vaccines 
being developed without primate data and risky therapeutic strategies not being 
abandoned suggests that in practice safety is not a major limitation. The data indicate 
that regulations are not seen as a challenge to primate experimentation but are in fact 
given as validation for the necessity of the work. The threat of work having to move 
abroad to less stringent countries was also given by some participants as a reason why 
primate use should not be banned. The differences in approach between primate and 
nonprimate users and the impact of regulations are all considered in the 
recommendations to overcome the primate impasse (Chapter 7). 
 
,1
	
	
 
In conducting this analysis the aim was to access the views of primate and alternatives 
scientists regarding the opportunities and challenges of using primates in this field. 
This data has allowed me to look in more depth at the theoretical themes indicated in 
the documentary analysis, and to investigate whether there are differences between the 
work of the specialists within this field, how that work is represented, and what 
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impact this has on the perception of primate experiments and the possibility for 
replacing them. 
 
This chapter discusses the analytical themes of: the Scientific Institution, Practical 
Science, Animals and Ethics, and Health and Ethics, in the context of the social 
dynamics of science, which explain the responses of the scientists involved in this 
study. The analysis indicates that scientists draw upon several factors related to those 
dynamics to justify their research choices and models − with some appearing to be 
more important than others. The data show many similarities between the responses of 
primate users and alternatives users, but this chapter describes that there are also some 
differences and  highlights the possible reasons for this.. When compared to the PD 
case study, differences in the justifications given by scientists and how they presented 
them were apparent and are described in Chapter 5. 
 
Within the theme of the Scientific Institution, participants indicated that competition 
was important and seen as more of a challenge than an opportunity to getting their 
knowledge claims accepted and for moving the field forward. This appeared to be 
related to the perceived low profile of the disease and paucity of collaboration due to 
fear of being anticipated (or scooped) by another researcher (Hagstrom 1974). Primate 
users were more positive about competition with nonprimate users, seeing it as more 
of a problem for progression of their research. The participants’ responses indicate an 
interplay between reputation and competition, with Merton’s (1968) ‘Matthew Effect’ 
possibly explaining why those viewed as having the greatest reputation (in this case 
primate users) fare disproportionately well in the competition for resources and 
acceptance. Another important challenge revealed by the analysis was the lack of 
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established data for alternatives, as primate users strongly emphasised the existing 
knowledge related to their models. A further problem identified by both types of user 
was the lack of opportunity to publish negative results. Indeed, ter Riet 	.(2012) 
found that not publishing negative results appears to be prevalent in laboratory animal 
research and argue it is conceivable that: 
 
…nonreporting of “negative” research findings may hamper progress in 
laboratory animal research through unnecessary duplications of experiments 
and may lead to premature firstinman studies. (p.1) 
 
They suggest some possible solutions to this publication bias problem that will be 
explored in Chapter 7. 
 
As well as challenges, participants identified some opportunities that were influencing 
the acceptance and direction of their research. These responses indicated an 
association between Collins’ (1988) ‘core sets’, expectations in the form of hype 
(Brown 2003) and publication. They noted the importance of gaining acceptance from 
peers and of using publication to overcome problems with getting novel ideas 
accepted. However, a core group (Collins 1999) of primate researchers is dominating 
which knowledge claims are accepted and is limiting publication via peerreview. 
Several saw hype from media publication as problematic, but it was acknowledged 
that ‘sexing up’ or selling their research was a means to getting it published and 
accepted. 
 
In terms of Practical Science, as would be expected, ‘scientific’ considerations were 
often given as justification for model choice. While the benefits of models were given 
more readily, participants seem to be very aware of the limitations of their models, 
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and are willing to discuss them even though they rarely appear in the peerreviewed 
literature. The analysis indicates that research questions are used by participants to 
justify their model choice, and emphasis is placed on only the most important 
questions requiring primate studies. There is conflict over the best research aim to 
follow, with enchantment (Hedgecoe 2006) and publication bias perhaps preventing 
schistosomiasis scientists from identifying the best way to progress the field. In 
addition, this theme highlighted that the concept of entrenchment (Collingridge 1980) 
might explain why the idea that primates will be necessary for the final stages of the 
vaccine process persists, despite examples from other fields of research indicating that 
this is not always the case. External, rather than science, policy was perceived as 
driving the scientific agenda in this field, which was being influenced by the public 
and lobbyists, sometimes to the detriment of progress in finding a vaccine. Logistical 
issues were also identified as being problematic when using primates and other 
animals. In the PD case study it can be seen that there are subtle links between 
entrenchment and policy that are not so evident here (Chapter 5). 
 
The Animals and Ethics theme revealed that, like those in the study by Birke 	. 
(2007), participants here have personal boundaries as to which species they will use, 
and these can act as challenges to conducting certain studies. This is linked to more 
consideration being given to primates and a kind of ‘speciesism’. An important aspect 
to note here that was not included in the main analysis was that several participants 
spontaneously discussed the Three Rs concepts either explicitly or in descriptions of 
their actions. This implies that this concept may be an important means by which 
scientists justify their methods implicitly to themselves. Another important finding is 
that participants talk about the influence of ‘other’ parties such as other scientists or 
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regulators on the decisions regarding which experimental model to use. However, they 
did not talk about ‘disreputable others’, as scientists in Michael and Birke’s (1994b) 
study did − with the possible exception of the public who misunderstand. Instead they 
focus on the role the ‘others’ play in providing justification for certain areas and types 
of research. A particularly interesting aspect of this was that European funders 
appeared to have shifted their emphasis away from primate studies, leading to them no 
longer being conducted. These ‘others’ are considered in Chapter 7 as they represent 
who or what else could be influential in affecting change in scientific attitudes or the 
course of the research and, as a consequence, in implementing the recommendations 
for overcoming the primate impasse. 
 
The final theme of Health and Ethics raised two seemingly important challenges to 
completely replacing primates in schistosomiasis. Both types of user gave safety 
concerns as a reason why primates would be needed, particularly at the end stages of 
vaccine development. However, this seems less important when giving further 
consideration to the actions of the scientists continuing to work on strategies that raise 
safety concerns, and the precedence in other fields for preclinical primate studies to 
be bypassed. It may also be related to the regulatory requirement to use primates. 
Several participants including both types of user said they thought that regulations 
stipulated that primate data were needed before going into clinical trials. Therefore, 
regulation was framed as a challenge to replacing primate studies, including raising 
concern that the research would then move abroad to less stringent countries. The 
analysis again indicated that expectations in the form of sickness narratives (Brown 
2003) are important for understanding why primate studies persist as the status quo. 
Primate scientists use sickness narratives more extensively than nonprimate users. 
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There could be several reasons for this, which are considered in Chapter 6. For 
example, the primate work may be perceived as more controversial so needing 
stronger justification through emphasising how important the benefits are, or that the 
alternative users perhaps need to use this approach more to gain resources for their 
area of research. 
 
This analysis reveals what scientists in schistosomiasis vaccine research identify as 
the main opportunities and challenges to their research, in particular their model 
choice. It indicates the factors which are important for the final phase of the project. 
These include the need to consider engagement with funders, policy makers and 
possibly lobbyists, and tackling entrenchment/regulatory perceptions about end stage 
use. The data from this and the next chapter also identified that some of the challenges 
and opportunities may be field dependent, and that different approaches will be 
needed for some aspects of the recommendations to overcome the primate impasse. 
 
The next chapter presents the analysis of the interviews from the second case study 
looking at PD research, where the same themes were identified, but important 
comparisons and contrasts between the two cases are described. 
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This and the preceding chapter provide an analytical summary of the data that were 
collected in the semistructured interviews described in Chapter 2. It reports findings 
from the second case study on Parkinson’s disease (PD) and builds upon the 
documentary analysis (Chapter 3). Once again the participants’ responses are 
presented in four themes: the Scientific Institution, Scientific Practice, Animals and 
Ethics and Health and Ethics. However, there are some differences in emphasis 
between this and the schistosomiasis case, which are highlighted within this chapter. 
 
PD is a chronic neurodegenerative disorder leading to severe motor impairments and 
cognitive dysfunction. In industrialised countries PD is estimated to affect 0.3% of the 
entire population (de Lau and Breteler 2006). Parkinson’s UK (2012; formerly 
Parkinson’s Disease Society) estimates this to be 120,000 people in the UK. Since the 
1960s, LDOPA, a dopaminergic agonist drug, has been successfully used to treat PD. 
However, LDOPA merely alleviates the symptoms of PD, can cause side effects and 
becomes less effective over time. This has led to other symptomatic treatments, such 
as other drugs, surgery, and dietary and rehabilitative management. 
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As in the previous case (4.1), PD participants justified their research using underlying 
factors that influence how science is done under the Mertonian inspired theme 
‘Scientific Institution’. Again, data is presented under the subthemes of: competition, 
reputation, knowledge acceptance and publication. Many PD responses echoed what 
was said in the schistosomiasis case, but some important differences were apparent in 
each subtheme. Additionally, there was less distinction between the answers given by 
primate and nonprimate PD scientists than there was between the different types of 
schistosomiasis users. 
 
 *!!#
Chapter 4 identified that competition in science is an established concept (Bonitz and 
Scharnhorst 2001), and according to the interviews it is affecting the field of 
schistosomiasis research. PD researchers view competition as an influencing factor, 
but its impact seems to be less prominent. 
 
As in Case Study 1, competition was seen as hindering progress in PD. Several 
participants discussed the problem of people not wishing to reveal their unpublished 
or new ideas due to the competitive nature of science, expressing this as a fear of 
being ‘		’(Hagstrom 1974 p.2), for example: 
 
I think they’re [working groups] useful to some degree but scientists are very 
secretive by nature Nobody is going to tell an audience of their very latest 
ideas the data cos you can’t trust your colleagues to be quite frank. You learn 
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the hard way that it’s a very competitive world and that people will steal your 
ideas. So usually there’s almost absolute ban on talking about something big in 
a laboratory until it’s finished and you’ve got it in some way accepted for 
publication. (I11P, participant’s emphasis) 

In comparison to schistosomiasis, there were fewer comments on competition as a 
positive influence on the field, and less discussion about winning or losing the 
competition, with only one example from I16NP who described their research group 
as winning the competition for acceptance of their idea. 
 
Fewer references to competition could indicate that it is not as influential in the PD 
field as it may be in schistosomiasis. Responses suggest that this may be due to 
collaborations between different researchers, both within and outside the PD field, 
overcoming the competition. Several participants commented on collaborations that 
they were either involved in or knew of and how, this had sometimes allowed 
significant progress to be made. For example, I16NP describes how the field of cell 
transplantation has been reinvigorated by collaboration, which has in turn attracted 
funding: 
 
That developed in to a working group on transplantation for Parkinson’s 
disease that involved the leading people in Europe and that’s now got new FP7 
funding and that’s now leading to a clinical trial… (I16NP) 
 
This contrasts to schistosomiasis, where much of the discussion was about the need 
for more collaboration rather than it actually occurring. A factor in making this 
collaboration possible could be the involvement of ‘core set’ scientists (Collins 1981). 
The PD participants argued that when scientists with specific expertise were included 
the discussions were more open and honest, and the fear of losing a competitive edge 
was diminished, for example: 
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…at the Parkinson’s Disease Society where they’ve brought ten people 
together round the table for an afternoon where it was all signed nobody would 
repeat anything that moved out of the room. I probably learnt more in that 
afternoon than I did in the last two years about what people do where they’re 
trying to get to and how that fits in with everybody else. (I13NP) 
 
There was evidence of some reluctance even within the core set to disclose some 
information, which I19NP said was sometimes due to certain scientists’ reputation: 
 
 …it’s very dependent on the makeup of the group, because obviously if 
people have big ambitions then it’s very hard to get them to believe that they 
need anyone else to fulfil those ambitions … (I19NP) 
 
However, this does not appear to be as problematic as it was in Case Study 1, which 
might be expected given the greater incidence of collaboration; because as Hagstrom 
(1974) identified, cooperating scientists are less secretive and communicate more. 
 
The nature of PD research could also account for competition being less prominent. 
As the following participant illustrates, when there are many possible solutions to the 
questions in a field, the competition can be less intense (Hagstrom 1974): 
 
…and it’s [competition] worse I think if you’re looking for absolute answers. 
So that’s always been a problem in the world of genetics. If you’re looking for 
a gene that causes x and you find it that’s great if you don’t find it you’re the 
second to find it no one’s interested So you know it depends what your 
outcome is as well. (I19NP) 
 
One participant indicated that it could be related to how close the scientist is to the PD 
patients as to whether they particularly engaged in the competition, with those that are 
closest or active clinicians being less likely to be competitive, and to be more open 
about their research: 
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Or it’s very easy when you’re working in a lab to forget about the patients so 
you know unfortunately you have this dichotomy I would say that there are 
some people who are in it and working for personal progression and then there 
are people like {name omitted} and {name omitted} who keep the patients at 
the forefront of their mind. And they’re very open about their research findings 
and they want to just move the field forward and not to you know keep their 
findings close to their own chest. (I14NP) 
 
This seems plausible as schistosomiasis researchers seemed to have less regular direct 
contact with patients even though several had witnessed the infection’s affects. 
 
#   )%&E competition is not as prominent as an influencing factor for PD 
scientists as it appeared to be in schistosomiasis. Responses indicate that this could be 
due to a greater incidence of collaboration in PD. This might be related to translational 
closeness to patients, which appears to be a unique observation in terms of 
competition theory. There were no noticeable differences between the primate and 
nonprimate user responses as there were in some instances in Case Study 1, perhaps 
because PD scientists make fewer references to competition in general. 
 
*!)!#
The reputation a person has is a key influential factor in participants’ explanations, in 
both of these cases, of why certain areas of research are more dominant, or more 
readily accepted than others. The participants’ responses in both cases were very 
similar with only slight differences. 
 
When asked if individuals with strong reputations had driven the direction of research 
within the field, several PD participants answered yes. Some participants indicted that 
the reputation of the group or institution was important in how influential they could 
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be in altering the direction of research, or getting their ideas accepted, which was not 
apparent in schistosomiasis. For example, I17P talks about how training received in 
certain laboratories has influenced the theme of people’s research, and stated that they 
are more willing to accept evidence presented by a laboratory with a good reputation.
 
Indeed, I14NP indicates that a reputable laboratory has to validate a novel finding for 
it to be generally accepted: 
 
I mean you can have serendipitous findings that can occur in any lab in any 
part of the world but usually I would say it would take a sort of a more 
established lab to validate or verify those serendipitous findings before 
everybody else is going to latch on if you know what I mean? (I14NP) 
 
There were several examples given where reputation was having a positive impact, 
such as in getting funding and/or publications on an individual basis, or in driving 
research forwards and getting outcomes for the field: 
 
…it was also led by a very well respected neurologist and neuroscientist and 
he was very active in driving it forward and keeping everyone on track… 
(I16NP) 
 
This might be expected from the perspective of the ‘Matthew Effect’, which Merton 
(1968) notes may result inB4	 		 3	
 		 	3	  3

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	’ 
(p.60). This is probably contributing to the observations made about those with the 
greatest reputations receiving larger levels of funding. 
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Participant I20NP made an interesting unique observation that whilst having a good 
reputation was a positive thing and gave the person concerned some influence; they 
had to actively engage with the scientific community to take full advantage of it: 
 
…you get somebody who’s solely interested in and pursuing the scientific 
findings and has no interest in sitting on committees and you know talking to 
the funding bodies and things like that. I guess that’s generally a rare 
individual. But yes without doubt the people who are perceived as the leaders 
in the field will often be there or have that perception because they are well 
known to the field well known to the funders well known to the journals well 
known to the conference organisers. So it’s certainly again another sort of 
snowball once you start getting recognition you can often build on that and 
increase your influence. (I20NP) 
 
This was an unusual response in this study but it is not unexpected, as Merton (1968) 
noted ‘…  	 3 $4 $	 	 3 	$

	 	 	)’ (p.4). In line with Case Study 1, several PD participants 
highlighted that while reputation can be positive for the individual or group 
concerned, it is not necessarily best from a scientific point of view. Avenues of 
research can continue despite being very disappointing, or promising areas can be 
ignored on the say so of certain individuals or groups, with the following being a 
typical response: 
 
Yes there’s no doubt that opinion leaders lead the field there’s no doubt about 
that. Strong driving personalities in the Parkinson’ disease arena have moulded 
where it’s gone for a long time now… that can be good and bad sometimes it 
will drive a field on the right direction other times it could be completely 
wrong to drive the field on in that direction. (I11P) 
 
Similar to the schistosomiasis scientists, PD participants identified that scientists with 
a big reputation can be negatively influential via the peerreview process, by blocking 
the publication of research they disagree with, for example: 
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I think they can have a large influence over it yes cos they often end up 
reviewing everything else and therefore if it doesn’t necessarily agree with 
their viewpoint they can be quite influential. (I19NP) 
 
Perhaps the biggest difference between the case studies is when participants discuss 
their views on their own or close colleagues’ reputations. The primate users were very 
positive about their reputation, as they were in the previous study. However, in 
contrast there are no examples of nonprimate users identifying themselves as less 
influential in driving the field, or building new knowledge. Indeed, this nonprimate 
user suggests that their reputation is good and has helped with driving the acceptance 
of the stem cell area of research: 
 
You can normally judge it by the number of invitations you get to talk about it 
and where you get asked to talk about it and the index is also how easy it is to 
publish and how much grant money you get. So cell therapies for Parkinson’s 
disease because of the big push on stem cells has become a much more 
popular field. And therefore you know having been in it a long time before that 
began its easier to sort of have credibility in that field really. (I19NP) 
 
#   )%&, the responses indicate that PD scientists see reputation as influential, 
and that its impact appears to be relatively similar in both cases. The findings suggest 
a broader applicability of Merton’s (1968) ‘Matthew Effect9) The main distinctions 
between the two cases were a difference in nonprimate user PD participants’ personal 
perceptions of their own reputation, and more emphasis in PD on group or 
institutional reputation. This may be due to broader avenues of research in PD 
resulting in a larger population of scientists engaging in research in this field, as 
opposed to schistosomiasis. Consequently, it could be easier to establish a reputation 
as an individual or group as less people are competing in the same area. 
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Another factor evident in both case studies is how knowledge claims become 
accepted; including who needs to accept them and what form they take. This appears 
to be related to the kind of research conducted and the models used. Two distinct 
differences between this and Case Study 1 were related to public perception and novel 
research.  
 
The majority of participants indicated that the acceptance/approval of their peers was 
important to them in validating what they had found, with some participants explicitly 
stating that the opinion of their peers was more important to them than the opinion or 
approval of the public: 
 
…but the public perception is not that important to me…You can’t really give 
the level of detail to members of the public…more important to me is the way 
my work is received by other researchers in the field and also by the clinical 
people in the field, so the clinicians…the doctors who are actually going out 
there and talking to the patients. (I14NP)

A reason for this finding may be that participants are setting the public apart from 
those most closely involved in the research, and are seeing them as outside because 
they do not understand the evidence or the scientific process as whole: 
 
…and people then are like oh well how quick is it I mean how can we get this 
compound or hope when is it? And then you’re like oh actually you know it 
was a very small trial and it was a very small effect and yeah it’s interesting 
but…when is it gonna be that this could possibly have any benefit to you is 
who knows… (I18NP) 
 
It seems that those placed outside are seen as less able, or even unable, to contribute to 
the scientific knowledge claims: 
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If the aim of the meeting is to talk about a very important and tricky scientific 
point there’s no point in having Mrs Smith the carer of Mr Smith who has 
Parkinson’s disease there because she’s not going to get anything out of it nor 
is able to contribute. (I12P) 
 
The perception that those outside the scientific expertise cannot make valuable 
contributions seems particularly strong when it comes to people who take an anti
vivisection stance. There is resistance amongst some of the participants to engage with 
this group of people. 
 
This reluctance to give antivivisectionist’s contributions any consideration may be 
related to how those who classify themselves as inside the scientific expertise set, 
characterise those they see as outside. For example, participant I17P separates anti
vivisectionists from other outsiders in the context that they are irrational, compared to 
people who may not agree, but accept that there is justification for the work: 

Oh apart from the animal liberation type of people a lot have their negative 
feedback people would say that they would feel uncomfortable with the type 
of work but they see why it’s necessary. (I17P) 
 
This separation has parallels with Case Study 1 and with Michael and Birke (1994a), 
where scientists involved in animal experimentation, particularly those in the core set, 
place criteria on whom they regard as having a legitimate membership, and 
consequently a voice in the debate. 
 
Despite describing having little consideration for public acceptance of their work, 
when asked how important public perception of their work was to them, several PD 
participants indicated that it was very important, and others suggested that it should at 
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least be taken in to consideration. This was not evident in the schistosomiasis 
responses. 
 
The data suggest three main reasons for this. Firstly, in contrast to schistosomiasis, PD 
participants indicate that the public are acutely aware of PD and its affects, and want 
information about the research that is being conducted, which is nicely summarised in 
this quote: 
 
…and people are very interested. I mean certain things attract more interest 
than others. People are very interested in stem cells. People are interested in 
you know diseases of the brain because as we live older more of us will get it, 
so there’s a vested interest in understanding it. So you know it’s normally a 
pretty receptive audience when you go round and talk about these things. 
(I19NP) 
 
This is unsurprising given that schistosomiasis is a disease associated with Developing 
countries, and so the European ‘public’ will very rarely come in to contact with it. 
This awareness may mean that it is easier to gain public acceptance of PD knowledge 
claims. 
 
Secondly, there appears to be greater emphasis on the need for public support for PD 
research. This is twofold, in that participants talked in terms of accountability, with 
several noting they needed public acceptance because they were funded with 
public/charitable money, so they had to account for how that money had been used: 
 
Certainly we get some very good and very generous support…and of course 
they are supported and are accountable to Parkinson’s patients and their 
families and caregivers and so on. So these are the people that we’re really you 
know supposed to be making a difference for and because they actively have 
an interest in funding us I think we’re beholden to some level to at least keep 
them informed about what we’re doing… (I20NP) 
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Others indicated that they need public support as it manifest into a willingness to help 
with the research either as clinical volunteers or by donating tissues etc. for research 
purposes. 
 
There is also an ethical aspect, in that if the scientist cannot justify it to the public then 
perhaps the work should not be conducted, which is explored further in section 5.3, 
but is illustrated here: 
 
I think scientists have a duty to go out and confront the public and talk about 
what they do and see how it goes down…If they can’t explain why they’re 
doing what they do then maybe they shouldn’t be doing it may be they should 
be doing something else. (I11P)
 
The final reason is a more general drive by funders and the scientists themselves to 
increase public engagement. For example, I18NP talks about Research Councils 
specifically pushing for scientists to do more public engagement: 
 
…in general I think it’s probably a good thing though cos you want people to 
be engaged in what kind of research is going on and you know people wanna 
know…I think a lot of the research councils are pushing towards this you 
know to disseminate our information to the public you know. (I18NP) 
 
Therefore, it seems that public acceptance is relatively more important to PD 
researchers than it is to those working on schistosomiasis, possibly because of the 
perception that the public is not really aware of schistosomiasis. However, while PD 
scientists may feel that PD has a reasonable public profile some of the areas of 
research may not be so well known, as illustrated by I18NP who feels that public 
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engagement is important to increase the understanding and awareness of their model 
system: 
  
…the use of these very simple model systems like yeast and flies is you know 
somewhat new and people are still in general the public are quite surprised that 
you can do important disease research in simple systems. (I18NP) 
 
As established in the previous case study (4.1), a second aspect of acceptability 
appears to be the nature of the knowledge, that is, whether it is novel or established. 
Unlike in Case Study 1, PD participants discussed novel knowledge quite extensively. 
Chapter 2 highlighted that theoretically it is difficult for scientists to achieve 
recognition when proposing alternatives to established knowledge (Gilbert 1976). 
Several participants indicated that it would be, or has been, a problem for them, for 
example: 
 
…sometimes I think we have struggled a lot with the graft work that has been 
quite a battle because it’s been about technology and language between Europe 
and America in a way. And the transplantation work has been viewed very 
differently in Europe and the States and trying to get some of that work 
published has been and probably will continue to be quite tricky. (I16NP) 
 
The participants that commented on this generally indicated that their ideas were 
eventually accepted, at least in part, but that it took time, persistence and further 
validation of the claims to achieve this. 
 
Some of the PD participants indicated that novelty was in fact important in making 
knowledge claims more likely to be accepted, for example: 
 
But I think you know they kind of go hand in hand to some degree I think if 
you find something that’s novel and interesting and you look at it in detail you 
probably gonna get a pretty good publication out of it. (I18NP) 
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No primate users described any particular difficulty with getting knowledge claims 
accepted, or mentioned novelty in the context of accepting the work of others. This 
could be because their work is already ‘established’, or that they place more emphasis 
on findings that come from an established background of work, for example: 
 
No it’s building on work that was there because the evidence dictated that was 
the target so I went to do my research in one of the groups that was central in 
establishing it. (I17P) 
 
Similarly to Case Study 1, the primate users were not alone in stating the importance 
of established knowledge, or in viewing their research as established in some cases. 
Therefore, there is an apparent dichotomy that, while theoretically and seemingly in 
practice, novel knowledge claims are more difficult to gain acceptance for, non
primate users appear to place special emphasis on novelty as a means of gaining 
acceptance. This could be because of nonprimate users utilising newer, less 
established techniques/models, so they are overtly emphasising that novelty is good. 
However, as was true for some of the Case Study 1 participants, they appear to 
appreciate the difficulty of getting the novel claims accepted, and that to improve this 
they should in general put them into the context of historical or established 
knowledge. 
 
#   )%&E knowledge acceptance was raised by participants in both cases, with 
established knowledge and approval of scientific peers apparently being important to 
them. However, in PD the responses indicate a dichotomy between novelty being 
regarded as a means to get scientific knowledge accepted, and it being difficult in 
practice to get such knowledge incorporated into the mainstream knowledge base. 
This was not seen in schistosomiasis, and appears to be limited to nonprimate using 
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PD participants. This could be related to the perceived greater public perception 
regarding PD, and the comparatively newer or more unusual techniques being used by 
nonprimate users making it necessary for them to focus on this aspect more. 

)!#
Participants in both cases see scientific publication as important for substantiating 
knowledge claims, and as a means by which their success is measured by others and 
themselves. In the case of PD all of the participants talked about scientific publication 
in this context, although some placed more emphasis on it than others. 

Bonitz and Scharnhorst (2001) note that, ‘"		3	
3	K
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	
K
L9(p.38). 
Therefore, it is not unusual that participants signified that publishing was one of the 
factors they used as a measure of the success of their work, and as an indicator that it 
was accepted. This was done in several ways including emphasising the number of 
publications or citations. 
  
Perhaps less obvious was the unusual suggestion by some participants that, while 
publication is the basis on which others or the ‘institution’ judged them, in some cases 
this was different to their own criteria for success. For example: 
 
…the motivation for my work is fundamental biological interest I have to 
justify my work to different people to regulatory authorities to government to 
university to grant agencies each of them have different sets of criteria. 
Usually they relate to things like publications…The papers I’m most proud of 
are quite different to the ones that the university flags up as high impact 
papers. (I15P) 

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Four PD participants identified that where a paper was published is important, and in a 
similar way to the schistosomiasis example, one pointed out that this did not 
necessarily guarantee the quality or importance of the work: 
 
…you’ve got to see them publish in good journals...You know just cos 
something’s published in Nature or Science believe me doesn’t mean it’s right 
But there’s not much publicity in the things that turn out to be wrong but there 
are things which are published in very good journals that are never reproduced 
by anybody else again. (I11P) 
 
Once again the dichotomy of novelty being both an opportunity and a challenge to 
gaining acceptance is raised in this context, with two participants indicating that it is 
important for initially getting published, for example: 
 
But I think you know they kind of go hand in hand to some degree I think if 
you find something that’s novel and interesting and you look at it in detail you 
probably gonna get a pretty good publication out of it. (I18NP)
 
Finally, as in schistosomiasis, some of the PD participants talked about the importance 
of publishing all data, especially negative data, in order to avoid unnecessary animal 
use. They expressed regret that this is often difficult to do, and is not seen as having as 
a high an impact, despite it being valid knowledge. 
 
In addition to scientific publication, some schistosomiasis participants, and most PD 
participants, mentioned media reporting of research. Many of the responses expressed 
concern or negativity towards how media outlets portrayed scientific findings. There 
were general comments that this type of reporting is overly optimistic and dishonest: 
 
But I think it’s more to do with the whole way the media presents science. I’m 
always disappointed about what comes out in terms of being simplistic it’s the 
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certainly in the media well my contacts with it honest an honest story is not a 
story it has to be wow bang or disaster. (I15P) 
 
Several participants indicated that this overoptimism or hype can consequently create 
false hope, which in turn can be detrimental to the research field, and harmful to those 
suffering from the disease, with this being a typical response: 
 
…I mean there is obviously it’s that way with everything though in the media 
right? I mean they hype everything right? Everything is very dramatic and they 
gotta...sell papers right so they need headlines. You know I think sometimes 
it’s a bit unfortunate because I think you know I think it maybe gives false 
hopes to patients and patients families…I mean they’re usually based on a 
scientific study that’s interesting but it becomes overstated. (I18NP) 
 
Despite the negativity expressed by some participants about the media, there were 
more positive responses than in the schistosomiasis case. For example, I17P indicated 
that engagement with media outlets was increasing: 
 
Yes more and more scientists are happy to be interviewed about their work and 
you can see that in the press as various successes are heralded. (I17P) 
 
I20NP noted that, while concerned about the frustration caused by hype, they 
appreciated that it can generate interest in, and funding for, the research, which would 
appear to be a clear example of using expectations and hope about research to 
generate space and resources for it (Brown 2003): 
 
…I can certainly recognise that people get frustrated when you know big 
stories a lot of publicity and there’s not always a tangible advance comes from 
that. One thing that it does often lead to that’s not necessarily tangible for 
patients and those people directly affected it leads to greater visibility for a 
particular disease or syndrome or whatever it is at that time and that itself 
brings in well if people conduct it properly and capitalise on it should bring in 
a lot of charitable funding a lot of support not necessarily charity but from 
government as well. (I20NP) 
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#   )%&, it would appear, as expected, that publication is used by scientists in 
both cases as a means of measuring success and, perhaps more subtly, as a means of 
quality assurance, although, as noted by several participants in both cases, this is not 
definitive. Perhaps more interesting in the context of this project are the responses 
related to media coverage of the research. Although still citing negative aspects of 
media hype, PD participants tended to be more positive about the role of the media 
such as, newspaper, radio and television reports in gaining resources and acceptance 
for their research than the schistosomiasis scientists were. These findings indicate that 
despite disappointments, hype continues in both these case studies, suggesting that 
hype/disappointment cycles function in the process of scientific change as well as in 
the context of technological change that Borup 	.(2006) proposed; ‘4		
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#!'#!!!###
Many of the findings related to ‘scientific institution’ are, as expected, generic to both 
cases, and possibly to biomedical research more broadly. Both cases show that the 
subthemes described are not mutually exclusive, with competition, reputation, 
knowledge acceptance and publication being interrelated in various ways. Of greatest 
interest are areas where there is a contrast between the two cases, or between primate 
and nonprimate users, which had to be taken into account when proposing the 
recommendations in Chapter 7. In particular, that competition appears to be less 
Page | 188  
 
important to PD participants, possibly due to greater levels of collaboration linked to 
the core set and nature of the field, as well as a potentially important relationship 
regarding the closeness of the researchers to the patient population. Descriptions of 
the influence of institutional reputation were also unique to PD participants. Despite 
there appearing to be less discrepancy in how primate and nonprimate users viewed 
their own reputations in PD, there was still evidence of the ‘Matthew Effect’ (Merton 
1968), with those with the greatest reputations being observed as gaining the most 
funding. The responses regarding scientific publication were similar to the first case 
including, the frustrations regarding publication of negative data. However, PD 
participants talked more extensively about publication via media outlets. They placed 
more emphasis on the impact of the public perception of their work, which might 
account for PD responders more positive attitude toward media hype and expectation 
building. Although not central to this project, given the apparent increasing interaction 
with media outlets in PD, these findings might be of interest to those studying the 
process of ‘medialization’ of science, that is, the changing relationship between 
science and the mass media, such as scientists being forced to engage with media 
outlets as a means to legitimate their research, or outcompete others for recognition 
(Rödder 2008). 
 
.%&	
 
As previously defined in Chapter 4, the second theme by which participants provided 
justification for their research and knowledge claims was that of ‘Practical Science’. 
This is divided into: physiological reasons for model choice, research question and 
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overall aims, policy and logistics, and alternatives. There were some differences 
between the two cases, and when comparing primate and nonprimate user responses. 
 
&())#'%"
PD participants responded similarly to schistosomiasis researchers by describing 
many scientific reasons for their choice of experimental model, which are summarised 
in table 11. This included describing the limitations of theirs and others’ models and 
emphasising that, due to deficiencies of each model, they had to use several different 
ones during the course of their research. Indeed, some were very explicit in saying 
none of the PD models were completely adequate, and this was not limited to either 
type of researcher, for example: 
 
I think the problem is we don’t have a relevant model. And I think the only 
way round that is to use all the models because each model has its own benefit 
each mostly each model takes one small aspect of how the cells die and you 
can test a drug against that for example (I12P) 
 
)-- A summary of the scientific reasons participants gave for and against using 
different experimental models for Parkinson’s disease research. 
" )#'% % 
1methyl4phenyl
1,2,3,6
tetrahydropyridine 
(MPTP) Primate 
 Develop dyskinesia 
 Investigating symptomatic 
treatments 
 Predictability due to back 
translation from humans 
 Develop akinesia 
 Postural instability 
 Bradykinesia 
 Acute doperminergic 
pathology  
 Studying onset of 
symptoms 
 Not predictive for evaluating 
antineuronal cell death 
drugs 
 No tremor 
 Pharmacokinetic handling 
not predictive due to size 
differences (marmoset) 
 Not a progressive model 
(marmoset) 
 No nondoperminergic 
pathology  
 No lewy bodies (but same in 
human mptp cases) 
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 Studying onset of side 
effects of symptomatic 
treatments 
 Remains stable for many 
years Anatomically similar 
for implantation studies 
(macaques) 
 surgical targets are the 
same (macaques) 
 Scaling up/validating 
methods 
 No spontaneous recovery 
 No alpha synuclein 
aggregation 
 Artificial lesion  
Rodent (model 
type not specified) 
 Drug metabolism and 
biochemical changes in the 
brain 
 Repeated dosing 
 Pharmacokinetic studies 
 Developing cell 
transplantation methods  
 Behavioural and cognitive 
testing possible  
 Neurochemical changes 
 Genetics 
 Do not mimic symptoms 
 No akinesia 
 No postural instability 
 No tremor 
 Bradykinesia is very subtle  
 Limited ability to study L
dopa side effects  
 No cell spreading (in 
transplantation) due to small 
size 
 Cannot translate complex 
function 
 Different brain structure –
surgical targets differ 
 Cannot do large scale 
genetic screening 
 Not experienced long term 
metabolic activity and 
exposure to damage that 
humans have 
6hydroxy
dopamine (6HD) 
Rat 
 Investigating symptomatic 
treatments
 Studying symptoms
 Early and late stages of 
disease Nondopaminergic 
symptoms
 Dopamine neuron loss
 Studying neuroprotective 
therapies
 Can do several 
manipulations e.g. 
serotonin or cholinergic 
systems
 Not predictive for evaluating 
antineuronal cell death 
drugs 
 No dyskinesia 
 Have to use unilateral model 
as bilateral kills animals 
 Does not exhibit all 
symptoms of PD  
 No alpha synuclein 
aggregation 
 Not progressive 
 Stable lesion unlike PD 
 Purely doperminergic 
Alpha synuclein 
Rat 
 Mild Parkinson’s like 
syndrome 
 Limited dopamine neuron 
loss 
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 Studying gene mutations 
 Study aggregation 
 Gene therapy 
 Early stages of disease 
Rotenone Rat  Parkinson like symptoms 
 Mechanistic perspective 
 Lesion less variable 
 Severe (kills half of the 
animals) 
 Might lead to a biased 
sample population 
MPTP Mouse  Late stage PD model  Not predictive for evaluating 
antineuronal cell death 
drugs 
 Neural protection does not 
translate to humans 
 No dyskinesia 
 No alpha synuclein 
aggregation 
Genetically 
Modified (GM) 
Mouse (genetic 
alteration not 
specified) 
 Pathways in cellular 
pathogenesis 
 Biochemical and molecular 
mechanisms 
 No nigral cell degeneration 
 No lewy bodies 
 Very little if any 
symptomology 
 Late stages of disease 
 Not useful for cell 
replacement or protection 
 Small percentage of PD 
caused by gene mutation 
 Genetic redundancy 
 No progressive degeneration 
Ubiquitin GM 
Mouse 
 Rapid neuropathology (in 
23 weeks) 
 Low variability 
 Ubiquitin system proteins 
conserved in humans 
 Study sporadic form of 
disease 
 Mitochondrial effects 
 Shows inclusions 
 Excessive neuro
degeneration 
 Young animals so cannot 
study behaviour 
 
Fruit Fly  Genetic  manipulation 
 Identifying therapy targets 
 Robust as many 
manipulation tools 
available 
 Can be made to express 
alpha synuclein to study 
aggregation Compound 
screening 
 No natural alphasynuclein 
expression 
 No microglia 
 Neuroanatomy different 
 Gene expression can differ 
 Lack of redundancy can 
result in compensatory 
mechanisms being missed 
 May be gene function 
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 Have a nervous system 
including glial cells 
 Behavioural observations 
possible 
 Identifying environmental 
toxins/causes 
 Rapid mutant generation  
 General biology conserved 
with human  
 Low genetic redundancy 
divergence 
 Cannot test stem cell 
effectiveness 
Worms  Investigate mitochondrial 
function effects 
 Investigate protein 
handling 
 General biology conserved 
with human  
 Can observe some 
behaviours 
 
Yeast  Genetic screening 
 Compound screening 
 Has human gene 
autologues 
 Can transfer human genes 
to study altering phenotype 
and rescuing it 
 Gene expression 
 Interactions 
 Identifying therapy targets 
 Cellular toxicity 
 Protein aggregation 
 Cannot study neuron or 
synaptic processes 
#'	  Mechanisms of neuronal 
cell death 
 Protection against cell 
death 
 Allow largescale 
screening 
 Drug mechanisms 
 Biochemical data 
 Primary cell culture – 
investigating areas affected 
by motor symptoms 
 Fluorescent imaging for 
cell interactions 
 Brain slices allow study of 
brain architecture 
 Gene identification 
 Cellular metabolic 
 Lack of functional readout 
 Not completely predictive of 
what happens in brain 
 No information on 
vulnerability of aged brain 
 Cannot measure behaviours 
 Don’t get full range of 
interactions 
 Artificial system 
 Use toxins so not replicating 
natural process 
 Different time course to 
disease 
 Disease isn’t cellular 
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pathway mutations  
 Controlled system – low 
variation 
 Protein aggregation 
PostMortem 
Tissue 
 Identification of disease 
processes in brain  
 Investigating anatomy and 
pathology of cells affected 
by disease 
 Identifying dopamine 
neuron death 
 Identifying disease 
pathology Changes in brain 
chemistry 
 Cannot identify primary 
processes vs. consequences 
Human 
Volunteers/Clinical 
Research 
 Epidemiological studies 
(i.e. large sample)  
 Imaging studies 
 Disease processes 
 Understanding the disease 
 Difficult to mimic clinical 
work in a lab 
 Cannot do brain 
manipulations 
 
#  )%&, the consensus in these scientific reason responses between the two cases 
suggests scientific justification is not unique to this topic. This emphasis on scientific 
aspects is not surprising because if there was no concordance with human diseases 
there would be little point in conducting the research, and scientists would not receive 
authorisation to do it. As noted in the previous case, while it is important to know the 
scientific basis for the scientists’ choices, what is more interesting and useful for the 
final stage of this project is the apparent willingness of participants to discuss the 
limitations of their own and other models, which is not apparent in the peerreviewed 
literature and could aid negotiation of replacement strategies suggested in the 
recommendations in Chapter 7. 
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As in schistosomiasis, as well as giving scientific reasons, many of the PD participants 
explicitly said that the scientific question they wanted to address had a large influence 
on their model choice, as did the overall aims where some conflict was again evident.
 
Of particular note was that two of the participants (I15P and I19NP) indicated that the 
scientific question had to be specific and especially important, in order to justify using 
primates. I15P made this point on several occasions but this quote is representative: 
 
…you know in this field…I don’t see any key questions that can only be 
addressed or require the use of primates. It’s partly the nature of the questions 
too…it has to be conceptually better addressed in primates… (I15P) 
 
Another aspect related to the scientific question is the overall research aim(s) that the 
scientist is working towards within the PD field. This can have a direct effect on 
which model a scientist decides to use. For example, I15P is discussing the possibility 
of a new strategy developing and that it may require primate models: 
 
…it could well be that the development of new trophic factor delivery 
strategies for neuroprotection…Because it’s so fundamentally different to say 
transplantation I think that probably is an area that requires primate validation 
before trying systematically in humans. (I15P) 
 
The literature review described in section 2.2.3 identified several areas of research 
that were being investigated in parallel within the PD field: surgical (DBS), surgical 
(cell transplantation), pharmacological (symptomatic), and pharmacological (neuro
protection). During the interviews these research aims were checked with participants. 
Similarly to schistosomiasis, responses indicated that there was conflict about which 
of these aims was the best to pursue in terms of finding an effective PD treatment. The 
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comments also suggested there were additional research aims that had not been 
identified, namely: surgical (viral vectors) and gene therapy Some of those working 
toward a specific aim were slightly more positive about that particular area of 
research, but in general the comments were relatively balanced, with some 
participants also highlighting the negative aspects of the aim they were pursuing. 
 
Conflict about the research aims was subtly and explicitly stated in some cases. For 
example, I20NP has actively and openly avoided becoming involved in a particular 
aim pursued by some PD researchers: 
 
…indirectly I’ve been opposing a certain faction of the of the field that is 
obsessed with alphasynuclein I say indirectly because I’ve actively avoided 
working on it cos I don’t think it’s worth it in with the type of approach that 
we take. I think some of the findings that have been done on that are not 
scientifically sound. I may well have said so in certain commentaries and 
reviews. (I20NP) 
 
 In contrast to schistosomiasis, where participants were more definite about which 
particular aims were best to work towards, several of the PD participants commented 
that rather than the research aims conflicting, or one being more likely to lead to an 
effective treatment, instead it was best to adopt a combination of strategies in the field 
as a whole, for example: 
 
I think we don’t know enough now to say oh let’s focus on our efforts put all 
our eggs in one basket and focus on this cos we just don’t know what’s gonna 
be the right way. I think maybe in ten years we will have a better idea what’s 
gonna be the idea the best way but I think they’re all equally important right 
now. (I18NP) 
 
#   )%&, perhaps unsurprisingly in both cases, participants placed emphasis on 
the importance of the research question in their choice of model, and that the question 
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had to be especially significant when deciding to use primates. These findings provide 
important insight into the main research aims in these two fields, and reveal conflict 
among researchers as to which is the most appropriate for the field in general, which 
is not evident from the literature. There appears to be more enthusiasm among PD 
scientists for different research aims to be targeted in parallel, whereas, in 
schistosomiasis, participants were more often saying that a particular aim should take 
precedence.
 
&)#"(!
The role of politics and logistical factors in influencing research was evident to 
different degrees in both cases. In PD it seems that logistical aspects, such as cost and 
available facilities may be having a greater effect than policy on which areas of 
research are pursued. 
 
In contrast to schistosomiasis, there was no evidence that participants viewed national 
policy as being influential in PD. There was very little discussion about policy, so the 
influence individuals or groups have on policy was not evident either. However, some 
responses indicate that antivivisectionists have been perceived as exerting pressure 
on the field that may have prevented some researchers from conducting primate work, 
but they have not particularly influenced any policies with regard to research strategy. 
Indeed this quote indicates this pressure has eased and can be dealt with: 
 
I think we’ve lived with the antiviv movement for a very long time I think the 
biggest moves are any changes to legislation and changes to the financing 
streams. (I16NP) 
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Schistosomiasis participants discussed how economic limitations affected their choice 
of model, with primates, and to some extent other animal models, being perceived as 
being too expensive to use. This problem of the cost outweighing the scientific utility 
of a model was also evident in the PD case, with both primate and nonprimate users 
commenting on it, for example: 
 
I mean it’s very expensive doing mouse work you know… (I18NP) 
 
One concern relating to economics that was consistently mentioned by both PD 
primate and nonprimate users, but was not evident in schistosomiasis responses in 
this context, was the problem of increasing costs leading to the research and/or 
scientists moving away from Europe. 
 
In contrast to other responses, participant I16NP noted that movement abroad may be 
beneficial, as there would be more funding available to conduct the research with 
more staff, which would result in improvements in the methodology: 
 
I think it’s in some ways it’s less of a concern because you can potentially 
afford more members of staff over there that they can give the drugs without 
necessarily knowing what they are and what they’re meant to do. I would 
worry more about the care of the animals. (I16NP) 
 
The issue of research moving abroad was also referred to in the context of regulation 
and is discussed further in section 5.4. 
 
Several participants stated that logistics was a factor affecting which model was 
utilised. For example, this primate user was not alone in indicating that the availability 
of primates can be problematic: 
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Well there have been problems it’s largely a supply problem not anything else. 
We use marmosets and marmosets they’re bred for research so we don’t use I 
don’t think we would use any feral animals wild captured animals at all. I 
think people who work with bigger monkeys than us have more of a problem 
with that. (I11P) 
 
I11P then went on to suggest that working with cells was a much easier option in 
terms of them being readily available. 
 
Similarly to Case Study 1, this nonprimate user indicated that they could not use 
primates even if they wanted to because of their unavailability, and the lack of suitable 
facilities and infrastructure at their institution: 
 
Well I mean for financial and logistical reasons…I would never use primates 
because I just don’t have the money or the resources or the infrastructure or 
the whatever to do primate research so that would be one reason for that. 
(I14NP) 
 
#  )%&, in a similar way to schistosomiasis participants, PD responses highlight 
economic and logistical factors, including available facilities as having a significant 
impact on model choice, which can in some circumstances outweigh the scientific 
utility of a given model. However, the PD participants appear to see national policy as 
less influential in terms of research aims and model choice than schistosomiasis 
participants. Another contrast between the cases was the PD participants’ comments 
on research moving out of Europe which did not appear in this context in 
schistosomiasis. There was very little distinction between the responses given by 
primate and nonprimate users in either case, perhaps indicating that these factors are 
universal to all scientists independently of which model they use, or research aim they 
pursue, despite general indications in the media that primate research is distinctly 
affected by some of the issues raised here (e.g. Wadman 2012). 
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Key to understanding the primate impasse and whether it can be overcome is 
determining if there are any alternatives to primate models available, or any that could 
be developed. Therefore, participants were asked for their views on this. In PD, the 
data indicate that there is some uncertainty, but more participants than in 
schistosomiasis indicated that replacement was, or could be, possible. The statements 
sometimes had caveats, for example, I16NP feels that primates could be replaced in 
the development stage, but perhaps not during final testing: 
 
…I think the development of is possible, I think very few treatments are 
actually developed to a significant extent with primates. I think they are tested 
at the final stage in primates… (I16NP) 
 
While the majority of positive responses were given by nonprimate users, some 
primate users suggested that replacement models were needed, or were available in 
certain circumstances. For example, I11P went into great detail to describe the 
beginnings of the development of two new models that, on the face of it, would 
replace the less reliable MPTP primate model. However, they added that this might 
then go on to be developed in primates, but the potential is evident: 
 
So we have two events changes in protein handling and inflammatory change 
both of which we know occur are real and occur in all the areas of the brain 
which are effected by the disease. My suspicion is that we need to set up 
models around those two. We do have one…model looks to be quite a useful 
model it’s still being evaluated. There are other models…which also look as 
though they could be useful and needed. At the moment most of it is in 
rodent… (I11P) 
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I12P was unsure about the need for primates as a second species, indicating that a lack 
of historical data might be the restricting the use of alternatives in a particular 
situation (neuroprotection), and this nonprimate user made a similar suggestion: 
 
…I mean every time you go to a new system then you have to develop new 
tools…so I mean if you’ve got you know certain primate systems that have 
been very well characterised and that are understood very well from kind of a 
pharmacokinetic pharmacodynamic sort of standpoint…and how you then 
translate that data in to humans. If all that’s in place from thirty years of 
research that’s a powerful tool and to kind of reinvent the wheel yeah it’s not a 
trivial task you know. (I18NP) 
 
Other alternative models that were suggested included: pigs, rats, sheep, human post
mortem tissue, noninvasive human imaging and mice, all of which are noted in the 
recommendations to overcome the impasse (Chapter 7). In addition, there was some 
indication that there was precedence within the field to avoid preclinical primate 
testing, and to move directly in to clinical trials, for example: 
 
…I think in general success rate’s been rather low from just going from mice 
to humans. I mean people they do it that’s the norm. It’s pretty normal to do 
compound trials in mice and then do you know tox testing in normal 
volunteers and then start clinical trials…I mean that’s not unusual. But 
obviously it’s also done where you go into primate models. (I18NP) 
 
In terms of negative responses, those adamant that it was not possible to replace 
primate models were mostly primate users. All of the primate users made comments 
in this context with the following being typical: 
 
Difficult cos we have nothing to replace it with that’s the trouble. If there were 
alternatives to be quite frank we’d be using them already. You know I can’t 
think of any sort of any way you could after the rodent that would make it very 
easy to take a drug into humans. (I11P) 
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Whereas, nonprimate users expressed uncertainty about primate replacement, with 
the following being a typical response: 
 
…obvious examples are if you wanna do gene therapy…in order to do that you 
have to look in aged monkeys…you really can’t do that type of experiment in 
a rodent cos they don’t have the same age and you don’t have the same ability 
to deliver it over a bigger area which was really what it was all about…But for 
most treatments I don’t think you need any primate studies. (I19NP) 
 
Both primate and nonprimate users gave reasons as to why it is difficult to replace 
primates in this field. These included: alternative models were not as good or could 
only be used in conjunction with the primate model; a lack of historical data for other 
models; low confidence in information from rodents translating to the human 
situation; a loss of scientific information when using simpler models and hesitancy in 
terms of safety when moving from other preclinical models directly in to humans. 
Participant I19NP made an interesting point in relation to this, that $	models had 
improved, and were capable of achieving much more than they used to, but that this 
information has apparently not disseminated widely throughout the field yet: 
 
…I think people understand the fact that you do have to use animals for certain 
aspects of the work I think what has become a unclear is that there are more 
things you can do in the dish. So in vitro studies are becoming are easier to do 
than they used to be. (I19NP) 
 
#  )%&, in contrast to schistosomiasis, and despite the adamant statements from 
primate users to the contrary, PD participants gave more examples of possible 
alternatives to primates, and seemed more amenable to the possibility of replacing 
primates. There were hints of entrenchment in the comments related to change being 
difficult because developing a set of data similar to the historical information that is 
available for primates would be a huge task. However, unlike the previous case study, 
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it may be that in PD the entrenchment of the primate research is being compensated 
for by increasing flexibility in approach and techniques. Knot 	. (2001) argue that 
this can be achieved in terms of technologies by developing: i) robust technologies 
that are appropriate in several relevant futures, ii) flexible options (technologies) that 
are adaptable to changing circumstances, such as changing concerns, or iii) flexibility 
by variety, that is, maintaining different technologies that can serve the same function. 
The latter of these seems to be applicable in this circumstance. 
 
%)!)###
These findings indicate that participants in both cases refer to aspects of practical 
science when justifying their research decisions. As might be expected, giving 
extensive scientific reasons for model choice was apparent in both fields. Perhaps 
more important are the data showing that scientists in both fields are aware of, and are 
willing to discuss, the limitations of current models, and the contrast of PD 
participants’ apparently greater enthusiasm for parallel research aims to be targeted, 
which both have a bearing on understanding the impasse and overcoming it (Chapters 
6 and 7). Both sets of participants noted logistical barriers to choosing and using 
certain models, especially primates. However, schistosomiasis scientists placed more 
emphasis on the impact of national policy than PD scientists did, indicating that a 
dialogue with policy makers may be particularly important in that case. When 
discussing alternatives, PD participants appeared more amenable to the possibility of 
replacing primates, which indicated that ‘flexibility’ to the ‘entrenchment’ (Knot 	. 
2001) seen in schistosomiasis may be at play. Flexibility may be easier in PD due to 
the higher public perception, relatively higher funding availability, and the 
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diverseness of the areas which can be studied, making it less costly to change from 
entrenched practices, and maintain a variety of approaches. In both cases the only 
major difference within this theme, between primate and nonprimate using 
participants, was that primate users were more adamant that primates could not be 
replaced, whereas nonprimate users were uncertain. Again this could be related to 
entrenchment and flexibility, with the financial, logistical, ethical and controversial 
nature of primate work highlighted throughout this project, meaning that primate users 
have invested heavily in the work. In contrast, nonprimate using participants may not 
have to contend with the same degree of pressure in this context, making it easier for 
them to foresee adaptations to current practice (Knot 	. 2001). 

.,		
 
This analytical theme helps to explain factors identified by participants as influencing 
their decisions about animal experimentation, which involve moral considerations and 
fall under the subthemes: personal choice, choice of species, and influence of other 
parties. Responses in both cases were similar, with a couple of exceptions that have 
consequences for the final recommendations (Chapter 7). 
 
%#)
As noted previously (4.3), participants made explicit reference to justifying the work 
to themselves when talking about model choice, and the moral challenges associated 
with biomedical science. In this case all of the primate users, and several nonprimate 
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users, made references in this context. Something that was apparent in 
schistosomiasis, and evident in PD, was participants emphasising how important 
ethics were to them by highlighting that they feel it necessary to teach it to others, for 
example: 
 
… I teach a module on behavioural pharmacology here at taught masters level 
it’s all about animal handling, welfare, ethics, maintenance all that kind of 
thing and I really enjoy it and it’s all about teaching the students to have 
respect for the animals… (I14NP) 
 
Participants indicated some of the ways that this personal justification was achieved. 
Firstly, by pointing out the faults of the animal; something which one schistosomiasis 
participant did in a jovial way, but here the response was serious: 
 
…I would also find it difficult to work with bigger monkeys. Marmosets look 
cute but to be quite frank they’ll have your hand off as soon as you turn your 
back. So they’re not shy about biting each other’s fingers off if the two males 
get close to each other they’re not cute… (I11P) 
 
Similarly to schistosomiasis, several primate and nonprimate using participants 
specifically emphasised the ethical acceptability of their models, including 
emphasising the priority they place on animal welfare. For example, I11P highlights 
their avoidance of unnecessary suffering even if it might disrupt the scientific 
findings: 
 
I really have some difficulty with anything that causes well it’s difficult to 
define unnecessary suffering I we have round here really quite high standards 
about how far we’ll go and if we think an animal is suffering then we put them 
down irrespective of how important that animal is. So we won’t go too far. 
(I11P) 
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This emphasis on ethical selfjustification is not surprising given as Wainwright 	.
(2006) describe ‘L4	L03				
’ (p.735) and Rollin (2007) notes; ‘4	
$$
	’ (p.525). Therefore, the scientists may feel more pressure to 
emphasise the moral consideration they have given to their career choices. 
 
Another factor related to personal ethics is where each scientist places the limit on 
what research they will personally do, and which models they will use. All 
participants, with the exception of I13NP, gave some indication as to techniques or 
models they would not use. This was related to various factors, including severity and 
emotional attachment. It was often explicitly stated as their choice with the caveat that 
they did not have a problem with others doing it, for example: 
 
… I’ve always veered away from pain but I realise it has to be done. I 
personally have always been veered away from pain research for that reason. 
I’ve colleagues who do that and they have excellent endpoints in their project 
licence to make it acceptable. (I12P)  
 
As in schistosomiasis there were examples where the participant indicated that their 
limit was perhaps not easy to rationally explain, for example: 
 
…at a flippant level I don’t and won’t work on eyes I’m squeamish and I don’t 
and won’t work on rabbits because I have pet rabbits and I have a great 
affection for them and you know completely emotional it’s not rational, but 
emotions are to be respected not ignored. (I15P) 
 
Again in PD there was some evidence that the perceived ethical concern appears to 
have overcome the scientific utility of some models, for example: 
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The one that’s shown the most promise is the rotenone model where the 
pesticide is given systemically…It hasn’t been widely accepted and the other 
problem with that model is that it actually kills about half of the animals that 
are injected with the pesticide die…I mean people don’t it’s not ethically 
sound to use a model like that where you kill half your animals. (I14NP) 
 
However, uniquely in this case, one participant described how the importance of the 
science had overcome his previous personal limit on working with mice: 
 
…it was actually kind of ironic that before I worked with mice I kind of said 
oh I’m never gonna work with mice cos I didn’t think I could…was a bit 
disturbing to me to actually have to sacrifice an animal to do an experiment 
and these sorts of things. But I just happened to get very interested in that area 
of research and it you know that was kind of where it was going and it was 
important for us to look in that system… (I18NP) 
 
#   )%&, these data show that participants in both fields place emphasis on 
ethically justifying the work to themselves. The ways the participants describe doing 
this are similar in most cases. Again, there was evidence of participants explicitly 
drawing personal ethical lines about which experiments they would conduct, which 
were seen by some as irrational and emotive, but could still outweigh the scientific 
utility of a model. However, one response did indicate that this was not always the 
case, as their personal limit had been altered by their perception that the science was 
too important not to use the model. As noted in the previous chapter, these types of 
response were observed by Birke 	. (2007), and this later example indicates that 
this mode of coping with the moral dilemmas associated with animal experimentation 
was successful for participant I18NP.
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There are several examples of participants differentiating the ease at which they can 
decide to use one species or another, or if an animal should be used at all. Again 
primates are generally given more consideration, but this is not universally the case. 
 
There were several instances, similar to schistosomiasis, where participants indicated 
that primates were given more consideration in terms of the choice to work with them 
being a harder decision than it is for other species. This included setting them apart 
from other animals in requiring large and specific amounts of information before 
using them.  
 
Two participants indicated that they give the highest level of consideration to humans 
for similar reasons to those given for limiting primate use. For example, I14NP 
indicated they set humans apart from other scientific ‘models’: 
 
I wouldn’t consider the human say post mortem tissue or PET scanning or that 
kind of stuff to be model that would be proper clinical based or human sample 
work. (I14NP) 
 
However, although primates appeared to receive the most consideration, in this case 
study two of the nonprimate users indicated that the decision to use mouse models 
was not easy, for example: 
 
I really strongly feel you kind of need to have really covered all your bases 
before you decide to do a mouse experiment you know that obviously people 
are more emotionally attached to primates which I can obviously understand 
we all are but even the mice I think you kind of want to be. (I18NP) 
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A difference in the ethical consideration afforded to different species was also evident 
in some of the descriptions of the actions of participants. For example, I12P indicates 
their willingness to continue to care for primates rather than to cull them, whereas 
I19NP is somewhat blasé about sacrificing the smaller animals: 
 
…we’ve actually just extended the period that we can keep them to six years 
because they were so healthy that we felt it was ethically wrong to cull them at 
the end of four years so we’ve increased it to six years… (I12P) 
 
…you get more information from it but fundamentally with small animals you 
can always sacrifice them and do histology. (I19NP) 
 
Apart from many participants generally appearing to be comfortable with using 
rodents, as they talked about them without expressing any concerns, there were no 
other indications that participants were particularly happier to use certain species, 
which contrasts to schistosomiasis. One slight exception to this was given by I18NP 
who indicated that perhaps people would be more comfortable working with livestock 
as opposed to primates, but they questioned if this is the right attitude to have: 
 
You know sheep obviously rats you know and these are probably important 
you know maybe they’d be good alternatives to primate models. But you know 
is the sheep you know any less worthy…I’m not sure I feel you know that 
much better about you know people working on pigs versus working on 
primates… (I18NP) 
 
#  )%&, these findings indicate that in both cases, some participants give greater 
consideration to primates. Unlike in schistosomiasis, there was no explicit reference to 
speciesism. However, taking both case studies in to consideration it seems that this 
differential consideration may be more indicative of the established capacitybased 
model of moral status evaluation, where ‘43 	 	   
KL 
$		$					
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KL 	’ (Walker 2006, p.315). This is linked to the idea 
of humans serving as the standard being with full moral status, due to possession of 
multiple capacities, relative to which all other beings are valued. This is also known as 
the slidingscale model (DeGrazia 2002). 
 
#'#'!%)%!
The descriptions of the influence of other parties, such as regulators and other 
scientists, on decisions about model choice, given by participants in Chapter 4 are 
evident in PD. 
  
The majority of comments made in this context indicated that the participant saw the 
decision of other scientists as a means to justify particular research. This was 
expressed by emphasis on being distant from the procedures, or that collaborators or 
colleagues do the work rather than them. Two participants also indicated that it was 
the scientific community as a whole that should be deciding what the correct action to 
take was, either directly as the first quote illustrates, or indirectly via peerreview as 
the second quote suggests: 
 
Well that happens in international meetings and local workshops well that is 
reflected in the ethical committees at the university and national levels and 
also there’s like the Nuffield Centre for Bioethics where multiple people of 
various disciplines talk about problems and a way forward either in science or 
in society. (I17P) 
 
Inherent I mean if you were say putting in a grant application…anybody who 
knows anything will know that that’s not gonna work…so I suppose you 
expect your reviewers will have some understanding of the models. (I14NP) 
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A second relatively common response was to explicitly talk about the ethical decision 
of society, which was not so overt in schistosomiasis. I15P was particularly vocal on 
this, making several comments. For example, noting that personal and societal ethics 
should be addressed: 
 
…I personally I feel very strongly and what I try and develop is to engage in 
any of this research you have to fulfil a double standard you have to have 
considered and abide by your own personal ethics…and you have to satisfy to 
a high standard the standards of the society as a whole in which we live. (I15P) 
 
I20NP indicated that the model they use is accepted by society, and that society’s 
decision not to raise concerns about it means that it is not regulated: 
 
I think it’s illustrated by the fact that it’s not legislated the use of these animals 
is not specifically legislated and no one ever appears to be too bothered about 
lobbying for fly rights things like that. No one else is particularly morally up in 
arms about it either. (I20NP) 
 
As it was in schistosomiasis, the link to regulators validating the ethical decisions for 
the scientists was made on several occasions. This included comments on the high 
level of legislation that covers animal experiments, and that it should prevent any 
incorrect research. 
 
Indeed, as in the first case, one PD participant indicated that primate research was 
more heavily regulated than human clinical work. 
 
The strength of, and need for, regulation were discussed in the context of concerns 
over research moving abroad, but this is covered in section 5.4. Finally another two 
parties, the first of which was not mentioned in schistosomiasis, which were referred 
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to in terms of influencing decisions about models were the Ethical Review Process 
(ERP)7 and the funders: 

…of course one has to continuously justify the use of primates both to the 
Research Councils which support my research and also to the ethics committee 
at the highest national level the Home Office. (I17P) 
 
…I believe that I should and it’s required in the every grant application these 
days. You have sections which require justification independent ethical 
appraisal licensing rules and the rest of. (I15P) 
 
It is implicit that funding is fundamentally important in facilitating biomedical 
research, as work would be impossible without it. The converse of this is that a lack of 
funding can slow or even prevent scientific progress. Participants provided several 
examples of both of these situations. Perhaps more interesting is that, rather than 
facilitate research that scientists want to do, funding and those providing it apparently 
dictate what research can be done. For example, I14NP indicates that funders, in fact, 
place emphasis on animal research, which may be a factor in why newer alternatives 
are more difficult to gain funding for: 
 
 
                                                 
7 The Ethical Review Process (ERP) has been a feature of UK regulation of animal experimentation 
since 1999. In practice they functioned in much the same way as the Animal Welfare and Ethical 
Review Body (AWERB), which replaced them when the UK laws were updated in January 2013 to 
conform with the new EU Directive 2010/63/EU. Every establishment licensed to conduct animal 
procedures must have an AWERB. The AWERB's minimum required tasks are; a) advise staff dealing 
with animals in the licensed establishment on matters related to the welfare of the animals, in relation to 
their acquisition, accommodation, care and use; b) advise on the application of the 3Rs, and keep 
informed of relevant technical and scientific developments; c) establish and review management and 
operational processes for monitoring, reporting and followup in relation to the welfare of animals 
housed or used in the licensed establishment; d) follow the development and outcome (retrospective 
review) of projects carried out in the establishment, taking into account the effect on the animals used; 
and to identify and advise on elements that could further contribute to the 3Rs; and e) advise on 
rehoming schemes, including the appropriate socialisation of the animals to be rehomed. As a 
minimum membership the AWERB must have at least one of the establishments Named Animal Care 
and Welfare Officers (NACWOs) and Named Veterinary Surgeon (NVSs) plus a scientific member − if 
the establishment is a user establishment (Jennings and Smith 2015). 
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But the drive is towards applied which means translational and the 
translational step you know between the bench and the bedside is the animals. 
So if you have an animal component in your research it’s your much more 
likely to get funded. (I14NP) 
 
In addition to the traditional biomedical funding agencies, several PD participants 
identified that Parkinson’s UK was particularly influential in directing research for PD 
treatments. Parkinson’s UK is a charity, which coordinates patient and carer groups, 
and funds biomedical research. There was no such advocacy group in the case of 
schistosomiasis, so in the context of this project this aspect is unique to PD. However, 
as the quote below illustrates it is not unique to neurodegenerative research more 
broadly: 
 
….In the Huntington’s Disease Society because it’s a genetic disease and runs 
in families there’s a completely different focus its discovery fundamental 
treatment for the future because it’s their children who have this…they want to 
see you know it’s too late for us but come up with something that will stop our 
children developing it… (I15P) 

Unlike in the schistosomiasis case, there were no examples of PD participants seeing 
an apparent shift away from funding primate use. This could indicate that it may be 
easier in schistosomiasis than in PD to move away from primate use, as the funding 
options may not be available. 
 
#  )%&, these findings, in conjunction with those from schistosomiasis, indicate 
that these scientists do not see themselves as working in a vacuum. Other parties have 
an influence on the research direction and choice of model system. Similar to the 
findings in Schistosomiasis, these ‘others’ were not portrayed as disreputable, which 
differs from the findings of Michael and Birke (1994b), who found that scientists were 
critical of the ‘others’ they deferred to. Instead, participants in schistosomiasis and PD 
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focused on the role of the ‘others’ in the model choice process. Because of this, these 
‘others’ are considered in the making and implementation of the recommendations for 
overcoming the impasse (Chapter 7). For example, where the two cases particularly 
differed was in PD having an influential advocacy group. Therefore, it may be that the 
group needs to be consulted in some way for this particular case. 
 
# ))#"!##
It is important to know what drives scientists’ decisions to utilise certain models or to 
explore certain aims, in order to effectively understand the impasse, and make 
recommendations as to how to overcome it. This analysis indicates that, in both cases, 
participants try to justify their experimental choices ethically and the ways in which 
they do this has consequences for how the recommendations are designed, and in 
particular where they might need to differ from each other. Participants draw personal 
‘emotional’ limits on what they are willing to do, which supports previous research by 
Birke 	. (2007), but there was some evidence in PD that this could be overcome, if 
the scientific case was strong enough. Particularly important for this project is the 
finding that participants in both cases appeared to give more consideration to 
primates, and exhibited a sliding scale attitude to how morally problematic models 
are. Participants from both fields identified that they did not see themselves as alone 
in making choices about animal models, highlighting other scientists, regulators, 
funders and society as having an influence. The latter of these could be understood as 
an example of Brown and Michael’s (2001) ‘switching’, where scientists can be seen 
to swap between science and culture as they go from personal scientific reasoning for 
their choices to being part of societal decisions. As the influence of society is only 
Page | 214  
 
inferred in schistosomiasis rather than being explicit as it is in PD, PD participants 
might be regarded by Brown and Michael (2001) as more ‘sociologically 
sophisticated’. Alternatively, these findings could be interpreted as ethical 
displacement, with participants potentially deferring the responsibility to regulatory 
frameworks, funders, society and other scientists to validate their own choices. 
Therefore, more constructivist scholars could argue this data could represent evidence 
of ethical boundarywork (e.g. HobsonWest 2012; Wainwright 	 . 2006), as an 
example of the concept being useful in understanding how scientists ethically 
legitimise their research, particularly that involving animals. Participants did not limit 
their discussions on ethics to animals it was also considered in terms of the health of 
the patients that may come to benefit from their research, as shown in the next section. 
 
..0	
 
In similar ways to the previous case (4.4), PD participants talked about factors related 
to the impact of the disease, and the controls surrounding treatments and patient 
safety. These moral and practical discussions are presented in the subthemes: disease 
severity, safety and regulation. However, there were some differences in the impact 
that participants indicated these factors had, particularly disease severity and 
regulation, and between different types of user. 
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In schistosomiasis participants used descriptions of the problems associated with the 
disease, or as Brown (2003) terms it ‘sickness narratives’, as a justification for their 
research. This was not such a dominant feature in PD. Indeed, only three participants 
made this kind of comment. Two were primate users, and all three had direct contact 
with patients either at present, or in the past. Instead, PD participants appeared to 
place more emphasis on the health benefits of their research, and on the complexity of 
the disease, in contrast to schistosomiasis where there was very little mention of these 
things. However, as in schistosomiasis, there was limited discussion centred on 
ensuring that those who were affected by the disease, or ‘the sufferers in the sickness 
narrative’, should be engaged with the research, in order for it to be successful, for 
example: 
 
The only way I can deal with it is I’m looking the patients in the eye and 
talking to the patients and the carers and understanding the need that they 
have… (I11P) 
 
Brown (2003) notes that ‘4	 		   	 3

 	 	   3	  	  	  	 	 	
4		’ (p.8), so this might be a way of alleviating 
the damage that might result from sickness narratives, such as patients suffering 
intense disappointment when a promised therapy does not materialise. 
 
In terms of health benefits six of the ten participants talked about the therapeutic 
advances made from their research, or emphasised how it has, or will, translate 
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positively into human medicine. All four primate users made comments of this nature. 
Of the nonprimate users, I18NP made the most references to it, for example: 
 
…they may not understand why you’d wanna work with flies or yeast but I 
think it’s important for them to understand how this can translate in to 
therapeutics for people. (I18NP) 
 
It was also common to explain the variety of health effects within the condition, with 
many responses including comments on the complexity of the disease as a means of 
explaining why a variety of animal models were required, and/or why progress maybe 
slower than expected. All participants referred to this, with the exception of I13NP. 
For example: 
 
…it’s a difficult question because depends on what aspect of the human 
condition, but if you were to say that there four key features of human 
Parkinsonism…Those would be what I would call the four pillars of 
Parkinson’s diseases modelling and so far to be quite honest none of the 
models that are used in drug discovery research have those four pillars. 
(I14NP) 
 
#  )%&, it seems that PD researchers, in contrast to schistosomiasis researchers, 
rarely use sickness narratives when justifying their research. This may be related to 
greater public awareness of PD, as illustrated by the quote below. This might mean 
that they do not find it necessary to describe the severity of the disease and its 
associated problems, as to them they are obvious or well known: 
 
…you know a combination of its disease research people are generally just 
interested in it more, or people the general public understands the concept 
behind it more. (I18NP)

Page | 217  
 
Greater awareness could have resulted in more funding being available and, in 
conjunction with the relatively low level of competition identified in 5.1, might mean 
that PD researchers have not found it as necessary to use sickness narratives to raise 
the profile of the disease and/or generate resources. Instead, it seems PD researchers 
placed greater emphasis on promoting the health benefits of their research. Other 
studies have found this emphasis on promissory health benefits in the context of 
animal experimentation (HobsonWest 2012 and Birke 	. 2007), and it has been 
used in other areas of scientific controversy, such as stem cell biology (Wainwright 	
. 2006). Primate users in particular talked about the health benefits. This may be 
because primate models are perceived as more controversial thereby needing ‘strong 
justification’, hence placing more emphasis on benefits. This might be expected given 
that European (&	$*++,-,!.) and UK (<;) regulations governing animal 
experimentation require a harm/benefit analysis to be conducted, so only studies 
where the potential benefits outweigh the harms to the animals should be conducted. 
 
)'!&
When asked about the possibility of replacing preclinical primate models, all 
participants expressed some concern about the impact this would have on human 
safety. As with schistosomiasis, there appeared to be less confidence that results in 
other models would translate to humans, with the following being typical: 
  
And as a clinician who would have to then administer it to patients you would 
feel much more reluctant having to do it if you hadn’t got that primate data. So 
if I…wanted to give you a gene therapy in to your brain, I could do it and you 
know I could base it on the rat stuff but I’d really really like to have seen some 
primate data… (I19NP) 
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Similarly, PD participants expressed concern about the safety of some therapeutic 
aims, in particular the need to proceed with caution with viral vector therapies. As the 
following quote illustrates, this may be related to the past problems with cell 
implantation that seems to have halted that area of research for several years, and 
which other participant also commented on: 
 
…I think there are a few potentials in the pipeline but they’re risky strategies. 
The use of viral vectors has potentially got a lot of risks and that’s what we’re 
moving towards now…The problem is the transplantation I think highlights 
the potential problems that we have if we move too quickly we end up with 
side effects and then we devastate the field.  And transplantation as a field as 
an area of research…took a big knock and well it was set back ten years by the 
development of side effects and the adverse publicity that gained. (I16NP) 
 
Unlike in Case Study 1, there is no mention in PD of the public perception of risk, or 
of societal influences on safety. Perhaps this is related to PD participants seeing the 
benefits of the work as greatly outweighing the risk, especially given the emphasis on 
the health benefits of the work in the previous section. 
 
#  )%&, there is a suggestion that despite the expressed safety concerns, there is 
precedence for clinical trials to go ahead without primate data, as shown in section 
5.2, and as illustrated in the next section on regulation. There are indications in both 
cases that risk does not prevent therapeutic developments from moving forward, as 
evidenced by the reemergence of cell transplantation studies, and the continuing 
development of viral vector therapies. Barber 	.(1979) found that, in the case of 
research on human subjects, ‘4			
	 1			 		     
 	 	 	 3
$$  	 	  $3 13	 	  38	’ (preface). 
The findings in schistosomiasis would seem to conform to this, as relatively greater 
Page | 219  
 
competition was described by participants in that case, so the riskier approach might 
be explained in this context. However, this is less apparent for PD, although it could 
again be the case that the participants see the benefits as being much greater than the 
risks.  
 
()!#
As noted in Chapter 4, safety and risk are intrinsically linked to regulation, but again 
in PD, participants mostly talked about regulation as a barrier to primate research, or 
as a validation that the work conducted in their country was justified, that is, in a ‘it is 
heavily regulated, so if it is legal it must be good’ context. In contrast to 
schistosomiasis, there was very little evidence of PD participants asserting that using 
primates was a regulatory requirement. This low incidence of comments about 
regulatory requirements may indicate that this is a less important factor for these 
scientists. Indeed, when asked to clarify why primates could not be completely 
replaced, participant I13NP stated factors other than regulation: 
 
I don’t think it’s a definite step I think it’s valuable it’s another living system 
which everything is talking to each other in which is certainly more developed 
than a mouse system talking mouse or rat. I’m not sure what other system 
people use now. I know pigs have come back in but yeah I mean I think I 
would be more confident taking it as a person. (I13NP) 
 
It may also be related to there being precedence for moving into human trials without 
primate data, as indicated by the following extract where regulatory bodies appear to 
be willing to accept rodent data alone in some cases: 
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…you know these days a lot of compounds you know I mean just go straight 
to humans from mice I mean it’s enough for most regulatory bodies to do if the 
data’s strong enough and it makes sense that they will go from mice directly to 
humans. (I18NP) 
 
What appeared to be a greater concern in the context of legislation for some primate 
and nonprimate using participants was that regulations may be limiting primate 
research by making it more difficult to conduct the studies, and through increasing the 
cost, for example: 
 
They’re fiendishly [expensive.] They’re heavily regulated they’re probably 
much more heavily regulated than clinical work. So I think they’re expensive 
they’re hard to find the places that do it they’re heavily regulated and so I 
think people sort of shy away slightly from it… (I19NP) 
 
In addition, as noted in earlier sections, participants were concerned about research 
moving out of Europe. Schistosomiasis participants spontaneously talked about this 
which prompted me to ask PD participants specifically about it. This accounts for 
there being more PD responses in relation to this, but not for all of them, as some 
participants mentioned it before they were asked. In either case, participants gave 
quite extensive comments about concerns that a European ban on primate 
experimentation would force scientists to conduct the research in countries where it is 
less heavily regulated, and that there may be consequences for animal welfare and 
scientific quality. For example: 
 
It would mean it would stop in England and maybe even Europe and it would 
carry on in China and it would be unlegislated. It would go to China and India 
and places where well it’s already doing that because it’s cheaper to do all 
these studies in China and India and everywhere else they have massive 
colonies, but it’s completely unlegislated they can do what they like to the 
animals out there. So it would actually be a big mistake to stop it in Europe 
and in the UK it’s not even as well legislated we don’t believe in the States. 
They can do a lot more to the animals than we can do. (I12P) 
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I17P took this point further suggesting that as well as losing out on medical 
developments a movement abroad would have negative economic and intellectual 
impacts: 
 
But with it is all the loss of income because all the research is not just done by 
the researcher their jobs in the university there are many people involved all 
that will go with it and also if we are not involved in the discovery of it our 
science will…Economical intellectual everything. (I17P) 
 
#  )%&, participants describe legislation as both a challenge to primate research 
(limiting the amount conducted), and as a justification for it. They also express 
concern that research will move abroad where it is not as well regulated. This raises 
important ethical questions about whether knowledge claims that come out of these 
‘less stringent’ countries should be accepted by the scientific community. A complete 
investigation as to whether or not this argument should be used as a challenge to 
replacing primates in the UK and Europe is beyond the scope of this thesis, but it is 
considered briefly when discussing the impacts on the impasse (Chapter 6), and in 
making the final recommendations (Chapter 7). 
 
)!)#"!##
These findings indicate that factors related to health and ethics are identified as 
influential by participants in both cases, but the impact and emphasis placed on them 
differ in some important ways. Most obvious was the relative low use of sickness 
narratives by PD participants, who, unlike schistosomiasis researchers, talked much 
more about the health benefits of their work. In keeping with Brown (2003), it could 
be that PD participants do not see their work as being as ethically problematic as 
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schistosomiasis researchers do, or that they simply have greater resources at their 
disposal, so do not need to engage in this way. There were comparable responses 
regarding human safety with participants in both fields talking about risk to human 
health as a challenge to completely replacing primates, and identifying certain 
research aims as less safe than others. Baber 	)’s (1979) notes on scientists’ risky 
behaviour, and the examples of continuing work, such as using viral vectors in PD, 
indicate that this may not be the challenge to research that it is initially described as. 
Again, in both fields participants identified regulation as a means of justifying their 
research, but it was given less as a direct barrier to conducting primate research in PD 
than it was in schistosomiasis. Instead, as in schistosomiasis, there was greater 
emphasis on it being a challenge because if primate use was banned in Europe the 
work would go to ‘less stringent’ countries where welfare and science might be 
‘questionable’. It would be interesting to conduct further research into this factor to 
see if it is a case of scientists painting other countries as ‘disreputable others’ 
(Michael and Birke 1994b), or of them performing ethical boundarywork to 
legitimise their actions (HobsonWest 2012), or both. 
 
.1
	
	
 
In analysing the interview data and comparing the two data sets, the aim was to access 
the views of scientists regarding the opportunities and challenges of using primates, in 
order to understand the primate impasse, and identify if it could be overcome in the 
two fields. These findings indicate that there are various factors to consider in this 
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endeavour, and suggest that several sociology and STS theories and concepts might be 
applicable in this context. 
 
Each of the analytical themes revealed important social dynamics of science that are 
essential for understanding the primate impasse and, for explaining the similarities 
and differences identified between the two fields, and the different types of user. 
Considering the Scientific Institution highlighted the impact of competition in 
conjunction with reputation, as well as an association between core sets, expectations 
and publication. The role of entrenchment and policy was indicated in Practical 
Science. Animals and Ethics revealed the interplay between ethics, speciesism and 
‘others’. Finally Health and Ethics reinforced that expectations in the form of sickness 
narratives are essential for interpreting the primate impasse. 
 
Throughout this and the previous chapter, theoretical concepts and literature that have 
aided the interpretation of the data, and provided some explanation for the findings 
have been identified. Most notably, the concept of ‘competition in science’ by 
scholars, such as Bonitz and Scharnhorst (2001) and Hagstrom (1974), helps to 
explain why competition is a dominant feature in schistosomiasis, and why 
collaboration is more likely in PD. Merton’s (1968) ‘Matthew Effect’ appears to be in 
operation in both cases, with reputation being seen as influential by scientists in both 
fields. Gilbert’s (1976) work supports participants’ assertions about the difficulty of 
getting alternatives to established knowledge accepted, but does not explain the 
apparent dichotomy that novelty is also necessary, in order to make knowledge more 
likely to be accepted. The expectations literature (e.g. Brown 2003; Borup 	) 2006) 
helped with interpreting why there are differences in schistosomiasis and PD 
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participants’ comments on the media, hype, and disease severity versus health 
benefits. The responses from participants regarding alternatives and replacing 
primates indicate that entrenchment (Collingridge 1980) and flexibility to compensate 
for it (Knot 	 . 2001) could be applicable to scientific, as well as technological 
change. Finally, the discussions about animals and ethics, and health and ethics may 
be of interest to researchers of ethical boundarywork (e.g. Wainwright 	.2006; 
HobsonWest 2012) and will contribute more broadly to the morality of animal 
experimentation literature (e.g. Walker 2006; Rollin 2007). 
 
The conclusions discussed under each theme are important to consider in developing 
the recommendations for overcoming the impasse. This analysis has shown the 
intricate interplay within and between these themes and subthemes, such as the links 
that participants express between, reputation, publication, knowledge acceptance and 
funding. Therefore, although they are presented in this and the previous chapter as 
distinct for the purposes of coherent reporting, these findings are not always mutually 
exclusive and will be considered together when applying them to understanding the 
primate impasse, and suggesting how to overcome it (Chapters 6 and 7). An additional 
finding not reported in the main analysis which could be influential in the 
implementation and dissemination of the recommendations was the participants’ 
awareness of the Three Rs. This was shown by spontaneous implicit and explicit 
references by all types of participant. Participants were not directly asked about the 
Three Rs or animal welfare, yet many of them expressed views on how it made animal 
work acceptable. This may illustrate this is in the consciousness of scientists, perhaps 
due to societal pressure or increasing emphasis on the Three Rs in animal 
experimentation legislation. 
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The key differences in the scientific aspects of these two fields of research suggest 
that a general single set of recommendations is not possible, with some areas of the 
research being easier to propose replacements for than others. However, the findings 
reveal that some aspects will be universal, such as any proposals relating to 
publication or ethics related species choice. That being said, this analysis indicates 
that it is necessary to incorporate fieldspecific approaches to some areas of the two 
sets of recommendations. For example, focusing on improving collaboration in 
schistosomiasis and encouraging researchers in the field to conduct more public 
engagement. Whereas, in PD a target might be to incorporate dialogue with the 
advocacy charity and maintain, and expand their collaborations. The responses also 
reveal that where differences between primate and nonprimate users were apparent, it 
might be important to target specific things at certain types of user. For example, 
primate users may need to be encouraged to develop more flexible approaches to 
compensate for ‘entrenchment’ in primate studies, or as shown in the documentary 
analysis (Chapter 3), nonprimate users might need to construct more expectations 
about their research to attract more resources. 
 
This and the previous interview analysis (Chapter 4) in conjunction with the 
documentary analysis (Chapter 3) inform the structuring, dissemination and hopefully 
implementation of the recommendations to overcome the primate impasse in 
schistosomiasis and PD detailed in Chapter 7. 
 
The next chapter will consolidate the findings presented here and in Chapters 3 and 4 
to discuss how the overall aim of understanding the primate impasse has been 
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achieved by identifying and appreciating how the social dynamics of science shape 
the arguments and justifications given about primate use. 
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This chapter draws together the findings of the analyses presented in Chapters 3, 4 and 
5 and directly addresses the research questions outlined in Chapter 1, highlighting 
how the overall research aim has been achieved. The discussion is presented in two 
main sections: Introduction and Background, and Social Dynamics Involved in the 
Impasse. The latter describes how various social dynamics interact and impact on the 
primate impasse, as well as highlighting the consequences for existing social scientific 
thinking. This provides the basis for the recommendations and policy and practice 
implications presented in Chapter 7, as well as the possibilities for future research. 
 
1	

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The role of animal experimentation in biomedical research has been debated 
throughout history with differences in opinions about its appropriateness being 
evident as far back as ancient Greece (Franco 2013). As noted in Chapter 1 this is 
particularly emotive when the experiments involve primates, due to their evolutionary 
closeness to people and their complex cognitive, social and habitat requirements. Over 
the past four decades there has been a continuing, consistently polarised discourse 
about whether or not primates should be used. This project was a consequence of 
personal experience with this polarisation and frustration with the impasse it creates. 
Ultimately, the two sides in the debate aspire to the same thing; for research to be 
done without using primates. Scientists insist they would not use primates if there was 
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another option, and those opposing primate use demand an immediate ban − yet 
neither side offers any constructive solutions to end primate experimentation. Instead 
the same arguments are repeatedly presented, as illustrated in the documentary 
analysis (Chapter 3) and somewhat in the case studies (Chapters 4 and 5). 
 
As detailed in Chapter 1, the existing literature regarding the animal experimentation 
debate rarely, if at all, explores how to resolve the debate, move away from 
biomedicine’s reliance on animal models, or specifically addresses understanding the 
controversy surrounding primate experiments. The lack of academic appraisal of the 
primate debate and ways to overcome the impasse, including what the impacts might 
be and how it could be achieved, was somewhat surprising. This led to the decision to 
undertake a new approach of applying social science methodologies, such as theory of 
expectations and core sets, to the primate experimentation debate. As noted in Chapter 
1, previous work on animal experimentation (Hedgecoe 2006), stem cell research 
(Wainwright 	. 2006) and human embryo research (Mulkay 1993) indicated that 
this was a productive strategy to adopt. There is an underlying assumption within 
social science that gaining access to and working with animal research scientists is 
extremely difficult (HobsonWest 2010), because of distrust, particularly when 
dealing with controversial aspects of science (Jensen and Holliman 2009). This 
probably explains the paucity of studies which do so. However, my research aim was: 
 
To understand the impasse in the animal research debate about whether 
primates should or should not be used, by examining how biomedical research 
scientists view the opportunities and challenges of primate use, to determine if 
and how the impasse can be overcome. 
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As outlined in Chapter 2, in order to meet this aim a fresh perspective was sought 
using a multimethod approach to address the following research questions: 
 
1. What arguments/justifications are given for and against using primates in 
biomedical science? 
2. Are there differences in the justifications/arguments between: 
a. Different fields of research? 
b. Different specialist users? 
3. To what extent do the social dynamics of science help to explain the continued 
impasse in the debate? 
4. What are the policy implications for primate use and scientific practice? 
 
This chapter will demonstrate that a greater understanding of the impasse is enabled 
through awareness of the arguments and justifications given about primate use, 
identifying the social dynamics involved, and appreciating how these dynamics shape 
the debate. As a consequence, Chapter 7 concludes that the impasse can indeed be 
overcome and presents recommendations for how this might be achieved. 
 
1!&
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Through the documentary analysis (Chapter 3) and interviews (Chapters 4 and 5) it 
became evident that various social dynamics are at work in the primate debate, which 
help to explain both why the impasse persists and how it might be surmounted. 
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Speaking to scientists, rather than the public and other stakeholders, to get views on 
the opportunities and challenges posed by primate research has given the perspective 
of those intimately involved in the research itself. This, in conjunction with the multi
method approach, gives a richer understanding of the issue than would be possible by 
discussing the science or social aspects separately. 
 
This section aims to illustrate that the social dynamics of science do help to explain 
the continued impasse in the debate, and that they may account for some of the 
differences observed between the two fields of research and between the different 
specialists. The sociological theories explored in the analyses in Chapters 3 to 5 
highlight that there are several common factors which will contribute to overcoming 
the impasse in both fields of research, which are discussed here. Additionally, any 
consequences that these findings have for the existing literature are highlighted. 
However, the analyses indicates that there are field and research aimspecific factors 
which need to be incorporated into overcoming the impasse and, these are explained 
as they arise. 
 
In order to explain the influence of social dynamics on the impasse, this section 
explores the intricate relationship between the various dynamics such as competition 
and reputation, in conjunction with additional information gleaned from this project 
on the differences between specialisms and specialists within them. The discussion for 
each social dynamic includes a summary of the general findings relating to it, 
followed by two subsections: impact on the impasse and consequences for existing 
social scientific thinking. 
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The interviews revealed that competition within the ‘scientific institution’ does have 
an impact on the primate debate. Despite there being a lack of contemporary literature 
and, as Bonitz and Scharnhorst (2001) noted, there being very little recent academic 
discussion about it, competition is key to understanding the mechanisms of science.  
 
The dual impact of competition on science has been identified previously, with 
Merton (1957) noting that it functions to motivate scientists to make discoveries, but 
can also lead to deviant behaviour. Later, Hagstrom (1974) acknowledged that 
competition leads to allocation of scientific effort, but can have several negative 
consequences such as duplication, fraud and reduced communication. The findings 
from the present project support this and illustrate that scientists are acutely aware of 
the effects of competition on science, with participants discussing the competitive 
nature of their work both explicitly and implicitly. It also appears to be more widely 
accepted by scientists beyond the fields studied here, as shown by online blogs and 
essays such as 		  : &$     	 
 by cancer researcher Alexis Barr (2009), or the Explorable.com article 
		<by Florence Colantuono (2009). 
 
Similarly, in describing the process of the ‘Matthew Effect’, Merton (1968) identified 
that reputation can be both functional and dysfunctional for different individuals 
within the scientific institution and at different times in their careers. He noted that 
scientists with established reputations are often given disproportionately more credit 
for their findings than those who have made similar discoveries but are less well 
known. In some cases this can mean that less experienced collaborating scientists are 
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overshadowed. But when looked at in the context of science communication, having a 
reputable scientist as coauthor or collaborator can in fact boost the visibility of new 
discoveries and can lead to lesser known scientists gaining acceptance for their work 
more easily than if they had not had the association. Again, this was evident in the 
findings of this project, with participants (I17P and I14NP) admitting being more 
willing to accept work if it was from a ‘good’ lab or if the author was supervised by a 
reputable scientist, as well as making explicit reference to those with the greatest 
reputations having too much influence and having a negative impact on the field. 
 
The analysis conducted in this project has highlighted that reputation and competition 
are intricately linked with those scientists who perceive themselves as ‘winning’ the 
competition often seen as having the greatest reputations. Having a strong reputation 
puts scientists at an advantage in the competition as they can attract more resources 
and have a disproportionately high probability of their findings being accepted over 
those in lessestablished positions.  
 
#		#
In the schistosomiasis case, competition is restricting progress in the development of 
an efficacious vaccine and in replacing primates. The competition evident in this field 
both explicitly described by participants and implied through their concerns about 
being anticipated, has led to secrecy and a reluctance to cooperate, resulting in there 
being very little collaboration within or external to the field. This is compounded by 
the ‘Matthew Effect’, with those scientists with the greatest reputations seemingly 
driving the field and limiting which areas are explored and/or accepted. 
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These two factors have contributed to explicit conflict about which research aims to 
pursue in schistosomiasis, with different aims all being explored independently with 
little, if any, withinfield or external interaction. This means that alternative methods 
and the limitations of the existing models and/or research aims are not being explored 
or addressed, as researchers will not share information and are reluctant to collaborate 
or explore different avenues or aims. The multiple aims appear to be an influencing 
factor in the continued use of primates and a reluctance to replace them. These 
consequences are not surprising; Barber 	.(1979) and Hagstrom (1974) both noted 
that those who are relatively successful in the competition are more likely to follow 
strict patterns of behaviour and are less likely to seek new ways to solve problems. 
The dominance of the view that primates are necessary in this field is likely also to be 
related to the nonprimate users’ perception that their reputation and consequent 
influence on the field is very low. This will add to reluctance by the more dominant 
scientists within the field to engage with alternative methods and/or accept them. 
 
In PD, competition was much less of a factor in determining progress in the field, 
which has provided insight into how competition functions and how countering it can 
help to overcome the impasse. Participants in the PD case placed much less explicit 
emphasis on competition. Instead, they focused on the relatively high level of 
collaboration that occurs within the field, which indicated that, in this case, this was a 
means by which the negative influence of competition seen in schistosomiasis was 
being overcome. Reputation was also viewed slightly differently, with participants 
placing more emphasis on group or institutional reputation rather than individual 
reputation and nonprimate users not seeing themselves as having less of a reputation 
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than primateusers. This has resulted in the general agreement that several research 
aims need to be explored in parallel and in conjunction with each other rather than any 
one being seen as more important than the others. It has given rise to broader 
collaboration whereby several models are utilised, and as such there is more 
willingness to discuss the possibility of replacing primates even if at present they 
remain in use. 
 
This higher level of collaboration in PD appears to be explained by several 
interrelated elements. The reduced negative impact of reputation is most likely to be a 
consequence of there being relatively more research questions to solve in this field 
which, as Hagstrom (1974) noted, leads to less intense competition. Therefore, it may 
have been easier for scientists in this field to establish reputations, but as a 
consequence no single individual or group has a greater influence on the direction of 
the field than another. This could also explain why in this case it was felt that when 
those with specific expertise were cooperating, the discussions were more open and 
honest; the fear of losing the competitive edge or being anticipated is diminished, as 
there is less focus on one breakthrough being the final answer to effective treatment in 
this field. It supports Hagstrom’s (1974) view that those who cooperate are less 
secretive and communicate more. The ability to communicate both within the field 
and to wider audiences is, as Merton (1968) argued, important for science to advance. 
One PD participant (I20NP) was particularly aware of this and noted that to fully 
benefit from a good reputation, a scientist needed to actively engage with the 
scientific community. This appears to be happening a great deal within PD research, 
as opposed to the situation in the field of schistosomiasis. 
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Another contributing and perhaps more unusual influence appears to be the PD 
scientists’ relative closeness to their patients. While Barber 	 . (1979) discussed 
how competition can affect researcher behaviour in a clinical setting, making those 
less successful more likely to take advantage of patients, there is, as far as I am aware, 
no literature on the influence that the clinic can have on competition. The findings 
from this case lead me to propose that when researchers either work as clinicians or 
are more focused on the final translation of their research into the clinic, they are more 
inclined to cooperate to reach a solution more quickly, in order to benefit the patients 
as soon as possible − and so are less competitive. I would argue that the pressure from 
a wellestablished patient support group (Parkinson’s UK) is contributing to this 
effect, as scientists are more routinely faced with the impact of PD and thus feel more 
obliged to find and develop effective robust treatments efficiently, to satisfy the 
support they receive. Stilgoe and Wilsdon (2009) noted that questions raised by the 
Alzheimer’s Society patient group, ‘…    	 )  
3 		  	 	9 (p.24). This proposition is 
strengthened by the finding that schistosomiasis is largely a disease of the Developing 
world, so participants noted that it has a low public profile in the western world and 
there is no patient support network to speak of. Therefore, although some researchers 
described visiting patients suffering with the disease, in general the research 
community in this field, in Europe, is much further removed from the translation of 
their research into effective therapy, and comes into contact with the effects of the 
disease much more irregularly than PD scientists do. 

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This project has revealed several interesting and important observations that could 
influence existing knowledge in the area of competition in science. In general, 
although studying competition in science has fallen out of favour, I believe it should 
play a more significant role than presently in STS. This is particularly true for those 
studies investigating controversial areas, and for aiming to understand if and how they 
might be resolved. 
 
However, the findings indicate that care should be taken when applying the existing 
competition framework, and that it may need to be augmented or changed in response 
to changes occurring in modern scientific practice. From the discussion above it is 
clear that some of the tenets of existing competition theory are supported by this 
project, particularly those of Hagstrom (1974). However, I feel that there are several 
aspects of the accepted thinking that need reexamining. To illustrate these I will 
focus on areas of my research which seem to contradict or at least question some of 
the statements and conclusions in Hagstrom’s (1974) work. Hagstrom (1974) 
identified that there may be some questions about the adequacy of the functional 
theory that: 
 
…the incidence of competition and concern about it will be greatest in 
specialities perceived to be most important for further developments in science 
because the number of competent researchers relative to the number of known 
research problems will be greatest there. (p.12). 
 
But he felt that it was more likely a result of a difficulty in measuring the importance 
of the speciality within a discipline rather than the theory . The findings of this 
project indicate that it may be just as important to consider the perceived importance 
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of the discipline as whole. If the theory is applied to the two cases investigated here 
then competition should not be an issue within schistosomiasis, because there is 
disagreement about which research aim (i.e. speciality) within the field is the most 
important, and there are also relatively few scientists within the field. Yet, in PD, 
there is agreement that all of the current research aims are important but there is a 
much larger pool of scientists working towards them, meaning that, theoretically, 
competition should be more acute in this field. However, the opposite situations seem 
to exist. Instead, it appears that the importance of the field in the eyes of the scientific 
community as a whole and to the wider public is a much greater determinant than the 
withinfield speciality importance. I believe this is linked to the availability of 
resources and, to some extent, to accountability to succeed quickly. In fields such as 
PD, which have a high public profile and are perceived as being highly regarded 
among other scientists and scientific funding bodies, there are more resources 
available, so competition is less intense. The high visibility of the research makes 
scientists more willing to cooperate in order to meet the research aims more quickly 
and robustly, which again diminishes competition. In contrast, in fields such as 
schistosomiasis in which profile is much lower, there are relatively few resources 
available, making competition greater and resulting in scientists being possessive 
about their research and not wanting to share the limited spoils with others. 
 
Hagstrom (1974) found that competition should increase productivity and allow for 
greater flexibility and increased acceptance of findings, because when competition is 
high scientists are more likely to be more open to exploring alternative strategies and 
questions. In addition, as Merton (1968) pointed out, in competitive situations there is 
increased chance of more than one group/individual independently making a 
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discovery. This functions to make the finding more acceptable as it has been produced 
more than once. Hagstrom (1974) concluded that the positive functions of competition 
in science are more important than the dysfunctions. My analysis indicates that this is 
not true of every case, with the dysfunctions due to competition apparently being 
much more significant in determining progress in schistosomiasis, and from the PD 
case that overcoming these by collaborating actually has a bigger positive influence 
on a field than the aboveoutlined functions of competition do. Therefore, I suggest 
that social scientists should undertake detailed work on different cases when 
investigating the influence of competition in science, rather than assuming that all 
science will be affected in the same way. 
 
These findings indicate that perhaps changes in the function of competition over the 
past 40 years, due to the impact of increasing public awareness, accountability and 
emphasis on applied research in science, mean that it is time to reexamine the 
existing competition in science framework. For example, Rödder’s (2009) analysis of 
the medialization of science suggested that scientists may attempt to exploit the media 
in order to secure priority, particularly in situations characterised by competition or 
controversy. In addition, Holliman and Scanlon (2009) note that controversial, 
contested science has more potential to be the subject of media reporting. Therefore, 
increasing media attention on scientific issues and the increasing orientation of 
science towards the media recently documented in the sociological literature (see 
Rödder 2009 for examples) may be another dimension which needs to be incorporated 
into the dynamics of competition, and how it functions within the scientific institution. 
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The documentary analysis (Chapter 3) suggested that the theory of expectations can 
help to explain why some of the arguments in the primate debate are presented as they 
are, including how the primate proponents’ views dominate. It indicated that ‘core 
sets’ could be an influencing factor in the existence of the impasse in moving towards 
replacing primates. The interviews (Chapters 4 and 5) provided more detailed insight, 
revealing that the social dynamics involved in expectation building, core sets and 
scientific publication intersect with two of my analytical themes, ‘Scientific 
Institution’ and ‘Health and Ethics’. In addition, the analysis has shown that these 
factors are interrelated, and together they can be used to interpret why nuanced 
differences in the impasse exists between the two cases. Also, they provide a means to 
resolve some of the restrictions placed on the research and primate replacement by the 
dominance of some models/methods and/or particular specialists. 
 
Individually, the concepts of the ‘core set’ and the ‘theory of expectations’ have 
become robust but, in general, distinct tools in the sociological analysis of a variety of 
areas in science and technology. Collins (1981) conceived the concept of ‘core sets’ to 
explain how scientific communities respond to experiments, controversy and outside 
influence, and many scholars have since implemented it successfully. A notable 
example in the context of this project is Michael and Birke’s (1994a) use of the idea to 
investigate animal experimentation. They found that animal experimenters attempt to 
exclude ‘irrational’ others such as antivivisectionists from their core set and, as a 
result, exclude their voices from the discussions about animal studies. Borup 	 .
(2006) provide a nice synopsis of the value of the theory of expectation: ‘3
	$	$			3	
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 ’ (p.287). 
Interestingly, the two concepts have rarely been combined, yet the work of Hedgecoe 
(2006) indicates that this may be a particularly productive way to examine 
controversy and dispute within science, and the findings of this project support this 
theoretical approach. Participants in both cases show evidence of constructing ‘core 
sets’ but these appear to be functioning in slightly different ways, with a ‘core group’ 
of primate users apparently dominating in schistosomiasis but a wider core set 
including nonprimate users being present in PD. This appears to be partially 
explained by the ability of the different specialists, i.e. primate and nonprimate users, 
to build expectations about their research. 
 
Hedgecoe (2006) also noted that Collins’ (1999) view of the different groups outside 
the core set as consumers of scientific papers glossed over the variations that exist in 
genres of scientific writing. He argued that different types of scientific publication 
influence how the science is communicated between those groups. This was evident in 
the documentary analysis, and in the interviews it was clear that publication was 
important to the majority of the participants for gaining acceptance of their scientific 
claims, particularly by their peers. Gilbert (1976) noted that scientific knowledge was 
constructed within research papers and that citations were used to establish the 
authority of the author’s arguments. He proposed that this method of construction 
made it extremely difficult for a scientist to achieve recognition when proposing an 
alternative to an established model. This view was supported by my findings, with 
participants describing practical difficulties with getting new ideas published. 
However, they often commented that novelty was necessary in order for a finding to 
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be noticed and publishable, seemingly creating a dichotomy whereby novelty is both a 
barrier and facilitator to creating scientific knowledge claims. The analysis showed 
that different emphasis was placed on the validity of a claim as a result of how and 
where the information was disseminated. This led me to view scientific publication as 
a consideration in combination with core set and expectation theory. The findings 
showed that the lack of publication of negative data; media hype; and the dichotomy 
of novelty were all influential in how the core set and expectations functioned in 
schistosomiasis and PD, and could impact on overcoming the primate replacement 
impasse. 
 
#		#
In schistosomiasis, a combination of the influence of a faction within the core set and 
an inequality in how the different specialists are creating expectations about their 
research is maintaining the impasse, slowing progress towards replacing primate 
models and creating conflict about which research aims to pursue. 
 
The existence of a core set in schistosomiasis research is a factor in the slow progress 
of the field in general, and more particularly in the adoption and use of nonprimate 
alternatives. Participants indicated that only the specialist group, that is, the ‘core set’ 
(Collins 1981 and 1988), can move the field forward and that those outside had to be, 
by their definition, rational, informed and accurate for their input to be valid. As a 
consequence, scientists in this field are very reluctant to engage with the public, 
particularly with antivivisectionists, and have a low opinion of their respective views 
and perception. This has contributed to the low profile of the research and the disease, 
Page | 242  
 
and the associated negative impact this has on cooperation to discuss alternatives 
highlighted in the previous competition and reputation section. However, the findings 
show that within this field ‘outsiders’ are not limited to the public or nonscientists but 
also to the researchers within the field. A ‘core group’ (Collins 1999) of primate users 
appears to have formed within the ‘core set’. Collins (1999) argued that the core group 
holds the dominant view within a field and the remaining members of the core set 
become marginalised because the core group ignore their claims even if they are 
potentially very important for the field. In schistosomiasis this has led to a delay in the 
acceptance of nonprimate methods and findings, via the core group blocking 
publication through peer review and because of a possible influence of ‘enchantment’ 
on the core group. Hedgecoe (2006), interpreted ‘enchantment’ as when people 
outside the core set are certain about results produced within it, but within the core set 
there is always doubt. I think this functions in this case to make those in the core 
group and to some extent those in the remaining core set unwilling to dismiss the 
primate models completely, just in case they are wrong in maintaining that they will 
not provide useful results. 
 
The impact of the core group has been compounded by the dichotomy of novelty 
described above and by the relationship between publication and the building of 
expectations. In schistosomiasis it seems that the nonprimate users are much less 
adept at building expectations about their research to attract resources and acceptance 
for it than the primate users are, making it more difficult for alternative methods to 
outshine or even become as mainstream as primate models. Unlike nonprimate users, 
primate users extensively use sickness narratives in their responses, which is a classic 
mechanism for justifying morally challenging research with visions of future benefits 
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that might accrue from that research (Brown 2003). In creating those visions the 
primate users are committing to that specific type of research (Hedgecoe and Martin 
2003), making them even more reluctant to deviate from it. Expectations are an 
established means of channelling, ‘					3	[ing]	
	   	3	  1	 		’ meaning that, ‘	
$3 	 
 	 3 	’ (Konrad 2006, p.430). Therefore, it makes 
sense that the benefits of the nonprimate users’ novel techniques and findings are not 
being realised. 
 
This is exacerbated by two interrelated factors: the negative view of media reporting 
and hype that the majority of participants voiced, and the problems they identified 
with being unable to publish negative data. Collins (1999) argues that relying on 
literature rather than engaging with members of the research community can result in 
outsiders, such as sociologists, producing a representation of results unrecognizable to 
those who specialise in the topic, that is, the ‘core set’. Hedgecoe (2006) felt that this 
could be extended to scientists within a field making the research of others in that 
field unrecognizable. Given the lack of collaboration in this field I would say that not 
only is a lack of engagement between primate and nonprimate users enabling the 
primate users to dismiss the alternatives, but also that only having a biased literature 
base to rely on, that is, one which does not report limitations of studies or 
negative/neutral findings, makes this easier. Additionally, even though some of them 
acknowledge that it is necessary, the reluctance by participants to engage with mass 
media or to ‘sex up’ their research is limiting the acceptance of alternative models and 
to some extent the primate ones as well. This is because, although it can have negative 
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consequences (see example in PD below), hype functions to enrol necessary allies and 
secure investment (Brown 2003). 
 
In PD there were some parallels with the issues in schistosomiasis, such as the 
presence of the dichotomy of novelty, problems with publishing negative data and 
negativity towards media reporting, which participants see as overly optimistic and 
dishonest, leading to false hope that can and has been detrimental for the field. This is 
restricting the development and acceptance of alternatives that might completely 
replace primates, and preventing nonprimate users from having some success with 
the methods already available. However, there is no evidence of a core group and the 
core set appears to be less influential due to a number of factors: more generally, 
dominance by any particular group is less pronounced because, unlike in 
schistosomiasis, there is a relatively large pool of specialists, much wider availability 
of resources and higher disease profile. 
 
While there was evidence that the participants in PD were constructing a core set and 
viewed those outside as irrational, there was more general respect for the public, with 
the acknowledgement that public support was important for accountability and for 
recruiting volunteers to help with the research. This seemed to stem from a drive by 
funders (particularly Parkinson’s UK) to increase public engagement, but was also 
viewed by the scientists, particularly nonprimate users, as a mechanism to increase 
awareness and understanding of certain models and methods. Therefore, this could be 
stopping the establishment of a core group, as members of the core set have more 
avenues for validating their work than just traditional publication, making it more 
difficult for one group of specialists to hinder dissemination. The PD participants were 
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more positive about media hype, showing more willingness to engage in that type of 
communication. There was still some caution about creating false hope, and an 
example mentioned by I16NP, of the cell transplantation field being halted by too
rapid progression leading to side effects and subsequent adverse publicity, illustrated 
that hype/disappointment cycles function in scientific change as well as in the 
technological change described by (Brown 2003). However, the positive value of 
having more outlets to create expectations about, and gain resources for, research 
seems to be reducing the relative dominance of primate use in this field. 
 
The findings highlighted a very interesting difference in how schistosomiasis 
researchers and PD researchers constructed expectations. As noted above, 
schistosomiasis participants extensively used sickness narratives, but in the PD case, 
these were replaced by health benefit narratives, with primate users in particular 
emphasising the therapeutic benefits that would accrue from their research rather than 
how ill the disease makes the patients. This is most likely because the high profile of 
PD leads to the assumption that people do not need to be told the impact of it as it is 
widely understood. Additionally, I think that it is possibly a more effective means of 
garnering support, evidenced by the increased amount of resources and number of 
researchers that are attracted to the field, and may again be contributing to the reduced 
impact of the core set. Several authors have commented on the dynamics of a rhetoric 
of hope and the benefits that derive from it (e.g. Brown 2003; Borup 	. 2006), and 
although it is acknowledged that the telling of sickness narratives can be a powerful 
means of creating space, attracting investment and justifying morally challenging 
research (Brown 2003) there is much less reference to it as a positive force in the 
theory of expectations. Indeed, indications from these interviews and the documentary 
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analysis (Chapter 3) suggest that it has more of a negative influence, as it is viewed by 
some as mean to justify research when the science might not be so good, possibly 
contributing to the slow progress in schistosomiasis research. 
 
Although nonprimate users do not appear to be as marginalised in PD as they are in 
schistosomiasis there is still resistance to replacing primates, including consideration 
of how alternatives might be developed. The main contributing factors in the context 
of this section appear to be a more acute impact of the dichotomy of novelty problem 
and a difference in how expectations are constructed by the two types of user. Primate 
users view their work as established, meaning that they are not troubled by the 
problems of needing to be novel to be published. In contrast, the dichotomy is more 
acute for the nonprimate users who acknowledge that although novelty is important 
they need to put their research in the context of what has gone before. This makes 
getting their newer models accepted much more difficult as the historical background 
is absent, particularly if they propose replacing a longestablished method such as a 
primate study. Additionally, all of the primate users emphasise the health benefits of 
their research, whereas only a minority of the nonprimate users do. This is probably 
related to the more morally challenging nature of primate research requiring more 
overt justification, but indicates that the primate users are more adept at constructing 
expectations, and so are gaining more resources and acceptance for their research 
relative to the nonprimate users. 
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<<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
This project provides support for several of the existing concepts of the theory of 
expectations and core sets. For example, it gives additional evidence for Michael and 
Birke’s (1994a) observation that scientists place criteria on who should be legitimate 
members of the core set and that enchantment does occur (Hedgecoe 2006). There are 
several instances, in the interviews and the documentary analysis, of expectation
building to gain resources for certain aspects of research, and examples of hype 
having both a positive and negative role in the social dynamics of science that are in 
accordance with authors such as: Brown and Michael (2003), Pollock and Williams 
(2010), Hedgecoe and Martin (2003) and Brown (2003). However, it raises some 
important questions that are either not addressed sufficiently by the existing literature 
or may need to be incorporated into it, which are now explored. 
 
Although Brown and Michael (2003) suggest that one approach to the relationship 
between forms of expectations and innovation change is to think about the 
relationship between different actors’ proximity to the actual scientific work (i.e. those 
closest are more uncertain than those ‘outside’), there is very little existing literature 
that combines ‘core set’ thinking with the theory of expectations as an analytical tool. 
The findings herein lead me to suggest that combining the theory of expectations with 
the concept of core sets, in a similar way to Hedgecoe (2006), is a fruitful means by 
which to more subtly analyse scientific controversy and practice. I would add a third 
dynamic of publication to the combination, because as shown in these findings and 
noted by Hedgecoe and Martin (2003) and more recently by Wainwright 	.(2009) 
‘4
	
				3
[hope 
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and hype]   	 	 	0  0 	 	 
				0				0		’ (p.962).

Additionally, these dynamics were involved in my analytic theme of ‘Health and 
Ethics’ as well as ‘Scientific Practice’ and the ethics of using primates have been 
examined on a number of occasions (e.g. Sauer 2004; Willemsen 2007). Therefore, in 
terms of future work, I would suggest that the primate debate could be a pertinent 
example to examine in the context of Hedgecoe’s (2010) recent research on bioethics 
and the reinforcement of sociotechnical expectations, and to investigate how the 
bioethicist’s role might alter the dynamics of the debate. 
 
This project indicates that when using the theory of expectations to examine 
biomedical science, care should be taken regarding the impact attributed to sickness 
narratives, as they may not be as beneficial as they first seem. In much the same way 
as hype has been carefully examined as both beneficial and disruptive to scientific 
advancement (e.g. Brown 2003), more emphasis should be placed on establishing if, 
as the present study indicates, sickness narratives can be detrimental to a field rather 
than simply assuming they are beneficial. This should be supplemented by an 
appraisal of what influences how sickness narratives function within the scientific 
dynamics of that field, such as public profile or disease complexity. 
 
The documentary analysis (Chapter 3) revealed an interesting and somewhat unusual 
approach to citation by some report authors (Hampson 	 . 1990; Bottrill 2000), 
which could not have been predicted by existing theoretical thinking. They appeared 
to be using what I termed ‘balanced’ rather than persuasive referencing and, although 
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this was not explicit in the interviews, the participants’ discussions around the 
honesty/dishonesty in media hype and the limitations of their research did indicate a 
more balanced approach than is normally taken when they publish findings. Although 
this was not sufficiently influential in this study to warrant inclusion in the discussion 
above, I feel that it may be an aspect for STS scholars to consider when they examine 
science in the context of core sets and theory of expectations. It could have 
implications for the transformation of knowledge and for who is admitted into the core 
set. 
 
The findings in this project do support Gilbert’s (1976; 1977) and more recent work 
(e.g. Golinski 1990) on transformation of scientific knowledge claims into accepted 
knowledge through persuasive referencing. However, as noted above, another 
dimension, ‘balanced referencing’ may need to be considered when examining how 
authors utilise citations. As Michael and Birke (1994a) noted, scientists in the animal 
experimentation controversy place criteria upon who can be a member of the core set. 
So, attempting to present a more balanced account could be a means to being accepted 
into the core set, and being seen by scientists as a credible voice in the debate. Scott 
(1990) argues that readers must assess the credibility and sincerity of a document by 
trying to determine any prejudices that led the author to adopt a certain stance toward 
what is being reported. Therefore, ‘balanced referencing’ could be a means to 
diminish bias by presenting matters in a neutral format rather than as favourable or 
unfavourable, perhaps with the aim of increasing the sincerity and credibility of the 
work. Balanced reporting or ‘false balance’ appears to be a consideration in media 
reporting of science (see for example Tom Chivers’ [2012] Telegraph blog or the 
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Understanding Science [2013] education website), but as yet it does not appear to 
have been considered in any depth in the social dynamics of science. 
 
Another interpretation could be, as noted in the documentary analysis, that the anti
primate participants in the debate are moving toward a more ‘scientific’ way of 
making and presenting their arguments, making it more difficult for scientists to refute 
or dismiss their claims. This would support existing literature on social movements 
becoming more ‘scientific’. For example, Eden 	.(2006) noted that increasingly in 
environmental and health lobbies ‘4	  	 	    	
	%		4’ (p.1063) and Epstein (1995) described 
how AIDS activists have learned the language and culture of medical science in order 
to establish their credibility as people who might legitimately speak on biomedical 
matters. 
 
6:+:0#!%# #!)#"&
Examination of participants’ responses analysed under the theme of ‘Practical 
Science’ revealed that there are many comments that express an inevitability about 
issues around model choice, policy and alternatives that they are somehow ingrained 
and unchangeable. Therefore, it appears that the concept of ‘entrenchment’ may be a 
key factor in restricting the development and use of alternatives, and in the resistance 
to adopting change in the fields studied. However, there is an interesting contrast in 
flexibility between the schistosomiasis and PD cases, which provides important 
insight into how to overcome the impasse. It seems that this might be influenced to 
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differing degrees by the participants’ experiences of policy, in terms of research 
agendas and legislation. 
 
Collingridge (1980) introduced the concept of the entrenchment of technology as 
‘4	8					$0		$	

	  	 		  
 3 	 	 	  18	 	 	
 	)’ (p.47). He argued that this leads to inflexibility in controlling or 
changing a technology. This is evident in the findings of this project, particularly in 
the schistosomiasis case; when scientists were directly asked, they could not even 
imagine that primates could be replaced. There are several of the nuanced 
consequences of entrenchment present in the data, such as change being hotly debated 
and the status quo (primate research) having an unfair advantage in the debate. 
 
More recently, Knot 	 . (2001) describe a series of flexibility strategies that aim 
‘4	  	 		  	 	  	 		 	
				$	4’ (p.342). Data supporting some aspects of 
these strategies are present in the current analysis and may explain the observed 
differences between the cases and different users, in their certainty that primates 
cannot be completely replaced. 
 
Additionally, Knot 	 . (2001) argue that their flexibility strategies could be 
enhanced by Government policies, which consider the problems associated with 
entrenched technologies and try to foster flexibility and the creation of more options. 
Salomon (1977) defined science policy as ‘	$	3
$	
0 	0 	 	$	 	 	
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00		0						
38	$9 (pp.4546). In the context of this thesis I have broadened this definition to 
include funding and scientific bodies that set priorities for research. While it is beyond 
the scope of this thesis to conduct a detailed review and analysis of the policies related 
to primate experimentation, it is apparent that they are taken into consideration by the 
interview participants. Legislative, funding and research agenda policy can exacerbate 
the perception of inevitability that a particular area of research will go in a particular 
direction, such as primates having to be used before therapies can be translated into 
humans. These policy implications are dealt with in Chapter 7. 
 
#		#
In schistosomiasis, entrenchment is making it extremely difficult for the field as a 
whole to move away from using the primate model. It has a role in the creation and 
maintenance of the primate debate, and so is a challenge to overcoming the impasse. 
To a lesser extent there is evidence that policy is viewed by some of the participants 
as influencing the direction of research in the field, and that this may be a positive 
way to move the field forward and to drive the replacement of primates; so 
overcoming some of the negative consequences of the entrenchment. 
 
When asked directly, both types of user were adamant that it was impossible to 
completely replace primates in schistosomiasis research, even when asked to theorise 
a situation where primates were unavailable. Yet despite this, at other times in the 
interviews, there were suggestions of possible alternatives to primates, such as pigs, 
and comments by I8P and I9P about precedence in other similar fields, such as 
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hookworm research, to bypass preclinical studies in primates. Therefore it seems that, 
while some participants could contemplate replacing primates, they were unwilling or 
unable to say overtly that it could be done. This inability to change from a default 
position of primate experiments being the only way to conduct the research appears to 
be a classic example of Collingridge’s (1980) ‘entrenchment’, but in the context of 
scientific rather than technological developments.  
 
Several of the consequences of entrenchment that Collingridge (1980) described are 
evident in the data, and help to explain why the impasse remains. For example, 
entrenchment means that change is expensive and, in this case, participants noted that 
primates and the specialised infrastructure needed to house and use them was very 
expensive. Given this investment, there would be financial implications for changing 
housing systems, investing in new laboratory equipment/animals and retraining staff 
to work with alternative models. There would be an additional expense of rehousing 
the animals or if this was not possible the ethical cost of euthanizing them. 
Additionally, entrenchment means that change is hotly debated. So in the case of 
schistosomiasis, because it would be difficult to move to other models given the 
academic as well as financial investment in primate models, the arguments about 
whether or not to use primates continue.  
 
Collingridge (1980) noted that entrenchment means that, in the debate about change, 
the status quo has an unfair advantage. In this case, participants provide scientific 
reasons for the nonprimate models they use and suggest other models that might 
supplant primates, but the associated costs and protracted timeframe for making the 
shift, mean that the scientific case for the alternatives has to be made much stronger 
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than it would otherwise have to be. This could account for the reluctance to explicitly 
state that alternatives could be used. In addition, when entrenchment occurs, ‘fixes’ 
are strongly favoured. That is, if a way to alleviate the problems which give rise to the 
call for change without actually making the change is proposed, it is received more 
favourably. In the primate context this might account for the emphasis in the 
interviews on the welfare of the primates, and on suggestions of how to reduce their 
use − for instance only using them when absolutely necessary at the endstages of 
research. 
 
Finally, entrenchment is particularly severe for highly valuable, low variety systems; 
that is, where the operation of the system depends heavily on one technology and 
where its failure is very costly. This is certainly true of primate research in 
schistosomiasis, which generally involves one or two specific species models, the cost 
of which is extremely high. If the research is not successful, not only is there a 
financial loss as outlined above, but there is also a high ethical cost.
 
Furthermore, David (1985) noted that expectations can contribute to ‘lock in’ (i.e. 
once led down a particular technological path, the barriers to switching to another, 
possibly more efficient, one may be prohibitive). Therefore, because the primate users 
in schistosomiasis are more adept at building expectations this may be compounding 
the entrenchment. As Knot 	 ) (2001) note and the interview findings indicate, 
policy may be a way to ameliorate some of the effects of this entrenchment. 
Participants indicated that changes in funding body policy and external health care 
agendas were making primate work more difficult and redirecting the research 
programme respectively. Participant I10P commented that engagement with policy 
Page | 255  
 
makers was essential for moving the field forward. These influences are not surprising 
as Huang and Murray (2010) note in their succinct overview of the role of science 
policy: ‘ 		    
  3 	 	3  	
$	    ) ;
  	 	 
 
 $  $	  	 	 	
) "	 	 

 	 	 
  	 8	0 	
   $	
  	
		   	 	  3	 	 $  	  	
’ (p.567). This has been observed in other fields with Peters 	 . (2012) 
noting that policy support is crucial in fostering technical changes, particularly for 
environmental innovations. However, there was also suggestion that policy, 
particularly if influenced by the public or lobbyists, can have negative or less effective 
consequences for research. This could exacerbate the entrenchment problem rather 
than help diminish it. Indeed, despite some arguing that ‘public engagement’ in policy 
decisions has several benefits, such as improving trust in policy makers and better 
compliance and decisions, there is also evidence that in many situations it may not 
lead to such benefits (see Rowe 	 . [2010] for references). The participants 
indicated that legislation prevents the replacement of primates, as the studies on them 
are required before permission to conduct clinical trials is given. This could be a 
perception rather than reality, but it also has implications in the next section on Ethics, 
Speciesism and ‘Others’. 
 
The PD interview findings indicate that while there is some entrenchment, in that 
there is still initial resistance to acknowledging even the possibility of replacing 
primates, there is much more flexibility to discuss potential alternatives than there was 
in schistosomiasis. This seems to have been helped by an apparent lesser impact of 
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policy on participants’ decisions and justifications, making the potential for 
overcoming the impasse in this field much greater. There are caveats to this, with 
certain areas such as surgical therapies appearing to be more resistant to change than 
others, but the data provide some indications of how perhaps to begin moving toward 
primate replacements in those areas by adopting the flexibility seen in others. 
 
Some PD interview participants noted a lack of historical data relating to alternatives 
to primates, which could be a contributing factor to the reduced but still noticeable 
entrenchment in this case. Knot 	.(2001) highlight that users choose technology, 
or in this case the primate model, because ‘4
 	 M 	  	
3	
0 	3	 	$3	

				0		
3		$3	
		

	
	4’ (p.337). However, unlike in schistosomiasis, more 
PD participants indicated that replacement was or could be possible. They gave 
examples of alternative models such as pigs, rats, sheep, post mortem human tissue, 
noninvasive human imaging and mice, and they indicated a precedent within the field 
of moving directly to clinical trials without primate studies. One participant (I19NP) 
noted that developments in some alternatives have not been widely disseminated yet. 
The collaboration identified in this field, the lack of evidence for influential policy 
and the apparent flexibility of the field are likely to account for this increased 
amenability to replacing primates. 
 
Actors, in this case scientists, that are closely linked to a technology are not likely to 
contribute to the flexibility for a substitute (Knot 	. 2001). This could account for 
the PD primate users in particular being adamant that primates cannot be replaced. 
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However, Knot 	. (2001) also argue that collaboration through multistakeholder 
alliances can create new options and increase variety and flexibility for choice. Thus, 
the higher level of collaboration in PD is probably able to ameliorate the impact of the 
low level of entrenchment, through the development and use of a variety of models to 
investigate several, parallel research aims. In conjunction with an apparent lack of 
restriction in having to follow a specific research path dictated by national policy, this 
enables them to adopt flexible strategies. There was some evidence that funding 
policy may be having some influence on primate use, but this is more in the context of 
ethics speciesism and ‘others’, and so is discussed in the next section. Of the 
flexibility strategies that Knot 	. (2001) discuss, two are particularly relevant to the 
PD situation. First, have ‘robust options’ – that is, technologies which would be 
appropriate in several relevant futures. In PD, several models are used to investigate a 
wide variety of research aims with some of them being relevant to more than one area 
of research, meaning that they can be applied to a variety of scenarios. The scientists 
should ensure that any expectations they create about alternatives (as recommended in 
the previous section) provide options for benefits in the distant, as well as the near, 
future − so that they continue to be viewed as being as robust as the present primate 
models. Second, have flexibility by variety – that is, the development and 
maintenance of different technologies that can serve the same function. As noted 
above, PD participants identified the need to use several different models in their 
research. Some of these can give the same or similar information as each other and as 
the primate models, which enables the scientists to switch between the alternatives 
when necessary. These options should be accompanied by conditions that make it easy 
and relatively cheap to make the switch, which collaboration can and probably is 
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facilitating, as each individual scientists does not have to own all the equipment etc. 
for using and analysing each of the models they can share the data. 
 
%!	<<	
This project has provided findings which have interesting analytical consequences for 
STS. They imply that the concept of entrenchment is not restricted to technological 
development (Collingridge 1980) but can be applicable to scientific practice and 
progression. It can be used to analyse and understand controversies and impasses. In 
the case of the primate debate, entrenchment is not only a problem because of the 
animals’ high economic value and historical academic investment, but also because its 
failure has ethical costs as well. Koch and Stemerding (1994) note that ‘4	
   	
 % 	 	   $	   
	  	
 3 ?0   	
  3 K	L 
(p.1212) and Knot 	 . (2001) admit that ‘4		  	 3	 
’ (p.336). Hence, one might argue that entrenchment is necessary for getting 
alternatives engrained within scientific practice, but in the cases studied here it 
appears to serve a more negative function. Therefore, when interpreting debates and 
conflicts within biomedical science, it may be advisable to focus on how flexibility 
within the scientific practice is functioning and can be increased, rather than how 
entrenched a new method, model or research aim is or should be. This is particularly 
true if the arguments that flexibility strategies also offer a way out of controversy 
(Knot 	.2001) are elucidated further. 
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Findings from the final analytical themes, Animals and Ethics and Health and Ethics, 
revealed aspects that involved moral considerations that participants identified as 
influencing their decisions about animal experimentation. These aspects provide some 
explanation as to why primate use persists, and give some insight into how to make 
replacement more plausible to the scientists in the two fields. These data indicate an 
intricate link between scientists’ views on ethics, what they report or demonstrate as 
speciesism, and how they describe the ethical decisions about primate use made by 
‘others’. 
 
Chapter 1 notes that an emphasis on ethics in science is not unexpected in studies of 
this kind. The findings of this project support Wainwright 	.’s(2006) suggestion 
that ‘4K	L0  3 	 	 	 	   ’ 
(p.375), as many participants justified their research by talking about the ethical 
decisions made by themselves and others. This is particularly pertinent in the primate 
debate as there have been specific discussions about the ethical considerations 
regarding experimental primates, which some regard as meriting ‘
	9 and having ‘ 	 3’ (Sauer 2004, p.312). This 
viewpoint is borne out by participants’ comments about work on primates requiring 
extra justification and prior evidence from other models, and only being conducted 
when the scientific questions are extremely important. This special consideration for 
primates is restricting the replacement of primates; the scientists feel that the extra 
precautions and justification for their use means that ethically the studies are sound, as 
the benefits in their opinion will far outweigh the costs to the primates due to the extra 
measures. 
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Peter Singer (1995) argued that, like racists, ‘…					
  	 $ 	 	 		 3  	 ’ and that 
‘(	3	’ (p.9). In the context of this project, in both cases, 
participants commented on their personal restrictions as to which experimental models 
they would use and, in schistosomiasis, specifically related this to being speciesists. 
Indeed, HobsonWest (2012) noted this kind of response from scientists, but in the 
present research these comments were in relation to certain species, rather than all 
experimental animals. Thus, as detailed in the next section, the special consideration 
given to primates over other animals, and the general consensus from the interviewees 
that working with rodents and livestock is easier does not completely fit with Singer’s 
definition of speciesism, and suggests that the capacitybased model of moral 
evaluation (Walker 2006) could be more applicable here. 
 
These data indicate that participants are using the actions or decisions of ‘others’ to 
place the responsibility for their own choices of experimental model with other 
parties. Birke 	 . (2007) note that ‘;  	  	$  	
		0	03
			$$	’ and that ‘	
3	 		  $ 	 	 9 	   	$
	’ (p.158). In doing so they provide examples of scientists’ interview responses 
that paint ‘others’ both inside and outside science as doing things improperly. 
Participants in the two cases described in this thesis discussed ‘others’ in a slightly 
different context. Rather than paint ‘others’ such as other scientists, regulators and 
society as doing things incorrectly or immorally to justify their own choices as 
appropriate, participants described how their choices were dictated or excused by the 
role the ‘others’ have in the decision process. 
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It is worth noting here that scholars taking a more constructivist approach might give 
an alternative interpretation of these findings in the context of ‘boundarywork’ or in 
light of emerging studies, more specifically ‘ethical boundarywork’. Gieryn (1983) 
argued that ‘43
	33	
%
	3
			3		9(p.792). HobsonWest 
(2012) interpreted ethical boundarywork as ‘4			3
13	
  10 	 3
1  	 		 3	
		
			$	
		’ (p.651). This approach 
is not particularly compatible with the objectivist approach adopted here, of taking the 
participants’ responses as giving direct access to their experiences and views. The 
concept of boundarywork requires taking participants’ responses as narrative 
accounts and interpreting the data as participants deliberately engaging in boundary
work to convince the interviewer of the moral legitimacy of their activities, which is 
not how this analysis is framed. 
 
Overall, however, the influence of ethics in terms of scientists’ choices is very 
apparent in this project, and has consequences regarding who else in each field, in 
addition to the scientists, will need to be consulted if the impasse in replacing primates 
is to be overcome. Of particular interest in this project was the impact of regulators 
and regulations, which appeared to have both negative and positive consequences for 
primate replacement and led to an interesting observation about primate use moving 
abroad. 
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The findings from the schistosomiasis case indicate participants’ personal ethical 
choices, based on what some of them see as speciesism and the deference to the 
decisions of ‘others’, are restricting the replacement of primate experiments. 
However, there is some indication that, if utilised in a slightly different manner, these 
dynamics could, in fact, act as opportunities to overcome the impasse. While the 
participants often see these personal choices as somewhat emotional or irrational they 
may function to make replacing primate experiments easier, as even primate users 
have expressed discomfort about some of the primate models they have or are using.
 
In schistosomiasis, the participants’ personal ethical boundaries indicated a reluctance 
to use primate models, even by primate users, with two participants (I5P and I6P) 
saying that although they had used chimpanzees in the past they would no longer feel 
comfortable using them. Importantly, this illustrated that scientific utility could be 
overcome by these personal preferences. Several participants indicated that they were 
much more comfortable working with rodents and livestock as opposed to primates 
and companion animals. Alone, this might prove to be beneficial for replacing 
primates as it could mean that schistosomiasis scientists were happy to adopt 
alternative models. However, both types of user indicated that they gave more 
consideration to the decision to use primates than for other models. In conjunction 
with participants expressing that their personal choices were irrational (i.e. not 
scientific), the extra measures they note in regard to only using primates when 
absolutely necessary could account for their continued use. 
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Theoretically, this emphasis on the moral aspect of the participants’ model choice is to 
be expected because, as Singer (1995) would argue, the scientists are speciesists, in 
that they are putting human interests above those of the experimental animals. Indeed, 
one participant (I2NP) specifically mentioned speciesism. However, the emphasis on 
more consideration for primates indicates that this is not speciesism as defined by 
Singer but is more nuanced. This is because while the researchers are still putting their 
own human interest above those of the primates, they are putting the primates’ 
interests above those of other species. Therefore, this is better explained by the 
capacitiesbased model of moral status (also known as the sliding scale model) which 
Walker (2006) describes as ‘3		IKLJ

$	 	 $  		 	 		    
IKLJ	’ (p.315). She defines capacities as cognitive, sensory, emotional 
and social abilities. Primates are generally regarded as having greater cognitive 
capacity than other mammals, although this is not universally agreed (see for example 
Nuffield Council on Bioethics 2005 pp.4144), hence the greater consideration and 
legislative protection they are afforded in biomedical science. 
 
Compounding the effect of these personal boundaries, it appears that schistosomiasis 
participants are referring to the ethical decisions made by ‘others’ that are beyond 
their control, which is enabling them to transfer the responsibility for their choices of 
experimental model on to other parties. This allows the continued use of primates to 
persist, although it also provides some opportunities for driving their replacement. 
Both types of user deferred the choices about experimental models to others. This 
included I7NP saying that, while they did not want to use primates, they were happy 
for others to, or I5P commenting that the research had been accepted by the scientific 
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community (via peerreview) and therefore must be justified. Indirectly, however, the 
participants indicated that the research decisions were the responsibility of society, via 
the views about research that communities suffering from the disease held. The 
greatest emphasis was on describing the role played by regulators and regulation in 
ethical decisions, with both types of user arguing that the rules governing primate 
research are very strict, so work deemed to satisfy the requirements must be justified. 
They also expressed this in the context of regulators requiring primate studies to 
progress clinical trials and so they would have to be done. Most significantly there 
were concerns that as the rules tighten, and if they go as far as banning primate use, 
the research would move abroad. This focus on careful regulation serves to tip the 
ethical balance in favour of experiments, because as Walker (2006) notes it can lead to 
the impression that the animals are protected by requirements of justice. 
 
However, when describing the ethical decision made by funders, some 
schistosomiasis participants (I8P and I7NP) noted that there had been a shift from 
experiments on primates being used to attract funding to funding agencies now 
expressing a preference for them not to be included in grants. This indicates that 
engagement with funding bodies will be particularly important for driving research 
towards nonprimate alternatives in this field. 
 
In PD there was a very similar response in terms of the participants’ personal ethical 
choices about which models to use, particularly in seeing this choice as generally 
irrational or emotional, rather than scientific . There were examples where the 
scientific utility of a model had been overcome by the associated ethical concerns. 
Unique to this case, one participant (I18NP) described how the opposite had occurred 
Page | 265  
 
and they had overcome a previous personal limitation about using mice because the 
scientific case was too strong not to conduct the research. This suggests that it could 
be important to make the scientific rationale for using nonprimate models stronger 
and more visible so that they are not seen as the ‘irrational choice’, which in 
conjunction with the general personal unease about primates could make replacing 
primate experiments less problematic. 
 
However, as was the case in schistosomiasis, in PD there was strong evidence that 
primates are given greater consideration than other species when it comes to making 
decisions about using them, which could partially explain why they continue to be 
used despite there being obvious reluctance to do so. There was more discussion about 
the ethical difficulties of using other species in this case, with no overt indication that 
some species were favoured over others or any explicit mention of speciesism. This 
indicates that it may be slightly easier to overcome the problem of primates being 
justified by the extra measures taken in making the decisions about them in the case of 
PD than in the case of schistosomiasis. 
 
Similar to schistosomiasis, there is evidence that the PD participants refer to the 
ethical decisions of ‘others’ to legitimise and justify their research, and that this could 
be contributing to the primate impasse, as it enables primate experiments to continue 
even when the scientists themselves do not really think they are necessary. Although 
some of the parties that PD participants defer the ethical decision to are the same as in 
schistosomiasis, such as other scientists, funders and regulators, there is an important 
contrast between how and where the participants in PD place many of their 
boundaries. 
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As noted PD participants do talk about the decisions of other scientists as justification 
for research, in that others do the work, the scientific community as a whole accepts 
the studies or that peer review means the work must be justified. In particular, where 
primates are concerned some participants (I17P and I14NP) felt that the validity of the 
primate models should be decided by the scientific community as a whole rather than 
by individuals. However, in PD, unlike in schistosomiasis, it was relatively common 
for participants to explicitly refer to the ethical decisions of society. This could be 
understood as an example of Brown and Michael’s (2001) ‘switching’ in which 
scientists can be seen to swap between science and culture as they go from scientific 
reasoning for their choices to being part of societal decisions. This indicates, that the 
PD scientists are more ‘sociologically sophisticated’, as Brown and Michael (2001) 
would term it, than the schistosomiasis researchers. They use the cultural/ethical case 
to add strength to the scientific case they make by utilising both sides of the boundary, 
i.e. scientists ‘	
 	$ 	 3 3	 	  
’ (Brown and Michael 2001, p.7). This may not be surprising given that PD 
has a much greater public profile than schistosomiasis, so this angle can be exploited 
more. This also links to comments about funders, with PD participants seeing 
Parkinson’s UK as particularly influential in directing research in this field, whereas 
there is no such patient advocacy group for schistosomiasis. There was no indication 
that funding bodies were shying away from funding primate work in this field, and 
indeed a nonprimate user (I14NP) felt that they actually place emphasis on animal 
research, which could contribute to the difficulty in getting newer alternatives 
developed. 
 
Page | 267  
 
As in the first case, in PD there was great emphasis on the difference in decisions 
between the scientists and the regulators/regulations. In a similar way to 
schistosomiasis this was framed in the context that the research is so highly legislated 
that it prevents inappropriate studies from occurring. Indeed, some participants went 
as far as to say that it was more heavily regulated than human research. In stark 
contrast to schistosomiasis, the PD participants rarely asserted that using primates was 
a regulatory requirement, which probably accounts for the greater willingness to give 
examples of alternatives to primates, as they do not perceive legislation as an 
immediate barrier. Instead, they saw regulation as a challenge to conducting primate 
research because of increasing associated costs etc. There was particular emphasis 
(similar to the first case) that, if there was a ban on primate use or if the current 
legislation became even stricter, research would move abroad to countries such as 
China which are more permissive, but where conditions and animal welfare are not as 
good as they are in the UK and Europe. The focus on this aspect of regulation could 
make it more difficult for scientists in this and other fields to envisage not using 
primates. Although it was beyond the scope of this project to investigate the validity 
of these claims, it is clear it contributes to the impasse in the primate debate. In short, 
it raises serious ethical questions about whether the knowledge claims that are 
produced in these less stringent countries should be accepted by the scientific 
community, which the scientists in these two fields need to address. 
 
%!	<<	
The interview findings from this project will be of significant interest to those 
involved in the discourse about the ethics of animal experimentation, including 
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sociologists and philosophers. Rollin (2007) argues that ‘4		 
 
    	  	
) #   		  
0	
		:KL	
M$$8	3	3	
	,		’ (p.523). This sentiment is echoed in 
many texts that focus on animal rights and animal ethics, with scientists being 
portrayed as morally corrupt or as not caring about or dealing with the ethical 
ramifications of their work. 
 
The data from this study indicates that while there was some evidence of the cost
benefit argument noted by Rollin, the participants in both cases showed a far more 
nuanced approach to the ethics related to their work and did not need to be pushed to 
discuss it. Although it could be the case that those who agreed to be interviewed 
tended to be more ethically aware, it was clear that these scientists had discussions in 
their own minds and with others in the community about the ethical implications of 
their choices. In some cases this has prevented them from conducting certain types of 
research or from using certain animals. Therefore, I believe it would be more fruitful 
to try to understand why scientists do not make these deliberations more public, 
despite it being evident that they are privately concerned about it. This could be 
related to the emotion versus scientific rationality which appears to restrict scientists 
from being more open about this. This might be eased by focusing more on the 
capacitiesbased model of moral status, as scientists in this study already think more 
in terms of this than animal rights. 
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Although, Walker (2006) makes a good point that the capacitiesbased model fails to 
justify any categorically different treatment of humans versus nonhuman animals, it 
does give rise to a more ‘scientifically’ measurable concept (animal capacity), which 
could work to diminish the irrationality scientists attribute to some ethical decisions. 
As illustrated by Walker (2006), it offers a means to explore the link between ethics 
and animal research regulation. The findings indicate that conducting interviews with 
scientists engaged in research is a useful means to bringing a new dimension to 
theoretical discussion about animal experimentation ethics. It provides rich data and 
insight into how animal users discuss, separate and implement moral considerations in 
their everyday doing of science. Methodologically, this project also provides 
insightful information into who else should be considered when examining 
controversial debates and impasses, by identifying who the scientists refer to when 
describing the impacts that the decisions of ‘others’ have on their area of research. 
 
1%
	
	
 
In bringing together the findings from the documentary analysis (Chapter 3) and the 
case study interviews (Chapters 4 and 5) this chapter has illustrated how the 
methodological approach taken (Chapter 2) has enabled me to address the research 
questions posed within the main aim of the project. Of the four research questions 
posed in Chapter 1 (and highlighted at the beginning of this chapter), the data in 
Chapters 35 have provided many examples of the arguments and justifications given 
for and against primate use in biomedical science, which are summarised within this 
discussion. The interview data in particular have revealed that there are differences in 
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those arguments between the different fields of research and between the different 
specialists. However, as the discussion presented here reveals, there are also areas of 
consensus. 
 
Despite much of the public and published debate about primate research revolving 
around their scientific utility and, to some extent, the ethical implications, this project 
has uniquely shown that in order to fully understand why the impasse exists and be 
able to find ways to overcome it, the social dynamics of science need to be examined. 
So in answer to question three the social dynamics of science are required to fully 
explain the continued impasse about primate use. They allowed much greater 
understanding of the primate debate and enabled me to suggest ways to overcome it. 
This project also illustrates that there is not a singular explanation, but rather several 
social dynamics that are interrelated in complex and important ways, resulting in this 
being a multifaceted problem requiring a multipronged and adaptable solution. It 
shows that while the use of primates in biomedical science is often portrayed as a 
special case in terms of the ethical and scientific justifications for and against it, which 
requires particular attention within the more general animal research debate, in many 
circumstances the social dynamics affect it in much the same way as other areas of 
science. 
 
Therefore, in outlining how this research examines the opportunities and challenges of 
primate use, this chapter shows that the impasse in moving towards replacing primates 
illustrated in publications is echoed by scientists in their conversations and practice. It 
also goes further, to explain why the polarisation continues and why challenges exist 
to moving beyond the welldocumented and repeated arguments. These explanations 
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are strongly influenced by the social dynamics of science, such as competition, 
entrenchment and expectations. 
 
This deeper understanding enables the conclusion that the primate impasse can be 
overcome, by identifying the social dynamics of science that are involved and by 
harnessing those dynamics to overcome or enhance aspects of the scientific practice. 
The final chapter now moves on to consider the last research question regarding the 
implications for primate use policy and good practice. It also considers opportunities 
for future research that arise from this project and discusses the key limitations of the 
research. 
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The aim of this project was to gain a deeper understanding of the primate debate to 
decide if it was possible to overcome the long term impasse which exists. That is, the 
two sides in the debate aspire to achieve the same aim of finding effective therapies 
and cures for disease without using primates, but neither side seems able to move 
beyond the arguments and work towards this goal. The findings revealed that this 
characterisation of the debate as paralysed by the pro vs. anticampaigns may be too 
simplistic. The interviews pointed toward a more complex situation with numerous 
tensions existing both within and between scientists involved in animal 
experimentation including primate users. As the discussion in Chapter 6 illustrates, 
exploring the social dynamics of science, and how they function has shown why the 
deadlock persists. This resulted in the conclusion that, the impasse in the primate use 
debate can be overcome in the cases studied. This chapter presents the details of that 
conclusion, and describes how it might be achieved. 
 
The findings from this research (discussed in Chapter 6) provided the means to make 
recommendations for how the two fields of research studied, schistosomiasis and PD, 
can move towards replacing primates. The long term history of the impasse and the 
ingrained nature of scientific practice identified in this research mean that it must be 
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acknowledged that implementing these recommendations will not be straightforward, 
but they represent the ideal situation and where difficulties might arise, these are 
considered. However, the recommendations cannot be implemented in isolation. They 
have implications for current policy and practice and will require input from various 
stakeholders if they are to be successful. Therefore, how the recommendations might 
be implemented and who and what will influence that are described. The multi
method design of the project enabled a unique vantage point from which to investigate 
the research aim and questions, and reflections on the nature of the findings and 
approaches used are discussed. Throughout this thesis, areas of further research have 
been identified and the limitations of the work noted, so this chapter closes with 
suggestions of how the findings from this project could be strengthened, how their 
applicability could be broadened and how they might be used as a basis to enrich 
current STS research. 
 
5! 
	
	
6+
	
 
The aim of this section is to present the recommendations for overcoming the primate 
use impasse in schistosomiasis and Parkinson’s disease research. These 
recommendations are based on the understanding gained from this project about the 
functions of the social dynamics of science and the arguments for and against primate 
use in these two fields. In general, the suggestions revolve around illustrating how the 
functions of the identified social dynamics of science can be utilised to overcome or 
enhance various aspects of scientific practice. There are no time scales indicated as 
this will be an evolving and dynamic process, dependent on when and how each of the 
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recommendations is implemented and how they might impact on each other. The 
section is divided by social dynamic to reflect the discussion in Chapter 6, with field 
specific recommendations made under each dynamic. A summary of all the 
recommendations can be found in Appendix 4. 
 
 *!!#)#"*!)!#
Improving collaboration in schistosomiasis research and maintaining and expanding it 
in PD research should be attempted. In general terms, increasing cooperation within 
the fields will reduce secretive and possessive behaviour and enable researchers to 
discuss more openly the limitations of their current research aims and models, what 
the alternatives are and how best to proceed. It may enable better allocation of 
resources and better distribution of research effort which, consequently, could 
improve productivity and progress towards meeting research aims. It should improve 
the acceptance of methods and findings that have been used or discovered by a wider 
variety of the scientists working in the field, with the consequence that the 		% 
and dominant views about the use of primate models are reconsidered and alternatives 
more readily tried. As noted in the previous chapter, this is a bigger issue in the 
schistosomiasis case, so fieldspecific recommendations of how enhanced cooperation 
might be achieved are given. 
 
  #")!# *%$!$')%)!##! )%)% 
to diminish the negative effects that competition is currently having on delaying 
general progress in the field, and on the possibility of replacing primates. In order to 
do this I recommend that the schistosomiasis community consider how they can 
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actively implement the following concepts and actions, none of which are mutually 
exclusive and will require a coordinated approach. 
 
a) Improve the profile of the disease within the scientific community and increase 
public awareness; some possibilities for doing this are outlined in the 
expectations section below (from p.282) 
b) Increase engagement with schistosomiasis patients and with clinical 
application of vaccines/treatments, perhaps by visiting areas with high disease 
incidence or establishing patient groups within those countries that can 
regularly be updated about research and can feedback their experiences to the 
researchers. 
c) Increase the nonprimate users’ reputation or perception of their reputation by 
improving the communication of their work. This might initially be through 
involvement with  media outlets through individuals such as journalists or 
communication professionals, and including social media, creating 
expectations about it (from p.282) or engagement with patient groups or the 
public. 
d) Where collaborations do exist, attempt to build on these to discuss the conflict 
surrounding which research aims in the field are the most important to pursue, 
and try to reach a consensus as to whether it is important to continue with all 
the aims, or whether any can be abandoned. This might require the facilitation 
of an external body such as the National Centre for the Replacement, 
Refinement and Reduction of Animals in Research (NC3Rs)8 or a funding  
                                                 
8 The NC3Rs was launched in 2004 in response to the House of Lords Select Committee report on 
Animals in Scientific Procedures 2002, available at: 
http://www.publications.parliament.uk/pa/ld200102/ldselect/ldanimal/150/15001.htm (accessed 
12/03/15), which recommended the establishment of a national centre to increase the focus on the 3Rs. 
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agency, and should include as many specialists in the field as possible. 
e) Investigate ways that the limited resources that are currently available can be 
cooperatively used to address more efficiently as many research questions as 
possible, by pooling expertise within the field and in some cases, externally. 
Despite currently being a contentious subject (see the discussion below), the 
emphasis should be on coauthorship to achieve an end rather than 
involvement in a race to be the first. This should become easier as the disease 
profile increases, more resources become available, and all scientists view 
what they contribute, as being of equal importance. 
 
Given the findings in PD research, these recommendations should improve the 
impetus to cooperate in schistosomiasis research by diminishing the competitive edge 
that some researchers have in the field, and emphasising the joint responsibility of the 
field as a whole to discover an efficacious vaccine. Improving the profile of the 
disease, increasing collaboration and reducing the explicit conflict regarding research 
aims should hopefully function to attract resources, and other researchers, to the field 
to expand what can be achieved in a shorter timeframe than currently seems possible. 
Cooperation should lead to a more open dialogue about the limitations of current 
methods, how they might be overcome and what alternatives exist or could be 
developed, including those that could replace primates. 
 
As noted above, some of these recommendations could be seen as problematic. For 
instance, here and in further recommendations, a case has been made for increasing 
public engagement in one form or another. That is, dialogueinformed engagement 
‘ 	 	 	$  3	 		  	 	
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3  	  3 ’ (Jensen and Holliman 2009 p.56). This 
requires an element of expertise to perform it effectively and may have financial 
implications for scientists, both in terms of additional training for and, for 
participating in, the public engagement. This is particularly true in schistosomiasis 
research for which many of the people they would ideally like to engage with are 
based in developing countries where language and distance are significant factors. 
This may be ameliorated somewhat with the emerging digital online forms of 
communication which Holliman (2011a), notes can afford ‘…  
	 		   	 0 		  	3	 	 	
0))			
		?		$
$3			3		$	’ (p.3). 
 
There is also literature questioning the value of engagement and whether the benefits 
proposed by its proponents can ever be realised (see Delli Carpini 	. 2004; Rowe 	
. 2010 for examples). This includes the dangers of overhyping research which can 
damage the legitimacy of, or trust in, a field (Porter 	.2012); this is discussed in 
more detail in the next section on expectations. However, increasing discourse on the 
concept of involving the public in researchfunding decisions (Rowe 	. 2010), and 
in increasing participation by scientists in the public understanding of science 
(Pearson 2001), has given greater emphasis to public engagement over recent years. 
Consequently, funders are actively encouraging researchers to undertake public 
engagement activities and, in some cases, making this a requirement of receiving 
support. For example, the Government’s Science and Innovation Framework 2004
2014 (HM Treasury 2004) states: 
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Over recent years the focus of the Government’s Science and Society public 
engagement activities has moved forward from simply promoting public 
understanding of science to the wider agenda of facilitating public engagement 
with science and its application… 
 
The office of Science and Technology’s Public Engagement work programme 
addresses these issues through: offering public engagement grants to widen 
participation to include people from across the diverse spectrum of social 
groups in the UK… (pp.103104). 
 
The Government pursues this agenda through the Research Councils UK and the 
British Science Association amongst others. The Councils have developed four 
specific initiatives to involve their funded researchers in public understanding 
activities/public engagement, two of which are particularly relevant here: offering 
financial inducements in grant schemes and providing training in communication 
skills. The experiences of some of the PD participants in being incentivised by 
Parkinson’s UK to participate in public engagement also indicate that this is not 
limited to traditional funders. Together, this suggests that the financial limitations 
indicated above could be eased by training and specific funds being made available 
for scientists to become involved with the public in this way. 
 
Based on the analysis in the previous chapter it is recommended that schistosomiasis 
researchers should focus on coauthorship. However, some critics of the Research 
Excellence Framework (REF) system for assessing the quality of research in UK 
higher education institutions believe that REF acts as a disincentive to collaboration 
within institutions (Wells 2012) or that it may incentivise dishonest coauthorship 
(Shaw 2012). For example, on the LSE blog, Dr Peter Wells (2012) argues that 
because ‘4
  	 	  			 	  3 	 	 	  
$’ then ‘4		3	
			’, 
which would encourage external collaboration but discourage the internal cooperation 
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that is urgently needed in the first instance in schistosomiasis research. However, 
others question the real impact that this has on scientific practice (Adam 2012) and 
evidence from funding bodies and some governments indicates that collaboration is 
actively being encouraged, and can be used as an asset to attract researchers. For 
example: the !. 6 ;  "  #$	 @ 5?
*+*+ has international cooperation as an important cross cutting priority (European 
Commission 2013b); the UK Government’s <		
  	 7 < 
(Department for Business, Innovation and Skills 2011) reports that in their 
forthcoming strategy on innovation and research they will attach considerable 
significance to international collaboration; and the Government of the Netherlands 
says in its *+*G   	 	'  < report ‘>  	$ 	
		 		 	’ (Ministry of Education, Culture and Science 
2014, p.23) and ‘	  	 3		 	 	  	0 
3	$			$	
’ (p.17). There are 
also examples of initiatives within institutions to encourage collaboration such as the 
University of Sheffield’s <<=	
 (University of Sheffield 2015). In 
conjunction with the experiences of Parkinson’s disease researchers, these examples 
indicate that coauthorship and collaboration are generally achievable and desirable. 
 
  #")!# @*)#" ! )%)!# #  %)% ! #"  %
#"# ' "''%#! *% )! %?%4#( !(!% )#"?%4#(?! ##

*% )!% to increase dialogue about the limitations that both types of user face, 
and discern whether some of the dominant views regarding what is and is not 
necessary in terms of using primates are perceived, regulatoryrelated or actual. In the 
long term, this should help with realistic exploration of alternatives to primate use. In 
the shorter term, it should enable the identification of instances where primate 
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numbers can be reduced by primate users collaborating rather than duplicating similar 
studies. It might also reveal that some of the nonprimate research can already, or with 
modification, completely or partially remove the need for primates. 
 
  #")!##%)!# %'#!%"*#)%&)%)!##
%)% to increase the likelihood of moving toward nonprimate methods. If 
discussions occur across disciplines and institutions that do not normally 
communicate, it may reveal that it is possible to ask a slightly different question or use 
a completely novel (in the field of PD research) methodology to investigate PD that 
will replace the need for certain primate models. For example, advances in non
invasive imaging of humans and small animals that might allow for different avenues 
to be explored, studies in fish or small mammals, or invertebrate models such as the 
yeast and fruit fly models used by some participants. 
 
Maintaining the impetus to collaborate in PD research should help progress within the 
field. Expanding it could see new innovations and resources becoming available to 
help to more quickly develop effective therapeutics without using primates. It should 
mean that the currently available resources are used to their maximum potential. 
 
@*!)!#E%!)#")!#
With the above in mind, it is suggested that, to make more progress towards replacing 
primates, both fields need to overcome, or at least diminish the impact of the 
dichotomy of novelty through changes in publication practice. Researchers must also 
address how the nonprimate users, in particular, communicate their work to attract 
support and resources for their research. Scientists should work to diminish the 
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influence of the core group of primate users in schistosomiasis, and prevent one from 
forming in PD research. In general this will enable alternatives to primate disease 
models to become more easily accepted by the scientific communities in each field 
and, as a consequence, hopefully speed up progress in overcoming the impasse. It 
should improve communication and acceptance of alternative viewpoints, and may 
even go so far as to make the alternatives users the core group within the field, making 
it easier for the field in general to progress and making it more likely that primates 
will be replaced. As noted in the previous section, some of the recommendations made 
here could provide a further means to reduce the impact of competition and improve 
collaboration. Brown (2003) noted that the most vociferous group are the most likely 
to have their expectations disseminated widely enough to win the competition for their 
work to be accepted, so in the context of this discussion this is the core set or, in the 
context of the previous section, those with the greatest reputation. So, as some of the 
recommendations here aim to diminish the influence of the core set to enable wider 
dissemination of expectations about alternatives, they will also be useful for 
improving the reputations of nonprimateusing scientists. 
 
Once again, there are differences in how the social dynamics discussed here affect the 
two fields, so some fieldspecific suggestions are given. However, it should be noted 
that some of the dynamics affect the two fields in the same way, so some of the 
suggestions are repeated in both cases but the emphasis may be slightly different. 
 
  #")!# " ! " #)# ' ! % (%* ' *% )!
%)%% # ! ) to enable information and claims about alternative, 
nonprimate research to be more widely disseminated and accepted and to allow the 
dominant view that primates are necessary to be questioned more readily. This could 
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be achieved by improving how and by whom expectations are created, and by 
changing practice in regard to communicating research by implementing the following 
recommendations. 
 
a) Nonprimate users should construct expectations about alternatives by 
focusing on the health benefits of the research, and discussing their methods in 
the context of what has already been found, and by emphasising the novel 
contribution they will make. This will require the writing of review papers 
and/or more engagement with the public and press (see below). 
b) Increase overall engagement with the public by being more willing to address 
their views and talk to them about the research to increase the public profile of 
the diseases. This may require some impetus from funding bodies and the 
development of a patient group could help with this. 
c) Increase engagement with media outlets including social media to disseminate 
expectations about alternatives and the research aims, using the ‘hype’ to 
initially raise the profile of the alternatives and the field to attract resources for 
them. 
d) Increase the publication of negative data. This will require dialogue with 
journal editors and/or funders. 
 
Each of these recommendations should function to draw researchers and resources to 
the schistosomiasis field to increase the pool of scientists available to form a core set, 
and reduce the marginalisation of the nonprimate users, as has been the case in PD 
research. By identifying and utilising different outputs for their research in 
combination with ‘selling‘ their research more effectively, nonprimate users should 
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be able to overcome the negative implications of the dichotomy of novelty and 
improve their reputation and standing within the core set. This will hopefully lead to 
greater acceptance of the alternatives to primates, and help to reduce the conflicts 
about research aims evident in the field, making progress towards effective vaccines 
more rapid. 
 
  #")!# %$#! ! !) #! ' ) % (%* ' *% )!
%)%% #  to ensure that nonprimate alternatives continue to develop and 
that the collaborative nature of the field is not disrupted, enabling progress toward 
overcoming the impasse to occur. Once again, how the research is communicated will 
determine whether this is achievable and the following are suggestions for a 
multipronged approach to changing and improving current. 
 
a) Continue to engage with the public and, in the case of nonprimate users, 
increase that engagement. 
b) Nonprimate users should construct more expectations about their research, 
focusing on the health benefits that will accrue from it and placing it in the 
context of the research that has already been done while emphasising its novel 
contribution. This could be facilitated by using existing collaborations to 
further validate nonprimate research in different labs or models. 
c) Increase engagement with media outlets including social media, in particular 
the nonprimate users. However, caution should be used to ensure that the 
‘hype’ does not entirely overestimate the shortmedium term potential of the 
research as the costs of hype could be more detrimental in this field. This is 
because there is much wider public awareness that could lead to more 
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exaggerated false hope and disappointment and, although there is some 
necessity to attract resources and acceptance to nonprimate studies, it is not as 
acute as it is schistosomiasis. 
d) Increase the publication of negative data. This will require dialogue with 
journal editors and/or funders. 
 
Implementing these actions should enable nonprimate using researchers to overcome 
the dichotomy of novelty, where, as detailed in Chapters 6, novelty is both a necessity 
and a hindrance to getting findings accepted, and build upon the successes they have 
already achieved in gaining acceptance for their research. They should help the field 
as a whole to reassess the dominant view that primates are essential to certain aspects 
of the PD research and can never be replaced, as well as, helping to make practical 
progress towards primate replacements in areas of research where the community 
seems to agree that it is more feasible. 
 
The problem of negative data publication was raised by participants in both cases and 
is recognised in the literature on medical research in humans, in which it has been 
shown that studies are more likely to be published if they report significant or positive 
results, which can overestimate the effectiveness of a treatment (Dwan 	. 2008). 
More recently, attention has begun to focus on the important consequences that such 
publication bias can have in laboratory animal research (ter Riet 	. 2012). As noted 
above, this problem will require action by journal editors and/or funders but there is a 
movement towards making publication of negative or neutral data a more readily 
available option, with the introduction of journals such as "	N:
2 and the N	$"	 2, as well as negative results 
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sections in other journals such as 3
. This is discussed in more 
detail in the Policy and Practice section. 
 
As well as the economic issues related to public engagement noted above (p.278), 
increasing public engagement, in the ways proposed in these recommendations, can be 
problematic from a professional reputation point of view. Porter 	. (2012) found 
that ‘ 	
  	 		 	   	 			

   $  	 
  		  		
))3		 	 	3 	 	
3KL		3
’ (p.420). However, this is likely to be less 
of an issue in the future because, as noted above, funders continue to incentivise 
scientists to take part in public engagement. Perhaps more importantly in this context, 
the 2015 REF will include some form of assessment of public engagement in addition 
to the evaluation of scholarly impact, which represents a significant step towards 
institutionalising the governmental and scientific commitment to developing a closer 
relationship between science and the public (Burchell 	. 2009).
 
#!%# #!)#"&
Taking the findings detailed in the previous chapter, it is suggested that overcoming 
the impact of any existing entrenchment and improving, the flexibility of available 
methods will reduce the evident restrictions on contemplating primate replacement. 
This should lead to alternative models being more routinely used and prevent the need 
for primate use being automatically assumed, thus helping to overcome the impasse. 
Science policy, as defined in the previous chapter, if properly developed, could assist 
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with the creation of flexible scientific practice. As well as the fieldspecific 
recommendations described below, it should be considered that Knot 	 . (2001) 
noted that competition can hamper flexibility because it restricts the free flow of 
information about the different possibilities or alternative options. Therefore, the 
recommendation made in the Competition and Reputation section (pp.275282) will 
also contribute to a reduction in entrenchment, as will recommendations to increase 
the expectations regarding alternatives. 
 
  #")!# $%  ! #!%# #! ' *% )!  " #
! )%)%to enable alternative methods to be considered and become 
more widespread throughout the field. In order to do this the schistosomiasis 
community should considers the following to improve flexibility within their 
scientific practice and to provide an impetus to embrace change. 
 
a) Implement flexibility strategies by: conducting more research on the 
alternative models proposed in this project (i.e. pigs) to establish a strong bank 
of background literature; disseminating information more widely on the non
primate models already used, including information on how they can be used 
in different circumstances, thus improving collaboration and expectations 
about alternatives. 
b) Engage with funders to discuss the possibility of making funds available to 
implement the logistical changes needed to switch to other methods and to 
encourage them to provide an impetus to collaborate by offering multicentre 
grants 
c) Engage with policy makers to determine what is required in terms of scientific 
evidence to remove the necessity for primate studies. In addition, discuss the 
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limitations of current research agendas and how more progress could be made. 
This could be facilitated by involving funders and could also require an 
element of public engagement. 
 
  #")!# )#!)# )#" #)# ! '@!& #  %)% to 
overcome the persistent but relatively less influential entrenchment of primate use. 
This should enable PD researchers to move beyond simply a willingness to discuss the 
potential for replacing primates, to actually conducting their research without them. 
They can do this by considering the following actions. 
 
a) Conduct studies to establish the applicability of the suggested alternatives (i.e. 
pigs, mice, rats, sheep, postmortem human tissue, and noninvasive human 
imaging) and the existing primate research (e.g. through systematic review 
and/or metaanalysis) to create and expand the available literature to reduce 
the reliance on historical data from primate studies and increase the validity of 
the alternatives. 
b) Increase the dissemination of findings from the nonprimate alternative models 
already in existence and being developed through publication and conferences. 
c) Maintain and increase collaboration within and external to the PD field. 
d) Engage with policy makers and primary legislators to determine how previous 
studies (such as those in hookworm identified by interview participants) have 
been able to bypass primate experiments and how future studies can do the 
same. Research agendas will then need to be modified to enable the 
appropriate studies to be conducted, which may require input from the funding 
agencies. 
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Implementing these proposals should help to curtail the automatic response that 
primates definitely cannot be replaced. They should enable the nonprimate methods 
to be more widely considered, accepted and used, and a move away from primate 
models to occur. 
 
Whilst proposing overcoming entrenchment, it is important to acknowledge that 
recognition of the concept by scientists will be key to achieving this recommendation. 
This will require work by Three Rs organisations and professional scientific societies 
to highlight the areas of research that have become stagnated and facilitate 
opportunities to refresh and reinvigorate thinking in the field. A recent report detailing 
the Government’s Delivery Plan to reduce the use of animals in scientific research 
does not quite go as far as describing entrenchment, but it does note that some of the 
challenges to rapid progress in the Three Rs ‘4
		$	1
$		’(Home Office 	. 2014, p.17). Therefore, this 
offers hope that the concept would not be entirely alien to the scientists and associated 
stakeholders so could be introduced, particularly with support from STS scholars via 
better dissemination of their work to the scientific communities that they study; 
something which the present author aims to do. 
 
Engaging with regulators could be seen by some as potentially difficult given the 
entrenched views about legal requirements and resistance to adopt change. However, 
recent developments regarding increased openness and transparency about animal 
experiments (e.g. the 	  A   "  	 .D
[Anonymous 2014]) and the scale of consultation regarding the revision and adoption 
of &	$ *++,-,!. and then ASPA, indicate that engagement with regulators 
such as the Animal Science Regulation Unit (ASRU) is possible. Indeed, (as noted 
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below in the Policy and Practice Implications section) the Government are now 
actively pursuing engagement between stakeholders, scientists, government 
departments and regulators on a domestic and international scale (Home Office 	. 
2014). 
 
Another potential but significant problem with implementing more flexibility by 
conducting new studies and exploring alternative models is how the work can be 
funded in austere economic times. The recent emphasis in Europe and particularly in 
the UK regarding the importance of the Three Rs and consequent changes/additions to 
funding research priorities both by the Government and some of the major funding 
bodies could alleviate this restriction. Indeed, one of the Governments key objectives 
in their Delivery Plan is to ‘<		-"	$
%	
  	 $ 	0 	  	  -"
’ (Home Office 	. 2014, p.20). 
 
The Government acknowledge that the funding given towards alternatives research is 
very small in relation to other areas of research but it has increased the amount to just 
over £8 million in 2014/15 when other areas are undergoing cuts. Initiatives such as 
the NC3Rs CRACK IT challenge (NC3Rs 2015a) and Innovate UK’s feasibility study 
and SMART funding competitions (Innovate UK 2015), offer opportunities for some 
of the studies recommended above to be conducted. In addition, five of the major 
scientific research funding bodies in the UK (Biotechnology and Biological Sciences 
Research Council [BBSRC], Department for Environment, Food and Rural Affairs 
[Defra], Medical Research Council [MRC], Natural Environment Research Council 
[NERC] and the Wellcome Trust) have coordinated with NC3Rs to clarify their 
expectations regarding animal use in the biosciences. In doing so they ‘…
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 	   		  $  -" 	%  	 
   ’ (NC3Rs 	 . 2014, pg.13), so some of these 
recommendations may initially need to be implemented as adjuncts to larger 
programmes of work. It appears that there is much more impetus for funders to 
provide resources for alternatives research than ever before and as detailed in the 
previous section, attracting alternatives funding and resources should become easier as 
improvements in dissemination, disease profile, collaboration and expectations occur. 
Further discussion of the impact funding bodies will have in terms of policy and 
practice is presented below (p.302). 
 
!E* )#"F!%5
In order to overcome the primate impasse in both fields studied it is suggested that the 
scientists involved need to address the ethical considerations and their views about 
them directly and as a community. In addition, schistosomiasis and PD scientists 
identified several parties whom they referred to as justification for certain aspects of 
research. This has served to highlight the parties that could be particularly important 
in facilitating many of the recommendations made in this chapter, as such the 
scientists should engage with these parties. This should further a move away from 
using ‘others’ as justification for the continuation of primate research and allow a 
more constructive dialogue about the moral capacity and scientific validity of all the 
models used. As noted above, there were some differences in how the ethical 
dynamics affected the research and participants in the two fields, and these are 
reflected in the recommendations that follow. 
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  #")!# ""% ! !) #"%)!# ' @*% #!)  "
#! )%)% to enable scientists to move beyond seeing their 
own choices as irrational and unscientific, and to prevent the decisions of others being 
used to justify existing primate use even when the scientific case might be 
questionable. This could be best achieved by implementing the following suggestions 
and engaging with various interested and involved parties. 
 
a) Nonprimate users should increase their sociological sophistication by 
considering how they can better address the cultural or social implications of 
their work and in so doing add strength to their scientific case by switching 
between the social and the scientific justifications. This will no doubt become 
more important, and perhaps easier if, as suggested in previous sections, the 
public profile of schistosomiasis disease and research improves. The 
requirement to report the impact of research in the most recent REF may also 
prompt more consideration toward this recommendation as its definition of 
impact includes B4 	 0   3	 	: 	 	$	
0 			0
0 3$0 	
0 		
0 0 
0 	0
  	   0 3
0 	
0
		
0	$’ (HEFCE 2012, p.26). 
b) Explore the ethical considerations and moral capacities associated with all the 
experimental models used and proposed for schistosomiasis more explicitly 
and directly. This should be done as a community, and the Animal Welfare 
and Ethical Review Bodies (AWERBs) will have a role to play. It may also 
need to be facilitated by an external party such as a Three Rs organisation or a 
specialist group such as the Boyd Group or the Nuffield Council on Bioethics. 
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c) Strengthen the scientific rationale for the nonprimate alternatives by 
implementing some of the recommendations from previous sections and 
emphasising each model’s scientific advantages to make it more difficult for 
scientists to see their model choice as irrational or unscientific. 
d) Researchers should continue to engage with funders to continue to move away 
from funding primate experiments and providing more resources for the 
alternative models. This will be especially important if a patient advocacy 
group develops with its own capability to fund research in this field. 
e) Researchers should consider how to improve dialogue with regulators in this 
field to remove the presumption that certain studies must be done. The 
scientists and regulators should also engage in discussions about research 
moving abroad and how this has and could impact on UK and European 
schistosomiasis research. This should be realistically based on evidence rather 
than anecdote. This could also be extended to journal editors to develop and 
adopt guidelines such as the ARRIVE guidelines (Kilkenny 	 . 2010) to 
prevent any ethically questionable research done in more permissive countries 
from being accepted for publication. 
f) Engage with welfare experts, industry and regulators to determine how to 
improve conditions abroad so that experiments are subjected to the same 
ethical, welfare and scientific rigor that scientists argue is the case in the UK 
and other parts of Europe. 
 
  #")!#"#!@!#(!)#"%)!#($#!! "
"#%)%to remove the scientists’ perception that their model choice (in 
terms of which species they are willing to use) is irrational and enable the alternatives 
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to primates to be viewed as scientific and justified. Directly addressing and engaging 
with the parties they indicate are influential in PD research will enable them to stop 
being used only as a reason to prevent replacing primates and instead as an 
opportunity for the change, which some participants have already identified as being a 
possibility. Achieving this will require input from several parties, but also a slightly 
different approach by the PD scientists themselves as suggested below. 
 
a) Explore the ethical considerations and moral capacities associated with all the 
experimental models used and proposed for PD more explicitly and directly. 
This should be done as a community and the AWERBs will have a role to 
play. It may also need to be facilitated by an external party such as a Three Rs 
organisation or a specialist group such as the Boyd Group or the Nuffield 
Council on Bioethics.  
b) Continue to strengthen the scientific rationale for the nonprimate alternatives 
by implementing some of the recommendations from previous sections and 
emphasising each model’s scientific advantages to make it more difficult for 
scientists to see their model choice as irrational or unscientific.  
c) Engage with funders, in particular Parkinson’s UK, to discuss how to create 
and inject more resources into nonprimate and also nonanimal alternatives 
for researching PD. 
d) Scientists and regulators should engage in discussions about research moving 
abroad and how this has and could impact on UK and European PD research. 
This should be realistically based on evidence rather than anecdote This could 
also be broadened to persuade journal editors to develop and adopt guidelines 
such as the ARRIVE guidelines (Kilkenny 	.2010) to prevent any ethically 
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questionable research done in less regulated countries from being accepted for 
publication. 
e) Engage with welfare experts, industry and regulators to determine how to 
improve conditions abroad so that experiments are subjected to the same 
ethical, welfare and scientific rigor as scientists argue is the case in the UK and 
other parts of Europe. 
 
This final series of recommendations have two specific challenges associated with 
them that must be taken into consideration. First, creating the space and opportunity 
for researchers to explore the ethical considerations and moral capacities associated 
with all their experimental models more explicitly and as a community. In the UK the 
AWERBs could play a significant role in encouraging researchers to discuss these 
issues more openly as one of the bodies’ additional tasks is to ‘$  
$		$ 	 		3	 
 		 	 	  0    	 	 	3	’ (Home 
Office 2014b, p.89). However, in order to broaden dialogue beyond individual 
research groups and institutions there will probably need to be facilitation by external 
organisations. In particular, specialist groups such as the Boyd Group could provide 
the necessary platform for discussions of this nature. For instance, one of the Boyd 
Group’s objectives is to promote dialogue between a diverse set of people and 
organisations, such as veterinarians, scientists using animals (from industry and 
academia), members of animal welfare organisations, antivivisectionists, members of 
government and charitable bodies funding or directly engaged in research, 
philosophers and others. The group has successfully achieved this for several areas of 
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concern related to the use of animals in science, including the use of primates (Boyd 
Group 2008). 
 
Second, the question of research moving abroad was identified as important in both 
case studies, and overcoming it will again require engagement and dialogue between 
several parties. The Government’s delivery Plan (Home Office 	 . 2014) has 
recently provided positive indications that the recommendations set out here are 
achievable. Echoing the responses of participant’s the Government notes that B4	
.D		
3			[legally required]0	

	$$	
3’ (p.17). In order to counter 
this they have committed to several actions related to international harmonisation of 
regulations and welfare standards, including supporting the NC3Rs’ international 
initiatives and engaging with other countries, especially through the International 
Conference on Harmonisation of Technical Requirements for Registration of 
Pharmaceuticals for Human Use (ICH) and the Organisation for Economic Co
operation and Development (OECD). They will also work with the Foreign and 
Commonwealth Office to support a Chinese initiative to develop standards for 
research animal welfare and ethical use. This is an ideal platform from which to drive 
the collaboration and engagement suggested in the recommendations above, but it is 
my belief that it will require the cooperation and assistance of as many stakeholders 
and organisations as possible to really press for international change. For example, 
organisations such as RSPCA International have run training events for several years 
on topics such as, legislation, ethical review, training for personnel, the Three Rs and 
animal care in countries such as China, South Korea and Taiwan. They have a history 
of collaborating with other animal and science organisations and groups (RSPCA 
Page | 296  
 
2015), so could contribute a great deal to realising the overall goal of harmonisation of 
standards and regulations. 
 
Putting these recommendations into practice will require a lot of collaboration 
between different interested parties, and a great deal of dialogue that would not 
traditionally occur. However, if effort is put into addressing these ethicsrelated issues 
it should make overcoming the primate impasse easier and, in the long term, more 
rapid. It will enable scientists to discuss more openly the limitations of the models that 
they are aware of, but which are generally not expressed in the everyday pursuit of 
science and to fully evaluate the moral standing of all the proposed models. It should 
also create greater awareness about the impact that those outside of the laboratory 
have, and how they can contribute to overcoming the primate impasse. It could have a 
positive impact on the international acceptance of the Three Rs and alternatives more 
generally. 
 
5%
)	
	
 
The discussion above illustrates that exploring the social dynamics of science and the 
roles of the various functions, should help to overcome the primate impasse, where the 
polarisation has prevented the two sides from achieving their joint aspiration of 
finding effective therapies and cures for diseases without using primates. It has 
provided a framework of recommendations for how the two fields of research under 
study, schistosomiasis and PD, can move beyond the established arguments, towards 
primate replacements. However, the recommendations (see Appendix 4 for a 
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summary) cannot be implemented in isolation, they have implications for current 
policy and practice and will require input from various stakeholders if they are to be 
successful. The aim of this section is to outline how the recommendations might be 
put into operation and who and what will influence that, so the section is divided to 
consider current policies and the stakeholders involved. 
 
()!%E$%# #!)#"()!#
In the two case studies undertaken, it was clear that legislation and the perception of 
what regulators require is important to the scientists in both validating and directing 
their research, and that their responses go deeper than just the fact that they can only 
perform studies sanctioned by legislation. As noted in the introduction (Chapter 1), 
recent changes to the European and UK legislation controlling animal experiments 
have included a greater emphasis on the Three Rs and on protecting primates, 
theoretically making it more difficult to use them. As the majority of the participants 
in this study were based in the UK the focus will be on the amended 
<	 ;  	 / (ASPA), the role of the Home Office and UK 
Government and the Medicines and Healthcare Regulatory Agency (MHRA). 
 
Under ASPA, all projects using primates must be retrospectively reviewed, which will 
include assessing if the objectives of the programme have been achieved, the amount 
of harm caused to the animals and whether any lessons can be learnt that will 
contribute to further implementation of the Three Rs. There is also a requirement for 
scientists to publish nontechnical summaries of their projects that must include 
information on the harms and benefits associated with the work. These two aspects 
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present an opportunity to increase transparency around how scientists make their 
decisions about model choice and give them an opportunity to properly address the 
limitations of their models, which, at present, they are willing to talk about but are 
rarely able or prepared to publish. The Home Office should ensure that the 
retrospective reviews are rigorous in order to facilitate progress towards overcoming 
the primate impasse. The advisory role that the Home Office Inspectors have in the 
legislative process provides great scope for the dissemination of information on 
alternatives which will give scientists another outlet through which to strengthen the 
scientific case and expectations for their use. The Home Office Inspectors are also 
ideally placed to disseminate the recommendations made in this thesis, through their 
establishment visits, conferences and electronic newsletters. This is particularly 
important given the regard in which the scientists in this study hold the Inspectors and 
their advice, and is bolstered by the Government plan to enhance the role of Home 
Office Inspectors and other regulators in disseminating Three Rs advances within the 
regulatory framework (Home Office 	. 2014). 
 
On the 18 July 2011, the Coalition Government pledged to reduce animal 
experimentation (Featherstone 2011), and the existence of Parliamentary Groups such 
as the Associate Parliamentary Group for Animal Welfare and the AllParty 
Parliamentary Group for the Replacement of Animals in Medical Experimentation 
indicates that, while not a top priority, animal experimentation and welfare are on the 
political agenda. If the concerns expressed by my participants, that large amounts of 
scientific research will move abroad become a reality, it may well move up that 
agenda. While the Government has acknowledged that this could be a problem and it 
has initiated some counter steps, it needs to consult further with scientists, the Home 
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Office and funding agencies to determine the current level of movement abroad, how 
this is predicted to change and what impact it will have on the UK economy, scientific 
reputation, animal welfare reputation and healthcare. They may then need to work 
with the various stakeholders to provide incentives for researchers to remain in the 
UK and to address how to continue to improve international standards, perhaps 
through accreditation and collaborative funding schemes as well as legislative 
harmonisation 
 
The MHRA controls whether medicines and medical devices are licenced for market 
and use. It is these controls that many of the interview participants refer to when they 
defer back to regulators requiring preclinical studies in primates before clinical 
studies in humans can proceed. However, this may be a perception held by the 
majority of scientists that needs to be clarified by the MHRA rather than a strict 
reality. Indeed, personal communications with MHRA staff and the responses of some 
of the participants indicate that primate evidence is not always a requirement. 
 
It appears from their website (MHRA 2015) and from the presence of staff members 
on various working groups associated with animal experimentation, that the MHRA 
are very willing to engage with stakeholders about how they regulate and what their 
role is. Nevertheless, the scientists’ perceptions about the inflexibility of the system 
remain, so it may now be necessary for the MHRA to be more overt and explicit about 
their willingness to discuss with scientists what they will and will not accept, in terms 
of preclinical data and to perhaps specifically invite them to submit data from novel 
methods. They should build upon: their work with the Home Office to push 
manufacturers and overseas regulators to adopt refinements in the batch testing of 
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Botulinum toxin. In addition the MHRA should conduct further collaboration with 
NC3Rs to investigate how to reduce the use of recovery animals in pharmaceutical 
development and using human tissue instead of animals for pharmacology safety 
studies (Home Office 	.2014), and engage with other stakeholders and scientists to 
ensure that the established tests are reviewed and updated as new information and 
scientific developments, particularly in the field of alternatives, become available. 
 
#"%)#")!#!%*
The findings in this study have shown funding priorities to be a factor in driving 
research in schistosomiasis and PD, and a means to justify the research. Therefore, 
funding agencies could have a significant impact on progress towards replacing and 
reducing the number of primate models used in several ways. This is especially so 
given the present political will to improve Three Rs funding and the recent impetus by 
the major funding bodies to facilitate greater collaboration and research related to 
alternatives to animal experiments noted above. 
 
As hinted at by schistosomiasis participants, the funding bodies can refuse or dissuade 
researchers from using primates by providing funding for alternative models and 
requiring very strict justification for primate work, which could include making 
reviews such as the Bateson review (Bateson 2011) mandatory. The Bateson review 
was commissioned and funded by the BBSRC, MRC and Wellcome Trust in response 
to a Weatherall Group recommendation (see primate report [17]). The aim of the 
review was: to assess the quality, outputs and impacts of research using primates 
supported by them over the last decade, on advancing knowledge in human and 
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animal health; to identify the strengths and weaknesses of the funded science in this 
field; to inform their future science and funding strategies; and to feed the outcomes 
of the review into any Government strategy on primate use. In addition, funders can 
provide more collaborative funding programmes in a similar vein to the European 
Framework programmes, such as Horizon 2020 (European Commission 2013b) in 
which multicentre participation is mandatory for getting the funding. Funding bodies 
should also work together with industry to create funding opportunities that inspire 
innovation and development in alternatives such as the NC3Rs CRACK IT challenges 
(NC3Rs 2015a). 
 
Patient groups or medical charities can also contribute significant funds for 
researching treatments and cures for their respective diseases as illustrated by the £65 
million investment by Parkinson’s UK. Therefore, they have the potential to influence 
the direction of research in much the same way as any of the other major funders. 
Perhaps, just as importantly, they can help scientists to be more widely exposed to the 
sufferers of the disease and push for more public engagement, as PD participants 
indicated was the case with Parkinson’s UK. This encourages greater cooperation and 
more accountability that, as discussed previously, will aid better acceptance of 
alternatives to primates and improve progress in both fields of research. Patient groups 
should help to disseminate realistic and responsible expectations and help scientists to 
communicate their work more effectively to audiences other than their peers. This is a 
role that Parkinson’s UK appears to be adopting as evidenced by the participants’ 
responses about the charity and also by news articles on their website, such as 
2 H	:   ;9F (Parkinson’s UK 2014), which gives a 
more realistic explanation of work described in a national newspaper as being a new 
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treatment for PD.Parkinson’s UK Research Communications Manager, Claire Bale, 
commented that, ‘E  $ 		 	 
	 3	  	
;E’ and ‘	
	0	E
		3	
				
	;E’. 
 
#!!)#"#!'%(%
Many of the recommendations made here have implications for established scientific 
practice; therefore, scientists will need to be openminded and willing to make some 
changes to their current behaviour. However, the incentives and support from the 
other parties discussed here should make this transition easier. Indeed, many of the 
participants acknowledged that things needed to change, so, if provided with the 
impetus and opportunity, they should be willing and able to adapt. 
 
The scientific community needs to come to a consensus about not accepting findings 
coming from what they describe as substandard labs in Europe or elsewhere in the 
world. Researchers will need to work with many of the stakeholders and international 
parties to develop guidelines on what will be accepted, and disseminate these widely 
through journals and international conferences. Examples of similar consensus being 
achieved include the ARRIVE guidelines for journals and, more recently, the 
European Cosmetic testing ban which is being adopted by India (Dhar 2013) and, in 
part, by China (Iaccino 2014). This should be very productive if the Government 
support in this area continues and is widened as suggested above (p.297). 
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As well as implications for the scientists, there will be important considerations for 
the progress of the two fields. There may be an initial slowing of progress as data are 
accumulated for nonprimate models and new methods are developed. Changes in 
funding etc. will not be instantaneous, and it will take time to set up the networks 
necessary, and for scientists to identify and form collaborations, either new or beyond 
what already exists. However, there will be long to mediumterm gains and, as more 
interest in the two fields (particularly schistosomiasis) is generated, more resources 
will become available. Coupled with movement away from expensive primate models 
and increased collaboration, those resources will ultimately go further, enabling more 
candidate treatments to be developed leading to an increased chance of an effective 
one being identified and more quickly progressed through clinical trials. If nonanimal 
or invertebrate methods are utilised, this could further improve the speed of 
progression as the administrative burden of needing a licence would be removed 
(indeed some participants highlighted this as a reason for using fruit flies and yeast in 
their research). This may be hindered by the timescale required to build the necessary 
evidence base to make the switch to alternatives, although, if the improvements in 
dissemination and collaboration suggested in the recommendations above are made, 
this could mitigate the delay somewhat. 
 
G%#)"!%E#  #)!#)#"#()( #!
As noted in this study and by others (ter Riet 	.2012), publication bias due to the 
nonreporting of negative data is an important problem that can hamper progress in 
laboratory animal research. Journal editors and, to some extent, funders need to 
address this. This presents a relatively shortterm and efficient way to improve 
progress in both of the fields studied here and in science more generally as it will 
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prevent unnecessary duplication of studies and use of animals, provide additional 
evidence to strengthen knowledge claims and enable better estimation of the potential 
for novel therapies in clinical trials. The paper by ter Riet 	.(2012) provides some 
useful suggestions for overcoming this problem, which editors, funders and scientists 
should investigate and consider implementing, such as developing a registration 
system for all animal experiments similar to that for clinical trials. This would be 
difficult due to the need to ensure security and minimise bureaucracy but they argue 
modern information technology should help. Indeed, Holliman (2011b) notes that 
‘<	 	   	
 	0 0 $  	$ $
		’ (p. 839). A second idea is to submit manuscripts without any results 
initially so that acceptance is not reliant on them and the value of the work can be 
judged on the other aspects of the manuscript. However, this would require consensus 
within the scientific community in order for peerreviewers to be willing to work in 
this way. Alternatively or additionally, there could be more dedicated journals similar 
to the N	$"	 2, and dedicated journal sections or 
repositories for negative results. 
 
The dichotomy of novelty is a problem in terms of publication and this has been 
recognised in part by the Government who note ‘    
$	  	 	  8 	  1$  	 	
3	 3  1 	%    	 K		L 
’ (Home Office 	.2014, p.17). They suggest that this is being ameliorated by 
the widespread adoption of the ARRIVE guidelines by a significant portion of 
international journals. While I agree that this is helpful, further work needs to be done 
to address the problems associated with peerreview, reputation and core sets etc. that 
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are noted in this study. This may involve guidelines for peerreviewers, paid reviewers 
or an element of continued professional development training for scientists for 
example. Researchers and journal editors should work together to devise additional 
ways to address this issue. 
 
Many of the observations and recommendations made in this project will require 
scientists to improve their scientific communication skills particularly in terms of 
public engagement. This could be problematic as it has been shown that scientists are 
concerned that they will not receive professional recognition for undertaking public 
engagement. For example, Stilgoe and Wilsdon (2009) note that ‘<		  	
  	 		  0   	  8 %	


		
  	0 3 	333
 	
		$

’ (p.23). As noted above, scientists willingness to engage 
can be driven by funders, but the Government can also influence this. Rodgers
Haydon and Pidgeon (2007) note that sectors of the Government, as well as civil 
society groups and science policy communities, are increasingly supporting early 
public engagement to consider technology, and any potential social or ethical issues 
before significant research decisions are made. In the context of this thesis this is 
particularly pertinent as they argue that early public engagement can avoid 
polarization of opinion. This would seem to be a reasonable and effective approach 
for Government and scientists to take in this case. 
 
Although this thesis provides support for increased public engagement, there is a 
broad range of existing literature which indicates that, for some areas of research as 
noted above, scientists will need to be cautious of the impact this could have on 
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policy. Wellestablished techniques such as consensus conferences (Einsiedel 	 . 
2001) may need to be employed to ensure there are no unnecessary negative 
consequences. 
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As described above, it is envisaged that Three Rs organisations such as FRAME and 
the NC3Rs, as well as scientific societies such as the Society of Biology and 
professional bodies such as the Institute of Biomedical Science will play a pivotal role 
in developing, implementing and disseminating the recommendations made as a result 
of this project. Societies and professional bodies have the infrastructure to disseminate 
best practice widely to their members within the scientific community, so are well 
placed to encourage more emphasis on alternatives and the recommendations in this 
thesis, particularly those around public engagement and science communication. For 
example, on its website, the Society of Biology describes itself as ‘  
$3
:$=$	
M$	
  $	M 	  30   
3			9(Society of Biology 2015). Similarly, 
the Institute of Biomedical Science (IBMS) has among its principal aims ‘setting 
standards of behaviour for its members, educating its members and promoting 
biomedical science to the public’ (IBMS 2013). 
 
In addition to the funding opportunities that Three Rs organisations can provide, they 
will also play a key role in facilitating collaboration, educating scientists about 
alternatives and disseminating and directly developing the recommendations made in 
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this thesis. I have noted some of the collaborations that the NC3Rs have already 
facilitated and its 2013 annual report provides more details about these (NC3Rs 2013). 
It could build on the proposals in the Governments delivery plan to help foster the 
collaborations recommended for PD and schistosomiasis in this project. 
 
Education initiatives such as the FRAME Training Schools (Howard 	. 2009) and 
the RSPCA’s international training events and work with AWERBs (RSPCA 2014) 
could also provide a platform for bringing scientists together to discuss the issues 
raised by this research and facilitate changes in scientific practice. 
 
As outlined in Chapter 1 ‘Phasing Out’ primate use or the ‘Zero Option’ as it was 
termed when first conceived (Balls 1995) has been suggested on several occasions as 
a means to move towards replacing primates in biomedical research. However, the 
limited proposals for how to achieve it have never been adopted into practice or 
meaningfully pursued by scientists. By viewing the impasse through the lens of social 
dynamics I can more accurately and sensitively suggest how the phasing out process 
could occur. Therefore, a further step could be to use the recommendations made here 
as the basis for a ‘phasing out’ strategy with further practical actions regarding the 
scientific reasoning to implement it. This will require support from those 
organisations and societies who can help to validate and refine any such strategies 
through their links with the scientific community, regulators and other interested 
stakeholders. 
 
While reducing or even completely replacing primates in some instances, the 
recommendations arising from this project will undoubtedly lead to increases in the 
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use of other animals such as livestock and rodents in these two fields of research. This 
is not without ethical or scientific problems and, in the same way that the validity of 
the primate models should be examined, so should these other models. While, 
generally, it is accepted within the scientific community (of these two fields at least) 
and to some extent by the public (Ormandy and Schuppli 2014) that it is more 
acceptable to use ‘lower’ or ‘food’ animals for research, it is questionable whether this 
is ethically preferable to using primates (which was noted by one participant). The 
scientific case also needs to be examined. Examining the consequences of alternatives 
could be greatly facilitated or even conducted directly by Three Rs organisations 
given their history of engagement with scientists as well as their experience and 
expertise in a wide variety of related factors such as, biomedicine, toxicology, ethics, 
animal welfare and alternative nonanimal approaches. Indeed, there is precedence 
such as the recent FRAME/BUAV report on the use of dogs in pharmaceutical 
research and development (Bailey 	 . 2013) and the NC3Rs ongoing work on 
mammalian models of epilepsy (NC3Rs 2015b). 
 
The successful implementation of the recommendations outlined in this chapter 
through the parties and policies detailed above is reliant on the effective dissemination 
of the proposals. This study has highlighted many of the difficulties of communicating 
novel findings, but the solutions that it has also revealed in terms of public 
engagement and publication will be applicable. Taking this into consideration the 
intention is to publish the recommendations in this thesis via the traditional route of 
peerreviewed journal and conference presentation, aiming at those relevant to the two 
fields of research initially. In addition, my position at FRAME will enable me to 
utilise the findings from this project regarding effective science communication to 
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publicise the recommendations more widely through various outlets such as, news 
media, social media and direct engagement with many of the parties highlighted in 
this chapter. 
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As outlined in Chapters 1 and 2 the multimethod design of this project is somewhat 
unusual in this particular area of research into the animal experimentation debate. 
However, it has enabled the successful elucidation of the nonscientific dimensions 
which drive the continued impasse in replacing primate studies and given a practical 
means by which to understand and explore how to overcome it. The resulting analysis 
and recommendations are more indepth than would have been possible if the focus 
had been on one particular phase of this study or with a single methodology. 
Reflections on taking this multimethod, STS informed approach and the resulting 
nature of the findings are discussed in this section. 
 
When approaching a qualitative study involving direct access to scientists this 
investigation has shown there is great benefit in having some prior experience with 
scientific practices and conducting a literature review of the research areas of the 
target population. It provides a knowledge base which helps to make the interviews 
successful, as it gives the interviewer an appreciation of the context and an 
understanding of the vocabulary which improves the rapport and flexibility. 
 
I felt that having a personal association with the topic, appreciation of the field and at 
least a basic understanding of the scientific aspects of each case study was invaluable 
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in gaining access to and building a rapport with the scientific participants. Although 
my role at FRAME might have been problematic in terms of the participants being 
reticent to give full and honest answers I found the opposite to be true. I believe that 
this was in part due to me showing an appreciation for the safety concerns of 
participants, and FRAME’s reputation as a nonthreatening scientific organisation with 
long standing associations in academia and industry. Having a scientific background 
but approaching this project as a social scientists gave me as an analyst a different 
perspective of  what the scientists views meant for scientific practice and perhaps a 
better understanding of the challenges and opportunities discussed in the interviews 
than perhaps I would have as purely a social science researcher. 
 
Collecting data in a semiinductive way and using multiple methods, namely 
documentary analysis, literature review and  a multiplecase study comparing semi
structured interviews gave the project the flexibility and roundness to identify 
important aspects that might not otherwise have been revealed. For example, if from 
the outset the data had been analysed with preconceived theoretical categories then the 
impact that social dynamic such as entrenchment and ethics were having could have 
been missed. If different cases had not been compared then the interplay between 
different social dynamics may not have been clear, which would have made 
constructing the recommendations for how to overcome the impasses more difficult 
and may even have meant that the possibility for doing so was not supported. 
 
In her discussion of the use of qualitative methods within health psychology, Yardley 
(2007) proposes four characteristics for assessing the validity of qualitative analysis: 
sensitivity to context; commitment and rigour; transparency and coherence; and 
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impact and importance, which make a useful reference point from which to summarise 
these reflections on the design and analysis of this study. In terms of context my role 
at FRAME and my scientific background gave me a broader view of the topic in 
which to place the findings and asses their impact and meaning. My commitment to 
the topic comes from my previous experience with the debate and exploring the views 
of scientists enabled me to become immersed in new information and to develop new 
methodological skills. The multimethod approach provided rigour as it resulted in 
rich data, and the thematic analysis of full transcripts gave plentiful information to 
address the research questions. Tackling the research in phases using appropriate 
methods gave coherence. Meanwhile, giving a detailed account of the methodological 
design and process as well as thick descriptions, including examples of contradictory 
or unexpected findings, was done to increase the transparency. Finally, in terms of 
impact this project set out to give a novel and challenging perspective to the primate 
debate to open up new ways to understand the topic. It has resulted in important 
recommendations that have practical implications for primate researchers and related 
stakeholders to enable a culture change to overcome the deadlock in replacing primate 
experiments. 
 
As with all research projects there are limitations and the next section aims to suggest 
how some of these might be overcome in future work. 
5.7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Throughout this thesis, areas for further research have been identified and attempts 
made to note the limitations of the work undertaken. The purpose of this section is to 
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draw all of these together to suggest how the findings from this project could be 
strengthened further, how their applicability could be broadened and how they might 
be used as a basis to enrich current STS knowledge. 
 
	@!!*)#"%)"%**)!&
 
While this thesis outlines how it might be possible to overcome the impasse on 
primate use in these two specific cases, the broader applicability of these findings to 
all primate research is less certain due to the complex and specialised nuances of each 
field of research. However, examining the debate through a social dynamics of 
science lens indicates that there are many common factors related to the impasse that 
should be applicable to other areas, or at least provide an analytical starting point from 
which to examine them within Europe. Therefore, to check the wider relevance of the 
findings in this study an investigation of related fields such as Alzheimer’s disease 
and malaria could be conducted to determine whether this is the case. This could then 
be broadened out to other diseases such as, HIV/AIDs. It would be important to look 
at other countries such as the US and China to identify if differences in legislation, 
culture and/or attitudes towards animals impact on the effects of the social dynamics 
of science highlighted in this study and, thus, the recommendations needed to 
overcome the impasse. 
 
The approach taken in this study of speaking to scientists, rather than other 
stakeholders and/or the public, gave the perspectives of those intimately involved in 
the impasse, resulting in a richer understanding of the scientific and social aspects of 
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the debate. However, the findings regarding ‘others’ indicate that this could be 
limiting in terms of thoroughly evaluating how effective the recommendations to 
overcome the impasse can be. Therefore, to ensure the recommendations are as robust 
as possible it would be useful to investigate the views of some of these key parties 
such as funding agencies, journalists and journal editors. For example, as a next step it 
would be very useful to conduct interviews with regulators/policy makers to get their 
views on dilemmas they face in developing the related policy, and on what is true and 
perceived in terms of current legislation and willingness to consult with others. 
Another interesting aspect to investigate would be the medialization of science by 
comparing news coverage of PD, schistosomiasis and perhaps other fields to see what 
impact it is having on the ‘scientific institution’ and whether it will become a more 
significant factor in overcoming or even exacerbating the impasse. 
 
While the advantages and disadvantages of the adopted methodology are discussed in 
Chapter 2, it is perhaps useful to reflect that given the nature of the problem under 
study, another productive way of investigating the primate impasse could be using 
action research methodology. Jenson and Holliman (2009) note that this methodology 
is based on the dual aim of: 
i. Increasing knowledge or understanding about a particular field or practice  
ii. Acting on the basis of that newly produced knowledge to effect positive 
change within this field 
This approach could be extremely useful for examining how to implement the 
recommendations or even refine them, incorporating more of the identified 
stakeholders than the present study does. 
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While this study generated many findings related to expectations and their role in the 
debate, the time constraints associated with a PhD project and the scope of this 
particular investigation prevented further investigation into the relationship between 
bioethics and expectations. Looking at this in more depth, perhaps via AWERBs 
and/or interviews with bioethicists could give an even deeper understanding of the 
impasse and why it persists. Another ethical aspect which deserves more attention is 
the movement of research abroad to countries and laboratories with levels of welfare 
and scientific practices that are of concern to the scientific community in the UK in 
particular. Reviewing to what extent this is occurring and deciding how to combat it 
would provide a timely project that could inform the Government’s efforts in this 
area. 
 
Finally, this thesis presents recommendations for changes in scientific practice and 
policy with regards to replacing primate experiments and identifies the main 
stakeholders that will be involved in implementing those recommendations. Further 
work is required to operationalise the recommendations and mobilise the stakeholders 
to effect the changes necessary. This could involve prioritising the recommendations 
in order to maximise their effectiveness. One way to do this would be to return to the 
case study participants and ask for their views on which recommendations could or 
should be tackled first. Conducting focus groups involving several of the stakeholders 
could also be a practical way to do this. It will also be necessary to give further 
consideration to identifying who among the stakeholders are the leaders and key 
agents of change and to develop mechanisms to incentivise them to adopt the 
recommendations and participate in the necessary actions to gain widespread 
acceptance and implementation of the proposals. In this context it might be useful to 
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explore the recommendations using Michael’s (2009) concept of Publics in General 
(PiGs) and Publics in Particular (PiPs), which examines the complexity of how 
different stakeholder groups might emerge over time and indicates that implementing 
engagement with these ‘publics’ may require different approaches. For example, in 
the context of the present research the PiGs strategy might require a sophisticated 
science communication scheme to inform more broadly about the primate debate or 
alternatives research. Whereas the PiPs strategy may need to involve a more targeted 
engagement approach with particular publics, for example patient groups or 
regulators, for particular purposes such as identifying key research aims or changing 
funding priorities. 
 
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Chapter 6 describes in detail where this study has revealed areas of interest to STS 
scholars and discusses how the present study is placed within the context of current 
thinking/literature. This section highlights the areas which have particularly 
significant or interesting consequences for existing STS practice and understanding, 
and suggests future research avenues. 
 
The role of competition in science has been largely neglected by academics in recent 
years. Further research should be done to address the relevance of the established 
functions of competition in science, to examine if changes in scientific practice have 
altered them or whether they can still be applied to science or explain how it is done. 
Additionally, work should be done on the influence of the clinical setting and patient 
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groups on competition, as competition may no longer be driving how scientists 
conduct research in this setting, but instead the clinic may be reducing competition. 
 
An aspect that would greatly help with understanding the ‘scientific institution’, 
particularly the primate impasse, would be to investigate further why scientists are 
willing to talk about limitations of research but will not publish them, and if this is a 
symptom of the current scientific reward system. 
 
In terms of the theory of expectations, this project has indicated that some of the 
established thinking may need to be adapted and further work will need to be done to 
determine if this is the case. For example, looking at the role of hype; is it more 
positive than negative or becoming increasingly so, as demand for more public 
engagement increase? There needs to be a more nuanced approach to sickness 
narratives to determine if they are particularly important for certain classes of disease 
and if their role is influenced by outside factors such as organised patient interest. 
 
Finally, this project has methodological implications. It shows that it is possible to 
work with scientists in controversial areas, and that interviews provide rich data that 
cannot be found in any traditional literature, but that have significant implications for 
understanding science and controversies within it. It illustrates that, when looking at 
the social dynamics of science, there are casebycase factors that make sweeping 
inferences about the doing and understanding of science problematic. The analysis 
shows that combining social dynamics of science such as expectations and core sets, 
is a productive approach for understanding scientific practices and contentious 
scientific research. Therefore, it is recommend that more indepth interdisciplinary 
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studies of this nature are conducted when investigating controversial areas of science 
and that more focus be placed on how they might be overcome as well as the more 
common discussion of why they exist. 
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The animal experimentation debate and, in particular, the polarisation arising around 
the use of primates in scientific research has persisted for decades. Using an unusual 
multimethod approach, this project has identified the arguments involved, explained 
the differences in the justifications given between different fields of research and 
different specialists within those fields and, importantly, identified that the social 
dynamics of science are essential to explaining the continued impasse in the primate 
debate and how to overcome it. This led to the conclusion that, in certain 
circumstances, the impasse can be overcome. This thesis offers constructive 
recommendations for how this might be achieved, involving improved collaboration 
and communication, increasing flexibility in scientific practices and by addressing 
ethical considerations surrounding experimental models. Implementing these 
recommendations involves various stakeholders and has important consequences for 
primate and alternatives research practices, and science communication. The 
conclusions of the study have implications for sociological thinking regarding 
scientific controversy, including the need to increase attention on competition, 
combine expectation and ‘core set’ theory, and highlight the applicability of the 
entrenchment concept to scientific practice. This is just the beginning of what will be 
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an interesting and important journey for those involved in the primate experimentation 
debate. 
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1. What is your position within the department/facility? 
2. How long have you worked on schistosomiasis? 
3. Which models/methods have you used in that time? 
4. What made you decide to work in this area? 
5. Is this something that you see yourself continuing to work on for the foreseeable 
future?  
6. Was the primary focus of the research to develop a vaccine? If not, could it have 
consequences for vaccine development? 

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1. Is the development of a schistosomiasis vaccine feasible and how long do you 
think it will take from now? 
2. What are your main reasons for using [animals/in vitro models/human studies]?  
3. Do you find that you emphasise these reasons in grant applications and/or when 
publishing the work?  
4. What do you consider to be your own most important findings towards the 
development of an effective vaccine? Which models did this involve?  
5. How do you personally measure/judge the success of your work?  



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1. There seem to be three main vaccine strategies: a) the attenuated vaccine model, 
b) the self cure model and c) naturally occurring infection in wild pops. What are 
your thoughts on these in terms of their relevance and likelihood of being 
successful for identifying and developing an effective human schistosomiasis 
vaccine? 
2. How likely do you think it is that knowledge from animal models will ever 
translate into an effective human vaccine?  
3. Of the animal models utilised in this field, which do you feel are the most relevant 
to the human condition? 
4. Considering the nonanimal models (human studies/ $	/omics), what impact 
do you believe they have had on the development of a vaccine and how important 
do you think they will be in the future? 
5. What do you see as the limitations of the model(s) you have used and what further 
developments do you see on the horizon? 
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1. Biomedical research is sometimes seen as morally challenging.  How do you think 
scientists generally deal with this? 
2. Are there any models or methods that you would personally not use for your 
research and why? 
3. When you read papers or listen to presentations at conferences, what are the things 
that tend to lead you to trust what is being said?  
4. In your opinion what factors help a scientist to gain a professional reputation 
within this field? What influence can these have on the field in general? 
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5. How important is the public’s perception of your work to you personally and to 
the field in general? 
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1. Is there anything that would or has ever led you to change the emphasis of your 
work or the models that you use? (This question was removed after the first couple 
of interviews as participants found it confusing) 
2. In your experience do previous findings in the field shape how you decide to 
conduct your research and if so in what ways?  
3. Have you ever experienced any difficulties with disseminating or gaining 
acceptance of your work and were you able to overcome these? 
4. Workshops/working groups with invited participants/members have been used to 
encourage dialogue between those holding different viewpoints within a field in 
order to determine the best ways forward. What are your thoughts on the types of 
outcomes that might result from these meetings and if you were invited to 
participate, what would your reaction be?  
5. Say you were asked to report on how best to move the field of schistosomiasis 
nearer to its vaccine goal and that stakeholders needed to be involved how would 
you approach the task?  

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1. It seems that unlike in other fields of research, with schistosomiasis investigators 
tend to work with a range of species and models. Do you have any ideas as to why 
this is? 
Page | 350  
 
2. In your opinion to what extent is the development of a schistosomiasis vaccine 
possible without using primates?  
3. a)    Theoretically if primate use was banned tomorrow could your work continue 
via other means of enquiry 
b) Thinking about colleagues who use primates, if primate use was banned 
tomorrow could their work proceed via other means of enquiry?  
4. Some people have suggested that it might be better to develop a tiered strategy to 
minimise primate use in schistosomiasis vaccine research. For example, using 
alternative models for basic research and initial development of vaccines then only 
using primates for the safety testing if this is deemed necessary. How feasible do 
you think this is? 
5. What existing models could be utilised for this and what methods would need to 
be developed or improved? 
6. If someone at the EU decided to act on the calls for primate use to be gradually 
phased out and appropriate legislation to that effect was put in place, how long 
would be needed to remove the need for primates in your particular research and 
in the field in general? 
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1. What is your position within the department/facility? 
2. How long have you worked on Parkinson’s disease? 
3. What made you decide to work in this area? 
4. Which models/methods have you used in that time? 
5. Is this something that you see yourself continuing to work on for the foreseeable 
future?  

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1. What are your main reasons for using [animals/in vitro models/human studies]?  
2. Do you find that you emphasise these reasons in grant applications and/or when 
publishing the work?  
3. What do you consider to be your own most important findings towards the 
development of an effective treatment? Which models did this involve?  
4. How do you personally measure/judge the success of your work?  
5. How far away do you think a completely effective treatment/cure is? 
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1. There seem to be 2 main strategies: Surgical approaches such as DBS and neural 
transplant and chemical, either systemic of targeted, would you agree?  
2. Which approach do you believe will be the most effective? 
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3. What do you think is the key piece of knowledge that has been gained from the 
animal models of PD? 
4. Of the animal models utilised in this field, which do you feel are the most relevant 
to the human condition? 
5. What do you see as the limitations of the model(s) you have used and what further 
developments do you see on the horizon?  
6. Considering the nonanimal models (human studies/ $	/omics), what impact 
do you believe they have had on the development of treatments and understanding 
of PD and how important do you think they will be in the future? 
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1. Biomedical research is sometimes seen as morally challenging.  How do you think 
scientists generally deal with this? 
2. Are there any models or methods that you would personally not use for your 
research and why? 
3. When you read papers or listen to presentations at conferences, what are the things 
that tend to lead you to trust what is being said?  
4. What factors help a scientist to gain a professional reputation within this field? 
What influence can these have on the field in general? 
5. How important is the public’s perception of your work to you personally  and to 
the field in general? 
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1. Do previous findings in the field shape how you personally decide to conduct your 
research and if so in what ways?  
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2. Have you ever experienced any difficulties with disseminating or gaining 
acceptance of your work and were you able to overcome these? 
3. How effective do you think workshops/working groups with invited 
participants/members are at encouraging dialogue to determine the best ways 
forward in a field?  
4. Have you or would you participate in such events? 
5. Say you were asked to report on how best to move the field of PD treatment 
forward and that stakeholders needed to be involved how would you approach the 
task?  

 .3?# *)!#'%*% )!*&)#"%()!#
1. To what extent is the development of a treatment or cure for PD possible without 
using primates?  
2. a)    Theoretically if primate use was banned tomorrow could your work continue 
via other means of enquiry 
b) Thinking about colleagues who use primates, if primate use was banned 
tomorrow could their work proceed via other means of enquiry?  
3. What existing models could be utilised for this and what methods would need to 
be developed or improved?  
4. If phasing out primates became law in the EU what time frame would be needed to 
make the necessary developments to remove the need for primates in your 
particular research and in PD in general? 
5. As well as the possibility of legislation do you see any other pressures that are or 
might force the replacement or reduction of primate use in PD research? (e.g. 
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financial, public perception, availability of animals, new technological 
developments) 
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1. Increase the amount of collaboration initially within the field and then externally 
by: 
a. Improving the disease profile 
b. Increasing engagement with schistosomiasis patients possibly by 
establishing patient groups 
c. Increasing nonprimate users reputations 
d. Addressing the conflict surrounding the research aims 
e. Using available resources cooperatively 
2. Reduce the dominance of the core group by: 
a. Constructing expectations about alternatives based on their health benefits 
b. Increasing public engagement 
c. Increasing engagement with media outlets and utilising hype 
d. Publishing negative data 
3. Overcome the entrenchment of primate models by: 
a. Implementing flexibility strategies 
b. Engaging with funders 
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c. Engaging with policy makers 
4. Address the ethical considerations of experimental model choice by: 
a. Increasing sociological sophistication of nonprimate using scientists 
b. Exploring the moral capacities and ethical considerations of experimental 
models explicitly 
c. Strengthen the scientific rational for nonprimate alternatives 
d. Engage with funders and patient groups 
e. Developing a dialogue with regulators 
f. Engaging with various parties to identify ways to ensure ethical, welfare 
and scientific rigor in countries outside UK and Europe 
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1. Continue, but expand collaboration by including increased numbers of: 
a. Different primate users cooperating with each other and with nonprimate 
users 
b. Interdisciplinary collaborations including across institutions 
2. Prevent the establishment of a core group of primate users by: 
a. Continuing public engagement and increasing it for nonprimate users 
b. Nonprimate users constructing more expectations about the health 
benefits of their research 
c. Increasing engagement with media outlets but being cautious about over 
hyping the research 
d. Publishing negative data 
3. Maintain and enhance the flexibility by: 
a. Conducting further studies on alternatives 
b. Increasing dissemination of nonprimate findings 
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c. Maintain and increase collaboration 
d. Engage with policy makers 
4. Build on existing ethical consideration given to experimental models and utilise 
ethical boundaries by: 
a. Explicitly exploring the ethical considerations and moral capacities for 
experimental models 
b. Continuing to strengthen the scientific rationale for nonprimate 
alternatives 
c. Engaging with funders, particularly Parkinson’s UK 
d. Developing a dialogue with regulators to address movement of research 
abroad 
e. Engaging with various parties to identify ways to ensure ethical, welfare 
and scientific rigor in countries outside UK and Europe 

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